{"meta":{"query_hash":"13e8c2465994","filters":{"venue":"Cancer Immunology Research"},"cohort_total":359,"direct_labels_cover":0,"predictions_cover":359,"exported":359,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/13e8c2465994","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Immunology+Research"},"results":[{"id":"W2084785039","doi":"10.1158/2326-6066.cir-14-0177","title":"Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Huazhong University of Science and Technology","keywords":"Antigen; Immunotherapy; Dendritic cell; Immune system; Cancer research; Immunology; DNA vaccination; T cell; Innate immune system; Antigen presentation; Biology; Immunization","score_opus":0.0358350077736466,"score_gpt":0.328043116793005,"score_spread":0.2922081090193584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084785039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863143,0.0026558263,0.007739104,0.00022036552,0.000093777875,0.00006456745,0.0001777856,0.00013673778,0.0025974778],"genre_scores_gemma":[0.9941795,0.00084195135,0.0031640257,0.00006309115,0.000029919933,0.000029003844,0.000102161226,0.000010775255,0.0015796429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999925,0.000015859327,0.000005579766,0.000013231819,0.000020380567,0.000019841731],"domain_scores_gemma":[0.999948,0.000013306482,0.000015948799,0.0000050880085,0.0000049465025,0.000012694253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007103492,0.00029762514,0.00014123792,0.00016038913,0.00006364867,0.00020542917,0.00007794748,0.00024589407,0.0009905697],"category_scores_gemma":[0.00008322505,0.00007746663,0.00022268646,0.00007660969,0.00013363047,0.00019069403,0.000180986,0.0004167582,0.0003026339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008484854,0.000028028391,0.000114093455,0.000043776574,0.000003394799,0.000043993954,0.000008862896,0.00012313454,0.99592054,0.00015947365,0.00006750016,0.003402288],"study_design_scores_gemma":[0.000025222957,0.0003318024,0.00093057303,0.000006683928,0.000013282313,0.00011997048,0.000013883433,0.0016455034,0.9946122,0.0001711202,0.002126771,0.0000029161208],"about_ca_topic_score_codex":0.00008533706,"about_ca_topic_score_gemma":0.00015596897,"teacher_disagreement_score":0.0009905697,"about_ca_system_score_codex":0.00021042091,"about_ca_system_score_gemma":0.00017086366,"threshold_uncertainty_score":0.0033137798},"labels":[],"label_agreement":null},{"id":"W2101338052","doi":"10.1158/2326-6066.cir-14-0113","title":"B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canada Research Chairs","keywords":"Immune system; Cancer research; Downregulation and upregulation; Biology; Tumor microenvironment; Carcinogenesis; Cancer immunotherapy; Cancer; Immunity; Immunology; Acquired immune system; MHC class I; Immunotherapy; Major histocompatibility complex; Gene; Genetics","score_opus":0.03392099231862885,"score_gpt":0.3403574733914932,"score_spread":0.30643648107286436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101338052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535406,0.001596609,0.000767256,0.000060548966,0.00001715652,0.000016095602,0.000053407784,0.000038829618,0.0020959915],"genre_scores_gemma":[0.99659216,0.0005561545,0.00064056256,0.00003082382,0.000022704726,0.00002040124,0.00013899342,0.0000090946705,0.001989141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986494,0.000033000728,0.000006603608,0.000015589896,0.00003148345,0.000048386784],"domain_scores_gemma":[0.99990284,0.000016169113,0.000019440722,0.000011264203,0.00001267742,0.000037679452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009901903,0.00019244848,0.00019323011,0.00036926987,0.00014162347,0.00027907148,0.000113229944,0.0002286987,0.0022553822],"category_scores_gemma":[0.00008842274,0.00011057543,0.00016534553,0.00009549101,0.00016791144,0.00015126288,0.00024523874,0.00042145033,0.0004891411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019715754,0.00005118842,0.0013993268,0.000025566753,0.000006207397,0.00013043279,0.000011766119,0.000042529064,0.99532473,0.00011395856,0.00006385635,0.0026332762],"study_design_scores_gemma":[0.000059896058,0.0010214084,0.030914526,0.000018842045,0.000051705374,0.0009698601,0.00017384355,0.0012684368,0.95899034,0.00027440712,0.006250146,0.0000066882344],"about_ca_topic_score_codex":0.00020603216,"about_ca_topic_score_gemma":0.00026052576,"teacher_disagreement_score":0.0022553822,"about_ca_system_score_codex":0.0001794128,"about_ca_system_score_gemma":0.00015271343,"threshold_uncertainty_score":0.0075449944},"labels":[],"label_agreement":null},{"id":"W2102986151","doi":"10.1158/2326-6066.cir-13-0155","title":"CD4 T Cells Require ICOS-Mediated PI3K Signaling to Increase T-Bet Expression in the Setting of Anti-CTLA-4 Therapy","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"CTLA-4; Immunotherapy; Medicine; Cancer research; Immunology; Cell biology; T cell; Immune system; Biology","score_opus":0.0604348810993394,"score_gpt":0.37876869473358404,"score_spread":0.3183338136342446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102986151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336916,0.0015449552,0.0019441661,0.00013962746,0.000026853273,0.000035722493,0.0000778116,0.00006131483,0.0028003152],"genre_scores_gemma":[0.99809474,0.00037852104,0.0005964694,0.000076186065,0.000016608532,0.00002801689,0.00011066078,0.00000497353,0.0006938107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998574,0.00001973925,0.000011833034,0.000027224867,0.000029394514,0.000054307715],"domain_scores_gemma":[0.9999287,0.000008380295,0.000029654477,0.000007989337,0.000006032451,0.000019189547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013572784,0.00022739216,0.00021477528,0.00016293312,0.00013241482,0.00035150597,0.00015012585,0.00026833953,0.0008514646],"category_scores_gemma":[0.00012764033,0.00009770357,0.00015934616,0.00012523,0.00023828143,0.00018374989,0.00015949772,0.0005908993,0.00021234811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070093275,0.0001896505,0.007637498,0.000107382286,0.000018170653,0.00066841376,0.000045810062,0.00038228024,0.97713053,0.00069882657,0.00025029405,0.012170365],"study_design_scores_gemma":[0.00019500783,0.0022555892,0.046790175,0.000038937378,0.00016447651,0.005843758,0.00016917111,0.0045782374,0.9261614,0.0010235175,0.012767222,0.000012441907],"about_ca_topic_score_codex":0.00018063997,"about_ca_topic_score_gemma":0.00020623677,"teacher_disagreement_score":0.0008514646,"about_ca_system_score_codex":0.00030647297,"about_ca_system_score_gemma":0.00019432134,"threshold_uncertainty_score":0.0028483868},"labels":[],"label_agreement":null},{"id":"W2108895019","doi":"10.1158/2326-6066.cir-15-0017","title":"Neutrophils Increase Oral Squamous Cell Carcinoma Invasion through an Invadopodia-Dependent Pathway","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Invadopodia; Paracrine signalling; Gentamicin protection assay; Cancer research; Cell culture; In vitro; Cancer cell; Cancer; Immunology; Medicine; Biology; Metastasis; Internal medicine; Receptor","score_opus":0.12205516892000047,"score_gpt":0.3560395586847223,"score_spread":0.23398438976472186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108895019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933708,0.004071324,0.00086098735,0.0001355793,0.000022158203,0.00004928654,0.00017587835,0.000025562791,0.0012884141],"genre_scores_gemma":[0.9936686,0.0029911518,0.0011770993,0.000061539846,0.000016987184,0.00004901179,0.00022977007,0.000003738517,0.0018021226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982125,0.000055906625,0.000015315945,0.000016251393,0.00004765135,0.000043587814],"domain_scores_gemma":[0.9999186,0.000016180413,0.000024302371,0.000006606949,0.0000143302805,0.000019998633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014056561,0.0003201612,0.00022105464,0.00023287658,0.00012044538,0.00024528877,0.00007715803,0.00015750669,0.0016943549],"category_scores_gemma":[0.00013174555,0.00009966309,0.0002649073,0.00011124543,0.00012799098,0.00018796546,0.0002512723,0.0004240517,0.00020977606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044899312,0.00014993931,0.0037101419,0.0001760064,0.000016073787,0.00022500893,0.000057304846,0.000052446103,0.98837215,0.00007832778,0.00014526963,0.006568395],"study_design_scores_gemma":[0.00012778662,0.00366778,0.15435545,0.00007247671,0.00012386462,0.0011848508,0.00048763407,0.0014847809,0.8298252,0.00017315356,0.00847974,0.00001723776],"about_ca_topic_score_codex":0.00044457676,"about_ca_topic_score_gemma":0.0010171938,"teacher_disagreement_score":0.0016943549,"about_ca_system_score_codex":0.00013733369,"about_ca_system_score_gemma":0.00020931155,"threshold_uncertainty_score":0.0056681633},"labels":[],"label_agreement":null},{"id":"W2110660168","doi":"10.1158/2326-6066.cir-14-0239","title":"PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CD8; Biology; Tumor microenvironment; Cancer research; Ovarian cancer; Cytotoxic T cell; Flow cytometry; Antigen; Tumor-infiltrating lymphocytes; Immunology; Immune system; Cancer; In vitro","score_opus":0.11156452962012832,"score_gpt":0.40350539865578133,"score_spread":0.29194086903565303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110660168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875486,0.0005255063,0.0000946793,0.000011864504,0.0000032082971,0.0000039893757,0.00012390623,0.000006892208,0.0004750271],"genre_scores_gemma":[0.9994797,0.000107944456,0.000050797582,0.00000643455,0.000003633216,0.0000044696476,0.0001575488,0.0000016034071,0.00018793486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999099,0.000010932032,0.000009183009,0.00002458436,0.000021948472,0.00002354584],"domain_scores_gemma":[0.9998497,0.00002756725,0.000047482907,0.000019024243,0.000026179023,0.000030100391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007910628,0.00007470361,0.0002112028,0.00040203254,0.00020062906,0.00038498474,0.000073532276,0.0001681529,0.0011468076],"category_scores_gemma":[0.00040237894,0.00011584388,0.000084637824,0.00047273882,0.000108116554,0.00016519897,0.00018293175,0.00016184768,0.00021350144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014196411,0.000057969097,0.8483099,0.000051822117,0.000047380952,0.00096295134,0.0003252688,0.00019337688,0.1269436,0.00009626057,0.0003806611,0.021211235],"study_design_scores_gemma":[0.000016029326,0.0001071216,0.9896828,0.0000052779315,0.000027610376,0.0020980653,0.00028204403,0.0004484627,0.0058539007,0.00009636509,0.0013768624,0.000005378299],"about_ca_topic_score_codex":0.0008250492,"about_ca_topic_score_gemma":0.000873965,"teacher_disagreement_score":0.0011468076,"about_ca_system_score_codex":0.00016410064,"about_ca_system_score_gemma":0.00008930538,"threshold_uncertainty_score":0.0038363934},"labels":[],"label_agreement":null},{"id":"W2115490568","doi":"10.1158/2326-6066.cir-14-0236-t","title":"Mass Cytometry Analysis Shows That a Novel Memory Phenotype B Cell Is Expanded in Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute","keywords":"Immunoglobulin D; Population; Immunology; Biology; Multiple myeloma; Peripheral blood mononuclear cell; Antibody; Memory B cell; Mass cytometry; Flow cytometry; B cell; Cancer; CD19; Cancer research; Phenotype; Medicine; Genetics; Gene; In vitro","score_opus":0.11130535440587887,"score_gpt":0.3444086314343332,"score_spread":0.23310327702845435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115490568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938646,0.0010052384,0.003588139,0.000042395295,0.000008013553,0.000016930848,0.00017748734,0.00009886443,0.0011983075],"genre_scores_gemma":[0.99683446,0.0002504966,0.0019854896,0.000029161536,0.000014328924,0.00001895555,0.00017267285,0.000009975241,0.00068452436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999094,0.0000073263936,0.0000067582655,0.000028378621,0.000028877303,0.000019189101],"domain_scores_gemma":[0.99990404,0.000025079427,0.000015902006,0.00001404587,0.000016425294,0.00002446867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018486263,0.00016133951,0.00018332375,0.0008237581,0.00018925886,0.00020752265,0.00014418711,0.00026302383,0.0020532932],"category_scores_gemma":[0.00019739721,0.000105807856,0.00014648282,0.00037798384,0.0001642509,0.00014504828,0.00019811375,0.00027551543,0.00045419575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014826354,0.000027622498,0.008711303,0.000020793128,0.000009777996,0.00014006834,0.00006684929,0.00006401107,0.98425204,0.00011684579,0.00007445382,0.0063680303],"study_design_scores_gemma":[0.000058843903,0.0011777427,0.45929468,0.0000218202,0.00008479925,0.0060851225,0.00017878764,0.0036150436,0.5228658,0.00090740505,0.005689513,0.000020527583],"about_ca_topic_score_codex":0.00049171085,"about_ca_topic_score_gemma":0.00044333554,"teacher_disagreement_score":0.0020532932,"about_ca_system_score_codex":0.00016384358,"about_ca_system_score_gemma":0.000076284916,"threshold_uncertainty_score":0.0068689585},"labels":[],"label_agreement":null},{"id":"W2123176392","doi":"10.1158/2326-6066.cir-14-0191","title":"Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada); Arbutus Biopharma (Canada); University of British Columbia","funders":"AstraZeneca","keywords":"Monoclonal antibody; Cancer research; CD80; Cancer immunotherapy; Antibody; T cell; Immunotherapy; In vivo; Cytotoxicity; PD-L1; Immune system; Chemistry; In vitro; Cytotoxic T cell; Pharmacology; Immunology; Biology; CD40; Biochemistry","score_opus":0.09984791139134354,"score_gpt":0.4369662327177876,"score_spread":0.3371183213264441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123176392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929215,0.004695539,0.010825498,0.00028682945,0.00003578296,0.00033671237,0.0010483713,0.0000973476,0.003381773],"genre_scores_gemma":[0.9782874,0.0034649754,0.010075012,0.00024099083,0.000048311143,0.00012573332,0.0040658815,0.000028421005,0.0036633313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998828,0.000018770692,0.000009631999,0.000018112883,0.000037972626,0.00003264796],"domain_scores_gemma":[0.9999058,0.000012955859,0.000017372804,0.000009762804,0.0000190315,0.000034961948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018833412,0.0005121847,0.00029735485,0.0004147004,0.000133122,0.00027992445,0.00031044145,0.00034705817,0.0010105883],"category_scores_gemma":[0.00019845026,0.00016745401,0.00039503383,0.00019369979,0.00013311769,0.00016627296,0.00016045781,0.0005038958,0.0006609783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017053631,0.00013282306,0.00044510077,0.000053909072,0.000013097331,0.00007582659,0.000017946613,0.0004332573,0.9911351,0.00013488294,0.00016820009,0.0072192266],"study_design_scores_gemma":[0.00016022494,0.0028370286,0.0059766523,0.000016547057,0.00007632567,0.0012835164,0.00001697308,0.0033926207,0.9696788,0.0001032768,0.016446771,0.000011275346],"about_ca_topic_score_codex":0.0004411354,"about_ca_topic_score_gemma":0.00038500145,"teacher_disagreement_score":0.0010105883,"about_ca_system_score_codex":0.00041125316,"about_ca_system_score_gemma":0.00028270116,"threshold_uncertainty_score":0.0033807755},"labels":[],"label_agreement":null},{"id":"W2124668663","doi":"10.1158/2326-6066.cir-14-0222","title":"Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Hospital for Sick Children","keywords":"T-cell receptor; Chemistry; Major histocompatibility complex; Antigen; T cell; Biology; Epitope; Molecular biology; Cell biology; Immunology; Immune system","score_opus":0.09014275203993506,"score_gpt":0.39063135939160626,"score_spread":0.3004886073516712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124668663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883003,0.0010605055,0.009025238,0.000046821937,0.000012810418,0.000040033727,0.00007456331,0.0000665658,0.0008434024],"genre_scores_gemma":[0.99458754,0.0008865087,0.0037741493,0.00003205906,0.000009159628,0.000029864521,0.000096457836,0.000017226943,0.00056694634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980944,0.000034284152,0.00001700153,0.000035576002,0.00005254304,0.00005108182],"domain_scores_gemma":[0.9998863,0.00002177373,0.00004634018,0.000011873685,0.000012364897,0.000021343201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019974721,0.0003426312,0.00022241977,0.0002006614,0.000084147476,0.00035569692,0.00016537958,0.00018936158,0.0006779924],"category_scores_gemma":[0.00013625587,0.000136835,0.00015271765,0.00017466703,0.00014312564,0.00020986189,0.00019029407,0.0005348626,0.00018917136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002626826,0.000019754674,0.000084420506,0.000013276481,0.0000021640874,0.000009107264,0.0000047591466,0.0002464494,0.99867296,0.000060455928,0.000007826269,0.0008525669],"study_design_scores_gemma":[0.00001954895,0.0004726526,0.0011583647,0.0000057008874,0.00003015801,0.00017497824,0.000016186894,0.002610822,0.9937649,0.00006043408,0.001680517,0.000005678071],"about_ca_topic_score_codex":0.00011031687,"about_ca_topic_score_gemma":0.00022528463,"teacher_disagreement_score":0.0006779924,"about_ca_system_score_codex":0.00019559803,"about_ca_system_score_gemma":0.00018166321,"threshold_uncertainty_score":0.0022681355},"labels":[],"label_agreement":null},{"id":"W2132290857","doi":"10.1158/2326-6066.cir-14-0215","title":"Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":468,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; York University; National Cancer Institute; National Heart, Lung, and Blood Institute; University of Pennsylvania","keywords":"Medicine; Pancreatic cancer; Immunotherapy; Immune checkpoint; Tumor microenvironment; Cancer research; Immunology; T cell; CTLA-4; Immunity; Immune system; Cancer; Internal medicine","score_opus":0.10303665455813443,"score_gpt":0.365672754383077,"score_spread":0.26263609982494257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132290857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805826,0.0005513017,0.0005756308,0.000050629118,0.000020497295,0.000026314781,0.00011467022,0.00008150373,0.00052124716],"genre_scores_gemma":[0.9974016,0.00060096354,0.0005546628,0.00003727813,0.000009367355,0.000040961226,0.0003383688,0.000014272632,0.0010025416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989104,0.000013477134,0.000014541411,0.00002028544,0.000024487494,0.00003626507],"domain_scores_gemma":[0.99988043,0.000017102639,0.000025439735,0.000022147618,0.000008107108,0.00004679297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012677378,0.0004535498,0.0005418006,0.0002920737,0.00013994973,0.00031073787,0.00030979337,0.00022713929,0.0006763931],"category_scores_gemma":[0.00013312112,0.00015721575,0.00030457758,0.00020211536,0.00019250263,0.00019616897,0.00021070137,0.0011563038,0.00019221961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066984363,0.0005150339,0.0003824386,0.00006313782,0.000017929939,0.00007284077,0.000027718042,0.00042114028,0.9919326,0.000088359346,0.00012532553,0.005683684],"study_design_scores_gemma":[0.00022194884,0.007889576,0.0057672295,0.00001371605,0.00005823867,0.0005537586,0.000042603773,0.0020611775,0.980828,0.0000710221,0.0024823311,0.000010449458],"about_ca_topic_score_codex":0.00050618674,"about_ca_topic_score_gemma":0.0005984819,"teacher_disagreement_score":0.0006763931,"about_ca_system_score_codex":0.00028680867,"about_ca_system_score_gemma":0.00032310703,"threshold_uncertainty_score":0.0022627711},"labels":[],"label_agreement":null},{"id":"W2139188064","doi":"10.1158/2326-6066.cir-13-0173","title":"Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université du Québec à Montréal","funders":"","keywords":"Immune system; Cytotoxic T cell; Immunology; Complement system; CD8; Biology; Natural killer cell; Complement receptor; Cancer research; In vitro","score_opus":0.04914346902087771,"score_gpt":0.33632520840867086,"score_spread":0.2871817393877931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139188064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436074,0.0014771882,0.0022417346,0.00007983102,0.000030199353,0.000040433635,0.00010447636,0.00014073707,0.0015246753],"genre_scores_gemma":[0.9972133,0.00039706743,0.00084436353,0.00003027097,0.000011646339,0.000029219284,0.0001240136,0.000012714344,0.0013373201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998117,0.000030986248,0.0000127303565,0.000024565074,0.00004790062,0.00007213545],"domain_scores_gemma":[0.99987316,0.000037321784,0.00003053785,0.000018039547,0.000013830055,0.00002717142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014044033,0.00041196865,0.00028546213,0.0002022534,0.00010981026,0.00027824574,0.0001765782,0.00023886396,0.0011760455],"category_scores_gemma":[0.00016780212,0.00009355925,0.00019455084,0.0001058232,0.00024743355,0.00014795297,0.00019139462,0.00062307855,0.00027955134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020388162,0.000047901627,0.00008764106,0.00002745402,0.0000036765703,0.000039378272,0.000007732913,0.0000585931,0.99802077,0.00013533063,0.000037076486,0.001330507],"study_design_scores_gemma":[0.00004141673,0.00086909824,0.0020160442,0.0000053775884,0.00001646696,0.00022848084,0.000011939262,0.0008511812,0.9946432,0.000081975806,0.0012308785,0.000003920171],"about_ca_topic_score_codex":0.0005049372,"about_ca_topic_score_gemma":0.0008563523,"teacher_disagreement_score":0.0011760455,"about_ca_system_score_codex":0.00030706782,"about_ca_system_score_gemma":0.0003221744,"threshold_uncertainty_score":0.003934324},"labels":[],"label_agreement":null},{"id":"W2139640503","doi":"10.1158/2326-6066.cir-13-0059-t","title":"Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"McMaster University; Cancer Research Society; Breast Cancer Alliance","keywords":"Oncolytic virus; Immunogenic cell death; Immune system; Antigen; Immunogenicity; Herpes simplex virus; Cancer research; CD8; Medicine; Immunotherapy; Cytotoxic T cell; Cancer; Immunology; Virus; Biology; In vitro; Internal medicine","score_opus":0.02820720336490473,"score_gpt":0.3353655360830851,"score_spread":0.3071583327181804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139640503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757975,0.00095733756,0.0008576131,0.000025162793,0.000012659212,0.000016818476,0.000043961554,0.000039721523,0.00046716392],"genre_scores_gemma":[0.9978588,0.0005431696,0.0010176585,0.00001057822,0.000006063893,0.000014657483,0.000064741704,0.000006672981,0.0004777101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998337,0.000031141157,0.000018095141,0.000026007898,0.000044303033,0.000046710396],"domain_scores_gemma":[0.99993646,0.000012058985,0.000021528918,0.000009857963,0.0000052083888,0.000014774781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014612135,0.0003206457,0.00046385342,0.00029342403,0.000086745225,0.000280764,0.00019341003,0.00022781339,0.0005587448],"category_scores_gemma":[0.000117522606,0.00011448839,0.00016852448,0.00020230471,0.00017069935,0.00024576375,0.00015808748,0.00042494922,0.00012171574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001528631,0.000075442644,0.00018822755,0.000023880815,0.0000062422673,0.00001634831,0.000007642848,0.00015472872,0.9965395,0.00006599946,0.000019260791,0.0027498791],"study_design_scores_gemma":[0.000026200438,0.0013461934,0.0020581353,0.0000027407186,0.000024880233,0.000139281,0.000006472218,0.00064818026,0.99491537,0.000018511968,0.00081054214,0.0000033924985],"about_ca_topic_score_codex":0.0002908455,"about_ca_topic_score_gemma":0.00047499643,"teacher_disagreement_score":0.0005587448,"about_ca_system_score_codex":0.00023531928,"about_ca_system_score_gemma":0.00016338601,"threshold_uncertainty_score":0.001869142},"labels":[],"label_agreement":null},{"id":"W2143000924","doi":"10.1158/2326-6066.cir-14-0146","title":"CD25 Identifies a Subset of CD4+FoxP3− TIL That Are Exhausted Yet Prognostically Favorable in Human Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"IL-2 receptor; FOXP3; Tumor-infiltrating lymphocytes; CD8; Immunology; Immune system; Biology; Cancer research; Interleukin 10; T cell","score_opus":0.07835711587237613,"score_gpt":0.36815878259923146,"score_spread":0.2898016667268553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143000924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982027,0.0006014109,0.00029712424,0.000015491802,0.0000050468643,0.000013852913,0.00009945991,0.000023306238,0.00074152777],"genre_scores_gemma":[0.99918634,0.00010632833,0.00018104039,0.000013769956,0.0000058425785,0.0000072159423,0.00015781951,0.0000026313928,0.0003389605],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999343,0.0000053653825,0.000005265673,0.00001764206,0.000013316887,0.000024022345],"domain_scores_gemma":[0.99995446,0.000007604244,0.000010972001,0.0000059181034,0.0000056419044,0.000015429723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012214477,0.00013590773,0.00016012095,0.0006920782,0.00019757365,0.00034990796,0.000084527885,0.00018186476,0.001146474],"category_scores_gemma":[0.00016080213,0.000100331534,0.000119011434,0.00028622957,0.00015766792,0.00012736993,0.000147461,0.00014187639,0.0001845238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015763226,0.00010948877,0.15219945,0.00010034967,0.000046016663,0.0019548514,0.0002441221,0.0004563749,0.817045,0.00021616368,0.00050960144,0.025542334],"study_design_scores_gemma":[0.00008291991,0.00075029477,0.8801336,0.000027745278,0.000118256125,0.0063165976,0.0005351178,0.0031238545,0.10207311,0.0004014449,0.0064126956,0.000024354798],"about_ca_topic_score_codex":0.00081810897,"about_ca_topic_score_gemma":0.0010252866,"teacher_disagreement_score":0.001146474,"about_ca_system_score_codex":0.00014836564,"about_ca_system_score_gemma":0.00010330732,"threshold_uncertainty_score":0.0038353205},"labels":[],"label_agreement":null},{"id":"W2147475006","doi":"10.1158/2326-6066.cir-13-0136","title":"Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; National Institute of General Medical Sciences; Cancer Research UK","keywords":"Ovarian cancer; Cancer; Gene; Biology; Scale (ratio); Variation (astronomy); Oncology; Medicine; Computational biology; Cancer research; Internal medicine; Genetics","score_opus":0.05060239366827162,"score_gpt":0.35329576349481945,"score_spread":0.3026933698265478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147475006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899787,0.0003598184,0.0002464031,0.000020147643,0.0000047923177,0.000008311284,0.00023477824,0.000004669782,0.00012329553],"genre_scores_gemma":[0.99939466,0.00006517134,0.00013712363,0.000018285626,0.000008464696,0.000010606137,0.00030975434,0.00000367021,0.000052264066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853325,0.0006399714,0.00009589546,0.0005059342,0.00013624295,0.000088560344],"domain_scores_gemma":[0.9972662,0.0012731873,0.0007316643,0.00042590956,0.00013106602,0.00017213685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001746742,0.00027231761,0.0004415544,0.00067306607,0.00037108638,0.0004156558,0.00039163537,0.00043171569,0.00084345206],"category_scores_gemma":[0.0028214292,0.00020400231,0.0005376465,0.0011445922,0.00051444856,0.00021258247,0.00053548365,0.00040258386,0.000111571564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008198402,0.0000390954,0.99225193,0.000025780224,0.0008846344,0.00013556576,0.000082591265,0.00017735793,0.0026900463,0.000033613844,0.00010302604,0.0027565374],"study_design_scores_gemma":[0.000058308993,0.00020666422,0.99817336,0.0000052766004,0.00029183348,0.00028455953,0.00007314472,0.00028009946,0.00027967375,0.0000718853,0.0002704914,0.000004652384],"about_ca_topic_score_codex":0.0016880867,"about_ca_topic_score_gemma":0.0022688168,"teacher_disagreement_score":0.001746742,"about_ca_system_score_codex":0.00017358073,"about_ca_system_score_gemma":0.00017624465,"threshold_uncertainty_score":0.009237766},"labels":[],"label_agreement":null},{"id":"W2160141570","doi":"10.1158/2326-6066.cir-14-0211","title":"Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Peter MacCallum Cancer Centre","keywords":"Adenosine A2A receptor; Immunotherapy; Granzyme B; Medicine; Blockade; CD8; Immune system; Adenosine receptor; Cancer research; T cell; Pharmacology; Immunology; Receptor expression; Tumor microenvironment; Cancer immunotherapy; Cytotoxic T cell; Receptor; Biology; Internal medicine; In vitro","score_opus":0.07078595446986687,"score_gpt":0.37898367900522667,"score_spread":0.3081977245353598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160141570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994027,0.0029474297,0.0011494582,0.000108515735,0.000050708277,0.000035155226,0.00012264763,0.00006784727,0.0014912408],"genre_scores_gemma":[0.9967,0.0008380964,0.0010748294,0.00010323465,0.000031251602,0.000040858547,0.00015573822,0.000007293071,0.0010486111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983954,0.000036010108,0.00001109371,0.000029241468,0.00003566326,0.000048491296],"domain_scores_gemma":[0.9999467,0.000012518066,0.000014303226,0.0000052863884,0.0000055333917,0.00001573616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015109264,0.0002481636,0.00041320125,0.0001490177,0.000072504474,0.0002900784,0.000109118315,0.00024696148,0.001335413],"category_scores_gemma":[0.00011566968,0.00009195416,0.00015363723,0.00008568501,0.0000966331,0.00017603136,0.00009884186,0.00069991924,0.00025765097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003841026,0.00023743583,0.00017912893,0.000051306513,0.000014703993,0.000024157625,0.000009368388,0.00015690169,0.9923414,0.000071661445,0.00014292219,0.006386871],"study_design_scores_gemma":[0.00025690414,0.008894885,0.0132291755,0.000015139439,0.00008579605,0.00033742827,0.00003642654,0.0032408035,0.967464,0.00013062138,0.0062940354,0.000014673564],"about_ca_topic_score_codex":0.00017287988,"about_ca_topic_score_gemma":0.00044694124,"teacher_disagreement_score":0.001335413,"about_ca_system_score_codex":0.00016609959,"about_ca_system_score_gemma":0.00016688972,"threshold_uncertainty_score":0.0044674277},"labels":[],"label_agreement":null},{"id":"W2168530155","doi":"10.1158/2326-6066.cir-14-0202","title":"Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Cancer Institute; Ludwig Institute for Cancer Research; Cancer Research Institute","keywords":"Adjuvant; Medicine; Immunogenicity; Internal medicine; Gastroenterology; CD8; Immunology; Vaccination; Immune system; Regimen","score_opus":0.04056324419270861,"score_gpt":0.33778034112680255,"score_spread":0.2972170969340939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168530155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984927,0.00080767676,0.000072888295,0.00009160078,0.000025217067,0.00009969539,0.000036779107,0.000006848028,0.00036663786],"genre_scores_gemma":[0.9987717,0.00039183727,0.00021944796,0.000115060444,0.000047588845,0.00010528887,0.00008073124,0.0000011678324,0.00026705884],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998443,0.000077748984,0.000011213661,0.000019349267,0.000016794973,0.000030575233],"domain_scores_gemma":[0.99980193,0.00005295979,0.00004496204,0.000010309483,0.000012222084,0.00007765884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000530482,0.0002713954,0.0006794157,0.00014190424,0.00019865774,0.00022296075,0.00015038074,0.00028298164,0.00081131916],"category_scores_gemma":[0.00056778954,0.00016773574,0.00037910292,0.00012643455,0.00020630402,0.00025847275,0.00012438229,0.00052368036,0.00016850086],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51535845,0.024355916,0.102444544,0.0006855428,0.0005864169,0.00088869693,0.0004079196,0.0023510458,0.11911853,0.00022565747,0.0027602434,0.23081703],"study_design_scores_gemma":[0.061605647,0.75932527,0.15943868,0.00007271767,0.00062338775,0.00090106286,0.0001632656,0.0023278021,0.010881068,0.0001577377,0.0044683227,0.00003494046],"about_ca_topic_score_codex":0.00043344346,"about_ca_topic_score_gemma":0.0010504454,"teacher_disagreement_score":0.00081131916,"about_ca_system_score_codex":0.0002950505,"about_ca_system_score_gemma":0.00048133187,"threshold_uncertainty_score":0.0028054714},"labels":[],"label_agreement":null},{"id":"W2177919716","doi":"10.1158/2326-6066.cir-15-0051","title":"Validation of Intratumoral T-bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Univariate analysis; Survival analysis; Pathology; Cancer; Multivariate analysis; Gastroenterology","score_opus":0.055572904644834754,"score_gpt":0.3663105896333311,"score_spread":0.3107376849884963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2177919716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955946,0.000103104976,0.00011455993,0.0000068064987,0.0000015669539,0.000003657254,0.000085638254,0.0000022491924,0.0001230253],"genre_scores_gemma":[0.9995647,0.00003268944,0.0000804528,0.000005744712,0.000004041832,0.00000614251,0.00022776586,0.0000014503506,0.000077025856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998369,0.000066204586,0.000013714108,0.000029520046,0.000025518324,0.000028062983],"domain_scores_gemma":[0.9992818,0.00026673748,0.00017447172,0.00008282567,0.00008520159,0.00010894499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007784086,0.00018873932,0.0002210559,0.00055549527,0.00019513103,0.00038580806,0.0002338536,0.00021599761,0.0006055604],"category_scores_gemma":[0.0014206127,0.00010162964,0.00016929691,0.0003510577,0.00017874278,0.00019385369,0.0002717258,0.00026611457,0.00022351652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008297971,0.000051137067,0.9925678,0.000008223617,0.000031059328,0.00007564419,0.00003094337,0.00022316356,0.0026646187,0.000014491239,0.000045650464,0.003457414],"study_design_scores_gemma":[0.000031452113,0.0005853969,0.9947023,0.0000045003535,0.000047511705,0.00058376585,0.00008285027,0.0020629584,0.0014754974,0.000084478226,0.0003344754,0.000004711623],"about_ca_topic_score_codex":0.00080073683,"about_ca_topic_score_gemma":0.0009824206,"teacher_disagreement_score":0.00080073683,"about_ca_system_score_codex":0.00013499329,"about_ca_system_score_gemma":0.00014424638,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2194675780","doi":"10.1158/2326-6066.cir-15-0141","title":"Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Melanoma; Immunotherapy; Pathology; Immunology; Oncology; Immune system; Cancer research","score_opus":0.11306137541957614,"score_gpt":0.4120534297064699,"score_spread":0.2989920542868938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2194675780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98711514,0.0046044006,0.0020245546,0.00085104734,0.00011128468,0.00010330038,0.000038944745,0.00008881514,0.0050624264],"genre_scores_gemma":[0.99799085,0.00062893366,0.00023656535,0.0005011816,0.00010032132,0.000011619672,0.000036533453,0.000007852057,0.0004860885],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997259,0.000087053544,0.000034329347,0.000043448617,0.000048369675,0.00006089233],"domain_scores_gemma":[0.9993119,0.0002075917,0.0001836239,0.000063272106,0.00006314781,0.00017046218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034801968,0.0006250279,0.00049771613,0.00047376624,0.0008258798,0.00040133332,0.00040849246,0.0011512185,0.00065277884],"category_scores_gemma":[0.00125948,0.00019968914,0.00036463194,0.0002925224,0.00059424003,0.0004256401,0.00035300237,0.0013930174,0.0002648798],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014570699,0.00036589816,0.045692038,0.00024863068,0.00021248304,0.8939932,0.00073237054,0.00059733144,0.020586975,0.00037991875,0.0006975461,0.03503666],"study_design_scores_gemma":[0.00024477436,0.004012296,0.077795796,0.00013826745,0.0002092632,0.89278835,0.0004259971,0.0024439662,0.01605412,0.0010333807,0.004812154,0.000041643656],"about_ca_topic_score_codex":0.0021220562,"about_ca_topic_score_gemma":0.004279643,"teacher_disagreement_score":0.0021220562,"about_ca_system_score_codex":0.0010019056,"about_ca_system_score_gemma":0.0005129969,"threshold_uncertainty_score":0.0072693825},"labels":[],"label_agreement":null},{"id":"W2258216786","doi":"10.1158/2326-6066.cir-15-0118","title":"Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"NKG2D; Medicine; Immune system; Immunotherapy; CD8; Immunology; Lymphoma; Cancer research; In vivo; Cancer; Ex vivo; Cytotoxic T cell; Natural killer cell; Cancer immunotherapy; Cell therapy; Cell; In vitro; Internal medicine; Biology","score_opus":0.02961590419996368,"score_gpt":0.34438242997220786,"score_spread":0.3147665257722442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258216786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457896,0.0010482413,0.00079727406,0.0001356659,0.00006729213,0.0022539312,0.00020504523,0.000056183893,0.00085737725],"genre_scores_gemma":[0.9928415,0.00085442205,0.0014656062,0.00028137895,0.00011817141,0.0025675108,0.00073061895,0.000017151413,0.0011236272],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995521,0.00018238892,0.000021640175,0.000091289614,0.000043779684,0.000108813474],"domain_scores_gemma":[0.99964833,0.000051980987,0.00004330089,0.000060937215,0.000023112445,0.0001724166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011523437,0.0012992907,0.0021460757,0.00043594502,0.00040944252,0.0005329072,0.00061323046,0.00082567835,0.0017615611],"category_scores_gemma":[0.00050392316,0.00038098035,0.0007698892,0.00034352246,0.00089098915,0.000469558,0.0004286354,0.0016610174,0.0005467992],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34670964,0.22877282,0.014168226,0.0007470128,0.000933615,0.0012741141,0.0007427428,0.0050594145,0.25520095,0.0010335098,0.0030509993,0.14230692],"study_design_scores_gemma":[0.12299531,0.8495797,0.008335518,0.000015422906,0.00023859015,0.00056785886,0.00006160749,0.0013091573,0.014309787,0.00021772915,0.002350885,0.000018458308],"about_ca_topic_score_codex":0.0004085104,"about_ca_topic_score_gemma":0.0005540396,"teacher_disagreement_score":0.0021460757,"about_ca_system_score_codex":0.0005619724,"about_ca_system_score_gemma":0.0012532353,"threshold_uncertainty_score":0.0060942173},"labels":[],"label_agreement":null},{"id":"W2264702568","doi":"10.1158/2326-6066.cir-15-0200-t","title":"Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Pancreatic cancer; Stable isotope labeling by amino acids in cell culture; Antibody; Cancer; Immunology; Medicine; Cancer vaccine; Antigen; Cancer research; Immunotherapy; Cancer immunotherapy; Internal medicine; Biology; Proteomics","score_opus":0.2264068331726535,"score_gpt":0.5496808490037097,"score_spread":0.3232740158310562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264702568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665618,0.008536236,0.021156473,0.00023719447,0.00008050433,0.00014721334,0.0016874257,0.0002608634,0.0013322576],"genre_scores_gemma":[0.9639493,0.0044244486,0.027870605,0.00041761616,0.000062469866,0.00012615419,0.001786226,0.000030425643,0.0013325779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998084,0.000037082373,0.00001395438,0.00004637561,0.00007230001,0.000021915146],"domain_scores_gemma":[0.99985516,0.00003245212,0.000050892762,0.000009978673,0.00003400408,0.000017539325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036918305,0.00044066992,0.0004021502,0.0010298216,0.00012834626,0.0004338864,0.00016600665,0.0003328647,0.00038121795],"category_scores_gemma":[0.00030800342,0.00015081972,0.00031659653,0.0005219367,0.00018328705,0.00021151274,0.00021794159,0.00043081085,0.00019996618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016969345,0.000048432186,0.007053538,0.00014907567,0.000069799964,0.000052118867,0.00002264399,0.00021235748,0.982163,0.00006384628,0.00013277552,0.0098628765],"study_design_scores_gemma":[0.00004406197,0.0008887494,0.12547448,0.000038337603,0.00020752981,0.0014878897,0.00011144868,0.013303065,0.8522346,0.00037110996,0.005801678,0.00003697162],"about_ca_topic_score_codex":0.00025746875,"about_ca_topic_score_gemma":0.00044082117,"teacher_disagreement_score":0.0010298216,"about_ca_system_score_codex":0.0001925476,"about_ca_system_score_gemma":0.00012704813,"threshold_uncertainty_score":0.0019524097},"labels":[],"label_agreement":null},{"id":"W2270309512","doi":"10.1158/2326-6066.cir-15-0186","title":"Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pembrolizumab; Eosinophilic fasciitis; Vasculitis; Adverse effect; Dermatology; Toxicity; Rash; Cancer; Internal medicine; Surgery; Gastroenterology; Fasciitis; Disease; Immunotherapy","score_opus":0.03993165404668665,"score_gpt":0.3415279533362609,"score_spread":0.30159629928957427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270309512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98073167,0.003176387,0.0015035358,0.0030760036,0.00013509078,0.00012991701,0.00010139236,0.00006369252,0.011082377],"genre_scores_gemma":[0.996653,0.00088514935,0.00035837645,0.0007937988,0.00020431545,0.00000887583,0.000043749023,0.000007853371,0.0010447601],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997454,0.00004908345,0.000029659703,0.000045843663,0.00003967461,0.00009024902],"domain_scores_gemma":[0.9992865,0.00021079571,0.00017166913,0.00003794556,0.00005442048,0.00023875329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028134522,0.00070209784,0.0006276497,0.00078708184,0.0013154398,0.00071343593,0.0003134168,0.001586123,0.0013490777],"category_scores_gemma":[0.0016795325,0.00043998548,0.0005420811,0.00043743718,0.0006555717,0.0008212098,0.0005197258,0.001659519,0.0003799298],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100046505,0.000053237516,0.020546053,0.000028261535,0.00001353955,0.97550815,0.00023250552,0.000094062736,0.0007517233,0.00011488265,0.00028168983,0.0022758006],"study_design_scores_gemma":[0.000019236724,0.00020310214,0.017195532,0.0000221617,0.000023613335,0.9805058,0.00014588801,0.00033638623,0.0005687371,0.00012225805,0.0008475835,0.000009601001],"about_ca_topic_score_codex":0.0017819189,"about_ca_topic_score_gemma":0.0026430727,"teacher_disagreement_score":0.0017819189,"about_ca_system_score_codex":0.00069109944,"about_ca_system_score_gemma":0.00050447875,"threshold_uncertainty_score":0.0050143003},"labels":[],"label_agreement":null},{"id":"W2313482121","doi":"10.1158/2326-6066.cir-13-0208","title":"Murine Splenic CD4+ T Cells, Induced by Innate Immune Cell Interactions and Secreted Factors, Develop Antileukemia Cytotoxicity","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Interleukin 12; Immunology; Cancer immunotherapy; Immune system; Immunotherapy; Biology; CD8; Acquired immune system; CTL*; Interleukin 21; Natural killer T cell; Antigen-presenting cell; T cell; Cell biology; Cancer research; In vitro","score_opus":0.03560949819122649,"score_gpt":0.314459115087851,"score_spread":0.2788496168966245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313482121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880882,0.0013635367,0.0051704464,0.00013003539,0.00006057453,0.00008995751,0.00058414706,0.0003275902,0.004185468],"genre_scores_gemma":[0.98633564,0.0006360604,0.005624745,0.00014271458,0.00003455653,0.000094421375,0.0011346476,0.000084332765,0.005912834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997744,0.00003090482,0.000018243916,0.000045037403,0.00004617346,0.00008527033],"domain_scores_gemma":[0.99979657,0.00002757741,0.00005437416,0.00002966716,0.00001847005,0.0000733985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019461541,0.00068108056,0.00026974906,0.00041691138,0.00017190987,0.00039219784,0.0002910705,0.00048504415,0.002110726],"category_scores_gemma":[0.000133249,0.00024080445,0.00031329194,0.00016743818,0.00025438354,0.00022509976,0.00023313295,0.0012439366,0.001501978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025047094,0.00008703708,0.00018492485,0.000018899373,0.000003150211,0.000038369704,0.000011597055,0.00013359443,0.9978243,0.00013351279,0.00005812962,0.0012560771],"study_design_scores_gemma":[0.000073666786,0.00067037117,0.0010030704,0.0000056717217,0.00001053313,0.00017870813,0.000015169921,0.0013218356,0.9949757,0.000095715695,0.0016459863,0.0000035682208],"about_ca_topic_score_codex":0.00035939127,"about_ca_topic_score_gemma":0.0005238551,"teacher_disagreement_score":0.002110726,"about_ca_system_score_codex":0.0004990056,"about_ca_system_score_gemma":0.00024893234,"threshold_uncertainty_score":0.0070610642},"labels":[],"label_agreement":null},{"id":"W2336577938","doi":"10.1158/2326-6074.tumimm14-b88","title":"Abstract B88: Combination therapy of reovirus and checkpoint inhibition","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada); Institute of Cancer Research","funders":"","keywords":"Oncolytic virus; Immune system; Immune checkpoint; Cancer research; Immunotherapy; Antigen; Immunology; Innate immune system; Medicine; Acquired immune system; Biology; Virology","score_opus":0.09997797559208603,"score_gpt":0.4035108601861042,"score_spread":0.30353288459401817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336577938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828571,0.005969766,0.0054544224,0.00023148464,0.00016673292,0.00029596186,0.00043772123,0.00022798385,0.0043587647],"genre_scores_gemma":[0.98921925,0.0019364802,0.004408684,0.00006546312,0.000036355465,0.0001617213,0.00037833463,0.00003217008,0.0037615767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999882,0.000019892828,0.000007522335,0.000024281977,0.000029107987,0.00003725689],"domain_scores_gemma":[0.99994886,0.0000067314,0.000012530849,0.000009520257,0.000005012705,0.000017377595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013380949,0.00059341313,0.0005806828,0.0003961843,0.00009336638,0.0003326769,0.0004121894,0.0003785121,0.001833778],"category_scores_gemma":[0.00007981681,0.00013197464,0.0003608225,0.00018293453,0.00014439542,0.0002140373,0.0002209322,0.00099844,0.00042250002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022974936,0.0014834469,0.00039475955,0.00023230787,0.00005306761,0.000104199826,0.00003127408,0.0011795266,0.95406467,0.0004017064,0.00054850447,0.03920893],"study_design_scores_gemma":[0.0009887217,0.020282814,0.0022977535,0.000049188624,0.0001360231,0.00065863505,0.000022108508,0.0025000612,0.96390104,0.000108180364,0.009035633,0.000019855626],"about_ca_topic_score_codex":0.00055959437,"about_ca_topic_score_gemma":0.0009190194,"teacher_disagreement_score":0.001833778,"about_ca_system_score_codex":0.00021239347,"about_ca_system_score_gemma":0.00025612314,"threshold_uncertainty_score":0.0061345696},"labels":[],"label_agreement":null},{"id":"W2338380682","doi":"10.1158/2326-6074.tumimm14-a12","title":"Abstract A12: PDL-1 blockade and Sunitinib enhance the efficiency of oncolytic viral therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Oncolytic virus; Sunitinib; Cancer research; Immune system; Myeloid-derived Suppressor Cell; Cytotoxic T cell; Medicine; Immunotherapy; In vivo; Immunology; Renal cell carcinoma; Cancer; Biology; In vitro; Oncology; Internal medicine; Suppressor","score_opus":0.08431225315404275,"score_gpt":0.41986677362980523,"score_spread":0.3355545204757625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338380682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939709,0.0019229001,0.0012566459,0.00009578907,0.00007967014,0.00006583386,0.0003621042,0.00016290728,0.0020833747],"genre_scores_gemma":[0.9959423,0.0003950008,0.0011080211,0.00002909068,0.000016353257,0.000044371445,0.00033666508,0.0000172473,0.0021109567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998565,0.000020124578,0.000015518977,0.000032339827,0.000031785596,0.000043700238],"domain_scores_gemma":[0.9999275,0.000010569776,0.000017827155,0.00000814451,0.00000813511,0.000027770528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013536954,0.0003106114,0.0005102696,0.0002021836,0.00011765144,0.00044723443,0.00023912694,0.00034201014,0.0037274307],"category_scores_gemma":[0.00010578526,0.00009893494,0.00028270762,0.00014694419,0.00014850988,0.00023799148,0.00014044864,0.0006687387,0.0007411495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003104789,0.0011008409,0.0004064848,0.00017806243,0.000037654012,0.000044496082,0.000029488754,0.0005940304,0.9750107,0.00017477584,0.00080456364,0.018514112],"study_design_scores_gemma":[0.0003419171,0.007018196,0.0036792571,0.000011915279,0.000050324332,0.0003583636,0.00002133105,0.0021866942,0.9812912,0.000040716553,0.00499051,0.0000096547365],"about_ca_topic_score_codex":0.00050705846,"about_ca_topic_score_gemma":0.000767311,"teacher_disagreement_score":0.0037274307,"about_ca_system_score_codex":0.0002778444,"about_ca_system_score_gemma":0.00029740986,"threshold_uncertainty_score":0.01246953},"labels":[],"label_agreement":null},{"id":"W2338745842","doi":"10.1158/2326-6074.cricimteatiaacr15-a084","title":"Abstract A084: Identification of mutation-reactive T cells in patients with gastrointestinal cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"clone (Java method); Cancer research; Cancer; CD8; Biology; Somatic cell; Mutation; Germline mutation; Cancer cell; Cell culture; Metastasis; Human leukocyte antigen; Exome sequencing; T cell; Molecular biology; Antigen; Immunology; Gene; Genetics; Immune system","score_opus":0.041750560219818406,"score_gpt":0.37331365738303157,"score_spread":0.3315630971632132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338745842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990709,0.00009309592,0.00008580546,0.00003681388,0.0000083015775,0.000008234516,0.00019765308,0.000008780615,0.00049036567],"genre_scores_gemma":[0.9994549,0.00002284649,0.00007528641,0.000033323304,0.000010683993,0.000008712939,0.00017262722,0.0000030353992,0.00021849634],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998017,0.000034948174,0.000020695918,0.00006861654,0.000036737485,0.000037325804],"domain_scores_gemma":[0.9996568,0.00009617381,0.00008029801,0.00001879098,0.00005649773,0.00009148823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013593365,0.00033532616,0.00028418694,0.00075829774,0.00043550288,0.00043413092,0.00022034423,0.00064428744,0.003433144],"category_scores_gemma":[0.0008309278,0.00017251265,0.00021028251,0.000505805,0.00016397533,0.0002533795,0.00017469219,0.00045873385,0.0005463012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081266224,0.00013222996,0.9716538,0.000028344662,0.000039014558,0.002378388,0.00011941607,0.00008450217,0.020159507,0.00003922475,0.00045879508,0.004094198],"study_design_scores_gemma":[0.00003289965,0.0006229866,0.98710036,0.000010282279,0.00006214061,0.007994257,0.00026284845,0.00056975026,0.0024312588,0.00007606841,0.00082794356,0.000009211879],"about_ca_topic_score_codex":0.0006125757,"about_ca_topic_score_gemma":0.00029616625,"teacher_disagreement_score":0.003433144,"about_ca_system_score_codex":0.00017104934,"about_ca_system_score_gemma":0.00009662306,"threshold_uncertainty_score":0.011484981},"labels":[],"label_agreement":null},{"id":"W2339872372","doi":"10.1158/2326-6074.tumimm14-a69","title":"Abstract A69: The immunological environment in triple negative breast cancer; impact on clinical outcomes towards a prognostic clinical test","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Tumor microenvironment; Stromal cell; CD8; Laser capture microdissection; Stroma; Cytotoxic T cell; Triple-negative breast cancer; Tumor-infiltrating lymphocytes; Breast cancer; Gene signature; Cancer research; Immunotherapy; Biology; Cancer; Medicine; Immunology; Immune system; Internal medicine; Gene expression; Immunohistochemistry; Gene; Genetics","score_opus":0.2470849145066478,"score_gpt":0.5129981754542506,"score_spread":0.2659132609476028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339872372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942899,0.00095162,0.0006679781,0.00023039662,0.000043806172,0.000015149537,0.00093508395,0.00003609592,0.002829838],"genre_scores_gemma":[0.9988318,0.00009016225,0.00026802512,0.0000376177,0.000036640995,0.000008488263,0.00039863784,0.000004135658,0.00032451027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976295,0.00006576795,0.000022762915,0.000044759683,0.000058492096,0.000045296798],"domain_scores_gemma":[0.9991673,0.00027168493,0.00021757296,0.00003586171,0.00013595854,0.00017165572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048004615,0.00022818665,0.00029340107,0.0007395761,0.000260976,0.00059574196,0.00015433674,0.00029806272,0.003597624],"category_scores_gemma":[0.0011870775,0.00005301741,0.00020646618,0.0006002008,0.00024127397,0.00027347673,0.00024474633,0.00033716875,0.0008060387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018987758,0.00010032681,0.9629971,0.000054260137,0.000075665754,0.00035359504,0.0000480369,0.00041699954,0.013009928,0.000086366206,0.00077847025,0.020180542],"study_design_scores_gemma":[0.000022473732,0.0006996659,0.9905868,0.00001635281,0.00010085715,0.0011169582,0.000115147224,0.0016299469,0.0041871257,0.0002516827,0.0012609015,0.000012082889],"about_ca_topic_score_codex":0.00045164893,"about_ca_topic_score_gemma":0.00049131986,"teacher_disagreement_score":0.003597624,"about_ca_system_score_codex":0.00021342633,"about_ca_system_score_gemma":0.00015582805,"threshold_uncertainty_score":0.012035251},"labels":[],"label_agreement":null},{"id":"W2346926528","doi":"10.1158/2326-6074.cricimteatiaacr15-b024","title":"Abstract B024: Single-chain traps targeting transforming growth factor-beta (TGF-beta) home to tumors and reduce tumor growth and metastasis by counteracting TGF-beta-mediated immunosuppression","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Transforming growth factor beta; Cancer research; TGF beta signaling pathway; Antibody; CD8; Monoclonal antibody; Immunotherapy; Metastasis; Biology; TGF beta 1; Immune system; Cancer immunotherapy; Angiogenesis; Transforming growth factor; Immunology; Medicine; Cancer; Cell biology; Internal medicine","score_opus":0.05835201712480142,"score_gpt":0.35704266751243385,"score_spread":0.29869065038763243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346926528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044085,0.0021013753,0.0044350517,0.000114350936,0.00006853578,0.000081381964,0.00036138354,0.00018065024,0.0022164476],"genre_scores_gemma":[0.9876638,0.0007602996,0.0055947592,0.00010041014,0.000017633482,0.00007403405,0.00061054924,0.000042846932,0.0051356847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999248,0.000008283166,0.0000047920453,0.000014866109,0.000025616786,0.000021680018],"domain_scores_gemma":[0.9999424,0.0000068014874,0.000016786966,0.0000031389036,0.00000768976,0.000023061813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095778094,0.00036261874,0.00021817548,0.00023329927,0.00010614873,0.0001822856,0.00026712782,0.000389194,0.003152091],"category_scores_gemma":[0.000061461644,0.00011568215,0.00022514335,0.00010062482,0.00014071929,0.00015086892,0.00011753606,0.00038603874,0.0006199175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002717698,0.00009413159,0.00004757295,0.000037847018,0.000006812993,0.000016828437,0.0000041073718,0.00010824224,0.9972096,0.00007938885,0.000102529295,0.002021245],"study_design_scores_gemma":[0.00013787487,0.001797366,0.0006675375,0.0000069180924,0.0000197662,0.00020561898,0.0000066642087,0.0010323502,0.9941806,0.000038470866,0.0019020383,0.0000047596527],"about_ca_topic_score_codex":0.0006460321,"about_ca_topic_score_gemma":0.0005248592,"teacher_disagreement_score":0.003152091,"about_ca_system_score_codex":0.000156166,"about_ca_system_score_gemma":0.00018134563,"threshold_uncertainty_score":0.0105448365},"labels":[],"label_agreement":null},{"id":"W2356803257","doi":"10.1158/2326-6066.cir-15-0302","title":"Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Colorectal cancer; Immune system; Adjuvant; Medicine; Stage (stratigraphy); Chemotherapy; Oncology; Immunotherapy; Cancer; Immunology; Internal medicine; Biology","score_opus":0.03448511688458177,"score_gpt":0.3306681204005528,"score_spread":0.29618300351597104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2356803257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993691,0.00015350006,0.00011554747,0.00002858059,0.0000023306218,0.0000040278096,0.00006271103,0.0000041427784,0.00026001726],"genre_scores_gemma":[0.9996805,0.00003128315,0.00005262261,0.000023568202,0.0000039681363,0.000002357473,0.00011825779,0.0000017140762,0.00008577876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988973,0.000028075094,0.000007789067,0.000030732994,0.000013938743,0.00002972416],"domain_scores_gemma":[0.99968374,0.000057819183,0.0001237424,0.00002590242,0.00001947916,0.00008938538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017838115,0.00018266733,0.0003633373,0.00043709227,0.0002349572,0.0004613468,0.00012948345,0.00028955867,0.0010885062],"category_scores_gemma":[0.00053466257,0.000106567495,0.0003518667,0.00027761722,0.00022802241,0.00015392156,0.00021484452,0.0003435141,0.0002489029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001011302,0.000029776134,0.9859784,0.000009625591,0.00004066082,0.00020659748,0.000039172253,0.00012364672,0.008185565,0.00003656099,0.00009761422,0.004241147],"study_design_scores_gemma":[0.000017149901,0.00024346431,0.99729174,0.0000030991043,0.000039696726,0.00072068424,0.0000880016,0.00066285185,0.00052747515,0.00010115042,0.00030093204,0.0000038226626],"about_ca_topic_score_codex":0.00096119085,"about_ca_topic_score_gemma":0.0011594114,"teacher_disagreement_score":0.0010885062,"about_ca_system_score_codex":0.0001582505,"about_ca_system_score_gemma":0.00014386479,"threshold_uncertainty_score":0.003641367},"labels":[],"label_agreement":null},{"id":"W2396416961","doi":"10.1158/2326-6074.cricimteatiaacr15-a137","title":"Abstract A137: Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and PD-1 blockade provides effective tumor control through a mechanism of epitope spreading","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Immunovaccine (Canada)","funders":"","keywords":"ELISPOT; Medicine; Immune system; Immunogenicity; Tumor microenvironment; Cancer vaccine; Immunotherapy; Cancer research; Immunology; CD8; Cytotoxic T cell; Epitope; Cancer; Peptide vaccine; Cancer immunotherapy; Cyclophosphamide; Antigen; Biology; Chemotherapy; Internal medicine; In vitro","score_opus":0.0236350580915843,"score_gpt":0.3161261455084398,"score_spread":0.29249108741685553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396416961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153227,0.0019616925,0.0035704211,0.00017130242,0.00012740586,0.00011326221,0.00046310358,0.00014967019,0.0019108654],"genre_scores_gemma":[0.99452883,0.00041683562,0.0024799411,0.00004969516,0.000025969972,0.000057636957,0.00035466166,0.000015585034,0.0020707909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999925,0.0000076246215,0.0000063655502,0.000019406623,0.000018949208,0.000022704831],"domain_scores_gemma":[0.9999577,0.000004758439,0.00001098041,0.0000037344003,0.0000042205384,0.00001870831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083156585,0.00034345745,0.00027551648,0.00015891372,0.00008560187,0.00025041754,0.00022405291,0.00029894468,0.0026618873],"category_scores_gemma":[0.0000713653,0.00008903456,0.00019667897,0.000098647615,0.00012888428,0.00019857593,0.00015875182,0.0006157441,0.0003683058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007577929,0.00028913617,0.00017234281,0.00008313006,0.000014385854,0.000034327106,0.0000083835,0.00028088625,0.9908433,0.00018630455,0.00027191194,0.0070580165],"study_design_scores_gemma":[0.0003356017,0.0065792836,0.0020293859,0.000014060804,0.000047935675,0.00046320166,0.0000099808585,0.00247437,0.9823653,0.00009939847,0.005574125,0.000007403279],"about_ca_topic_score_codex":0.00044692718,"about_ca_topic_score_gemma":0.00046854423,"teacher_disagreement_score":0.0026618873,"about_ca_system_score_codex":0.0002634,"about_ca_system_score_gemma":0.00033569528,"threshold_uncertainty_score":0.008904874},"labels":[],"label_agreement":null},{"id":"W2397071140","doi":"10.1158/2326-6074.cricimteatiaacr15-a176","title":"Abstract A176: Efficacy and safety of allogeneic double negative T cell as anti-AML therapy and its underlying mechanism","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Institute of Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Chemotherapy; Leukemia; CD8; Minimal residual disease; Stem cell; Immunotherapy; Oncology; Immunology; Transplantation; Cytotoxic T cell; Cancer research; Internal medicine; Immune system; In vitro; Biology","score_opus":0.16024945242818145,"score_gpt":0.42543022106325934,"score_spread":0.2651807686350779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397071140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926352,0.0034607942,0.0006300868,0.00010930967,0.00014722161,0.00013323853,0.00023899939,0.0000356687,0.0026094187],"genre_scores_gemma":[0.9949065,0.0011902576,0.0005390741,0.00012716965,0.000098787394,0.000070238326,0.0004909244,0.000007638704,0.002569361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999379,0.000012686378,0.0000071160603,0.0000127345,0.000019514628,0.000010007958],"domain_scores_gemma":[0.9999403,0.000008894274,0.000014825847,0.000008930873,0.0000072939233,0.000019857367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013018839,0.00028693888,0.00031367177,0.00015712791,0.00012811113,0.0002455307,0.00019678497,0.0003257975,0.0021518776],"category_scores_gemma":[0.00013597486,0.000053754833,0.00016858347,0.00013894873,0.00015634748,0.00017799325,0.00008333742,0.00051412475,0.00042822128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014166955,0.0042958567,0.0032639026,0.00041781637,0.00007037363,0.0011634474,0.00011043046,0.0007197328,0.8740503,0.00084628677,0.001308806,0.09958607],"study_design_scores_gemma":[0.005375251,0.17250387,0.026622243,0.00009831404,0.00033946513,0.007371532,0.00013232906,0.0035898958,0.73353124,0.0006411568,0.04975631,0.000038400005],"about_ca_topic_score_codex":0.00022112165,"about_ca_topic_score_gemma":0.00017933447,"teacher_disagreement_score":0.0021518776,"about_ca_system_score_codex":0.00015561067,"about_ca_system_score_gemma":0.0002856037,"threshold_uncertainty_score":0.007198751},"labels":[],"label_agreement":null},{"id":"W2397649686","doi":"10.1158/2326-6074.cricimteatiaacr15-b077","title":"Abstract B077: Evaluating oncolytic vaccines targeting mutated epitopes in a murine fibrosarcoma model CMS-5","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"","keywords":"Oncolytic virus; Immune system; Epitope; Antigen; Immunotherapy; Vaccination; Tumor antigen; Immunology; Biology; Cancer research; Virology; Medicine","score_opus":0.08255336065278163,"score_gpt":0.43335719420822527,"score_spread":0.35080383355544364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397649686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688643,0.00036202007,0.0016064275,0.00005819579,0.000037924816,0.00010380816,0.00026544213,0.000041613985,0.00063815806],"genre_scores_gemma":[0.9943462,0.00037985612,0.0030080434,0.00003538012,0.000016784039,0.00009733344,0.00058231,0.000015100153,0.0015189362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982566,0.00004000387,0.000013956272,0.000027056383,0.000059292634,0.000034186785],"domain_scores_gemma":[0.9998105,0.000046404908,0.000045756056,0.000016094547,0.000025947442,0.000055302036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037959294,0.00045062325,0.0002069465,0.00034250808,0.00013162513,0.00016730875,0.00021483016,0.00044160662,0.0008644175],"category_scores_gemma":[0.00013443283,0.000120043034,0.0002669712,0.0001163174,0.00019452896,0.00019652995,0.00012351689,0.0006187933,0.00023351693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021908588,0.00020017994,0.0000984711,0.00002888688,0.0000048798147,0.000024866165,0.000009558086,0.00028949886,0.9984674,0.00004433237,0.000029558745,0.0005832604],"study_design_scores_gemma":[0.000065261665,0.007001826,0.0014228423,0.000006343643,0.00002014958,0.00009717833,0.000017321985,0.0014740442,0.989127,0.000025231453,0.00073879014,0.0000040579575],"about_ca_topic_score_codex":0.0013661991,"about_ca_topic_score_gemma":0.0010224077,"teacher_disagreement_score":0.0013661991,"about_ca_system_score_codex":0.00027389865,"about_ca_system_score_gemma":0.00023887808,"threshold_uncertainty_score":0.002891779},"labels":[],"label_agreement":null},{"id":"W2397997709","doi":"10.1158/2326-6074.cricimteatiaacr15-a135","title":"Abstract A135: Phosphodiesterase-5 inhibition augments postoperative natural killer cell antitumor immunity by reducing myeloid-derived suppressor cell function","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Myeloid-derived Suppressor Cell; Medicine; Immune system; In vivo; Cancer research; Immunotherapy; Immunology; Cancer; Natural killer cell; Perioperative; Cytotoxic T cell; Cell; Adoptive cell transfer; T cell; Pharmacology; Internal medicine; In vitro; Suppressor; Biology; Surgery","score_opus":0.02674075746872229,"score_gpt":0.3068978497950183,"score_spread":0.280157092326296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397997709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950956,0.0014786063,0.0011949713,0.00016758504,0.00014300199,0.000051204268,0.0005837144,0.00008261062,0.0012028655],"genre_scores_gemma":[0.9955434,0.0006575331,0.0007768427,0.00008569075,0.00004182854,0.000044977787,0.0006520392,0.000007335591,0.002190449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999237,0.000009201739,0.000011171576,0.00001436126,0.000018476274,0.000023092369],"domain_scores_gemma":[0.9999342,0.000009524087,0.00002051564,0.000007164572,0.000006588572,0.000022043552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000966519,0.0003852535,0.00023370427,0.00012599347,0.00009199978,0.00019067712,0.00017835053,0.0002106865,0.0034536878],"category_scores_gemma":[0.000086252134,0.00007675887,0.00025424972,0.00007130095,0.0002025819,0.00014558453,0.00012504183,0.0007211885,0.00040925818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020632006,0.00032637647,0.00033404838,0.00013482598,0.000018957357,0.000057201454,0.000012892532,0.00011403652,0.99079883,0.00012318816,0.00027648354,0.0057399054],"study_design_scores_gemma":[0.00032387165,0.008733648,0.0064215274,0.000015344678,0.000058659873,0.00029663419,0.000038198785,0.000733926,0.97999805,0.00007373767,0.0033005718,0.000005875777],"about_ca_topic_score_codex":0.00026899812,"about_ca_topic_score_gemma":0.0003704219,"teacher_disagreement_score":0.0034536878,"about_ca_system_score_codex":0.00014314939,"about_ca_system_score_gemma":0.00027504144,"threshold_uncertainty_score":0.011553764},"labels":[],"label_agreement":null},{"id":"W2398791138","doi":"10.1158/2326-6074.cricimteatiaacr15-b032","title":"Abstract B032: Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aptamer; Immunogenicity; Immune system; Antibody; Epitope; Ipilimumab; Monoclonal antibody; Cancer research; Cancer immunotherapy; In vivo; Immunotherapy; PD-L1; Biology; Immunology; Chemistry; Molecular biology; Medicine","score_opus":0.04202662263459932,"score_gpt":0.3342557354737899,"score_spread":0.29222911283919056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398791138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94729525,0.0054301447,0.03662493,0.00053516333,0.00025556315,0.0003142962,0.00088016514,0.0006005963,0.008063951],"genre_scores_gemma":[0.96925,0.0011051508,0.018495772,0.0002874754,0.000038857812,0.00017079886,0.0007516849,0.000065371976,0.009834886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988663,0.000017531363,0.000009244576,0.000030193047,0.000034385,0.000022047865],"domain_scores_gemma":[0.99995077,0.000007925434,0.000016065243,0.000003939038,0.000008376741,0.000012939673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012552302,0.00036707267,0.00017888156,0.00021379418,0.00007280294,0.00027544846,0.00026604632,0.00047593412,0.0016507054],"category_scores_gemma":[0.00011404623,0.00014113533,0.00018455618,0.00012059168,0.00014711902,0.00015649693,0.00014212918,0.00057273655,0.0009061162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001226309,0.000050916013,0.000045569403,0.00003562258,0.0000048938814,0.000027340588,0.0000070241485,0.0002546726,0.9952231,0.00022376099,0.00017579707,0.0038287367],"study_design_scores_gemma":[0.00004470806,0.0004190412,0.0002562218,0.000004501565,0.000008375926,0.00014539015,0.0000035568632,0.0016140324,0.9931698,0.00006501344,0.0042641335,0.000005146904],"about_ca_topic_score_codex":0.00030053954,"about_ca_topic_score_gemma":0.0002284901,"teacher_disagreement_score":0.0016507054,"about_ca_system_score_codex":0.0003387904,"about_ca_system_score_gemma":0.000198329,"threshold_uncertainty_score":0.005522132},"labels":[],"label_agreement":null},{"id":"W2401152531","doi":"10.1158/2326-6074.cricimteatiaacr15-b096","title":"Abstract B096: Oncolytic vaccination for HPV induced cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; McMaster University","funders":"","keywords":"Oncolytic virus; Vaccination; Medicine; Cervical cancer; Cancer; Head and neck cancer; Immunotherapy; Immunology; Antigen; Disease; Oncology; Head and neck squamous-cell carcinoma; Cancer research; Virology; Internal medicine","score_opus":0.09600100539049997,"score_gpt":0.44479630692068883,"score_spread":0.3487953015301889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401152531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98276764,0.0031105967,0.009181483,0.00024411826,0.00016344404,0.0002050247,0.00086828065,0.0002079515,0.003251358],"genre_scores_gemma":[0.98695856,0.0017843,0.0053725773,0.00008147258,0.000026217118,0.000096195006,0.0011920822,0.000023644569,0.0044648894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999192,0.000011327957,0.0000054726884,0.000015005944,0.000025831001,0.000023164568],"domain_scores_gemma":[0.99997425,0.0000031353413,0.000006728311,0.0000029901178,0.000005005161,0.000007935936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008439548,0.000300307,0.00018502805,0.00019549846,0.00008807637,0.00018400043,0.00021295252,0.00034837154,0.0013435136],"category_scores_gemma":[0.00005926588,0.000097409225,0.00020961111,0.00009921165,0.00010664912,0.00013131097,0.00015287093,0.00068565825,0.00054878485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003204088,0.00028624953,0.0001475379,0.00006981796,0.000007280654,0.000030635863,0.000010332374,0.0002520839,0.99249333,0.00022730921,0.0002687112,0.0058863084],"study_design_scores_gemma":[0.00010881814,0.0056658746,0.0023221502,0.000019018342,0.000034670124,0.0004733435,0.0000128148,0.002429804,0.97833055,0.000106033316,0.010490069,0.000006880549],"about_ca_topic_score_codex":0.0005549415,"about_ca_topic_score_gemma":0.00032208042,"teacher_disagreement_score":0.0013435136,"about_ca_system_score_codex":0.00020940695,"about_ca_system_score_gemma":0.00018353766,"threshold_uncertainty_score":0.0044944882},"labels":[],"label_agreement":null},{"id":"W2401647293","doi":"10.1158/2326-6074.cricimteatiaacr15-a029","title":"Abstract A029: Cell-based cancer immunotherapy using tumor presenting cells: A phase II trial with local advance prostate cancer patients","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axela (Canada)","funders":"","keywords":"Immunotherapy; Medicine; Prostate cancer; MHC class I; Cancer research; Cytotoxic T cell; Cancer; Population; Antigen presentation; Cancer immunotherapy; Immunology; T cell; Antigen; Internal medicine; Major histocompatibility complex; Oncology; Immune system; Biology; In vitro","score_opus":0.036754641157797426,"score_gpt":0.36560618642976217,"score_spread":0.32885154527196475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401647293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196494,0.001752416,0.0007448631,0.00044930098,0.00021618721,0.003016834,0.00048661535,0.0000647548,0.0013040996],"genre_scores_gemma":[0.9810816,0.0016117124,0.002741878,0.0011215211,0.00039632167,0.005286086,0.0013372693,0.000021799302,0.0064017237],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997061,0.00014365195,0.000011554461,0.000048636633,0.000034937435,0.000055115255],"domain_scores_gemma":[0.9996309,0.0000783027,0.0000405424,0.000030823685,0.000026283604,0.00019313516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009958597,0.00091061246,0.0012522718,0.00038401576,0.00034840955,0.000728847,0.0005319881,0.0011565048,0.004563351],"category_scores_gemma":[0.00046483957,0.00024658526,0.00088756427,0.0003022778,0.00055289693,0.00037919782,0.00029434584,0.002209465,0.00056731136],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6843646,0.13942754,0.0028721285,0.0014244458,0.0007233333,0.0004427612,0.00019845167,0.002202295,0.06737342,0.0008069615,0.0037773317,0.09638677],"study_design_scores_gemma":[0.47291726,0.5179393,0.0022450832,0.000034796878,0.0001920579,0.00015525178,0.000033085198,0.00087278645,0.003473506,0.00015787601,0.0019618769,0.000017111844],"about_ca_topic_score_codex":0.00040134997,"about_ca_topic_score_gemma":0.000723997,"teacher_disagreement_score":0.004563351,"about_ca_system_score_codex":0.00025895226,"about_ca_system_score_gemma":0.0006527226,"threshold_uncertainty_score":0.015265942},"labels":[],"label_agreement":null},{"id":"W2407340489","doi":"10.1158/2326-6074.cricimteatiaacr15-b082","title":"Abstract B082: Reovirus treated NK cells exhibit enhanced cetuximab mediated antibody- dependent cellular cytotoxicity against colorectal cancer cell lines","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cetuximab; Cytotoxicity; Cytotoxic T cell; Cancer research; Antibody; Interleukin 12; Immune system; Cancer cell; Chemistry; Immunology; Biology; Cancer; Monoclonal antibody; In vitro; Biochemistry","score_opus":0.028833994554002384,"score_gpt":0.3471352347735426,"score_spread":0.3183012402195402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407340489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371874,0.0012257225,0.0010731393,0.00010876395,0.00009351303,0.00003959168,0.000962673,0.00007961728,0.0026981176],"genre_scores_gemma":[0.9874873,0.00040569718,0.001736824,0.000074244585,0.000013218783,0.00006266682,0.002308225,0.00002068086,0.007891227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983287,0.000023454697,0.000020530646,0.000032139065,0.000045520133,0.00004543712],"domain_scores_gemma":[0.999923,0.00001715044,0.000009715324,0.000014370729,0.000019377068,0.000016250444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008499556,0.00027112826,0.00030675327,0.00011524901,0.000096503994,0.00027200443,0.00015811958,0.0003579045,0.0036006302],"category_scores_gemma":[0.00012019091,0.00010182054,0.00022646828,0.00009523139,0.00011017011,0.00014306916,0.00013564296,0.0006103261,0.000941542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018680375,0.000057063222,0.0001372164,0.000038336166,0.0000034988311,0.000044157452,0.000012713185,0.00006270793,0.9984641,0.000029538809,0.00012796822,0.0008359633],"study_design_scores_gemma":[0.000031115156,0.00073052594,0.003786402,0.000007841908,0.0000100320485,0.00031661638,0.000028558048,0.0005999815,0.9920976,0.000013310168,0.0023737694,0.000004306631],"about_ca_topic_score_codex":0.0014738146,"about_ca_topic_score_gemma":0.0012537326,"teacher_disagreement_score":0.0036006302,"about_ca_system_score_codex":0.00023190543,"about_ca_system_score_gemma":0.00014299278,"threshold_uncertainty_score":0.012045324},"labels":[],"label_agreement":null},{"id":"W2407448809","doi":"10.1158/2326-6074.cricimteatiaacr15-a134","title":"Abstract A134: The immunoregulatory enzyme IDO induces resistance to common chemotherapy drugs via base excision repair pathway","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute","funders":"","keywords":"Cancer research; Immune system; Indoleamine 2,3-dioxygenase; Medicine; Immunotherapy; CD8; Immunology; Biology","score_opus":0.05595747684208299,"score_gpt":0.3480774577969711,"score_spread":0.2921199809548881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407448809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314296,0.001407244,0.0020204368,0.00015760213,0.00009636818,0.000042098374,0.0008569701,0.00009464134,0.0021816827],"genre_scores_gemma":[0.9953381,0.00037196945,0.00057695986,0.00006453776,0.000011494763,0.00002159939,0.0007978746,0.000009651871,0.0028077594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999014,0.000012713409,0.000009280665,0.000021870896,0.00002565024,0.000029066114],"domain_scores_gemma":[0.99994016,0.000009861705,0.000013927155,0.000011241527,0.000008285569,0.000016416727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007606852,0.00020224357,0.00023599782,0.00014610631,0.00010266133,0.0001637121,0.00011566858,0.000226067,0.0033854255],"category_scores_gemma":[0.00006930678,0.00007065962,0.00029002424,0.00012992337,0.0001303551,0.00009850088,0.00011783141,0.0005142353,0.00058320205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018471853,0.00005780238,0.00029396187,0.000028182616,0.00000589297,0.00004803782,0.0000060727657,0.000034801615,0.9977895,0.00006497248,0.00011131908,0.00137476],"study_design_scores_gemma":[0.000024470939,0.00068067823,0.005113673,0.0000033672468,0.000015236286,0.00028571868,0.00001752793,0.00044416223,0.9911404,0.00004090852,0.002231691,0.0000021436738],"about_ca_topic_score_codex":0.00040141903,"about_ca_topic_score_gemma":0.00025180855,"teacher_disagreement_score":0.0033854255,"about_ca_system_score_codex":0.00018746003,"about_ca_system_score_gemma":0.00012907787,"threshold_uncertainty_score":0.011325359},"labels":[],"label_agreement":null},{"id":"W2408318972","doi":"10.1158/2326-6074.cricimteatiaacr15-b074","title":"Abstract B074: Tumor-reactive CD4+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"CIITA; Cancer research; CD8; Cancer; Major histocompatibility complex; Immunotherapy; T cell; Tumor-infiltrating lymphocytes; MHC class I; Medicine; Biology; Immune system; Immunology; MHC class II; Internal medicine","score_opus":0.0541671101081283,"score_gpt":0.3716468242514702,"score_spread":0.3174797141433419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408318972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887234,0.00031871127,0.00009302941,0.000040199666,0.0000046314317,0.000019365387,0.000047953654,0.000010141304,0.0005935935],"genre_scores_gemma":[0.99903643,0.00010598964,0.00017995124,0.000079644415,0.000025055753,0.000021384774,0.00020341037,0.0000040838004,0.0003440819],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989545,0.000026132751,0.000010364283,0.000023122679,0.000016016198,0.000028925684],"domain_scores_gemma":[0.9998233,0.000054089807,0.000027162758,0.000010748187,0.00001524732,0.00006942851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022526164,0.0002927562,0.0004528737,0.00029525254,0.00031041037,0.0002688158,0.0001704081,0.00043599406,0.0026415237],"category_scores_gemma":[0.00042576218,0.0001371034,0.00016801617,0.00017300982,0.00020588901,0.00017162439,0.0001292487,0.00029202137,0.00044519998],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015396419,0.0013115242,0.5535121,0.00038619223,0.00013842889,0.018594325,0.000599229,0.000849935,0.35243714,0.00020265114,0.0022319441,0.054340135],"study_design_scores_gemma":[0.0011761502,0.026667621,0.863766,0.000074879776,0.00028117202,0.053396367,0.0003762394,0.003047779,0.04461858,0.0001753205,0.0063939285,0.000025896743],"about_ca_topic_score_codex":0.00043263208,"about_ca_topic_score_gemma":0.00043854778,"teacher_disagreement_score":0.0026415237,"about_ca_system_score_codex":0.00027713116,"about_ca_system_score_gemma":0.00014721417,"threshold_uncertainty_score":0.008836806},"labels":[],"label_agreement":null},{"id":"W2421079281","doi":"10.1158/2326-6074.tumimm14-a49","title":"Abstract A49: Systemic oncolytic reovirus for the treatment of primary and secondary brain tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Virotherapy; Glioma; Immunotherapy; Radiation therapy; Cancer research; Systemic administration; Immune system; Immunology; In vivo; Internal medicine; Biology","score_opus":0.08491880032555363,"score_gpt":0.3954175406100843,"score_spread":0.3104987402845306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421079281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985879,0.0027582955,0.005176875,0.00024213201,0.00015521768,0.00052064325,0.0007653946,0.00019231516,0.004310148],"genre_scores_gemma":[0.99046296,0.0014310357,0.0032632495,0.000102177095,0.000063538806,0.00031785312,0.0010755325,0.000039215483,0.0032444028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991965,0.00001344676,0.0000045934,0.000021791053,0.000016123635,0.000024417555],"domain_scores_gemma":[0.9999156,0.000017629922,0.0000115602,0.000011935477,0.0000075178546,0.00003573587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019000687,0.00039587697,0.00052924635,0.00024639044,0.00015630289,0.00032124936,0.00023907133,0.000345154,0.0034972364],"category_scores_gemma":[0.000110679546,0.00008606973,0.0003814786,0.00014529219,0.00027427473,0.0001898993,0.00018903251,0.0009436992,0.0006135318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006124793,0.003525284,0.0015338026,0.0002632077,0.00008877455,0.00039964035,0.000060968072,0.0009961805,0.9244115,0.00053028716,0.0021540176,0.059911452],"study_design_scores_gemma":[0.005934323,0.12520869,0.021579355,0.00006697521,0.00031088913,0.0036365103,0.00007210068,0.0056176335,0.81966215,0.00036977508,0.017505063,0.00003643373],"about_ca_topic_score_codex":0.0007607598,"about_ca_topic_score_gemma":0.0010420955,"teacher_disagreement_score":0.0034972364,"about_ca_system_score_codex":0.00024890815,"about_ca_system_score_gemma":0.00040732723,"threshold_uncertainty_score":0.011699438},"labels":[],"label_agreement":null},{"id":"W2510555501","doi":"10.1158/2326-6066.cir-15-0189","title":"Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université du Québec; Sunnybrook Hospital; Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval; Mediprobe Research (Canada); Hamilton Health Sciences; McMaster University","funders":"National Cancer Institute","keywords":"MUC1; Glycopeptide; Immunotherapy; Medicine; Antigen; CD8; Immunology; Immune system; Prostate cancer; Vaccination; Cancer; Internal medicine; Biology; Microbiology","score_opus":0.03450507726481634,"score_gpt":0.3604231592846476,"score_spread":0.32591808201983125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510555501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616396,0.0011332405,0.00025681956,0.00023923679,0.000097355456,0.0010634846,0.00021554703,0.000045915855,0.00078430487],"genre_scores_gemma":[0.99530965,0.00082805764,0.00052924827,0.00036429102,0.000108111555,0.0010102792,0.0004904381,0.000012945287,0.0013470851],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971443,0.00012483362,0.000011633169,0.000042785454,0.00002323185,0.00008299098],"domain_scores_gemma":[0.99955004,0.00005088155,0.00005899172,0.00005113865,0.000030281719,0.00025871664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010807115,0.0011674761,0.0012386144,0.0002806267,0.00040075643,0.0005235351,0.000557622,0.00080592046,0.0013689604],"category_scores_gemma":[0.00048324087,0.00037095428,0.00062590867,0.00019748663,0.00077740743,0.0003181973,0.00023925921,0.0018301342,0.0003310753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4577325,0.1469866,0.009243672,0.0012388867,0.0011665549,0.00095867406,0.0008293793,0.0035852632,0.25543016,0.00068684225,0.0045043402,0.11763716],"study_design_scores_gemma":[0.14559002,0.8240605,0.014144763,0.000031295793,0.00030416236,0.00034535944,0.00007739602,0.001504558,0.010565525,0.00013070928,0.0032229053,0.00002272479],"about_ca_topic_score_codex":0.002112208,"about_ca_topic_score_gemma":0.002603278,"teacher_disagreement_score":0.002112208,"about_ca_system_score_codex":0.00068797177,"about_ca_system_score_gemma":0.0013224719,"threshold_uncertainty_score":0.00571537},"labels":[],"label_agreement":null},{"id":"W2513504681","doi":"10.1158/2326-6066.cir-16-0179","title":"Zeroing in on Tumor-Reactive TILs","year":2016,"lang":"en","type":"letter","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Adoptive cell transfer; Cancer immunotherapy; Cancer; Immunotherapy; Cancer research; Adoptive immunotherapy; Tumor cells; Medicine; Immunology; T cell; Immune system; Internal medicine","score_opus":0.11938313846503769,"score_gpt":0.4404190876862732,"score_spread":0.3210359492212355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513504681","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49699757,0.024337068,0.05001809,0.18472901,0.027734268,0.00056552596,0.0006263657,0.0030082131,0.21198393],"genre_scores_gemma":[0.8798923,0.0039838483,0.00505855,0.0358831,0.006620576,0.0001077393,0.00017560196,0.00012306633,0.06815526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962306,0.00009836391,0.000021716285,0.000058728827,0.000100115496,0.00009798987],"domain_scores_gemma":[0.9995752,0.00019954176,0.00004053743,0.00007506145,0.00006107524,0.000048569313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028595273,0.00040298182,0.0003952318,0.00019321518,0.00042384048,0.00075741427,0.00025528885,0.0017131813,0.0040241326],"category_scores_gemma":[0.0012367329,0.00010984137,0.0003602605,0.00009772966,0.00044265165,0.00055898906,0.00024504567,0.0028888886,0.002687611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002871351,0.0007203134,0.008862596,0.0008844819,0.00008764232,0.056845304,0.00073603354,0.0013461635,0.19063672,0.03983763,0.18528764,0.51188403],"study_design_scores_gemma":[0.00035081757,0.0017735953,0.0040317075,0.0001761814,0.00011210814,0.048015896,0.00040370304,0.0046137674,0.20020033,0.028915415,0.7113643,0.000042115793],"about_ca_topic_score_codex":0.00020478926,"about_ca_topic_score_gemma":0.0003228924,"teacher_disagreement_score":0.0040241326,"about_ca_system_score_codex":0.00082190736,"about_ca_system_score_gemma":0.00020115275,"threshold_uncertainty_score":0.013462007},"labels":[],"label_agreement":null},{"id":"W2546886006","doi":"10.1158/2326-6066.imm2016-a144","title":"Abstract A144: Urease-mediated alkalization of tumor microenvironment and its effects on T cell proliferation, cytokine release, and PD-1/PD-L1 interactions","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Tumor microenvironment; Jurkat cells; Cancer cell; Cytotoxic T cell; Cytokine; Chemistry; Immunoconjugate; Cancer immunotherapy; Cancer research; Immunotherapy; Cell culture; T cell; Immune system; Biology; Molecular biology; Biochemistry; Cancer; In vitro; Immunology; Antibody; Monoclonal antibody","score_opus":0.017164598413812765,"score_gpt":0.31769814106090993,"score_spread":0.3005335426470972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546886006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644333,0.0012446344,0.0010327665,0.000047417947,0.000028755803,0.000026845235,0.00020016795,0.000030394116,0.0009456681],"genre_scores_gemma":[0.9964204,0.0005085374,0.00088381843,0.000044540404,0.000012555938,0.000028563274,0.00033459664,0.000005883795,0.0017610863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993455,0.000011157302,0.000005666089,0.000012726252,0.00001813093,0.000017718428],"domain_scores_gemma":[0.9999647,0.000006349124,0.000011276561,0.0000030079561,0.0000058083306,0.0000087314775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008494565,0.00022479071,0.00015882753,0.00009318866,0.00007370961,0.00014722862,0.00010563597,0.0001870094,0.0019288522],"category_scores_gemma":[0.0000646587,0.00005950123,0.00017667252,0.00008106227,0.00011110972,0.00010635764,0.00010222292,0.00024882416,0.00027115748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017022944,0.0000250829,0.00012819102,0.000029265932,0.0000023639607,0.000032362103,0.0000053493727,0.000038912152,0.9985453,0.000022940903,0.00003642162,0.00096361194],"study_design_scores_gemma":[0.000017045795,0.000570997,0.0013559897,0.0000023742366,0.000004972801,0.00008879551,0.0000071229642,0.00029510455,0.9967739,0.000012176157,0.0008698058,0.000001666382],"about_ca_topic_score_codex":0.00024266279,"about_ca_topic_score_gemma":0.00020450419,"teacher_disagreement_score":0.0019288522,"about_ca_system_score_codex":0.0001281506,"about_ca_system_score_gemma":0.00010221209,"threshold_uncertainty_score":0.0064526796},"labels":[],"label_agreement":null},{"id":"W2547013708","doi":"10.1158/2326-6066.imm2016-a019","title":"Abstract A019: Chimeric antigen receptors (CARs) as a low-impact treatment of pediatric ependymomas","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Chimeric antigen receptor; Medicine; Oncology; Cancer research; Internal medicine; Antigen; Targeted therapy; Immunotherapy; Pathology; Immunology; Cancer","score_opus":0.07416632144904588,"score_gpt":0.42540981846735254,"score_spread":0.35124349701830665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547013708","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96133983,0.017178705,0.00614928,0.0010650964,0.00034457623,0.0003069002,0.002676946,0.0005657277,0.010372909],"genre_scores_gemma":[0.96692574,0.010523872,0.007434179,0.00056397903,0.000078123725,0.00024657798,0.004889947,0.00010464105,0.009232802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999099,0.000012238531,0.0000063136176,0.000019786328,0.000030831197,0.000020911348],"domain_scores_gemma":[0.9999294,0.000012902098,0.000013883006,0.0000044296567,0.000017161086,0.000022272405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019835132,0.000251684,0.00029446176,0.0003012194,0.00013933801,0.00061201426,0.00029019764,0.0003212273,0.0031873279],"category_scores_gemma":[0.00019043166,0.00007870883,0.00034325026,0.00031889032,0.00012542766,0.00033396832,0.0002650238,0.0006900698,0.00096876663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043554143,0.0010678018,0.008888511,0.0009882449,0.00018393593,0.0021902998,0.00012283816,0.0029406631,0.7378698,0.0018089969,0.012226838,0.22735672],"study_design_scores_gemma":[0.0016017987,0.020315377,0.03376107,0.00025653144,0.00055729586,0.010869387,0.0003351968,0.008011067,0.7339853,0.000819676,0.18941309,0.000074201555],"about_ca_topic_score_codex":0.00060979294,"about_ca_topic_score_gemma":0.00091533025,"teacher_disagreement_score":0.0031873279,"about_ca_system_score_codex":0.0003564653,"about_ca_system_score_gemma":0.00030032702,"threshold_uncertainty_score":0.010662675},"labels":[],"label_agreement":null},{"id":"W2547018141","doi":"10.1158/2326-6066.imm2016-b092","title":"Abstract B092: Therapeutic targeting of tumorigenic EphA2+/EphA3+ brain tumor initiating cells with bi-specific antibody in glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Cancer research; Erythropoietin-producing hepatocellular (Eph) receptor; EPH receptor A2; SOX2; Population; Biology; Brain tumor; Glioma; Medicine; Immunology; Receptor; Pathology; Internal medicine; Embryonic stem cell; Receptor tyrosine kinase","score_opus":0.08607020072303567,"score_gpt":0.3796350187056222,"score_spread":0.29356481798258655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547018141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934196,0.0013400755,0.0022449812,0.00010825133,0.00003935858,0.00009399919,0.00058239984,0.0001844472,0.0019869031],"genre_scores_gemma":[0.99323386,0.00096248323,0.002567082,0.000075871365,0.000011068772,0.000081512524,0.0009115598,0.000026488944,0.002130109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992645,0.000009137289,0.0000061146275,0.000011500681,0.000020455756,0.000026284757],"domain_scores_gemma":[0.99997807,0.0000021627964,0.0000047566214,0.000002731852,0.0000036329275,0.00000867901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010503852,0.00034604062,0.00030224552,0.00023459793,0.00012241914,0.00024973182,0.00019297031,0.00021756702,0.00086763623],"category_scores_gemma":[0.00004685403,0.000098756784,0.00020398713,0.00018482299,0.000096605654,0.00008995968,0.00015091122,0.00041425097,0.000373356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016629415,0.000118579475,0.0001277469,0.000028292348,0.000010011715,0.000040850697,0.000007038984,0.00011835532,0.99624807,0.00008701768,0.00016817302,0.0028796133],"study_design_scores_gemma":[0.000101140926,0.0016140848,0.0055206222,0.0000060648676,0.000054471126,0.0005273773,0.000014874403,0.0023531998,0.9863712,0.00004727517,0.0033832537,0.0000064070296],"about_ca_topic_score_codex":0.0015939069,"about_ca_topic_score_gemma":0.00206513,"teacher_disagreement_score":0.0015939069,"about_ca_system_score_codex":0.00024312735,"about_ca_system_score_gemma":0.000273113,"threshold_uncertainty_score":0.0031692386},"labels":[],"label_agreement":null},{"id":"W2547041422","doi":"10.1158/2326-6066.imm2016-b028","title":"Abstract B028: Blockade of the CD47 “Do not eat” signal by TTI-621 (SIRPαFc) leads to enhanced antitumor CD8+ T cell responses in vitro","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Jurkat cells; Phagocytosis; CD47; Macrophage; T cell; Antigen; Biology; Antigen presentation; CD8; Cell biology; Molecular biology; Immunology; Immune system; In vitro; Biochemistry","score_opus":0.040441897818639314,"score_gpt":0.3396606586410613,"score_spread":0.299218760822422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547041422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951439,0.00089859724,0.0009200946,0.0001360195,0.000101317266,0.000056328292,0.0004694716,0.00008944731,0.0021848788],"genre_scores_gemma":[0.99352705,0.00043686634,0.0009318251,0.0001126592,0.000037917885,0.00007704731,0.0010901181,0.00002798771,0.0037584454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997789,0.000046005855,0.000023925908,0.000029822455,0.000045283396,0.000076049146],"domain_scores_gemma":[0.99983156,0.00003636036,0.00002422998,0.000020858066,0.000014182774,0.000072806804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018119905,0.0005432547,0.0004260395,0.00017049699,0.00014293853,0.0002949692,0.00022258182,0.0004277097,0.0021393897],"category_scores_gemma":[0.000119165874,0.00015319823,0.0002659568,0.00014000379,0.00018204884,0.00014524163,0.00013966684,0.0011526803,0.0010255093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084918557,0.00030991255,0.00006162497,0.00003337891,0.000006732114,0.00005331824,0.000014663426,0.000088158115,0.9973328,0.000045364024,0.00012935365,0.0010753697],"study_design_scores_gemma":[0.00018912181,0.00441321,0.0022365113,0.0000093418685,0.000021763064,0.00023174717,0.000023157252,0.0010674185,0.98997974,0.000030606137,0.0017920906,0.0000053141075],"about_ca_topic_score_codex":0.0005472059,"about_ca_topic_score_gemma":0.00039805783,"teacher_disagreement_score":0.0021393897,"about_ca_system_score_codex":0.00016250057,"about_ca_system_score_gemma":0.0002062521,"threshold_uncertainty_score":0.007156968},"labels":[],"label_agreement":null},{"id":"W2547074011","doi":"10.1158/2326-6066.imm2016-a029","title":"Abstract A029: A vaccine-induced, antigen-specific TH9 immune response blocks tumor cell engraftment","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immune system; Medicine; TLR3; Immunology; Carcinoembryonic antigen; Antigen; Cancer immunotherapy; Immunotherapy; Cancer research; Cancer vaccine; Cancer; Adjuvant; Toll-like receptor; Innate immune system; Internal medicine","score_opus":0.10201419043821038,"score_gpt":0.42256135599510314,"score_spread":0.3205471655568928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547074011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875073,0.0012342373,0.0067814407,0.00024447072,0.00025686828,0.00019941725,0.00048378253,0.00026930406,0.0030231134],"genre_scores_gemma":[0.9919045,0.00039379537,0.0030788423,0.00016858384,0.000060198883,0.00012048833,0.00045053975,0.00003335429,0.003789689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976176,0.000044375487,0.000021779657,0.000054397944,0.000045682977,0.00007201246],"domain_scores_gemma":[0.99989235,0.000026452617,0.00002482272,0.0000152125685,0.00001397052,0.000027185444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019221193,0.0005489,0.000342568,0.00019900942,0.00012378549,0.0002610427,0.00023051398,0.0006022436,0.003035436],"category_scores_gemma":[0.00014421847,0.00013024005,0.00033681004,0.000084336025,0.00025007373,0.00020069795,0.00017764703,0.0013254464,0.0008594659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036867344,0.00021944706,0.000049187103,0.00005511758,0.0000051453753,0.00002829595,0.0000073278466,0.000064121305,0.99759954,0.00008811015,0.00010054293,0.0014145123],"study_design_scores_gemma":[0.00012475572,0.0036113262,0.00072100485,0.000011228368,0.000017046157,0.00024639402,0.000011720671,0.0012605241,0.99144804,0.000061535386,0.0024826818,0.000003752738],"about_ca_topic_score_codex":0.00023729386,"about_ca_topic_score_gemma":0.00021936571,"teacher_disagreement_score":0.003035436,"about_ca_system_score_codex":0.00018858517,"about_ca_system_score_gemma":0.0002172037,"threshold_uncertainty_score":0.010154486},"labels":[],"label_agreement":null},{"id":"W2547344275","doi":"10.1158/2326-6066.imm2016-b058","title":"Abstract B058: Development of AVID200, a novel and highly potent TGF-beta neutralizing immunotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; National Research Council Canada","funders":"","keywords":"Cancer research; Immunotherapy; Tumor microenvironment; T cell; Ex vivo; Cancer immunotherapy; CD8; In vivo; Immune system; Medicine; Chemistry; Immunology; Biology","score_opus":0.12319739948423505,"score_gpt":0.4122587525665377,"score_spread":0.28906135308230263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547344275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570522,0.006661364,0.028520802,0.00037955685,0.0001052167,0.00034053656,0.0005729055,0.00031155895,0.0060558375],"genre_scores_gemma":[0.9731222,0.0023932455,0.01708278,0.0002114358,0.000046752655,0.00016380931,0.0013387685,0.000026098021,0.0056150244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999161,0.000009238546,0.000004467541,0.000017282526,0.0000338059,0.000019145855],"domain_scores_gemma":[0.9999653,0.0000031337051,0.000008464822,0.0000025717977,0.0000065983095,0.000013941405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018864847,0.00044597298,0.00017371435,0.00025155395,0.00009647942,0.00026981055,0.00046242587,0.0004969875,0.0011729711],"category_scores_gemma":[0.00007191867,0.00011406429,0.00020026421,0.00010586357,0.00011875705,0.00020835678,0.00016812434,0.0005794126,0.00042422916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002134878,0.00030790336,0.00013786517,0.00006857887,0.000010506324,0.00007878669,0.000016805332,0.00044272884,0.9798078,0.00035092593,0.00035824612,0.01820635],"study_design_scores_gemma":[0.00029656946,0.0045913276,0.0016181776,0.000017898667,0.000039175236,0.0010808777,0.000009345593,0.0046834038,0.9746027,0.00010937714,0.012939761,0.0000113412925],"about_ca_topic_score_codex":0.0005671678,"about_ca_topic_score_gemma":0.00055967196,"teacher_disagreement_score":0.0011729711,"about_ca_system_score_codex":0.0003094958,"about_ca_system_score_gemma":0.0002738791,"threshold_uncertainty_score":0.0039239526},"labels":[],"label_agreement":null},{"id":"W2547397748","doi":"10.1158/2326-6066.imm2016-b047","title":"Abstract B047: Combining natural killer T cell immunotherapy with chemotherapy induced immunogenic cell death to target post-surgical breast cancer metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Beatrice Hunter Cancer Research Institute","funders":"","keywords":"Immunotherapy; Medicine; Cancer research; Metastasis; Natural killer T cell; Cancer; Cyclophosphamide; Gemcitabine; Breast cancer; Metastatic breast cancer; Immunology; Dendritic cell; Immune system; T cell; Chemotherapy; Internal medicine","score_opus":0.029922730648486405,"score_gpt":0.32446925554331646,"score_spread":0.2945465248948301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547397748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98801804,0.0033203156,0.003107365,0.00045051676,0.00028628286,0.0003445122,0.00047623413,0.00019077481,0.0038059545],"genre_scores_gemma":[0.98807436,0.0020745734,0.0040883166,0.00025390257,0.000104427534,0.0002830517,0.0008383374,0.000025060073,0.0042578853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985504,0.000027082659,0.000010971401,0.00002026174,0.000033113356,0.000053434735],"domain_scores_gemma":[0.99994373,0.0000066754415,0.000013572546,0.000006882956,0.000007327833,0.000021842825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015957438,0.00043236229,0.00045362287,0.00035592247,0.00011663238,0.00031831532,0.00033870904,0.00045838475,0.0024392828],"category_scores_gemma":[0.000090441434,0.00013042621,0.00038847234,0.00017229271,0.00020254984,0.00018287663,0.00022331478,0.0008527999,0.00066196837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024174668,0.0019746204,0.00038453512,0.00021854816,0.000043546366,0.000100558565,0.000019256398,0.0005480568,0.97198695,0.00026593593,0.0007601588,0.021280289],"study_design_scores_gemma":[0.0012145999,0.024011852,0.0039444384,0.000036923797,0.00012162441,0.00054211874,0.000031185726,0.0023764083,0.959356,0.00016603869,0.008185625,0.0000132340165],"about_ca_topic_score_codex":0.00043197747,"about_ca_topic_score_gemma":0.00050436694,"teacher_disagreement_score":0.0024392828,"about_ca_system_score_codex":0.00022744681,"about_ca_system_score_gemma":0.00036840572,"threshold_uncertainty_score":0.0081602335},"labels":[],"label_agreement":null},{"id":"W2547825706","doi":"10.1158/2326-6066.cir-16-0197","title":"Immunological Mechanisms Underneath the Efficacy of Cancer Therapy","year":2016,"lang":"en","type":"review","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Cancer; Medicine; Immunotherapy; Immune system; Cancer therapy; Radiation therapy; Cancer immunotherapy; Immunology; Cancer cell; Cancer research; Internal medicine","score_opus":0.17314985950208764,"score_gpt":0.44932260760969994,"score_spread":0.2761727481076123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547825706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024137458,0.99652725,0.0002746796,0.0006058286,0.00025972433,0.0000044474054,0.000008184783,0.000010598282,0.0020679499],"genre_scores_gemma":[0.0054514,0.99100727,0.00030322268,0.0008559868,0.0009684424,0.000017936289,0.00001853875,0.0000041446183,0.0013730011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925524,0.00019699002,0.000071388065,0.00011261176,0.00027051303,0.000093218565],"domain_scores_gemma":[0.9996166,0.00018067566,0.000056233304,0.000019221301,0.00008308446,0.00004411985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010783873,0.00077516754,0.0016384334,0.0016019125,0.0003948663,0.0019623123,0.001099088,0.001974308,0.0026839415],"category_scores_gemma":[0.00088515953,0.00028578457,0.00041629243,0.0010123011,0.0023257856,0.0017903323,0.0011447137,0.003542416,0.0020802775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014977115,0.000074875905,0.00034327258,0.008494481,0.000061586885,0.0004993591,0.0002112948,0.00045762386,0.01159489,0.031454638,0.01780766,0.92885053],"study_design_scores_gemma":[0.000018957993,0.00019919648,0.0015673919,0.0026031246,0.00005033835,0.0021637848,0.00012304695,0.00012479885,0.0034943619,0.010743375,0.9788871,0.000024542356],"about_ca_topic_score_codex":0.0005034493,"about_ca_topic_score_gemma":0.0005125368,"teacher_disagreement_score":0.0026839415,"about_ca_system_score_codex":0.0011938136,"about_ca_system_score_gemma":0.0010349355,"threshold_uncertainty_score":0.008978665},"labels":[],"label_agreement":null},{"id":"W2548114147","doi":"10.1158/2326-6066.imm2016-b113","title":"Abstract B113: Translational studies demonstrate that treatment with anti-PD-1 in unresponsive tumors can be improved by enhancing T cell activation in the tumor microenvironment with vaccine based immune therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre; Ottawa Hospital; Immunovaccine (Canada)","funders":"","keywords":"Tumor microenvironment; Cancer research; Immunotherapy; ELISPOT; Immune system; Tumor antigen; Medicine; T cell; Antigen; Immunology; Tumor-infiltrating lymphocytes","score_opus":0.04414680086246734,"score_gpt":0.3164271387736874,"score_spread":0.27228033791122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548114147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8825777,0.0441151,0.010276155,0.00571982,0.0021330614,0.0007771087,0.004835667,0.00081183115,0.048753534],"genre_scores_gemma":[0.93458056,0.015804635,0.004358422,0.001435347,0.00040149348,0.00043115925,0.005765841,0.00014496711,0.037077576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988806,0.000015934162,0.000009305658,0.00002260323,0.000032656666,0.000031416483],"domain_scores_gemma":[0.99988234,0.0000124963035,0.000022463035,0.000012509897,0.000026250405,0.000043977263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004089676,0.00037388722,0.00029592888,0.00025060502,0.00018043218,0.00053067465,0.0002913431,0.00047262709,0.01495231],"category_scores_gemma":[0.00016942706,0.000088255525,0.0002703286,0.00019808275,0.00026241213,0.00028778735,0.00019377533,0.0015537995,0.0034333577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023276843,0.0021704482,0.0006631192,0.0006491507,0.000041699237,0.000114170245,0.00003711188,0.00021956244,0.92277235,0.0015584187,0.0067647863,0.0626815],"study_design_scores_gemma":[0.0015887714,0.0222861,0.017426418,0.00021560428,0.00015524478,0.0009438769,0.000105776104,0.00080313627,0.82388276,0.0009957122,0.1315779,0.00001859759],"about_ca_topic_score_codex":0.000557769,"about_ca_topic_score_gemma":0.000494769,"teacher_disagreement_score":0.01495231,"about_ca_system_score_codex":0.0003764026,"about_ca_system_score_gemma":0.0005720047,"threshold_uncertainty_score":0.050020456},"labels":[],"label_agreement":null},{"id":"W2548161278","doi":"10.1158/2326-6066.imm2016-a068","title":"Abstract A068: Determinants of efficacy in cancer immunovirotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Medicine; Immune system; Immunotherapy; Antigen; Immunology; Melanoma; Cancer immunotherapy; Cancer research; Cancer; Internal medicine","score_opus":0.0705228761182105,"score_gpt":0.4335871343961777,"score_spread":0.3630642582779672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548161278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929738,0.002488934,0.00088076264,0.00010544997,0.00003390804,0.000051360563,0.0002505463,0.000041677704,0.0031736253],"genre_scores_gemma":[0.99847454,0.00017880493,0.00047909722,0.00002852613,0.000013196972,0.000024291056,0.00014841443,0.000010199445,0.0006429253],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99924767,0.00026946614,0.0000596228,0.00008487154,0.00021203957,0.00012631863],"domain_scores_gemma":[0.9989404,0.0005497232,0.00015440019,0.000051359035,0.00016264284,0.00014140563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075396936,0.00026388388,0.00029608523,0.00045945263,0.00014137711,0.00062668766,0.00021670414,0.00054913363,0.0036695127],"category_scores_gemma":[0.001017963,0.00011675556,0.00019367428,0.00023747447,0.00026568916,0.00037091097,0.00022075386,0.0005748552,0.0008670721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001721258,0.00056890555,0.008062786,0.00010327251,0.00004281374,0.000066949695,0.000049805396,0.0010791273,0.9665062,0.00055446377,0.0004165192,0.020827904],"study_design_scores_gemma":[0.00011921752,0.013925637,0.047470734,0.000049618266,0.000094672876,0.0009013591,0.0001246057,0.008879922,0.9216302,0.0006389253,0.0061388267,0.000026328498],"about_ca_topic_score_codex":0.00026795093,"about_ca_topic_score_gemma":0.0001447192,"teacher_disagreement_score":0.0036695127,"about_ca_system_score_codex":0.0003363369,"about_ca_system_score_gemma":0.00017733258,"threshold_uncertainty_score":0.012275696},"labels":[],"label_agreement":null},{"id":"W2548323002","doi":"10.1158/2326-6066.imm2016-b053","title":"Abstract B053: Characterizing the effects of the DNA methylation inhibitor 5-AZA-CdR during CD8 T cell expansion","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Cytotoxic T cell; Cancer research; Immune system; Immune checkpoint; DNA methylation; Immunology; CD8; Cancer; Biology; T cell; Medicine; Genetics","score_opus":0.021777528994655,"score_gpt":0.3148692084796589,"score_spread":0.29309167948500386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548323002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939452,0.0015644728,0.0016355892,0.000063087595,0.000041784773,0.000044260596,0.00046676229,0.00006528193,0.0021734915],"genre_scores_gemma":[0.99608564,0.00027274567,0.0011165893,0.000056932993,0.000008927664,0.000026702515,0.0004908593,0.000013563365,0.0019280069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998779,0.000020912055,0.000007483908,0.000026334765,0.000031196276,0.000036104062],"domain_scores_gemma":[0.9999484,0.000013159503,0.000010678367,0.000004795944,0.00000794368,0.0000149064535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014554511,0.00015959052,0.00014295992,0.00010047937,0.000075799224,0.00018816844,0.00018273736,0.0002235636,0.0022009308],"category_scores_gemma":[0.00010533481,0.00006938256,0.00014058009,0.00008437962,0.00008510521,0.00009602894,0.00007010483,0.0005115694,0.00042406967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004915644,0.00012870276,0.00017309915,0.000030687064,0.000005734227,0.000015880027,0.0000080933,0.00029833303,0.99563414,0.000052489646,0.00012052504,0.0030408008],"study_design_scores_gemma":[0.00004814966,0.0023873055,0.0017978923,0.000003689832,0.000014698198,0.000046252604,0.000008017555,0.0020616879,0.99202126,0.00002531846,0.0015827293,0.0000030328467],"about_ca_topic_score_codex":0.0005770375,"about_ca_topic_score_gemma":0.00070533133,"teacher_disagreement_score":0.0022009308,"about_ca_system_score_codex":0.00018634638,"about_ca_system_score_gemma":0.00012683266,"threshold_uncertainty_score":0.0073628426},"labels":[],"label_agreement":null},{"id":"W2548441506","doi":"10.1158/2326-6066.imm2016-b034","title":"Abstract B034: Smac mimetics synergistically improve the efficacy of cancer immunotherapies including immune checkpoint blockade in preclinical models","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Oncolytic virus; Cancer research; Immune system; Cancer immunotherapy; Immune checkpoint; Cancer; Immunotherapy; Necroptosis; Immunogenic cell death; Cancer cell; Programmed cell death; T cell; Tumor necrosis factor alpha; Immunology; Biology; Medicine; Apoptosis; Internal medicine","score_opus":0.1215056807900822,"score_gpt":0.4196001246765551,"score_spread":0.2980944438864729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548441506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819935,0.0061664702,0.0041581225,0.00039826788,0.0003095393,0.00038418735,0.0013816619,0.0004413922,0.00476687],"genre_scores_gemma":[0.98453736,0.0030542298,0.0046254476,0.00017221553,0.00006110437,0.0004027531,0.0015455928,0.00006120498,0.0055400585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998111,0.000037365906,0.000015797987,0.000029605751,0.000049231545,0.000056868772],"domain_scores_gemma":[0.99986506,0.000016763686,0.000030620806,0.000014938453,0.000017772467,0.000054828477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033679223,0.0006918979,0.0005380438,0.00062467024,0.00016616407,0.00025636403,0.00037814296,0.00051553024,0.0028326106],"category_scores_gemma":[0.00011179126,0.00015954532,0.0003610883,0.00026504803,0.0002132819,0.00029950697,0.00015821338,0.001317205,0.0006189891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029731537,0.0018333357,0.00016381136,0.0002212526,0.00004541664,0.000055864326,0.000019594372,0.00045273613,0.9832888,0.00020825214,0.0008494524,0.009888449],"study_design_scores_gemma":[0.00038583955,0.01304352,0.0014942379,0.00001663142,0.000076482655,0.0001658363,0.000015207018,0.0008167191,0.9794997,0.000058467285,0.0044198832,0.0000074815143],"about_ca_topic_score_codex":0.0005437544,"about_ca_topic_score_gemma":0.00081594114,"teacher_disagreement_score":0.0028326106,"about_ca_system_score_codex":0.0002944626,"about_ca_system_score_gemma":0.000433671,"threshold_uncertainty_score":0.009476066},"labels":[],"label_agreement":null},{"id":"W2548887552","doi":"10.1158/2326-6066.imm2016-b079","title":"Abstract B079: The efficacy of CD133 BiTEs and CAR-T cells in preclinical model of recurrent glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Antigen; Flow cytometry; Antibody; Population; Peripheral blood mononuclear cell; Immunophenotyping; Monoclonal antibody; Cancer research; Immunology; Medicine; Chimeric antigen receptor; Immunotherapy; Biology; In vitro; Immune system","score_opus":0.13215498967667308,"score_gpt":0.44975309362495114,"score_spread":0.31759810394827803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548887552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945328,0.0009255153,0.0013592307,0.00022636612,0.00014071338,0.00019338167,0.0007442776,0.00022557932,0.00165199],"genre_scores_gemma":[0.992374,0.0009408886,0.0014759897,0.00012318684,0.000040451603,0.0003219261,0.0012822861,0.000034027464,0.0034071172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997261,0.00004606106,0.000021517902,0.0000467907,0.000059340862,0.00010010816],"domain_scores_gemma":[0.99987245,0.000015446505,0.0000202887,0.000017175267,0.000016881118,0.000057713954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003738646,0.00070537336,0.0008273973,0.0004991431,0.0002016232,0.00033661406,0.0004680248,0.0006964364,0.0019974273],"category_scores_gemma":[0.0001417079,0.00022559353,0.000487478,0.00029266352,0.00033556842,0.00031462868,0.00018846472,0.0020406127,0.00056596653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003986506,0.005568776,0.00019210845,0.00022475031,0.00006071364,0.00011832987,0.00009469504,0.00074647146,0.9763776,0.00035912753,0.001057104,0.011213787],"study_design_scores_gemma":[0.0007970295,0.054216165,0.0023576727,0.00002280221,0.00013006697,0.00021132799,0.000077714685,0.0033583294,0.93547404,0.00015957763,0.0031752966,0.00002006143],"about_ca_topic_score_codex":0.0016383849,"about_ca_topic_score_gemma":0.001313027,"teacher_disagreement_score":0.0019974273,"about_ca_system_score_codex":0.00031694566,"about_ca_system_score_gemma":0.00053169666,"threshold_uncertainty_score":0.006682098},"labels":[],"label_agreement":null},{"id":"W2548964503","doi":"10.1158/2326-6066.imm2016-b052","title":"Abstract B052: Peroxisome proliferator-activated receptor delta agonist GW501516 enhances the efficacy of adoptive cell therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Biology; Carnitine; T cell; Cancer research; Agonist; Receptor; Peroxisome proliferator-activated receptor delta; Cell biology; Transcription factor; Nuclear receptor; Immunology; Immune system; Endocrinology; Biochemistry","score_opus":0.054252749332955014,"score_gpt":0.3480888424261176,"score_spread":0.2938360930931626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548964503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224514,0.0015444312,0.0011338777,0.0002709566,0.00022098981,0.00013384459,0.0010937223,0.00025219878,0.0031048479],"genre_scores_gemma":[0.99275583,0.0007831972,0.0010767851,0.00020035366,0.0000343258,0.00017397237,0.00089649943,0.000024734534,0.004054284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982774,0.000029453437,0.00002040215,0.000028303977,0.000041893327,0.00005224101],"domain_scores_gemma":[0.9998969,0.000012055484,0.000022530816,0.000013164625,0.000008663107,0.000046609042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014208812,0.0005029361,0.00048593775,0.0003075976,0.00011664973,0.0003094474,0.00022435305,0.00048626025,0.0031919156],"category_scores_gemma":[0.000091175236,0.000111048284,0.00025975244,0.00020776737,0.0002598676,0.00018693131,0.00017498726,0.0013827592,0.0009292371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031604338,0.0012838971,0.00037853947,0.00021155502,0.000027661199,0.00009173528,0.000035997724,0.00046561504,0.98071516,0.0001584566,0.00093571865,0.012535272],"study_design_scores_gemma":[0.0004547983,0.010664314,0.0033337744,0.000029420104,0.00006539546,0.00021657419,0.00006297831,0.001219458,0.9788754,0.00008268386,0.0049853628,0.000009931506],"about_ca_topic_score_codex":0.00050727115,"about_ca_topic_score_gemma":0.0005571388,"teacher_disagreement_score":0.0031919156,"about_ca_system_score_codex":0.00016983047,"about_ca_system_score_gemma":0.00030659538,"threshold_uncertainty_score":0.010678053},"labels":[],"label_agreement":null},{"id":"W2548970834","doi":"10.1158/2326-6066.imm2016-b103","title":"Abstract B103: Intralesional administration of CTLA-4 blocking monoclonal antibodies as a means to optimize bladder cancer therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Cancer; Cytokine release syndrome; Immunology; Oncology; Internal medicine; Chimeric antigen receptor","score_opus":0.11231420276211847,"score_gpt":0.4422574268791818,"score_spread":0.32994322411706334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548970834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575514,0.017020049,0.017425578,0.0005992749,0.0003072521,0.00025604342,0.00031964402,0.00048463463,0.006036039],"genre_scores_gemma":[0.9874352,0.0024148596,0.0065478752,0.00021769456,0.000054921733,0.00011656896,0.00021904404,0.00004976085,0.0029441086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999936,0.000012773569,0.000004333051,0.000014079336,0.00001677348,0.000016095462],"domain_scores_gemma":[0.99995196,0.0000070572546,0.000015571935,0.00000409721,0.0000054897623,0.000015833157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013541292,0.00027656762,0.0002743432,0.0002497999,0.00009923511,0.0003217192,0.00024569206,0.00030470305,0.0024144365],"category_scores_gemma":[0.000097863296,0.00007781194,0.0001353387,0.00015611583,0.00012376283,0.00013973996,0.00011882117,0.0007352971,0.00046534877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065546157,0.0005730425,0.00021451918,0.0001752022,0.000012032718,0.00005113093,0.000011929882,0.0003213767,0.96006846,0.00017273353,0.0004974816,0.03724665],"study_design_scores_gemma":[0.00041980456,0.013103332,0.003648543,0.000054084583,0.000116782256,0.000655772,0.000020953266,0.0024791711,0.96699464,0.00013716135,0.012354179,0.000015522677],"about_ca_topic_score_codex":0.0005931352,"about_ca_topic_score_gemma":0.00059968786,"teacher_disagreement_score":0.0024144365,"about_ca_system_score_codex":0.00020684213,"about_ca_system_score_gemma":0.00023704422,"threshold_uncertainty_score":0.008077085},"labels":[],"label_agreement":null},{"id":"W2566878474","doi":"10.1158/2326-6074.tumimm14-ia22","title":"Abstract IA22: Regulation of metabolic plasticity in effector T cells","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Effector; Cell biology; Biology; AMPK; T cell; Acquired immune system; Bioenergetics; Immune system; Kinase; Protein kinase A; Immunology; Mitochondrion","score_opus":0.09428215381281056,"score_gpt":0.40043620735981783,"score_spread":0.30615405354700725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566878474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9104953,0.023771774,0.017250868,0.0028451984,0.0010802265,0.00013206805,0.0022430818,0.0008950189,0.041286547],"genre_scores_gemma":[0.9682433,0.0052822125,0.0037498474,0.0005001358,0.00013625265,0.00006548524,0.0012177299,0.00010763988,0.020697411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998845,0.000017710783,0.000009361221,0.0000307886,0.000028760684,0.000028818095],"domain_scores_gemma":[0.99992406,0.000009585533,0.00002064491,0.000009612886,0.00001349107,0.000022597751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012876722,0.00035210125,0.00026709444,0.0002911601,0.00018875353,0.00067630614,0.00037514343,0.00036730195,0.004424814],"category_scores_gemma":[0.000120651704,0.000111658635,0.00020322323,0.00025828797,0.00027134677,0.00024783114,0.00029078923,0.0005834792,0.001286999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029727977,0.000028268425,0.00024090846,0.000075643584,0.000004309012,0.00014417357,0.000009031582,0.00017166977,0.99169135,0.00057233684,0.00062332564,0.0061417334],"study_design_scores_gemma":[0.000048678303,0.0003484885,0.01054719,0.000022202119,0.000019971687,0.00060937484,0.000049093695,0.001042105,0.96696186,0.0007861088,0.019544622,0.000020353691],"about_ca_topic_score_codex":0.00027196034,"about_ca_topic_score_gemma":0.00032894785,"teacher_disagreement_score":0.004424814,"about_ca_system_score_codex":0.00047375966,"about_ca_system_score_gemma":0.00019199833,"threshold_uncertainty_score":0.014802456},"labels":[],"label_agreement":null},{"id":"W2585311655","doi":"10.1158/2326-6066.cir-16-0162","title":"NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Interleukin 12; Oncolytic virus; Medicine; Cancer research; Dendritic cell; Cytotoxic T cell; Immunotherapy; Immunology; Debulking; Ovarian cancer; Ex vivo; Immunogenic cell death; Cancer; Immune system; In vivo; Biology; Internal medicine; In vitro","score_opus":0.10533089748509131,"score_gpt":0.40601420218892603,"score_spread":0.30068330470383475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585311655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522203,0.0011846361,0.0011333562,0.00014454203,0.000042863023,0.00004772677,0.0002058063,0.000093708004,0.0019252398],"genre_scores_gemma":[0.9974886,0.00030719268,0.00076175167,0.000026763495,0.000008234381,0.000028583918,0.0002411268,0.0000072418898,0.0011304975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990106,0.000018045142,0.0000081202525,0.0000147909495,0.00002157189,0.00003638648],"domain_scores_gemma":[0.9999281,0.000015739844,0.00002010741,0.000011288362,0.00000796672,0.000016766518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008198341,0.00021063027,0.00021326443,0.00007825067,0.000118882585,0.00027398512,0.00011469426,0.00021421247,0.0021659278],"category_scores_gemma":[0.00012475812,0.00007679599,0.00014732973,0.00005575313,0.00019530172,0.00011879725,0.00014231484,0.00061094883,0.0005046983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029649228,0.00010290949,0.00045940437,0.000048996004,0.000003794987,0.00007020375,0.000013507403,0.00011331321,0.9961119,0.0001185921,0.000122457,0.0025383572],"study_design_scores_gemma":[0.00012427913,0.0019588957,0.017575234,0.000026266507,0.000034000917,0.00089299225,0.00007649805,0.0028551957,0.96634865,0.000109869725,0.009991515,0.000006638661],"about_ca_topic_score_codex":0.0005990421,"about_ca_topic_score_gemma":0.00072722486,"teacher_disagreement_score":0.0021659278,"about_ca_system_score_codex":0.00026061892,"about_ca_system_score_gemma":0.000280289,"threshold_uncertainty_score":0.0072457194},"labels":[],"label_agreement":null},{"id":"W2592537573","doi":"10.1158/2326-6074.tumimm16-a64","title":"Abstract A64: Mast cell expressed FcεR beta subunit (MS4A2) is prognostic in lung adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Adenocarcinoma; Gene signature; Lung cancer; Immune system; Biology; Cancer research; Carcinogenesis; Microarray analysis techniques; Gene expression profiling; Cancer; Immunology; Medicine; Oncology; Gene; Gene expression; Genetics","score_opus":0.05939431534377648,"score_gpt":0.34024845308764096,"score_spread":0.2808541377438645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592537573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969591,0.00043325892,0.00038157232,0.00008478107,0.000008333617,0.0000073142987,0.0018958971,0.000015962893,0.00021383527],"genre_scores_gemma":[0.99702376,0.00006977826,0.0002908354,0.000021406879,0.000008967377,0.000008449948,0.0023972376,0.0000031461468,0.0001764021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974626,0.000052453506,0.000030383713,0.00008249687,0.000056037476,0.00003241546],"domain_scores_gemma":[0.999252,0.00027974107,0.00020339277,0.00005188264,0.00009784966,0.00011520682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054719753,0.00025063226,0.00034541107,0.000601403,0.00024403424,0.0005156747,0.00026837407,0.00033377545,0.0023831395],"category_scores_gemma":[0.0014891755,0.000089774396,0.00042814497,0.00075783505,0.00017750532,0.00023522574,0.00030119068,0.0003164933,0.0003357026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018040395,0.000056930676,0.96198386,0.00008797855,0.00025588955,0.00012057329,0.000024792262,0.00048480084,0.027189262,0.000027680486,0.00061400107,0.0073502986],"study_design_scores_gemma":[0.000028491779,0.00016156801,0.99185634,0.000012967771,0.00017973405,0.00046732795,0.00005853492,0.002309423,0.0042641,0.00012813875,0.0005278372,0.000005548762],"about_ca_topic_score_codex":0.00091805536,"about_ca_topic_score_gemma":0.0011652563,"teacher_disagreement_score":0.0023831395,"about_ca_system_score_codex":0.0002333638,"about_ca_system_score_gemma":0.00031464308,"threshold_uncertainty_score":0.007972419},"labels":[],"label_agreement":null},{"id":"W2593211024","doi":"10.1158/2326-6074.tumimm16-a51","title":"Abstract A51: Early-life infection delays B cell precursor leukemia onset in Eu-Ret mice via an IL-23-dependent depletion of leukemia-initiating cells","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Leukemia; Medicine; Immunology; Epidemiology; Population; Disease; In utero; Internal medicine; Cancer research; Biology; Pregnancy; Fetus","score_opus":0.05886984749239877,"score_gpt":0.37392411001597525,"score_spread":0.3150542625235765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593211024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210453,0.00082213874,0.0026708762,0.00025327652,0.000059270755,0.000068679255,0.0015448384,0.0003587297,0.00211765],"genre_scores_gemma":[0.98570895,0.00050232856,0.0035673955,0.00015632385,0.000030940126,0.00013734319,0.0009334212,0.00013105666,0.008832352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944085,0.00010038155,0.000069779264,0.00014141914,0.0001113898,0.00013607708],"domain_scores_gemma":[0.9992914,0.00009158134,0.00027544834,0.00006899849,0.000037042562,0.0002354828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030868954,0.00077317783,0.00038145823,0.0008750924,0.00026494698,0.0005182304,0.00059995544,0.00093518844,0.0033209722],"category_scores_gemma":[0.00023635702,0.00038261915,0.000462466,0.00020813338,0.0006924919,0.00041690204,0.0003436407,0.002036926,0.001088724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002641043,0.00008104904,0.00014401092,0.00002354095,0.000004076721,0.000075089185,0.00001567261,0.000043871452,0.9985989,0.00009996849,0.000041168005,0.00060859113],"study_design_scores_gemma":[0.00007502435,0.0016738034,0.0060641416,0.0000233165,0.000025845664,0.00034986442,0.000066188186,0.0008596054,0.98859113,0.00007594173,0.0021818525,0.000013266931],"about_ca_topic_score_codex":0.0007778462,"about_ca_topic_score_gemma":0.0013774381,"teacher_disagreement_score":0.0033209722,"about_ca_system_score_codex":0.00046967308,"about_ca_system_score_gemma":0.00023116304,"threshold_uncertainty_score":0.01110971},"labels":[],"label_agreement":null},{"id":"W2594407313","doi":"10.1158/2326-6074.tumimm16-pr09","title":"Abstract PR09: A novel chimeric antigen receptor containing JAK-STAT signaling domains mediates superior antitumor effects","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chimeric antigen receptor; Cancer research; CD19; Cytokine; CD28; STAT5; T cell; T-cell receptor; JAK-STAT signaling pathway; Cytokine receptor; Signal transduction; Immunology; Biology; Medicine; Tyrosine kinase; Cell biology; Antigen; Immune system","score_opus":0.08268631610408858,"score_gpt":0.4196002134770678,"score_spread":0.33691389737297917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594407313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904794,0.0012757285,0.0053045917,0.00019464124,0.00004865423,0.000054470464,0.00037553662,0.00022369508,0.002043308],"genre_scores_gemma":[0.9949915,0.00033050057,0.0022588423,0.000041812607,0.000009305838,0.000022798818,0.000559878,0.00001901765,0.0017665055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998839,0.000018707125,0.000010554527,0.00002223088,0.000033089847,0.00003138985],"domain_scores_gemma":[0.99994993,0.0000070731144,0.00001318085,0.0000059446284,0.0000063461307,0.00001754619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014440849,0.00036062422,0.00020605259,0.00014944117,0.00008928376,0.00029019822,0.00028358796,0.00033218533,0.001882942],"category_scores_gemma":[0.00007187959,0.00011889948,0.00024869086,0.000109090855,0.00020681215,0.0002261804,0.00017334652,0.0006595926,0.0007596449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015249956,0.00006134335,0.00006616939,0.000023378116,0.000003825694,0.00002663268,0.0000042343663,0.00014238023,0.998054,0.0001528652,0.00008697595,0.0012256718],"study_design_scores_gemma":[0.00017105526,0.0012694314,0.0010686081,0.0000036959775,0.000027986413,0.00042469037,0.0000072544694,0.0023274287,0.99061066,0.000036123078,0.004048393,0.000004563231],"about_ca_topic_score_codex":0.0002710856,"about_ca_topic_score_gemma":0.00023989125,"teacher_disagreement_score":0.001882942,"about_ca_system_score_codex":0.00027284102,"about_ca_system_score_gemma":0.00020411282,"threshold_uncertainty_score":0.0062990785},"labels":[],"label_agreement":null},{"id":"W2594628337","doi":"10.1158/2326-6074.tumimm16-a28","title":"Abstract A28: Adenoviruses up-regulate IL17F, but not IL17A, and activate NK cells, with potential impact on oncolytic adenovirus efficacy","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Oncolytic virus; Oncolytic adenovirus; Chemokine; Biology; Cytokine; Adenoviridae; Immune system; Immunology; Cancer research; Genetic enhancement; Gene","score_opus":0.05472093910081956,"score_gpt":0.39546851840541564,"score_spread":0.3407475793045961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594628337","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370074,0.0014223417,0.0017507278,0.00009230545,0.00006158598,0.00004281318,0.0014414993,0.00008387164,0.0014041162],"genre_scores_gemma":[0.99195683,0.00051558245,0.0023408737,0.00006575299,0.000016852819,0.00007227458,0.0012251319,0.000038872928,0.0037677872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997483,0.00003389009,0.00003289699,0.000045991368,0.000062167244,0.000076747994],"domain_scores_gemma":[0.9997557,0.00006190798,0.0000566255,0.000029333025,0.000048761656,0.0000477183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022856878,0.00037790296,0.0002776299,0.00027009906,0.000109702676,0.00043095622,0.00013158885,0.00024260703,0.0051805703],"category_scores_gemma":[0.00021394649,0.00010270059,0.00030110285,0.00016824255,0.00027429746,0.00022880624,0.00017558511,0.0005550314,0.0008572772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002679553,0.000037518526,0.00030577503,0.000045293804,0.0000048097136,0.000012096785,0.0000069550315,0.00004400715,0.9980013,0.000035470744,0.000068104375,0.0011708036],"study_design_scores_gemma":[0.000032121345,0.0006048917,0.004416778,0.000008667665,0.0000119606475,0.00011891298,0.000030292069,0.0002976432,0.99229974,0.000031001524,0.0021447677,0.0000032497296],"about_ca_topic_score_codex":0.00050278177,"about_ca_topic_score_gemma":0.00039996734,"teacher_disagreement_score":0.0051805703,"about_ca_system_score_codex":0.00038173544,"about_ca_system_score_gemma":0.000251624,"threshold_uncertainty_score":0.017330706},"labels":[],"label_agreement":null},{"id":"W2594697025","doi":"10.1158/2326-6074.tumimm16-a74","title":"Abstract A74: CAR-T cells harboring camelid single domain antibody as targeting agent to CEACAM6 antigen in pancreatic cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Helix Biopharma (Canada)","funders":"","keywords":"Antigen; Antibody; Cancer research; Cytotoxic T cell; Biology; CD28; Chimeric antigen receptor; T cell; Pancreatic cancer; Molecular biology; Immunology; Cancer; Immune system; In vitro; CD8; Biochemistry","score_opus":0.0871099523506898,"score_gpt":0.44197770087871424,"score_spread":0.35486774852802444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594697025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904868,0.0013363671,0.0036096664,0.00014147827,0.00008450922,0.000095227646,0.00064166734,0.0002358013,0.0033684957],"genre_scores_gemma":[0.99364835,0.00042873496,0.0019214789,0.000097948556,0.000026595244,0.00006730192,0.0007269165,0.000023696544,0.0030589476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998242,0.000023771287,0.000013895558,0.000053752778,0.000030614738,0.000053683772],"domain_scores_gemma":[0.9999472,0.00000952689,0.000008237063,0.000007679274,0.000010322354,0.000016959077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012602842,0.0002849648,0.00037978406,0.0002718043,0.00016912249,0.00034626204,0.00023856104,0.00059029507,0.0024866194],"category_scores_gemma":[0.000088933324,0.00013219014,0.00043606042,0.0002386384,0.00013371703,0.000203064,0.00018274764,0.0006461503,0.0009716603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019821063,0.000091426475,0.00017885368,0.000038731792,0.0000064237024,0.000119286735,0.000015148955,0.00014184564,0.997652,0.00010292696,0.00020916415,0.0012459966],"study_design_scores_gemma":[0.00006465149,0.0011312565,0.002051373,0.000004976856,0.00002933503,0.0007235454,0.00001596117,0.0017386234,0.9898262,0.000036223788,0.0043711048,0.000006617156],"about_ca_topic_score_codex":0.0006788604,"about_ca_topic_score_gemma":0.00024607373,"teacher_disagreement_score":0.0024866194,"about_ca_system_score_codex":0.00035733153,"about_ca_system_score_gemma":0.00015615171,"threshold_uncertainty_score":0.008318543},"labels":[],"label_agreement":null},{"id":"W2594818459","doi":"10.1158/2326-6074.tumimm16-a68","title":"Abstract A68: Phosphodiesterase-5 inhibition modulates surgery-induced myeloid-derived suppressor cells to reduce postoperative metastatic disease","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Université de Sherbrooke","funders":"","keywords":"Medicine; Perioperative; Immunosuppression; Myeloid-derived Suppressor Cell; Immune system; Cancer; Metastasis; Immunotherapy; Pharmacology; Cancer cell; Immunology; Cancer research; Surgery; Internal medicine; Suppressor","score_opus":0.098180305023975,"score_gpt":0.3799785207298601,"score_spread":0.2817982157058851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594818459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915701,0.0039047548,0.0016222324,0.00023094301,0.00022599654,0.00006952747,0.00059026084,0.00011804057,0.0016680468],"genre_scores_gemma":[0.9949281,0.0012522368,0.00079996407,0.0001425409,0.00006929692,0.000049757047,0.00051429885,0.000008493686,0.0022352876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992657,0.000008823936,0.000009627241,0.000013544074,0.000019536863,0.000021838056],"domain_scores_gemma":[0.9999523,0.000005451517,0.000015320933,0.0000036853442,0.0000052983796,0.000017885528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009585969,0.0003321993,0.00025367245,0.00010961797,0.00009904443,0.0002048539,0.00013798909,0.00020822689,0.002896208],"category_scores_gemma":[0.00006996438,0.00006692872,0.00025793706,0.000068165034,0.00015451698,0.00010458735,0.00009309372,0.000595566,0.00045288104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017980369,0.0004790537,0.00087535486,0.0002005836,0.000025900856,0.000043174125,0.000017911063,0.00013723235,0.9829185,0.00011987861,0.00049498084,0.012889389],"study_design_scores_gemma":[0.00053811836,0.012503808,0.020872338,0.000027481683,0.00012964437,0.0002821466,0.000055814777,0.0015437794,0.9566062,0.000070866154,0.0073603424,0.000009409048],"about_ca_topic_score_codex":0.0002479387,"about_ca_topic_score_gemma":0.0004403604,"teacher_disagreement_score":0.002896208,"about_ca_system_score_codex":0.00013574427,"about_ca_system_score_gemma":0.00024873164,"threshold_uncertainty_score":0.009688795},"labels":[],"label_agreement":null},{"id":"W2621331192","doi":"10.1158/2326-6066.cir-17-0224","title":"Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology Keystone Symposia Meeting Summary","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Institutes for BioMedical Research; California Institute of Technology; University of California, San Francisco; Memorial Sloan-Kettering Cancer Center; University of California, San Diego; National Cancer Institute; National Institutes of Health; Cancer Research Institute","keywords":"Tumor immunology; Immunotherapy; Medicine; Cancer immunotherapy; Mainstream; Cancer; Cancer immunology; Clinical Oncology; Immunology; Oncology; Internal medicine; Political science","score_opus":0.06634672360924461,"score_gpt":0.4207497187492648,"score_spread":0.3544029951400202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621331192","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009408327,0.090541534,0.003930159,0.36229897,0.43501055,0.00048368392,0.0010257763,0.0005999925,0.096700996],"genre_scores_gemma":[0.08651348,0.1279164,0.00787254,0.08145237,0.3360361,0.00081441307,0.003502642,0.00064896257,0.3552431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740845,0.000482585,0.00014607178,0.0001846362,0.00083633355,0.00094183226],"domain_scores_gemma":[0.9896067,0.00047520842,0.00034963366,0.00016497729,0.0024127883,0.0069906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006964389,0.0011234414,0.0005369623,0.0015577786,0.0017866021,0.008087722,0.0011303265,0.0026634801,0.049644537],"category_scores_gemma":[0.0048501436,0.0003610713,0.0007948846,0.0008645782,0.0008659719,0.0032164522,0.0050380966,0.006479963,0.018157395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001484232,0.00008451304,0.0006540441,0.00047391362,0.000013326075,0.00015119335,0.00027952236,0.00007298302,0.0019097882,0.0023722395,0.9090148,0.08482515],"study_design_scores_gemma":[0.00002203514,0.00008875944,0.001908913,0.00031451604,0.000011734413,0.0001520938,0.00059236144,0.000053418156,0.00054309017,0.0011087892,0.9951886,0.000015670215],"about_ca_topic_score_codex":0.0013414455,"about_ca_topic_score_gemma":0.003800212,"teacher_disagreement_score":0.049644537,"about_ca_system_score_codex":0.0030546742,"about_ca_system_score_gemma":0.006761868,"threshold_uncertainty_score":0.1660775},"labels":[],"label_agreement":null},{"id":"W2740828344","doi":"10.1158/2326-6066.cir-17-0012","title":"Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute","keywords":"Biology; Phenotype; Antibody; Multiple myeloma; Bone marrow; Plasma cell; Lineage (genetic); Somatic cell; B cell; Immunology; Molecular biology; Genetics; Gene","score_opus":0.12933774684445906,"score_gpt":0.42897214913289894,"score_spread":0.29963440228843985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740828344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958217,0.0005071819,0.0029940333,0.000010982608,0.0000018486021,0.000017740074,0.00012280956,0.000032157026,0.00049143995],"genre_scores_gemma":[0.997147,0.00017226524,0.0021309278,0.00001616418,0.0000022583602,0.000016623393,0.00021008519,0.000008750294,0.00029584832],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998418,0.000019332303,0.000010992212,0.000046161203,0.000057613146,0.000024097008],"domain_scores_gemma":[0.99984586,0.000037425976,0.000038424016,0.000021076301,0.0000360848,0.000021138641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021270616,0.000113409325,0.00015130716,0.00042249841,0.00013597707,0.00027984066,0.00011923668,0.00017796966,0.00060747203],"category_scores_gemma":[0.00018534217,0.0001137467,0.00010576428,0.00024251384,0.00010433992,0.00011703222,0.0002605022,0.00022063014,0.00015928995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048844628,0.0000079144365,0.0052658985,0.0000141364035,0.000005264228,0.000035796646,0.000022987198,0.00005437555,0.992312,0.00005947262,0.000014197484,0.0021590057],"study_design_scores_gemma":[0.000020148422,0.00033015438,0.19966629,0.000012429596,0.000058962476,0.0017101057,0.00012011665,0.0035550653,0.79163045,0.00027165635,0.0026140823,0.0000104874025],"about_ca_topic_score_codex":0.00040895515,"about_ca_topic_score_gemma":0.0005058508,"teacher_disagreement_score":0.00060747203,"about_ca_system_score_codex":0.00014497887,"about_ca_system_score_gemma":0.00008937269,"threshold_uncertainty_score":0.0020321608},"labels":[],"label_agreement":null},{"id":"W2743158281","doi":"10.1158/2326-6066.cir-16-0392","title":"Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Lung cancer; Adenocarcinoma; Hazard ratio; Gene signature; Medicine; Immune system; Oncology; Cancer; Internal medicine; Microarray; Context (archaeology); Stage (stratigraphy); Proportional hazards model; Confidence interval; Immunology; Biology; Gene; Gene expression","score_opus":0.04431057520144525,"score_gpt":0.33784700821927166,"score_spread":0.2935364330178264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743158281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846774,0.0003285628,0.00023097184,0.000071205184,0.000008487613,0.0000028445481,0.0006292757,0.0000067196097,0.00025427385],"genre_scores_gemma":[0.99937904,0.000031146796,0.00007503012,0.000010004988,0.00000628407,0.0000024797712,0.00041396564,8.011409e-7,0.00008114686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979895,0.000055510747,0.00001975574,0.00005592255,0.000037942653,0.00003191967],"domain_scores_gemma":[0.9993499,0.0001890753,0.00020603844,0.000048267084,0.00008190127,0.00012484546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003996472,0.00015126693,0.00024674658,0.00038457554,0.00019315626,0.0003277008,0.00019282871,0.00035731113,0.0019012005],"category_scores_gemma":[0.0011945963,0.000085866755,0.0003264149,0.0003760169,0.00012375868,0.0002360154,0.00022733428,0.00036541247,0.00029151372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035618473,0.000019402065,0.9942849,0.000009834748,0.000058284328,0.0000510995,0.000009764749,0.00019706298,0.0026356566,0.000013445456,0.00019039166,0.0021740373],"study_design_scores_gemma":[0.000005044631,0.00005651872,0.9975859,0.0000024172361,0.000033679775,0.00016534819,0.00002803435,0.0014749937,0.00045539343,0.000044470107,0.00014505029,0.0000030471554],"about_ca_topic_score_codex":0.000856933,"about_ca_topic_score_gemma":0.0011579599,"teacher_disagreement_score":0.0019012005,"about_ca_system_score_codex":0.00016301518,"about_ca_system_score_gemma":0.00013943091,"threshold_uncertainty_score":0.006360173},"labels":[],"label_agreement":null},{"id":"W2754197885","doi":"10.1158/2326-6066.cir-17-0056","title":"Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC Receptors","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Ottawa","funders":"","keywords":"Immunoediting; Immunosurveillance; Biology; MHC class I; Immune system; Cancer research; Major histocompatibility complex; NKG2D; Immunology; Cancer; Granzyme B; Immunotherapy; CD8; Cytotoxic T cell","score_opus":0.04309160312057609,"score_gpt":0.36013517898809067,"score_spread":0.3170435758675146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754197885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942814,0.0013290806,0.002783185,0.00007278667,0.0000126300465,0.000014807323,0.00010534403,0.000058600977,0.0013420684],"genre_scores_gemma":[0.99812585,0.0003472192,0.00062708766,0.000017779153,0.0000057767816,0.00000996417,0.00008450406,0.000008422468,0.00077340164],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998274,0.000042533964,0.000011907504,0.000021744703,0.000037207523,0.000059175123],"domain_scores_gemma":[0.9998485,0.000030000569,0.000053270902,0.000027833235,0.000014349748,0.000026077749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013307492,0.00018874364,0.0001531103,0.00018871177,0.00007969269,0.00027996182,0.00016742125,0.00024343215,0.0012394647],"category_scores_gemma":[0.00012953421,0.00009010794,0.00017701853,0.0000594376,0.00017701466,0.00026351857,0.00023643252,0.00037533554,0.0004090292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005769003,0.000011781877,0.0003645582,0.000011307873,0.0000013228458,0.000036476264,0.000005455878,0.000035214027,0.9984634,0.000099424054,0.000016809745,0.00089656806],"study_design_scores_gemma":[0.000015581658,0.00036500976,0.009273186,0.0000067934257,0.00000940733,0.0006106983,0.00004136475,0.0015145215,0.9863855,0.00009040305,0.0016839928,0.000003485652],"about_ca_topic_score_codex":0.00018974401,"about_ca_topic_score_gemma":0.00018034034,"teacher_disagreement_score":0.0012394647,"about_ca_system_score_codex":0.00020598267,"about_ca_system_score_gemma":0.000080686856,"threshold_uncertainty_score":0.0041464567},"labels":[],"label_agreement":null},{"id":"W2755137651","doi":"10.1158/2326-6066.cir-17-0102","title":"Customized Viral Immunotherapy for HPV-Associated Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; McMaster University Medical Centre","funders":"Terry Fox Foundation","keywords":"Oncolytic virus; Immunotherapy; Cancer immunotherapy; Immunology; Immune system; Cancer; Vaccination; CD8; Virotherapy; Cancer research; Medicine; Tumor microenvironment; Cytotoxic T cell; Epitope; Priming (agriculture); Virology; Biology; Antibody; Internal medicine; In vitro","score_opus":0.0796066015998657,"score_gpt":0.4180975750450982,"score_spread":0.3384909734452325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755137651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433233,0.00891848,0.037347578,0.0003686819,0.00027128312,0.0004101438,0.0005026323,0.0006862105,0.008171738],"genre_scores_gemma":[0.9820269,0.0030846135,0.010440594,0.00012208903,0.000045291486,0.0001514153,0.00033719477,0.000038809343,0.0037532065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989176,0.000014205246,0.000004985521,0.000020522459,0.000035376335,0.00003305592],"domain_scores_gemma":[0.99996376,0.000004089533,0.000010939733,0.000007737824,0.0000045625866,0.000008894026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012678043,0.00038218385,0.00022413219,0.00023119785,0.00011554556,0.00035634518,0.00026670916,0.00033335565,0.0019464736],"category_scores_gemma":[0.00008650229,0.00010132425,0.00020293336,0.00018145477,0.00016766634,0.00020362782,0.0003545085,0.0006451689,0.0004584713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098390155,0.00016363109,0.0001939851,0.00010357956,0.000012662489,0.00006264428,0.00002263837,0.0014715898,0.9747342,0.0014528598,0.00032734504,0.021356503],"study_design_scores_gemma":[0.00012669046,0.0025088936,0.0019924368,0.000034201417,0.00006054757,0.00097247295,0.000025681036,0.007608159,0.942241,0.0011180895,0.043292858,0.000018897943],"about_ca_topic_score_codex":0.00026079666,"about_ca_topic_score_gemma":0.00033444437,"teacher_disagreement_score":0.0019464736,"about_ca_system_score_codex":0.00037545775,"about_ca_system_score_gemma":0.00019711265,"threshold_uncertainty_score":0.0065116286},"labels":[],"label_agreement":null},{"id":"W2760662626","doi":"10.1158/2326-6066.cir-17-0131","title":"Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Cardiff University; Canolfan Ymchwil Canser Cymru; National Cancer Institute; National Institutes of Health; Cancer Research UK; Wellcome Trust; Deutsches Krebsforschungszentrum; Genentech; American Association for Cancer Research","keywords":"High endothelial venules; Immune system; Tumor microenvironment; Cancer research; Biology; Immunology; FOXP3; T cell; CD8; Chemokine receptor; Chemokine","score_opus":0.05112450620899809,"score_gpt":0.33041443515903307,"score_spread":0.27928992895003496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760662626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855026,0.0019351582,0.0044297855,0.00018432848,0.0001278005,0.0001020371,0.0005538386,0.00045974535,0.006704702],"genre_scores_gemma":[0.9935231,0.00046280172,0.0013510338,0.00008188732,0.000023793667,0.000058555554,0.0004044111,0.000044135268,0.0040501673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966717,0.00006939848,0.00002549733,0.000056530276,0.00007856622,0.00010289024],"domain_scores_gemma":[0.9997913,0.00004533473,0.00004340615,0.000047641744,0.000012383925,0.00005990174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020471643,0.0002899399,0.00025175526,0.0004263489,0.00015009881,0.0003344976,0.00022347325,0.0002702812,0.0024989601],"category_scores_gemma":[0.00012646215,0.00011728292,0.00024184881,0.00013128467,0.00029545696,0.0001550891,0.00022431134,0.0010673195,0.0007219428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000260484,0.00033822373,0.00036648946,0.000051981613,0.000009634779,0.00011678008,0.000018866609,0.00021557124,0.9922404,0.0005302934,0.00050406525,0.0053472524],"study_design_scores_gemma":[0.00010812357,0.0011597212,0.0039132712,0.000015484226,0.000016585162,0.0004810797,0.000033772474,0.0037728148,0.9828911,0.00017024895,0.0074323798,0.000005323973],"about_ca_topic_score_codex":0.00076581753,"about_ca_topic_score_gemma":0.0010073008,"teacher_disagreement_score":0.0024989601,"about_ca_system_score_codex":0.0002627103,"about_ca_system_score_gemma":0.00024450192,"threshold_uncertainty_score":0.008359849},"labels":[],"label_agreement":null},{"id":"W2765326687","doi":"10.1158/2326-6066.cir-17-0175","title":"Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Rosetrees Trust; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Subversion; Immune system; Tumor necrosis factor alpha; Immunotherapy; Immunology; Medicine; Cancer research; Biology; Political science","score_opus":0.058015048956315964,"score_gpt":0.3881521610682535,"score_spread":0.3301371121119375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765326687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575174,0.0016277994,0.00095660816,0.00012129308,0.000027120961,0.000020766578,0.00015404275,0.00008615909,0.0012544942],"genre_scores_gemma":[0.99837506,0.00025169854,0.0002794183,0.000023305085,0.000007243178,0.000009151459,0.000086525666,0.0000054048533,0.0009621645],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986076,0.000018780984,0.000009841897,0.000037848065,0.000024491026,0.000048287566],"domain_scores_gemma":[0.99986863,0.000014059819,0.000042797477,0.000023988008,0.000010521043,0.00004003261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011147563,0.00015678848,0.00029394706,0.000101565594,0.000099469304,0.00045850934,0.00012542683,0.000178828,0.0016712617],"category_scores_gemma":[0.00010634771,0.000110539164,0.00017541995,0.00008176808,0.00023042146,0.00016726473,0.00016880881,0.0009476958,0.00055947836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004259457,0.00014808364,0.0020172868,0.00005046351,0.000009098488,0.00014807613,0.00002801222,0.00013150171,0.9910287,0.00022185297,0.00025049588,0.00554047],"study_design_scores_gemma":[0.00011273398,0.0020974698,0.03765728,0.000018521812,0.00003509818,0.0022943784,0.000117696174,0.0028523493,0.94866025,0.00026389846,0.0058821887,0.000008227632],"about_ca_topic_score_codex":0.0003636934,"about_ca_topic_score_gemma":0.00036594694,"teacher_disagreement_score":0.0016712617,"about_ca_system_score_codex":0.00034871593,"about_ca_system_score_gemma":0.00019056626,"threshold_uncertainty_score":0.0055909157},"labels":[],"label_agreement":null},{"id":"W2766991138","doi":"10.1158/2326-6066.cir-17-0229","title":"Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Canadian Cancer Society","keywords":"Immunotherapy; Breast cancer; Medicine; Immunogenic cell death; Metastatic breast cancer; Immunology; Cancer immunotherapy; Cancer; Natural killer cell; Chemotherapy; Immune system; Cancer research; Active immunotherapy; T cell; Cytotoxic T cell; Biology; Internal medicine","score_opus":0.037686869023074596,"score_gpt":0.3424158288692887,"score_spread":0.30472895984621406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766991138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945866,0.002373004,0.0012962893,0.00014022118,0.00009060753,0.000121201425,0.00008774515,0.00007484827,0.001229563],"genre_scores_gemma":[0.9962425,0.0012203488,0.0011191738,0.000039039987,0.00003833625,0.00008697604,0.00013433011,0.0000069452253,0.0011123298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986327,0.000029480789,0.000010001124,0.000023018329,0.000032926044,0.00004129694],"domain_scores_gemma":[0.9999596,0.0000050640665,0.0000100979305,0.0000061237356,0.000004461256,0.000014728907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111534864,0.00036661176,0.00053171057,0.00024761882,0.0000881024,0.00022752423,0.00019870435,0.00020442891,0.0007311215],"category_scores_gemma":[0.00008158706,0.00009518237,0.00021659775,0.00015091352,0.00017683093,0.00015222827,0.00019352531,0.0005500037,0.00020732173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012451868,0.0007084225,0.0004018065,0.0001139363,0.000024804336,0.000099540535,0.000020187777,0.00067697273,0.9791511,0.00015160252,0.00021678959,0.0171895],"study_design_scores_gemma":[0.00073187106,0.012372329,0.005285431,0.000022002676,0.00012127108,0.0008233071,0.000028560333,0.0036033783,0.9689687,0.00017562359,0.007856235,0.00001129853],"about_ca_topic_score_codex":0.0003106484,"about_ca_topic_score_gemma":0.0006293953,"teacher_disagreement_score":0.0007311215,"about_ca_system_score_codex":0.000255423,"about_ca_system_score_gemma":0.00022499397,"threshold_uncertainty_score":0.002445817},"labels":[],"label_agreement":null},{"id":"W2781496272","doi":"10.1158/2326-6066.cir-17-0383","title":"Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Rosetrees Trust","keywords":"Ectodomain; CD8; Cancer research; Cytotoxic T cell; Immunotherapy; Melanoma; T cell; Cytolysis; Biology; Immunology; Cancer immunotherapy; Immune system; Receptor; In vitro; Biochemistry","score_opus":0.03098202432855256,"score_gpt":0.3138554816612241,"score_spread":0.28287345733267155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781496272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571145,0.0010067506,0.0010695904,0.00013667197,0.000071775314,0.00004114181,0.00023621893,0.0001841302,0.0015422282],"genre_scores_gemma":[0.99587613,0.00044132303,0.0009575296,0.000068210764,0.00002446966,0.000027483631,0.00056202017,0.000019385841,0.002023401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998965,0.000018753055,0.0000088473225,0.000012156894,0.000020936572,0.000042794592],"domain_scores_gemma":[0.9999386,0.0000066607176,0.000015111173,0.000007279484,0.0000073057254,0.000025001273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011088247,0.00038274043,0.0003031011,0.00017697246,0.00007270893,0.00017682808,0.00015565832,0.00025523847,0.0013560673],"category_scores_gemma":[0.00009002446,0.00008102325,0.00022656504,0.0000839785,0.00012906556,0.00014875166,0.00009541345,0.00074078655,0.0005140513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051877624,0.0003007264,0.00012301763,0.000032588374,0.000007680891,0.000045133806,0.0000065726413,0.00008008719,0.99427867,0.00003780599,0.00021317006,0.00435569],"study_design_scores_gemma":[0.00022773078,0.0074759442,0.0041781655,0.0000072881285,0.000033999535,0.0005113155,0.000017475379,0.00090195116,0.98375124,0.000040328192,0.0028495835,0.0000048993497],"about_ca_topic_score_codex":0.00026572868,"about_ca_topic_score_gemma":0.00034688815,"teacher_disagreement_score":0.0013560673,"about_ca_system_score_codex":0.00013910356,"about_ca_system_score_gemma":0.00011598999,"threshold_uncertainty_score":0.0045365095},"labels":[],"label_agreement":null},{"id":"W2799597692","doi":"10.1158/2326-6066.cir-17-0475","title":"The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"National Cancer Institute; Dana-Farber/Harvard Cancer Center; Memorial Sloan-Kettering Cancer Center","keywords":"Renal cell carcinoma; Medicine; Immunotherapy; PD-L1; Cancer research; Internal medicine; Oncology; Cancer","score_opus":0.13248197790817184,"score_gpt":0.43656753841307966,"score_spread":0.3040855605049078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799597692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648947,0.0026796227,0.00012059717,0.00005502837,0.000008820642,0.000050040533,0.00013227374,0.000007102735,0.0004570282],"genre_scores_gemma":[0.9990165,0.00044567895,0.00017212567,0.000032576092,0.000016333037,0.000027208118,0.00016906048,0.0000017908633,0.00011878329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995617,0.00023153627,0.00003716665,0.000049676404,0.000077042816,0.000042777323],"domain_scores_gemma":[0.99946815,0.00014870612,0.00012421912,0.000029644014,0.00006983761,0.00015940213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014031676,0.00019184955,0.00084246934,0.00019716039,0.00017211586,0.00031876782,0.00015958856,0.00014306765,0.00062405976],"category_scores_gemma":[0.0009562411,0.00008369485,0.0004015461,0.00024489878,0.00015893615,0.0002282963,0.00016347405,0.00035009166,0.00009170407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0657972,0.0068543605,0.51655746,0.0010120171,0.001273009,0.0013186472,0.00027277143,0.0067390385,0.13994798,0.00044826732,0.0033168907,0.2564624],"study_design_scores_gemma":[0.006533498,0.12901746,0.8060826,0.00008685527,0.0008995772,0.0025861352,0.00023403377,0.009638776,0.038295545,0.0004274962,0.0061563887,0.000041729683],"about_ca_topic_score_codex":0.0007946233,"about_ca_topic_score_gemma":0.0019945283,"teacher_disagreement_score":0.0014031676,"about_ca_system_score_codex":0.0004900551,"about_ca_system_score_gemma":0.00066523714,"threshold_uncertainty_score":0.0074207783},"labels":[],"label_agreement":null},{"id":"W2883414028","doi":"10.1158/2326-6066.cir-18-0144","title":"Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; McMaster University Medical Centre","funders":"","keywords":"Ovarian cancer; Cytotoxic T cell; Medicine; Immunotherapy; Cancer research; Cancer; Immunology; NK-92; Immunosuppression; Lymphokine-activated killer cell; Interleukin 21; Immune system; T cell; Biology; Internal medicine; In vitro","score_opus":0.034070945913177456,"score_gpt":0.30890500519864555,"score_spread":0.2748340592854681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883414028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775153,0.00036936117,0.0007801147,0.00004105027,0.000029940447,0.000050029517,0.00021316827,0.000029950672,0.0007347596],"genre_scores_gemma":[0.99692994,0.00025197212,0.0008458747,0.000037935293,0.000009676585,0.00006005021,0.0005377889,0.000008313124,0.0013185069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998878,0.000020008778,0.000015952694,0.00002495829,0.000028361153,0.000022859982],"domain_scores_gemma":[0.9999095,0.000020110567,0.000015119484,0.000024593734,0.00000753528,0.000023081848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016201878,0.00025281723,0.0003583989,0.00015240329,0.00008439861,0.0002029945,0.00014000178,0.00019776986,0.002390549],"category_scores_gemma":[0.00011219001,0.00010160552,0.00018746234,0.00009135756,0.00013428717,0.00017875335,0.00016728499,0.0007380353,0.0003253623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011186779,0.0005460941,0.00104845,0.000068433874,0.000019241623,0.0001439261,0.00006952554,0.00045779897,0.9892096,0.00016498187,0.0002153578,0.006937923],"study_design_scores_gemma":[0.00050445925,0.0116554415,0.016804136,0.000023853376,0.000099251636,0.0022343772,0.00010547865,0.0050711203,0.9562368,0.00015816397,0.0070936647,0.000013337443],"about_ca_topic_score_codex":0.00023349866,"about_ca_topic_score_gemma":0.0002680603,"teacher_disagreement_score":0.002390549,"about_ca_system_score_codex":0.0001203097,"about_ca_system_score_gemma":0.0001640928,"threshold_uncertainty_score":0.007997215},"labels":[],"label_agreement":null},{"id":"W2883866956","doi":"10.1158/2326-6066.cir-18-0037","title":"Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"MedImmune","keywords":"Alveolar soft part sarcoma; Sarcoma; Medicine; Soft tissue sarcoma; Immunotherapy; Immune checkpoint; Immune system; Cancer research; Immunology; Pathology","score_opus":0.0473021969530328,"score_gpt":0.3882202883024161,"score_spread":0.34091809134938333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883866956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620605,0.0003220294,0.00037702982,0.0004963796,0.000030215313,0.00005933342,0.00007808229,0.00002270316,0.0024082172],"genre_scores_gemma":[0.9992981,0.0000734911,0.0001480005,0.00014659898,0.000027543425,0.000009847377,0.00006621006,0.0000029176663,0.00022729288],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997354,0.000042446176,0.000033238506,0.000062650906,0.000037534464,0.000088650304],"domain_scores_gemma":[0.99945265,0.00014333887,0.00006463229,0.000034691086,0.000036862,0.000267909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026327622,0.0005462476,0.0006105958,0.00044991612,0.0006601825,0.0006084971,0.00031194475,0.0011146909,0.000880032],"category_scores_gemma":[0.0011180434,0.00021613647,0.00047214952,0.0002443805,0.00048826908,0.00029214055,0.00042899512,0.0009991585,0.0002340142],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048023644,0.001794914,0.32459483,0.00014585428,0.00017219894,0.5898018,0.0012669208,0.0014894734,0.03277174,0.0010465926,0.0015255465,0.040587783],"study_design_scores_gemma":[0.0008103005,0.008842554,0.22237745,0.000038543556,0.00015077753,0.75080585,0.00061669305,0.0045565474,0.0073812157,0.0006997301,0.0036566772,0.000063687854],"about_ca_topic_score_codex":0.0006140404,"about_ca_topic_score_gemma":0.0007174993,"teacher_disagreement_score":0.0011146909,"about_ca_system_score_codex":0.00075455196,"about_ca_system_score_gemma":0.00031268797,"threshold_uncertainty_score":0.0054746866},"labels":[],"label_agreement":null},{"id":"W2891038428","doi":"10.1158/2326-6066.cir-18-0309","title":"Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; Cancer Research UK","keywords":"Oncolytic virus; Virotherapy; Antibody; Immune system; Immunotherapy; Immunology; Virology; Neutralizing antibody; Internalization; Medicine; Biology; Receptor","score_opus":0.044798546805281045,"score_gpt":0.45064326492100243,"score_spread":0.40584471811572137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891038428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833966,0.004837895,0.0027578983,0.00014124162,0.0001367828,0.00006897103,0.0001034827,0.00010218476,0.0035118058],"genre_scores_gemma":[0.9963942,0.0006985877,0.00086439314,0.00003556563,0.000011550654,0.000014449322,0.000101691665,0.000013665857,0.001865917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998325,0.000039161092,0.000009604584,0.000022202874,0.000038405113,0.000058054065],"domain_scores_gemma":[0.99990845,0.000026466545,0.0000135189875,0.000015743755,0.000011536824,0.000024312281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001720276,0.00018329386,0.0003273386,0.00018894458,0.0001144444,0.00053562917,0.00015974033,0.00033617343,0.001575443],"category_scores_gemma":[0.00016986285,0.000091865295,0.00019155892,0.00009147568,0.00022827584,0.00014212064,0.00012953668,0.0006284689,0.0003608347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006738848,0.00030001535,0.0002466492,0.000053456773,0.000013382788,0.00006405484,0.00002461664,0.00021496021,0.9890732,0.00042242365,0.00021202875,0.008701304],"study_design_scores_gemma":[0.00015684072,0.0035041983,0.0039489553,0.000013966174,0.000045025405,0.00043207777,0.000026328964,0.0015341374,0.9828538,0.00015064579,0.0073272986,0.0000066809052],"about_ca_topic_score_codex":0.00091226946,"about_ca_topic_score_gemma":0.0011926049,"teacher_disagreement_score":0.001575443,"about_ca_system_score_codex":0.00028639444,"about_ca_system_score_gemma":0.00034871613,"threshold_uncertainty_score":0.005270362},"labels":[],"label_agreement":null},{"id":"W2901601525","doi":"10.1158/2326-6066.cir-18-0136","title":"Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Zürich; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Melanoma; Immunotherapy; T-cell receptor; Medicine; Blockade; Oncology; Immunology; Exact test; Internal medicine; Peripheral blood mononuclear cell; Proportional hazards model; Immune system; Cancer research; T cell; Biology; Receptor","score_opus":0.08599289826017605,"score_gpt":0.38266565641827377,"score_spread":0.29667275815809774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901601525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337316,0.0013539589,0.0030110122,0.0001327638,0.000022031198,0.000034090222,0.0005248641,0.00006726076,0.0014808725],"genre_scores_gemma":[0.9968941,0.00023077724,0.002080037,0.000088326735,0.000025056639,0.000020450048,0.00031769508,0.0000059394306,0.0003376758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999801,0.00007186339,0.000027419239,0.00004283811,0.000030582072,0.00002627439],"domain_scores_gemma":[0.9992434,0.0003604444,0.00018251789,0.000047172558,0.000084638385,0.00008178445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006881757,0.0003909794,0.00037163176,0.0008468977,0.00015702592,0.0006176358,0.000120867386,0.00031446165,0.0019412725],"category_scores_gemma":[0.0016036402,0.000113241505,0.00012826294,0.00042100402,0.000098694654,0.00027870986,0.0002821263,0.000396115,0.00047586314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018603201,0.00013563143,0.88129324,0.000078349294,0.000057916008,0.0002733804,0.000067285946,0.0008704996,0.05446278,0.000112131966,0.00071148085,0.060077034],"study_design_scores_gemma":[0.000048717877,0.0011561825,0.96199685,0.00007830194,0.000104072606,0.0021083127,0.00020153596,0.0135723585,0.016303675,0.0007448903,0.0036664647,0.000018674784],"about_ca_topic_score_codex":0.000219193,"about_ca_topic_score_gemma":0.00042484165,"teacher_disagreement_score":0.0019412725,"about_ca_system_score_codex":0.000111027744,"about_ca_system_score_gemma":0.00007980844,"threshold_uncertainty_score":0.0064941645},"labels":[],"label_agreement":null},{"id":"W2902041530","doi":"10.1158/2326-6074.tumimm17-a81","title":"Abstract A81: Early TLR-mediated killing of leukemia in bone marrow is correlated with durable protection against B cell precursor acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"TLR9; Immunology; TLR7; Immune system; Innate immune system; Cancer research; TLR3; Antigen; Leukemia; Biology; Toll-like receptor; CpG Oligodeoxynucleotide; DNA methylation","score_opus":0.02269565846293876,"score_gpt":0.2776890770287185,"score_spread":0.25499341856577973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902041530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944014,0.0013516686,0.0015418062,0.00009476154,0.0000415707,0.00007361795,0.0006345208,0.00013589725,0.0017247676],"genre_scores_gemma":[0.99534047,0.00039971186,0.00080784457,0.00006920389,0.000018330755,0.00005983383,0.0010772462,0.000016115795,0.0022113326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983346,0.000033767952,0.000016264492,0.000026840433,0.000035407855,0.000054300614],"domain_scores_gemma":[0.9997745,0.000042849275,0.00005593035,0.000026835625,0.000026336513,0.00007353492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002108734,0.00032525902,0.00031062885,0.0002849178,0.00011526879,0.0002752576,0.00020426273,0.00030548082,0.0037568663],"category_scores_gemma":[0.00017618197,0.00009295747,0.00021457509,0.00013456415,0.00021447404,0.0001662425,0.00019558778,0.00088089413,0.00090900576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009403073,0.00024411228,0.0007970055,0.000052624036,0.0000081488715,0.0000807877,0.00001323514,0.000051252176,0.99392396,0.00009199501,0.00014232386,0.0036542225],"study_design_scores_gemma":[0.00015585053,0.0064435843,0.027339699,0.000016055052,0.00003937543,0.0013712146,0.000048838403,0.00076082454,0.9592046,0.00011365063,0.0045005074,0.000005819231],"about_ca_topic_score_codex":0.0002509814,"about_ca_topic_score_gemma":0.00022201042,"teacher_disagreement_score":0.0037568663,"about_ca_system_score_codex":0.00019679451,"about_ca_system_score_gemma":0.00016959419,"threshold_uncertainty_score":0.012567997},"labels":[],"label_agreement":null},{"id":"W2905648583","doi":"10.1158/2326-6074.tumimm17-pr03","title":"Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Microsatellite instability; Loss of heterozygosity; Biology; Colorectal cancer; Immune checkpoint; Immune system; Cancer research; Cancer; Exome sequencing; Human leukocyte antigen; Exome; Transcriptome; Immunotherapy; Gene; Genetics; Antigen; Mutation; Allele; Microsatellite; Gene expression","score_opus":0.0740276616415938,"score_gpt":0.4108042553806031,"score_spread":0.3367765937390093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905648583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788765,0.0029321527,0.010187603,0.00032441213,0.00002961259,0.000037972623,0.0041938233,0.00038663283,0.0030314215],"genre_scores_gemma":[0.99141484,0.00062883104,0.0034864414,0.0001052246,0.000019397548,0.000024188805,0.0026390417,0.000057618465,0.0016244708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976975,0.00003289773,0.000020383699,0.0000684896,0.00008141444,0.000027099002],"domain_scores_gemma":[0.9997328,0.000039784292,0.00013968909,0.000027890568,0.000031156964,0.000028724966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032242635,0.00024733166,0.00020388135,0.0006959895,0.00016772599,0.00036535153,0.00030579144,0.0002959701,0.0022995018],"category_scores_gemma":[0.0005256349,0.000105550076,0.0002593847,0.0010483754,0.0001815936,0.00021902127,0.00030424353,0.0003308686,0.0008219305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010743677,0.00008970529,0.1057618,0.00043150785,0.00013162881,0.0013215452,0.000093517716,0.0015164826,0.81698024,0.0016990739,0.0016263672,0.06927368],"study_design_scores_gemma":[0.000096084485,0.00090994255,0.74702626,0.00007217846,0.00019308351,0.009359185,0.00019615353,0.0127957035,0.21093003,0.0024056484,0.015981883,0.000033814915],"about_ca_topic_score_codex":0.0007690302,"about_ca_topic_score_gemma":0.0006703713,"teacher_disagreement_score":0.0022995018,"about_ca_system_score_codex":0.00032522244,"about_ca_system_score_gemma":0.0002424609,"threshold_uncertainty_score":0.0076925755},"labels":[],"label_agreement":null},{"id":"W2911247197","doi":"10.1158/2326-6074.cricimteatiaacr18-b052","title":"Abstract B052: Immunotherapy for melanoma by adenovirus-mediated full-length antibody, nivolumab","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Nivolumab; Melanoma; Immunotherapy; Medicine; Antibody; Cancer research; Cancer immunotherapy; Cancer; Immunology; Immune system; Monoclonal antibody; Virology; Oncology; Internal medicine","score_opus":0.04798463207347491,"score_gpt":0.4053823627487281,"score_spread":0.35739773067525316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911247197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560928,0.011308091,0.022655198,0.00047134003,0.00071396877,0.0002965818,0.0012962638,0.00033689284,0.006828954],"genre_scores_gemma":[0.9639993,0.002851974,0.019096892,0.00020773409,0.00006804635,0.00010072214,0.0025390366,0.000047832134,0.011088548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989295,0.000014212662,0.000012291286,0.000028789385,0.000030482968,0.000021237844],"domain_scores_gemma":[0.9999784,0.0000023768953,0.0000048271536,0.000002726442,0.0000034006114,0.000008235506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011718119,0.00044925077,0.0001723867,0.00029324586,0.00015450342,0.0003262948,0.00023889882,0.00041063226,0.0014098817],"category_scores_gemma":[0.00006528883,0.00011340684,0.0003628724,0.00014946853,0.0001969988,0.00023665557,0.00017031908,0.00055112777,0.00066838885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018087664,0.00010621199,0.0003489259,0.00009625663,0.000015099417,0.00007125434,0.000013857986,0.00017362418,0.9907548,0.00047390632,0.0004125763,0.007352664],"study_design_scores_gemma":[0.00012115187,0.0010186265,0.0030432695,0.000019380712,0.000060463015,0.000997615,0.000024946323,0.0025681679,0.9629217,0.00016617352,0.029042019,0.000016481705],"about_ca_topic_score_codex":0.0010107105,"about_ca_topic_score_gemma":0.0007253036,"teacher_disagreement_score":0.0014098817,"about_ca_system_score_codex":0.00048184098,"about_ca_system_score_gemma":0.0002800123,"threshold_uncertainty_score":0.004716575},"labels":[],"label_agreement":null},{"id":"W2911283537","doi":"10.1158/2326-6074.cricimteatiaacr18-b101","title":"Abstract B101: Novel oncolytic vaccinia virus platform for systemic delivery of immunotherapeutic payloads","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Immune system; Vaccinia; Immunotherapy; Cancer immunotherapy; Medicine; Immune checkpoint; Cancer; Cancer research; Immunology; Biology; Internal medicine; Gene","score_opus":0.06529744179029018,"score_gpt":0.38105970624199254,"score_spread":0.31576226445170236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911283537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86311686,0.015658565,0.10171516,0.00090849196,0.0005754998,0.00043307003,0.00077373744,0.00086724514,0.015951429],"genre_scores_gemma":[0.967437,0.0023874461,0.02024793,0.00022740285,0.000037397025,0.00016815035,0.0006704151,0.00006138574,0.008762844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991,0.000010728217,0.0000046244045,0.000024949326,0.000027942504,0.0000217854],"domain_scores_gemma":[0.99996746,0.000004606319,0.00000891562,0.0000029507758,0.0000048388815,0.000011150201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001352858,0.00039393446,0.00023508607,0.00018948675,0.00014283074,0.0004117635,0.00027368698,0.00057654496,0.0012223667],"category_scores_gemma":[0.00008088785,0.0001327525,0.00019826586,0.0001193706,0.00016823548,0.00032422744,0.0002520913,0.00066226657,0.0008388574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088315974,0.00007024744,0.00008764842,0.00008148388,0.000006966737,0.00009282059,0.000013014586,0.00035553426,0.9884906,0.0008481649,0.00051267946,0.009352558],"study_design_scores_gemma":[0.00008330883,0.0007660498,0.0006996812,0.00001890079,0.000018747176,0.0004913343,0.000011651737,0.006436932,0.97157437,0.00023675371,0.019647794,0.0000146126],"about_ca_topic_score_codex":0.00045081077,"about_ca_topic_score_gemma":0.00034936363,"teacher_disagreement_score":0.0012223667,"about_ca_system_score_codex":0.00040636872,"about_ca_system_score_gemma":0.00026266446,"threshold_uncertainty_score":0.0040892363},"labels":[],"label_agreement":null},{"id":"W2911359328","doi":"10.1158/2326-6074.cricimteatiaacr18-b170","title":"Abstract B170: Therapeutic implications of altered epigenetics and DNA damage responses in IDH2-mutated hematologic diseases","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"IDH2; Epigenetics; Cancer research; Biology; Myeloid; DNA methylation; Histone; Myeloid leukemia; IDH1; Haematopoiesis; Mutation; Stem cell; Genetics; Gene; Gene expression","score_opus":0.08231214431460641,"score_gpt":0.42227017969243935,"score_spread":0.3399580353778329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911359328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8555842,0.06697448,0.0047480618,0.004631443,0.0019810863,0.00027936875,0.0016211864,0.00061453186,0.06356552],"genre_scores_gemma":[0.9782736,0.008182485,0.0018201177,0.0012190371,0.0005930945,0.00009796981,0.0009808209,0.000060317223,0.008772516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994516,0.000009355737,0.0000033576584,0.000007998969,0.00001653973,0.00001762804],"domain_scores_gemma":[0.9999391,0.000008032776,0.000008812584,0.0000036698427,0.000007650061,0.00003278831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016684325,0.00024073856,0.00026581888,0.00032769583,0.00015308973,0.00035128705,0.00019568292,0.0003484187,0.0068634884],"category_scores_gemma":[0.000180636,0.000052165542,0.00014337643,0.00021552015,0.00011737321,0.00016554525,0.00026259935,0.0005254796,0.0013167452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010049362,0.0016976142,0.0067935726,0.0010300023,0.00013972912,0.002871357,0.00012233212,0.0011359707,0.44808558,0.005685029,0.018256204,0.50413334],"study_design_scores_gemma":[0.006684122,0.026373677,0.078062624,0.000606576,0.0006025152,0.025124224,0.0003382328,0.004270183,0.38658273,0.009387637,0.46187505,0.00009244809],"about_ca_topic_score_codex":0.00023372586,"about_ca_topic_score_gemma":0.0002697298,"teacher_disagreement_score":0.0068634884,"about_ca_system_score_codex":0.00020586132,"about_ca_system_score_gemma":0.000220044,"threshold_uncertainty_score":0.022960603},"labels":[],"label_agreement":null},{"id":"W2912011158","doi":"10.1158/2326-6074.cricimteatiaacr18-a008","title":"Abstract A008: Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Cystectomy; Medicine; Gemcitabine; Bladder cancer; Nivolumab; Oncology; Internal medicine; Cisplatin; Neoadjuvant therapy; Chemotherapy; Urology; Lymph node; Cancer; Immunotherapy; Breast cancer","score_opus":0.05267920487446963,"score_gpt":0.3912411751698508,"score_spread":0.33856197029538115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912011158","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04368242,0.93364674,0.0009899524,0.005504765,0.0015596263,0.0010340061,0.004113381,0.00013352829,0.00933554],"genre_scores_gemma":[0.19302355,0.76810795,0.003018321,0.013843753,0.004064172,0.0027384595,0.010885476,0.00012229598,0.0041960785],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99913776,0.0003904551,0.00020708791,0.000080970516,0.00012934093,0.000054353313],"domain_scores_gemma":[0.9954384,0.0021895464,0.0010504177,0.00015649095,0.0007903685,0.00037479485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040504523,0.00059369113,0.002585525,0.0009046135,0.00021920491,0.0019632622,0.0009556481,0.0010363365,0.0039192815],"category_scores_gemma":[0.004734535,0.00026618713,0.002039469,0.0018789629,0.0003137564,0.0010521786,0.0006302404,0.001669906,0.0008608519],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02998597,0.0012172448,0.017341314,0.06282209,0.011621817,0.00026281166,0.00019562418,0.0005813785,0.004577513,0.0006572301,0.0519154,0.8188216],"study_design_scores_gemma":[0.051492985,0.055771027,0.12795769,0.07661907,0.07791159,0.002754287,0.00057213166,0.0012964219,0.004203681,0.0019816402,0.5992017,0.00023774579],"about_ca_topic_score_codex":0.0011635964,"about_ca_topic_score_gemma":0.003407049,"teacher_disagreement_score":0.0040504523,"about_ca_system_score_codex":0.0008135464,"about_ca_system_score_gemma":0.0021314106,"threshold_uncertainty_score":0.021421075},"labels":[],"label_agreement":null},{"id":"W2912104291","doi":"10.1158/2326-6074.tumimm17-b41","title":"Abstract B41: Neutrophils modulate T-cell recruitment and promote hepatic metastases in lung cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nivolumab; Tumor microenvironment; Medicine; Ipilimumab; Immune system; Immunotherapy; Docetaxel; Lung cancer; Immunology; Cancer research; Cancer; Neutrophil elastase; Internal medicine; Inflammation","score_opus":0.08936223421624875,"score_gpt":0.39917292594889975,"score_spread":0.30981069173265097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912104291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253535,0.0027216712,0.001182712,0.00040427403,0.00008965439,0.00008093894,0.00061140064,0.000075680175,0.0022983295],"genre_scores_gemma":[0.993997,0.00071562035,0.00057278137,0.00012815729,0.000026927888,0.00006438949,0.00035776835,0.0000086348355,0.0041288245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998921,0.000027538072,0.000007274219,0.0000145226195,0.00002105602,0.00003747189],"domain_scores_gemma":[0.99994075,0.000009777644,0.000013129619,0.000005788777,0.000008066637,0.000022482436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001536683,0.00027813064,0.0002227003,0.00014317752,0.00013024315,0.00020287474,0.00011972546,0.00026061918,0.0033100809],"category_scores_gemma":[0.00008203541,0.00009634088,0.000161284,0.000083345134,0.00015778402,0.00013929537,0.0001396394,0.0006480967,0.0006248492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015682044,0.0002757815,0.0007099649,0.000109761495,0.000007487643,0.00013777119,0.000023650888,0.000109962035,0.9923355,0.00012088259,0.0004237585,0.004177206],"study_design_scores_gemma":[0.00040645612,0.0055095586,0.024895689,0.00002697171,0.000036774938,0.0005605207,0.00010138307,0.0017562329,0.96177995,0.00015988432,0.004757506,0.0000090853155],"about_ca_topic_score_codex":0.00059600204,"about_ca_topic_score_gemma":0.0008156438,"teacher_disagreement_score":0.0033100809,"about_ca_system_score_codex":0.00023098853,"about_ca_system_score_gemma":0.00019080316,"threshold_uncertainty_score":0.011073351},"labels":[],"label_agreement":null},{"id":"W2912419979","doi":"10.1158/2326-6074.cricimteatiaacr18-b085","title":"Abstract B085: High mutation burden and response to immune checkpoint inhibitors in angiosarcomas of the scalp and face","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angiosarcoma; Internal medicine; Exome; Exome sequencing; Oncology; Pathology; Biology; Mutation; Gene","score_opus":0.022701377113953584,"score_gpt":0.3323981553661915,"score_spread":0.3096967782522379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912419979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740404,0.00018043556,0.00017260025,0.00016651346,0.00001206216,0.000015860749,0.00076067843,0.000019490477,0.0012684407],"genre_scores_gemma":[0.9987651,0.000059344064,0.0001754802,0.00007037845,0.000014788412,0.0000057393386,0.00048085683,0.000008004689,0.00042023574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998307,0.00002043473,0.000014327806,0.000047032587,0.000050278948,0.0000371489],"domain_scores_gemma":[0.9995228,0.00008377312,0.00016124317,0.000022610366,0.00006623802,0.00014338501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025914688,0.0001695048,0.0001703626,0.00051254703,0.00040730956,0.00046506853,0.00014979868,0.00028479478,0.0038613528],"category_scores_gemma":[0.0006721718,0.0000947598,0.00016199374,0.00047634786,0.00018878108,0.00019137344,0.00020598916,0.00032763052,0.000474436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020534764,0.0001904896,0.9164441,0.00008366357,0.00007863543,0.018763358,0.00020161527,0.00028271784,0.03503117,0.00018100532,0.0037597446,0.022929927],"study_design_scores_gemma":[0.000040231058,0.0002788799,0.96476173,0.000024487974,0.00005214454,0.02811924,0.00028239065,0.0005470612,0.003315497,0.00018913286,0.00237867,0.000010543029],"about_ca_topic_score_codex":0.0027690032,"about_ca_topic_score_gemma":0.0027078784,"teacher_disagreement_score":0.0038613528,"about_ca_system_score_codex":0.00035254782,"about_ca_system_score_gemma":0.00028378403,"threshold_uncertainty_score":0.012917459},"labels":[],"label_agreement":null},{"id":"W2912829588","doi":"10.1158/2326-6074.cricimteatiaacr18-b035","title":"Abstract B035: Enhancing antitumoral activity of cell-based immunotherapies by modulating the JAK-STAT axis","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Priming (agriculture); Chimeric antigen receptor; Adoptive cell transfer; CD40; Immunology; Antigen; Cytotoxic T cell; T cell; Cancer research; Medicine; Immunotherapy; Interleukin 21; Antigen-presenting cell; Immune system; Biology; In vitro","score_opus":0.050236515303171025,"score_gpt":0.3845353745239244,"score_spread":0.33429885922075336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912829588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95860165,0.020955961,0.0060097747,0.00076128234,0.0005748045,0.00017271124,0.0015743343,0.0005303084,0.010819163],"genre_scores_gemma":[0.98869926,0.003943007,0.0021857526,0.00023071971,0.000054608387,0.000070753136,0.000855875,0.000026480504,0.0039335717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992204,0.000010791742,0.000005499769,0.000010281107,0.00002495122,0.000026438047],"domain_scores_gemma":[0.99997294,0.0000030203012,0.000005126815,0.0000016914295,0.0000026374505,0.000014628677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011179414,0.00033306342,0.00020782601,0.0002490197,0.000111048175,0.0003218321,0.00019958598,0.00026128523,0.0057136766],"category_scores_gemma":[0.00004371698,0.00008857879,0.00022709186,0.00015327013,0.00015328999,0.0001363358,0.00012435016,0.0007832712,0.0011483894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017053485,0.0006142821,0.00018345294,0.0002876719,0.000027485143,0.000066722845,0.000014308689,0.0006499538,0.97288245,0.0006824338,0.001255868,0.021630038],"study_design_scores_gemma":[0.00071272644,0.006201341,0.0032104503,0.00005754574,0.00010754702,0.0004499291,0.000030225383,0.0049777115,0.9633718,0.000328635,0.020534359,0.000017794258],"about_ca_topic_score_codex":0.00039226588,"about_ca_topic_score_gemma":0.00054205756,"teacher_disagreement_score":0.0057136766,"about_ca_system_score_codex":0.00024121025,"about_ca_system_score_gemma":0.00025823186,"threshold_uncertainty_score":0.019114137},"labels":[],"label_agreement":null},{"id":"W2912834094","doi":"10.1158/2326-6074.cricimteatiaacr18-b059","title":"Abstract B059: Synergistic activation of antitumor immunity by an oncolytic virus VG161 armed with multiple immune-stimulating genes","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada); University of British Columbia","funders":"","keywords":"Oncolytic virus; Immune system; Tumor microenvironment; Cancer research; Immunotherapy; Cancer immunotherapy; Virotherapy; Immunology; Biology; Herpes simplex virus; Virus; Medicine; Virology","score_opus":0.04479246324704107,"score_gpt":0.37554749852184816,"score_spread":0.3307550352748071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912834094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252844,0.001357754,0.0028728454,0.00007648292,0.00006572542,0.00005961218,0.0003241922,0.00009877804,0.00261621],"genre_scores_gemma":[0.9944621,0.00044950814,0.0021252923,0.0000345361,0.000010454537,0.000042748437,0.00043826882,0.000016601702,0.0024205558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991226,0.000010061982,0.0000071240534,0.000017876115,0.000022568043,0.000030070656],"domain_scores_gemma":[0.9999653,0.0000040357972,0.0000078215535,0.000003744457,0.000003626536,0.000015430493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008354207,0.00038692408,0.00020547501,0.00020547422,0.00006832839,0.00021694062,0.00015865453,0.0002484015,0.0011527197],"category_scores_gemma":[0.00004526071,0.00008414548,0.00024967824,0.00014010341,0.0001459512,0.00012001843,0.0001889138,0.0003972485,0.00034907402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002872606,0.000076933706,0.00009191818,0.000025714646,0.0000056445683,0.000022492759,0.000004896992,0.0001673232,0.9971975,0.00011129718,0.00007451951,0.0019345966],"study_design_scores_gemma":[0.000057326615,0.0010360981,0.00080858986,0.0000059108434,0.000017115897,0.00013575675,0.000006875085,0.0012663294,0.9943276,0.000041858973,0.0022934123,0.0000031190168],"about_ca_topic_score_codex":0.0004314902,"about_ca_topic_score_gemma":0.00031198846,"teacher_disagreement_score":0.0011527197,"about_ca_system_score_codex":0.00022481686,"about_ca_system_score_gemma":0.00017699559,"threshold_uncertainty_score":0.0038562417},"labels":[],"label_agreement":null},{"id":"W2912868925","doi":"10.1158/2326-6074.cricimteatiaacr18-pr09","title":"Abstract PR09: Intratumoral delivery of engineered modified vaccinia virus Ankara expressing Flt3L and OX40L for \"in situ\" therapeutic cancer vaccination","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Modified vaccinia Ankara; Vaccinia; Virology; Medicine; Cancer research; Immune system; Vaccination; IRF3; Genetic enhancement; ELISPOT; Immunotherapy; Cancer immunotherapy; Immunology; CD8; Cancer vaccine; Biology; Innate immune system; Gene; Recombinant DNA","score_opus":0.04892804453989135,"score_gpt":0.37222510054183366,"score_spread":0.3232970560019423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912868925","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806804,0.0012710937,0.012767382,0.00021922006,0.0002554319,0.00026386257,0.0012918593,0.00038706098,0.002863611],"genre_scores_gemma":[0.9802419,0.00047748207,0.011683817,0.0000793391,0.000038202532,0.00015636456,0.0013725501,0.00006337794,0.005886975],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981767,0.000016743048,0.000013215758,0.00005409059,0.00003967309,0.000058545247],"domain_scores_gemma":[0.99993694,0.0000067778287,0.000021279326,0.00000728614,0.000005842859,0.000021868836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013162513,0.00047189218,0.00028846366,0.00019886206,0.00011700266,0.00027042656,0.0002719645,0.0005428745,0.0017767266],"category_scores_gemma":[0.00006096692,0.00013298486,0.0003245624,0.000112965085,0.00023288147,0.00023635881,0.00018200754,0.00090279843,0.0006194291],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018475969,0.000072249575,0.00004370585,0.000028982782,0.000003981761,0.000028755894,0.0000061579103,0.000059478058,0.9981641,0.0001531982,0.000087018656,0.0011676637],"study_design_scores_gemma":[0.00004845377,0.00074337947,0.00046984886,0.0000035421601,0.000014806737,0.0002039365,0.0000052028904,0.00084742624,0.9946812,0.000027272068,0.0029516132,0.0000032839173],"about_ca_topic_score_codex":0.00058761745,"about_ca_topic_score_gemma":0.00032990007,"teacher_disagreement_score":0.0017767266,"about_ca_system_score_codex":0.0003145477,"about_ca_system_score_gemma":0.00025352812,"threshold_uncertainty_score":0.0059437156},"labels":[],"label_agreement":null},{"id":"W2914404219","doi":"10.1158/2326-6074.cricimteatiaacr18-b146","title":"Abstract B146: The tumor necrosis factor superfamily member RANKL suppresses effector cytokine production in group 3 innate lymphoid cells","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"RANKL; Innate lymphoid cell; Tumor necrosis factor alpha; Cytokine; Immunology; Cancer research; Biology; C-C chemokine receptor type 6; Receptor; Chemokine; Innate immune system; Chemokine receptor; Inflammation; Activator (genetics); Immune system; Biochemistry","score_opus":0.04108454160267023,"score_gpt":0.31037854177232105,"score_spread":0.2692940001696508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914404219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97446376,0.006774182,0.0055264616,0.0008751453,0.0004441147,0.00007108641,0.0018664558,0.0007026429,0.00927628],"genre_scores_gemma":[0.972312,0.0015284647,0.0026933528,0.00026519605,0.00009605167,0.000059649847,0.0015775594,0.000088411194,0.02137933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997998,0.00002942266,0.00001932515,0.00002565573,0.00008330892,0.000042525655],"domain_scores_gemma":[0.9998921,0.000010326561,0.00002884196,0.000013132951,0.000018393273,0.00003716837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013517671,0.0003296762,0.0002865474,0.00030518248,0.00018996758,0.0004184112,0.00019206681,0.00035480162,0.0059143146],"category_scores_gemma":[0.000098526616,0.00009068956,0.00024842305,0.00017141899,0.00020858653,0.00016068289,0.00021900059,0.0006069957,0.0018083105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011776864,0.000024137182,0.00007619402,0.000043093,0.000002293742,0.000038993254,0.000005678961,0.000018927522,0.998099,0.00007086219,0.00024897762,0.0012539786],"study_design_scores_gemma":[0.00004226507,0.00045234695,0.002791906,0.000011027352,0.000012105819,0.00037941805,0.000025751006,0.00030188478,0.98623383,0.000065726774,0.009679241,0.0000044883855],"about_ca_topic_score_codex":0.0005931041,"about_ca_topic_score_gemma":0.0006374731,"teacher_disagreement_score":0.0059143146,"about_ca_system_score_codex":0.00020985788,"about_ca_system_score_gemma":0.0003370863,"threshold_uncertainty_score":0.019785285},"labels":[],"label_agreement":null},{"id":"W2914496384","doi":"10.1158/2326-6074.cricimteatiaacr18-a147","title":"Abstract A147: AO-176, a next-generation anti-CD47 antibody, induces immunogenic cell death","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD47; Immunogenic cell death; Innate immune system; Immune system; Antibody; Acquired immune system; Immunology; Cytotoxic T cell; Immunotherapy; Cancer immunotherapy; Antigen; Biology; Programmed cell death; Dendritic cell; Phagocytosis; Cancer research; Apoptosis; In vitro","score_opus":0.12017062604383288,"score_gpt":0.3780008427254079,"score_spread":0.257830216681575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914496384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986984,0.0016864784,0.004641725,0.00024461932,0.00011136066,0.0000842102,0.00046104062,0.00015073118,0.0056358473],"genre_scores_gemma":[0.98887575,0.0006079323,0.004129223,0.00020367843,0.00003076982,0.000050330935,0.00076530734,0.00001649607,0.0053205634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986196,0.000021083453,0.000011695852,0.000018811084,0.00005147142,0.00003490351],"domain_scores_gemma":[0.9999261,0.000018484672,0.000017517666,0.000008631396,0.00001234736,0.00001681316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119359436,0.00030757734,0.0001756583,0.0001923199,0.00008782685,0.00015152879,0.00017073516,0.00036744925,0.0036643054],"category_scores_gemma":[0.000094816474,0.00009991479,0.00018062342,0.00009297467,0.00013342433,0.00012667433,0.000107513784,0.00053842936,0.00077319256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009713759,0.000048622253,0.00007979225,0.000021261189,0.0000034801403,0.00004076536,0.0000033179117,0.00004250537,0.9986179,0.000065858716,0.000111199945,0.0008682009],"study_design_scores_gemma":[0.00001892161,0.0003711865,0.00085920666,0.0000016080683,0.000004562953,0.0002222504,0.0000031515633,0.0004110688,0.9965006,0.00001485255,0.001591377,0.0000012257175],"about_ca_topic_score_codex":0.00022236738,"about_ca_topic_score_gemma":0.000175633,"teacher_disagreement_score":0.0036643054,"about_ca_system_score_codex":0.00020452953,"about_ca_system_score_gemma":0.0001582419,"threshold_uncertainty_score":0.012258351},"labels":[],"label_agreement":null},{"id":"W2921210767","doi":"10.1158/2326-6066.cir-18-0517","title":"A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Universitair Medisch Centrum Groningen; Wellcome Trust; Ministry of Earth Sciences; Academy of Medical Sciences; KWF Kankerbestrijding; National Institute for Health and Care Research; Jan Kornelis de Cock Stichting","keywords":"CXCL13; CD8; Biology; B cell; Immunology; T cell; Tumor microenvironment; Cancer research; Acquired immune system; Chemokine; CXCR5; Immune system; Population; Antibody; Chemokine receptor; Medicine","score_opus":0.09239662447523743,"score_gpt":0.3867133403020323,"score_spread":0.29431671582679486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921210767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983191,0.0003880331,0.00049097335,0.000019059538,0.0000047633444,0.000020910658,0.00025600262,0.000038191683,0.00046299462],"genre_scores_gemma":[0.99810046,0.00013146632,0.0003387478,0.00001888127,0.0000052468313,0.000033994616,0.0004414499,0.0000073884644,0.00092249294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999125,0.000010895673,0.0000073015012,0.000023822044,0.000016825154,0.000028693192],"domain_scores_gemma":[0.99989295,0.000014276564,0.00002472141,0.000010280925,0.000018953948,0.000038802027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008244243,0.00009380877,0.00018983158,0.00038370545,0.00014398007,0.00030599674,0.00006506898,0.0001735923,0.0027010748],"category_scores_gemma":[0.00011837762,0.000107255844,0.00007889624,0.00030962683,0.00011900804,0.00009355666,0.00013395758,0.00027326326,0.00042840914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008609414,0.000085078,0.03283225,0.000051047897,0.000009439184,0.0001772532,0.000084556435,0.000043348788,0.9601031,0.00003961928,0.00014075032,0.005572788],"study_design_scores_gemma":[0.00009000111,0.0012475122,0.67241114,0.000019593523,0.00006111043,0.0044879243,0.00055407477,0.0016072902,0.31457987,0.00016169884,0.0047644037,0.00001535911],"about_ca_topic_score_codex":0.00052188046,"about_ca_topic_score_gemma":0.0005022091,"teacher_disagreement_score":0.0027010748,"about_ca_system_score_codex":0.0001321047,"about_ca_system_score_gemma":0.00010777461,"threshold_uncertainty_score":0.009036005},"labels":[],"label_agreement":null},{"id":"W2924812697","doi":"10.1158/2326-6066.cir-18-0499","title":"Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Foundation","funders":"National Cancer Institute","keywords":"Immune system; Tumor microenvironment; Cytotoxic T cell; Tumor-infiltrating lymphocytes; Immunohistochemistry; CD8; Cancer research; Immune checkpoint; PD-L1; Immunotherapy; Cancer; T cell; Medicine; Immunology; Biology; Internal medicine","score_opus":0.040802647508878714,"score_gpt":0.35138590238406125,"score_spread":0.31058325487518257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924812697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933473,0.0051867077,0.0004328731,0.00004067977,0.000005394375,0.0000132761415,0.00003246056,0.000019882938,0.00092142296],"genre_scores_gemma":[0.9994771,0.0002952275,0.00010320744,0.000015090506,0.000008664641,0.000003845784,0.00002268635,8.0412224e-7,0.00007332427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989164,0.000021690801,0.000012133507,0.000017879584,0.000030332192,0.00002630044],"domain_scores_gemma":[0.9998411,0.000033294684,0.00006332966,0.000012975696,0.00001943092,0.00002984377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023363385,0.00019675776,0.00015502509,0.00090255373,0.0002247305,0.00027109517,0.00015162448,0.00025907374,0.00068580895],"category_scores_gemma":[0.00033920864,0.00007141615,0.00013610692,0.00031012198,0.00025898486,0.0002493994,0.00025977843,0.00014973557,0.00013153705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011962226,0.00019464821,0.6412565,0.00046871314,0.00008099533,0.023020748,0.00046998856,0.000498414,0.2632465,0.0009645876,0.00047156852,0.06813112],"study_design_scores_gemma":[0.00008767831,0.00078955793,0.8369101,0.000108444336,0.0001547783,0.09081244,0.0008423196,0.00377106,0.057678845,0.00086977653,0.007949102,0.000025908046],"about_ca_topic_score_codex":0.00046902747,"about_ca_topic_score_gemma":0.00048090584,"teacher_disagreement_score":0.00090255373,"about_ca_system_score_codex":0.00024759708,"about_ca_system_score_gemma":0.00010320895,"threshold_uncertainty_score":0.0022942424},"labels":[],"label_agreement":null},{"id":"W2928326859","doi":"10.1158/2326-6066.cir-18-0013","title":"Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Institutes of Health; Oncolytics Biotech; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Phenotype; Immunotherapy; Cancer research; Cell culture; Cell; Biology; Immunology; Medicine; Cancer; Genetics; Gene","score_opus":0.0742356342109851,"score_gpt":0.36868867120983173,"score_spread":0.2944530369988466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928326859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960765,0.00036213908,0.0025201489,0.000049119455,0.000013685376,0.000035863774,0.00011163561,0.000098382036,0.0007324583],"genre_scores_gemma":[0.9971624,0.00014588708,0.0016802707,0.000031139218,0.0000053891526,0.000024725692,0.00013394182,0.000032325912,0.00078394666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997613,0.000047633996,0.000036819474,0.00004432446,0.000054167085,0.000055871715],"domain_scores_gemma":[0.99972075,0.00008239797,0.000077614706,0.000040504303,0.000024106916,0.000054635435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017106108,0.00028020056,0.0004271916,0.00016658193,0.00009775819,0.00033426203,0.00020040078,0.00034023874,0.0010624491],"category_scores_gemma":[0.00021812244,0.00012947332,0.00017001355,0.000102870945,0.00016978123,0.00013778871,0.00020607165,0.0007364643,0.0004355527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034928544,0.000022657407,0.000087230255,0.000008693033,0.000002073259,0.0000125768165,0.000004453452,0.000083266415,0.9993173,0.00004426005,0.000017638657,0.0003650029],"study_design_scores_gemma":[0.000013671237,0.00032184387,0.0012364764,0.0000036714348,0.00000788369,0.0001576266,0.0000090337135,0.0018612228,0.9956938,0.000028833325,0.0006631937,0.000002738796],"about_ca_topic_score_codex":0.0003723071,"about_ca_topic_score_gemma":0.00044527082,"teacher_disagreement_score":0.0010624491,"about_ca_system_score_codex":0.00037978822,"about_ca_system_score_gemma":0.00015960862,"threshold_uncertainty_score":0.0035542846},"labels":[],"label_agreement":null},{"id":"W2945184742","doi":"10.1158/2326-6066.cir-18-0657","title":"Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Immune checkpoint; Immune system; Cancer research; Tumor microenvironment; Melanoma; Immunotherapy; Blockade; PD-L1; Tumor hypoxia; Hypoxia (environmental); Biology; Medicine; Immunology; Chemistry; Internal medicine; Receptor; Radiation therapy","score_opus":0.02197598036315715,"score_gpt":0.30964866186925105,"score_spread":0.28767268150609393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945184742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961002,0.001266579,0.001065466,0.00013178837,0.000028552517,0.000035477056,0.00007156332,0.00004457223,0.0012559664],"genre_scores_gemma":[0.998287,0.0003623059,0.00035365517,0.000033714052,0.000009897433,0.000015874048,0.00006747162,0.0000034968832,0.0008664739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995494,0.0000069989637,0.0000022950853,0.000009059794,0.000010662664,0.00001617105],"domain_scores_gemma":[0.99997425,0.000003305346,0.000008715165,0.0000019260322,0.000002780788,0.000009025654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007099537,0.00013596061,0.0001641158,0.00008138541,0.000059978916,0.00017202596,0.00009655941,0.00009873711,0.0009412313],"category_scores_gemma":[0.000051621584,0.000043229116,0.000094117175,0.00005379971,0.00009590248,0.0000792242,0.00009813991,0.00032270004,0.00013424197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057698216,0.00022714955,0.0007227009,0.000052779087,0.0000187616,0.000021624435,0.0000079567335,0.00036987197,0.9874765,0.00009661759,0.00023491184,0.01019419],"study_design_scores_gemma":[0.00027142782,0.0061635394,0.015094612,0.000013312158,0.0000712,0.00030967567,0.000028869721,0.004081562,0.96806437,0.00006946448,0.0058265463,0.000005391535],"about_ca_topic_score_codex":0.00045275086,"about_ca_topic_score_gemma":0.0012456438,"teacher_disagreement_score":0.0009412313,"about_ca_system_score_codex":0.00021694518,"about_ca_system_score_gemma":0.00015853882,"threshold_uncertainty_score":0.003148675},"labels":[],"label_agreement":null},{"id":"W2948733916","doi":"10.1158/2326-6066.cir-18-0891","title":"Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Labex Immuno-Oncology; Sorbonne Université; Institut National de la Santé et de la Recherche Médicale; Ligue Contre le Cancer; Les Laboratories Pierre Fabre; Institute of Cancer Research; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Complement system; Tumor microenvironment; Cancer research; Immune system; Tumor progression; Inflammation; Cancer; Biology; Immunotherapy; Clear cell renal cell carcinoma; Alternative complement pathway; Immunology; Medicine; Renal cell carcinoma; Pathology","score_opus":0.05467390408719436,"score_gpt":0.362362333252701,"score_spread":0.30768842916550665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948733916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965994,0.0007694273,0.0007757367,0.00008933491,0.000024396268,0.00002820788,0.0004317296,0.000061428334,0.0012203802],"genre_scores_gemma":[0.9972842,0.00021720536,0.0005023023,0.000042521126,0.0000058145624,0.000029632063,0.00027284137,0.0000060931907,0.0016394606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986553,0.000014931396,0.000008826015,0.000022863049,0.000029303086,0.00005845722],"domain_scores_gemma":[0.99992836,0.000010952446,0.000012548087,0.000011016631,0.0000091758075,0.000027985689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011290273,0.00023942192,0.00025952543,0.00021159707,0.00014426661,0.00024268733,0.00012902927,0.00020161588,0.0018297596],"category_scores_gemma":[0.00007214466,0.000084145795,0.00020023118,0.00011601888,0.00013320633,0.00014576345,0.0001762902,0.0005806114,0.00047061397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002549702,0.0001440591,0.0006631518,0.000038069127,0.000005682421,0.00005010615,0.000019826508,0.00009660065,0.9969363,0.00014510093,0.0002368063,0.0014094057],"study_design_scores_gemma":[0.00007698041,0.0016029673,0.011736668,0.0000094931775,0.000025485166,0.00036676822,0.00007334448,0.0026174437,0.9796026,0.00010339009,0.0037783752,0.000006530156],"about_ca_topic_score_codex":0.000923779,"about_ca_topic_score_gemma":0.0013928011,"teacher_disagreement_score":0.0018297596,"about_ca_system_score_codex":0.00027227087,"about_ca_system_score_gemma":0.00028109775,"threshold_uncertainty_score":0.006121218},"labels":[],"label_agreement":null},{"id":"W2961898921","doi":"10.1158/2326-6066.cir-18-0691","title":"TGFβ Programs Central Memory Differentiation in <i>Ex Vivo</i> –Stimulated Human T Cells","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; BC Children's Hospital; University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Leukemia and Lymphoma Society of Canada","keywords":"Cytotoxic T cell; Adoptive cell transfer; Ex vivo; Biology; Immunology; T cell; CD8; Memory T cell; Cell biology; Immunotherapy; Cancer research; In vivo; Immune system; In vitro","score_opus":0.06344752022462088,"score_gpt":0.39404221541498,"score_spread":0.3305946951903591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961898921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941907,0.001228479,0.0023705636,0.00006086581,0.000032369175,0.000034786357,0.00022344427,0.000066773915,0.0017920911],"genre_scores_gemma":[0.99730945,0.0003604439,0.0009768456,0.000053997614,0.000020842052,0.000025146477,0.00028443066,0.000014706216,0.000954196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999255,0.000021605689,0.000008611215,0.000013342143,0.000011438094,0.000019492625],"domain_scores_gemma":[0.9999379,0.000015510535,0.00001395933,0.0000127328485,0.000008441316,0.000011479193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000137447,0.00029797407,0.0001689043,0.00012228788,0.00007333193,0.000280075,0.000085360254,0.00013668009,0.0012759726],"category_scores_gemma":[0.0000864355,0.000082635415,0.00016670093,0.00008924894,0.000115185496,0.00010551316,0.00011453818,0.00053813076,0.0004674051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001482415,0.000031460233,0.00017057889,0.00002311764,0.0000016999295,0.000035615947,0.000017474391,0.00004314263,0.9983942,0.000028761478,0.000027270036,0.0010784516],"study_design_scores_gemma":[0.00003892532,0.0008349813,0.0031817437,0.000010784737,0.000017665936,0.00030464516,0.000039349845,0.0006615462,0.9924482,0.000055464716,0.0024036847,0.0000030025233],"about_ca_topic_score_codex":0.00014873093,"about_ca_topic_score_gemma":0.00018232942,"teacher_disagreement_score":0.0012759726,"about_ca_system_score_codex":0.00008848634,"about_ca_system_score_gemma":0.00009754531,"threshold_uncertainty_score":0.0042685866},"labels":[],"label_agreement":null},{"id":"W2987656669","doi":"10.1158/2326-6066.cir-19-0144","title":"IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"KWF Kankerbestrijding; Landsteiner Foundation for Blood Transfusion Research","keywords":"CD47; Cancer research; Cancer immunotherapy; Immunology; Immunotherapy; Antibody; Biology; Chemistry; Cell biology; Immune system","score_opus":0.023930129426210815,"score_gpt":0.30845955820054627,"score_spread":0.28452942877433546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987656669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946812,0.0016281962,0.002490101,0.00006353427,0.000019405745,0.00003365468,0.00009353774,0.0000676226,0.0009227223],"genre_scores_gemma":[0.99773186,0.0004485823,0.00072646147,0.0000273673,0.000008108325,0.000022571616,0.000119931785,0.000008544193,0.00090665946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983764,0.000039294173,0.00001289303,0.000017475406,0.00004076225,0.000051926218],"domain_scores_gemma":[0.9999342,0.000013210153,0.00001961851,0.000009438422,0.000007866823,0.000015607564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020609838,0.00036333903,0.00027497066,0.00010879831,0.00005608133,0.00019139079,0.0001302023,0.00020258401,0.0009823396],"category_scores_gemma":[0.000107675995,0.000078363126,0.00025819123,0.00006274986,0.00012234725,0.00012624022,0.00020557317,0.00041891966,0.00021465163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013835198,0.000036298345,0.00009561406,0.000028273762,0.0000053804174,0.000019398702,0.000006458632,0.00004101844,0.9984213,0.000040820745,0.000023986751,0.0011432015],"study_design_scores_gemma":[0.000030687766,0.0004650165,0.0023083717,0.0000041569615,0.000010665533,0.000096205265,0.000007313298,0.00082104676,0.9951566,0.000017963923,0.0010804469,0.0000015248611],"about_ca_topic_score_codex":0.00033467653,"about_ca_topic_score_gemma":0.0002955984,"teacher_disagreement_score":0.0009823396,"about_ca_system_score_codex":0.00017198251,"about_ca_system_score_gemma":0.000109811626,"threshold_uncertainty_score":0.0032862425},"labels":[],"label_agreement":null},{"id":"W3001787418","doi":"10.1158/2326-6066.cir-19-0521","title":"IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada); Vector Institute; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"CD8; Cytotoxic T cell; Biology; Chimeric antigen receptor; T-cell receptor; Cancer research; Cytokine; Immunology; Immunotherapy; T cell; Cell biology; Antigen; Immune system; Genetics","score_opus":0.13213537955766047,"score_gpt":0.39498686672623684,"score_spread":0.26285148716857637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001787418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598324,0.0005710776,0.0014956945,0.000063657135,0.00001961263,0.00004102217,0.000173705,0.00007071554,0.0015813722],"genre_scores_gemma":[0.9969597,0.00018814609,0.0009650628,0.00005217926,0.00002002372,0.000031929656,0.00023277385,0.000016248907,0.0015339131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998971,0.000022725255,0.000008652969,0.000018935616,0.000017153776,0.00003535244],"domain_scores_gemma":[0.99992025,0.000010569255,0.000013397204,0.000013581006,0.0000124652,0.000029758736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000803189,0.00030799198,0.00017531945,0.00012000321,0.0000902377,0.00026053545,0.00005771827,0.0001455161,0.0016637571],"category_scores_gemma":[0.00006748102,0.00006231413,0.00013551097,0.000073581374,0.000077449055,0.00008491042,0.00011875184,0.00037796603,0.00061400654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010384034,0.000037633774,0.00037182914,0.000017351756,0.0000020305606,0.000035961635,0.000007055441,0.00004711545,0.997733,0.000025467029,0.000047638787,0.0015710797],"study_design_scores_gemma":[0.000055609285,0.001429217,0.009418011,0.000008791,0.000020697198,0.0006660796,0.000054663775,0.001144773,0.9824226,0.00005126814,0.004724358,0.000003837047],"about_ca_topic_score_codex":0.00009328514,"about_ca_topic_score_gemma":0.00020928538,"teacher_disagreement_score":0.0016637571,"about_ca_system_score_codex":0.00008903482,"about_ca_system_score_gemma":0.000083323204,"threshold_uncertainty_score":0.0055657625},"labels":[],"label_agreement":null},{"id":"W3006446512","doi":"10.1158/2326-6066.cir-19-0541","title":"Proteogenomics Uncovers a Vast Repertoire of Shared Tumor-Specific Antigens in Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Terry Fox Research Institute","keywords":"Biology; Ovarian cancer; Immunotherapy; Antigen; Cancer; Genetics; Cancer research","score_opus":0.08396748384329009,"score_gpt":0.3402985964987779,"score_spread":0.2563311126554878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006446512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952311,0.0013731318,0.0016384994,0.000095609335,0.0000081347325,0.000011156505,0.0010550827,0.0000534318,0.000533751],"genre_scores_gemma":[0.9961443,0.0004201285,0.0014759542,0.0000657959,0.000010489152,0.000009116568,0.0015870491,0.000014663925,0.00027256957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998323,0.000022751146,0.000012830967,0.000053703716,0.000044840675,0.000033528973],"domain_scores_gemma":[0.99983823,0.000029795881,0.00006537036,0.000016111226,0.000025748663,0.000024820762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030679657,0.0002900751,0.0003703167,0.0011607844,0.0002887069,0.00055442547,0.00011839997,0.0002165038,0.00057847536],"category_scores_gemma":[0.00040494598,0.00013734416,0.0003966784,0.001019767,0.00015504504,0.00020984188,0.00044024453,0.0002320326,0.00017273752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004962336,0.00007449579,0.28400922,0.00022763667,0.0005226746,0.00071327796,0.0001923891,0.00112395,0.68389755,0.00041524097,0.001056897,0.02727037],"study_design_scores_gemma":[0.000018056777,0.00016581806,0.94783896,0.000019015477,0.00025620658,0.0017522373,0.00027374152,0.00810798,0.035442054,0.00077302527,0.005334729,0.00001810777],"about_ca_topic_score_codex":0.00082464993,"about_ca_topic_score_gemma":0.0010979333,"teacher_disagreement_score":0.0011607844,"about_ca_system_score_codex":0.00018985332,"about_ca_system_score_gemma":0.00017064858,"threshold_uncertainty_score":0.0019351244},"labels":[],"label_agreement":null},{"id":"W3009949817","doi":"10.1158/2326-6066.cir-19-0703","title":"Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Innovates - Health Solutions; Government of Canada","keywords":"Oncolytic virus; Vaccinia; Immune system; Virus; Immunology; Breast cancer; Virology; Cancer; Immunotherapy; Medicine; Virotherapy; Cancer immunotherapy; Biology; Recombinant DNA; Gene; Internal medicine","score_opus":0.04842172544349591,"score_gpt":0.3854856642971151,"score_spread":0.3370639388536192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009949817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974831,0.0010312679,0.001074104,0.000043664495,0.000012422656,0.0000128861675,0.000051421288,0.000012036134,0.000279236],"genre_scores_gemma":[0.99789137,0.0004927688,0.0012589919,0.000025995474,0.000007937416,0.00001015642,0.000072412055,0.00000425203,0.00023610095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991965,0.000016698605,0.0000052602,0.000011467036,0.000017447463,0.000029546347],"domain_scores_gemma":[0.9999627,0.000010352227,0.000007901047,0.00000523406,0.000005468523,0.000008333525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016436074,0.00016853107,0.00019307653,0.00012679688,0.00007045507,0.00021504721,0.00011979021,0.00020201209,0.00041245905],"category_scores_gemma":[0.00008427484,0.00006673835,0.00016160743,0.00006141085,0.00015326851,0.00016823516,0.00009557008,0.0004111114,0.00008571908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000810936,0.000028966098,0.0001727618,0.00001570459,0.000002539969,0.000008205761,0.00000635084,0.00011496218,0.9983328,0.000064798274,0.000008064057,0.001163794],"study_design_scores_gemma":[0.000015812657,0.0008502155,0.0025802536,0.0000039949787,0.000016547929,0.00007754205,0.000021412567,0.0013704468,0.99378717,0.000057000827,0.0012174002,0.0000021981718],"about_ca_topic_score_codex":0.00019897868,"about_ca_topic_score_gemma":0.00020368453,"teacher_disagreement_score":0.00041245905,"about_ca_system_score_codex":0.00016113043,"about_ca_system_score_gemma":0.00010536726,"threshold_uncertainty_score":0.0013798475},"labels":[],"label_agreement":null},{"id":"W3013133988","doi":"10.1158/2326-6074.tumimm19-b16","title":"Abstract B16: Identification of tumor-specific antigens shared by induced pluripotent stem cells","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Induced pluripotent stem cell; Cancer stem cell; Cancer immunotherapy; Biology; Stem cell; Cancer research; Embryonic stem cell; Cancer; Immunotherapy; Antigen; Immunology; Cell biology; Genetics; Gene","score_opus":0.0569917876543167,"score_gpt":0.3631866938506854,"score_spread":0.3061949061963687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013133988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736202,0.002631344,0.016061721,0.00016485942,0.00007809763,0.00019681324,0.00346242,0.0001913384,0.0035932795],"genre_scores_gemma":[0.9651441,0.0015641387,0.017744198,0.00011877475,0.000023217814,0.00012665978,0.008211241,0.00009889272,0.0069687036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998745,0.000016904414,0.000017574894,0.00003167112,0.000043922046,0.000015563188],"domain_scores_gemma":[0.99985087,0.000024894662,0.00004155622,0.000026696714,0.000027866183,0.00002806937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025833008,0.0003023265,0.00017882409,0.00044186326,0.00010338734,0.0003008001,0.00016963268,0.00023546044,0.0024836208],"category_scores_gemma":[0.00019437117,0.00012728895,0.00020366376,0.0002331743,0.00014658523,0.00011749539,0.0002431473,0.00034790023,0.00088202837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003095302,0.0000072293947,0.00029347834,0.000017571727,0.000003339975,0.00003082796,0.0000052518526,0.000042844447,0.9979645,0.00006598953,0.00003099709,0.0015070385],"study_design_scores_gemma":[0.000019809331,0.00026460696,0.0068573016,0.000013358629,0.00002098139,0.00059320586,0.000016437334,0.00086881884,0.9855408,0.00014799685,0.005651162,0.0000054172224],"about_ca_topic_score_codex":0.00022043542,"about_ca_topic_score_gemma":0.00021563318,"teacher_disagreement_score":0.0024836208,"about_ca_system_score_codex":0.00013474791,"about_ca_system_score_gemma":0.00015633585,"threshold_uncertainty_score":0.00830847},"labels":[],"label_agreement":null},{"id":"W3013248902","doi":"10.1158/2326-6074.tumimm19-a59","title":"Abstract A59: Inhibition of Glycogen Synthase Kinase 3 (GSK-3) synergizes with anti-PD-1 by potentiating tumor-infiltrated CD8+ T-cells","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Fluidigm (Canada); McGill University Health Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cancer research; CD8; Cytotoxic T cell; Immune checkpoint; Melanoma; Blockade; Immunotherapy; PD-L1; Medicine; Perforin; Tumor microenvironment; Tumor-infiltrating lymphocytes; Immune system; Chemistry; Immunology; Internal medicine; Receptor; Biochemistry","score_opus":0.03330822633405862,"score_gpt":0.30292046428008945,"score_spread":0.26961223794603084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013248902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634964,0.002561681,0.0020121997,0.0005130417,0.00043524138,0.00017423101,0.0016492249,0.00029510295,0.0060096225],"genre_scores_gemma":[0.99114966,0.00097455597,0.0018320903,0.00021483931,0.000045612072,0.00013474272,0.001100357,0.000025431527,0.0045227585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998615,0.00001717377,0.00001642378,0.000023642486,0.000039503684,0.000041757645],"domain_scores_gemma":[0.99993134,0.000009607604,0.000013646461,0.0000071828176,0.000004996381,0.000033282296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001248819,0.0003661961,0.00033798828,0.00024926057,0.000116852236,0.00029481572,0.00018583713,0.0003115798,0.0055719935],"category_scores_gemma":[0.00010019013,0.00013978528,0.00039106884,0.00015032124,0.00022813964,0.0001984039,0.00016763453,0.0010851967,0.0010204045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017394042,0.00058414985,0.00015930533,0.00011810341,0.000024331282,0.000059307906,0.000010733668,0.0002750576,0.99006116,0.0001633437,0.00092522334,0.005879841],"study_design_scores_gemma":[0.0007368717,0.00830971,0.003790814,0.000020261246,0.000060154736,0.0003110365,0.000022386406,0.001710125,0.9790467,0.00017528003,0.0058067054,0.000009994524],"about_ca_topic_score_codex":0.00037479133,"about_ca_topic_score_gemma":0.0006190909,"teacher_disagreement_score":0.0055719935,"about_ca_system_score_codex":0.00023683411,"about_ca_system_score_gemma":0.00039573736,"threshold_uncertainty_score":0.01864016},"labels":[],"label_agreement":null},{"id":"W3013332782","doi":"10.1158/2326-6074.tumimm19-b88","title":"Abstract B88: GPNMB expression modulates the tumor immune microenvironment in mouse models of breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Immune system; Tumor microenvironment; Granzyme B; Cancer research; CD8; Biology; Cytotoxic T cell; Immunology; Immunotherapy; Acquired immune system; Breast cancer; T cell; Cancer; In vitro","score_opus":0.050569529708301766,"score_gpt":0.31617392874241246,"score_spread":0.2656043990341107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013332782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913229,0.0013949885,0.002342244,0.00034145603,0.00004998479,0.00009757228,0.0018474031,0.00019063304,0.0024127746],"genre_scores_gemma":[0.98445153,0.0011258394,0.004011684,0.00020136408,0.000026096612,0.0003312507,0.0022138385,0.0001178243,0.0075205737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994337,0.000098610304,0.000044407236,0.00010232973,0.00016287887,0.00015798901],"domain_scores_gemma":[0.9997336,0.000031945783,0.00008368809,0.00003849239,0.000027178668,0.00008506235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033783333,0.00066837994,0.00043883632,0.0010211602,0.00027656526,0.0004860719,0.00036163643,0.0008047777,0.0025869112],"category_scores_gemma":[0.00012321315,0.00035539828,0.0004222931,0.00044910389,0.00047446473,0.00035012135,0.00028851154,0.0020923296,0.0010831882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033355315,0.00016517134,0.00021967833,0.000033381453,0.0000051702823,0.000036496094,0.00001867207,0.000061997525,0.9981377,0.00007713377,0.00008400489,0.0008271399],"study_design_scores_gemma":[0.0000874203,0.0013087543,0.005961278,0.000016283764,0.000027372414,0.00036275203,0.00007810364,0.0011251915,0.98819983,0.00007306498,0.0027511604,0.000008892245],"about_ca_topic_score_codex":0.0008088887,"about_ca_topic_score_gemma":0.0010070853,"teacher_disagreement_score":0.0025869112,"about_ca_system_score_codex":0.0006450084,"about_ca_system_score_gemma":0.00027133073,"threshold_uncertainty_score":0.008654058},"labels":[],"label_agreement":null},{"id":"W3013420908","doi":"10.1158/2326-6074.tumimm19-a53","title":"Abstract A53: Phosphorylation of eIF4E promotes phenotype switching and MDSC-mediated immunosuppression in melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Melanoma; Cancer research; Immunotherapy; EIF4E; Cytokine; Immune system; Microphthalmia-associated transcription factor; Immunology; Biology; Medicine; Transcription factor; Gene","score_opus":0.04469111608526693,"score_gpt":0.3249136380126815,"score_spread":0.2802225219274146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013420908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965306,0.0007470144,0.0011287233,0.000088381545,0.000040804025,0.00002239333,0.00042083106,0.00007038916,0.0009509613],"genre_scores_gemma":[0.99755484,0.00022781942,0.00037326693,0.00003175019,0.000011723095,0.000023268401,0.00029614125,0.000010172698,0.0014710551],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990094,0.000013248901,0.000010701021,0.000022528651,0.000023807777,0.000028743854],"domain_scores_gemma":[0.9998996,0.000007948834,0.000041041152,0.000011477528,0.000007777453,0.00003215602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009856459,0.00031687613,0.0001861725,0.0002693828,0.00010884968,0.00020439248,0.00009834836,0.00023616689,0.0023163268],"category_scores_gemma":[0.00009072285,0.00010157431,0.00018504992,0.0001023219,0.00019994825,0.0001333128,0.0001676876,0.00062359066,0.0004952031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029614667,0.000047057336,0.000556566,0.000025631689,0.00000425976,0.000093149545,0.0000058022138,0.000036872272,0.99768245,0.000055093726,0.00007332962,0.0011236055],"study_design_scores_gemma":[0.000096218806,0.0014901069,0.04311058,0.000016678056,0.000028835928,0.0014612989,0.000076324686,0.0014192221,0.94861615,0.00020979354,0.003466597,0.000008168613],"about_ca_topic_score_codex":0.00009500355,"about_ca_topic_score_gemma":0.000113574904,"teacher_disagreement_score":0.0023163268,"about_ca_system_score_codex":0.00016276883,"about_ca_system_score_gemma":0.0000792827,"threshold_uncertainty_score":0.007748902},"labels":[],"label_agreement":null},{"id":"W3013453726","doi":"10.1158/2326-6074.tumimm19-b62","title":"Abstract B62: Development of novel chimeric antigen receptor T cells for immunotherapy of hepatocellular carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Epitope; Monoclonal antibody; Antigen; Immunotherapy; Effector; Cancer immunotherapy; Immunohistochemistry; Cancer research; Hepatocellular carcinoma; Antibody; Adoptive cell transfer; Molecular biology; T cell; Biology; Immunology; Immune system","score_opus":0.1458943262138125,"score_gpt":0.39103270112138505,"score_spread":0.24513837490757256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013453726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890266,0.0024379345,0.0057367496,0.00014854367,0.000063361644,0.00010559947,0.00014071359,0.00012717723,0.002213382],"genre_scores_gemma":[0.9880165,0.0011210226,0.0072007296,0.00011570353,0.00003569751,0.000071146096,0.00045500486,0.000012369423,0.002971858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993694,0.000012147812,0.000004199733,0.00001250656,0.000017471542,0.000016754726],"domain_scores_gemma":[0.9999733,0.0000029997718,0.0000051023358,0.000002746491,0.0000061043675,0.000009769424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009492757,0.00026991835,0.0001731108,0.00012801905,0.000071125876,0.00014929032,0.0001388756,0.00032909404,0.0010832162],"category_scores_gemma":[0.000070888746,0.000072520445,0.00015860067,0.00007317518,0.00007107055,0.00011815466,0.000117850956,0.00039598983,0.00042729932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002093569,0.000114826915,0.00027878696,0.000060244263,0.0000094573525,0.00009132651,0.00001643251,0.00048094857,0.98860407,0.000116793126,0.00020118225,0.009816638],"study_design_scores_gemma":[0.00063051196,0.007102307,0.008304023,0.000036367845,0.00011625287,0.0017722753,0.000040253617,0.010849567,0.94873977,0.00023088642,0.022156643,0.000021109809],"about_ca_topic_score_codex":0.0002455293,"about_ca_topic_score_gemma":0.00026153072,"teacher_disagreement_score":0.0010832162,"about_ca_system_score_codex":0.00013397241,"about_ca_system_score_gemma":0.00013619014,"threshold_uncertainty_score":0.003623724},"labels":[],"label_agreement":null},{"id":"W3014079509","doi":"10.1158/2326-6074.tumimm19-b103","title":"Abstract B103: Molecular heterogeneity of gastric cancer explained by methylation-driven key regulators","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Epigenetics; DNA methylation; Tumor microenvironment; Biology; Methylation; Stromal cell; Cancer; Cancer research; Computational biology; Genetics; Gene; Gene expression","score_opus":0.08158889648798251,"score_gpt":0.3876243804889234,"score_spread":0.3060354840009409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014079509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841632,0.0005959169,0.01294159,0.00016237855,0.000016174881,0.00003840858,0.0011020784,0.00013089296,0.00084923656],"genre_scores_gemma":[0.9983809,0.000066786655,0.0009784496,0.000025651054,0.0000070780025,0.000011506946,0.00039190552,0.000009770885,0.00012802212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999534,0.00011740805,0.00003087954,0.00016571817,0.00007876257,0.00007327741],"domain_scores_gemma":[0.9992531,0.00027633968,0.00023591748,0.00008639158,0.000064094325,0.00008415364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009285711,0.00046112516,0.0004469668,0.0010248447,0.000293365,0.00055029837,0.0003358989,0.00028515776,0.003109663],"category_scores_gemma":[0.0018352869,0.00016512605,0.0010239902,0.00071392057,0.00048707417,0.00031155956,0.00050933345,0.00046748712,0.0001839143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015398139,0.00007676569,0.86936104,0.00016337525,0.00060825516,0.000805317,0.00014451033,0.0057400865,0.09838303,0.0019997759,0.00046449385,0.020713622],"study_design_scores_gemma":[0.000112491856,0.00047092547,0.8928781,0.000025741185,0.00094055623,0.0022839338,0.0003083934,0.06779578,0.02304345,0.010160425,0.0019373865,0.0000427645],"about_ca_topic_score_codex":0.0026752825,"about_ca_topic_score_gemma":0.0015748617,"teacher_disagreement_score":0.003109663,"about_ca_system_score_codex":0.00035110072,"about_ca_system_score_gemma":0.0005449371,"threshold_uncertainty_score":0.010402858},"labels":[],"label_agreement":null},{"id":"W3016847734","doi":"10.1158/2326-6074.tumimm18-b65","title":"Abstract B65: Mathematical modeling studies on spatial profiles of tumor-infiltrating T cells","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cytotoxic T cell; Tumor microenvironment; Stromal cell; Infiltration (HVAC); CD8; T cell; Cell; Biology; Chemistry; Cancer research; Antigen; Immune system; Tumor cells; Immunology; Materials science; In vitro; Biochemistry","score_opus":0.14759933396227182,"score_gpt":0.3955689120957886,"score_spread":0.24796957813351678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016847734","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13113838,0.0025382645,0.831149,0.0033871343,0.00026973814,0.00016048153,0.0007981635,0.00046157654,0.030097289],"genre_scores_gemma":[0.93769056,0.0013506927,0.034158003,0.00057921605,0.00016658242,0.00041445345,0.00042448184,0.00022779543,0.024988163],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99951184,0.00018748226,0.000019788567,0.00008117219,0.00008798143,0.00011183307],"domain_scores_gemma":[0.99781215,0.0012790727,0.0002977456,0.0000734875,0.00041062845,0.00012692297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013796949,0.0011552926,0.00091343845,0.0012883376,0.000649792,0.0016652207,0.0013948851,0.00261468,0.004247625],"category_scores_gemma":[0.004481176,0.0005842419,0.0013775234,0.00090005767,0.0010624689,0.0014391671,0.0012248352,0.0015737533,0.00097370567],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021860467,0.000028025395,0.0008483466,0.00004183353,0.000014007666,0.00009951702,0.000047365233,0.979852,0.001215362,0.01595319,0.00054501847,0.0013334546],"study_design_scores_gemma":[0.0000020412508,0.00000425654,0.0000620231,0.000004811993,0.0000020345728,0.00000927728,0.0000066716293,0.9981021,0.00008175276,0.0015225734,0.00019982734,0.0000027106137],"about_ca_topic_score_codex":0.016002396,"about_ca_topic_score_gemma":0.003638361,"teacher_disagreement_score":0.016002396,"about_ca_system_score_codex":0.001564499,"about_ca_system_score_gemma":0.0011067716,"threshold_uncertainty_score":0.03181851},"labels":[],"label_agreement":null},{"id":"W3017464623","doi":"10.1158/2326-6066.cir-18-0508","title":"Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Ontario Institute for Cancer Research","keywords":"Chimeric antigen receptor; T cell; Immunology; Immunotherapy; Adoptive cell transfer; Cytotoxic T cell; Cell therapy; Biology; T-cell receptor; Cancer research; Medicine; Immune system; Stem cell; Cell biology; In vitro","score_opus":0.09584839896265963,"score_gpt":0.3678044325559333,"score_spread":0.2719560335932737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017464623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663385,0.0014013662,0.028156098,0.0000827086,0.00009821954,0.00009646386,0.00046634796,0.0002787486,0.0030814991],"genre_scores_gemma":[0.99232364,0.00046884414,0.0047650044,0.000045748002,0.000011565538,0.00005021614,0.0003489501,0.000030133977,0.0019558193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988914,0.0000144177675,0.000014379978,0.000028313574,0.000028472925,0.0000252571],"domain_scores_gemma":[0.9999366,0.000006194584,0.000020072366,0.00001561399,0.0000064252613,0.000015096536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009373919,0.0003315497,0.00018817438,0.00013642643,0.00009837303,0.0003405941,0.00016330907,0.00022824387,0.0012529918],"category_scores_gemma":[0.00007016904,0.00009514081,0.00016580622,0.00010609509,0.00015798665,0.00016841332,0.00020080093,0.00052663847,0.0005295524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021842918,0.000014082767,0.00010861827,0.000013073861,0.0000023043133,0.000020486475,0.0000036602455,0.000037261125,0.9988166,0.00009096287,0.000030019322,0.00084121013],"study_design_scores_gemma":[0.000010022028,0.00019391454,0.0008318916,0.00000428756,0.00002173071,0.00023110336,0.000011840228,0.0006482202,0.9939738,0.000048478545,0.004021925,0.0000026847604],"about_ca_topic_score_codex":0.00015485252,"about_ca_topic_score_gemma":0.00017756778,"teacher_disagreement_score":0.0012529918,"about_ca_system_score_codex":0.0001053092,"about_ca_system_score_gemma":0.00012898215,"threshold_uncertainty_score":0.004191637},"labels":[],"label_agreement":null},{"id":"W3021897149","doi":"10.1158/2326-6074.tumimm18-b63","title":"Abstract B63: Immune gene expression profiling of acute myeloid leukemia identifies predictors of survival and actionable targets for treatment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immune system; Myeloid; Immunotherapy; Immune checkpoint; Cancer immunotherapy; Biology; Gene expression profiling; Tumor microenvironment; Immunology; Cancer research; Innate immune system; Medicine; Gene; Gene expression; Genetics","score_opus":0.06833407773161575,"score_gpt":0.37581714269050154,"score_spread":0.3074830649588858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021897149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909684,0.0020413096,0.0016568433,0.00012347451,0.000015493872,0.000037747377,0.0040302034,0.00006888578,0.0010576564],"genre_scores_gemma":[0.99073666,0.0006425047,0.002168255,0.000120705554,0.000021541035,0.00006823448,0.005180841,0.000013340484,0.0010478979],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986506,0.000016721995,0.000010907371,0.000040603056,0.000042277148,0.00002435908],"domain_scores_gemma":[0.9998902,0.000023721897,0.000035984955,0.0000058691853,0.000023927752,0.000020231731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001791933,0.00018480113,0.00033388525,0.00059640495,0.00013752488,0.00030307713,0.000103878185,0.0001988446,0.0017087677],"category_scores_gemma":[0.00028631472,0.00006258641,0.00013182811,0.00067583926,0.00015074539,0.00009310739,0.00014056494,0.00022209108,0.00047130216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002481,0.00016733029,0.2882173,0.0003462059,0.000100175086,0.00018568747,0.00009376,0.001161771,0.6562355,0.00014140997,0.0019342678,0.048935518],"study_design_scores_gemma":[0.00006159264,0.0007382505,0.8910206,0.000041950334,0.00014324515,0.00093930465,0.00015416903,0.0035812757,0.09763333,0.0003278933,0.0053466274,0.000011763101],"about_ca_topic_score_codex":0.000508629,"about_ca_topic_score_gemma":0.0007417582,"teacher_disagreement_score":0.0017087677,"about_ca_system_score_codex":0.00019294146,"about_ca_system_score_gemma":0.000194667,"threshold_uncertainty_score":0.005716443},"labels":[],"label_agreement":null},{"id":"W3031072535","doi":"10.1158/2326-6074.tumimm18-a20","title":"Abstract A20: Enhancing checkpoint inhibitor therapy with ultrasound stimulated microbubbles","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Microbubbles; Ultrasound; Radiation therapy; Immunotherapy; Chemotherapy; Colorectal cancer; Cancer research; Cancer; Pharmacology; Oncology; Internal medicine; Radiology","score_opus":0.05365946276296409,"score_gpt":0.31198822522056163,"score_spread":0.25832876245759756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031072535","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588747,0.002906654,0.0084666265,0.00020955199,0.000086779764,0.00010528157,0.00017774221,0.00020896568,0.0019509299],"genre_scores_gemma":[0.9900637,0.0011748481,0.005888734,0.00008635636,0.00003353277,0.00007630216,0.00015959177,0.000019908783,0.0024970304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993336,0.00001281138,0.0000038888707,0.0000155073,0.000018031258,0.000016421702],"domain_scores_gemma":[0.9999461,0.000010456496,0.000015204439,0.0000034058826,0.000005179472,0.000019591653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015377325,0.00037489925,0.00021860257,0.000279937,0.00008035759,0.0002121868,0.00020021247,0.0003562102,0.0013494587],"category_scores_gemma":[0.00009519571,0.00010183772,0.00020303826,0.00012991557,0.0001853526,0.00026561925,0.00019059861,0.00040709198,0.00018980245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035316957,0.00012923148,0.000081087084,0.00006210259,0.0000072748994,0.000033531815,0.000009539503,0.000270172,0.9940923,0.0001448654,0.00011976582,0.0046971315],"study_design_scores_gemma":[0.00007563617,0.0019929262,0.0005739283,0.000005277021,0.000019277119,0.00008517817,0.0000069469993,0.0022038815,0.9926651,0.00004625782,0.0023211476,0.0000044155204],"about_ca_topic_score_codex":0.00046466017,"about_ca_topic_score_gemma":0.00043034964,"teacher_disagreement_score":0.0013494587,"about_ca_system_score_codex":0.00020316837,"about_ca_system_score_gemma":0.00015297868,"threshold_uncertainty_score":0.0045143366},"labels":[],"label_agreement":null},{"id":"W3035392729","doi":"10.1158/2326-6074.tumimm18-b15","title":"Abstract B15: The oral Chk1 inhibitor, SRA737, synergizes with immune checkpoint blockade in small-cell lung cancer (SCLC)","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living Society of British Columbia","funders":"","keywords":"Immune checkpoint; Cancer research; Immunotherapy; Cancer; CHEK1; Immune system; In vivo; Blockade; Medicine; Lung cancer; T cell; Cancer immunotherapy; Immunology; Biology; Cell cycle checkpoint; Cell cycle; Oncology; Internal medicine; Receptor","score_opus":0.0738198577910945,"score_gpt":0.3948078948909215,"score_spread":0.320988037099827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035392729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932797,0.0046766084,0.00053235725,0.000331465,0.00015910207,0.00036022847,0.0007191965,0.00031693772,0.003576043],"genre_scores_gemma":[0.99496883,0.0015451867,0.00056967355,0.0001588211,0.000062450636,0.00016442648,0.00088530045,0.00001656969,0.0016286608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998166,0.000038168553,0.000017966659,0.000020258101,0.00003950338,0.00006752727],"domain_scores_gemma":[0.99986064,0.000023895984,0.000022151766,0.000011822941,0.000012494781,0.00006892504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030108474,0.00076378055,0.0009849656,0.00055161444,0.00029289242,0.00038949726,0.0004218137,0.00057873235,0.0032850276],"category_scores_gemma":[0.00017696587,0.00017281066,0.00057029806,0.00040387944,0.00028823412,0.00023931739,0.0002111736,0.0011426874,0.00079377973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035687096,0.013721001,0.0026029532,0.0012452177,0.0005379818,0.0006653542,0.000088910056,0.001911696,0.7992964,0.00052925316,0.005472676,0.13824147],"study_design_scores_gemma":[0.015417242,0.22454987,0.03338514,0.00012728292,0.0009823424,0.0016341137,0.00012046699,0.005671837,0.7051335,0.00023683913,0.012680054,0.0000613806],"about_ca_topic_score_codex":0.0014390162,"about_ca_topic_score_gemma":0.0038520116,"teacher_disagreement_score":0.0032850276,"about_ca_system_score_codex":0.00039050425,"about_ca_system_score_gemma":0.0010862827,"threshold_uncertainty_score":0.010989487},"labels":[],"label_agreement":null},{"id":"W3036965359","doi":"10.1158/2326-6074.tumimm18-b49","title":"Abstract B49: Development and characterization of a novel CA9 targeting dual-antibody T-cell engager for renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer research; Antigen; Flow cytometry; T cell; Immunotherapy; Biology; Antibody; Clear cell renal cell carcinoma; Immunology; Medicine; Immune system; Renal cell carcinoma; Pathology","score_opus":0.10713529950958542,"score_gpt":0.37959568119280607,"score_spread":0.2724603816832206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036965359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555365,0.002403264,0.03372221,0.00034824,0.00009223667,0.00082721194,0.0014956928,0.00031455193,0.0052600857],"genre_scores_gemma":[0.96364623,0.0010693748,0.023815552,0.00019174791,0.000022066608,0.0002177705,0.0025947453,0.00005751878,0.008385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982256,0.000020476427,0.000011816618,0.00003574812,0.00007783966,0.000031588188],"domain_scores_gemma":[0.9999225,0.000007533035,0.000013679593,0.000009148363,0.000020594909,0.000026469163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020082697,0.00031038641,0.00028511128,0.00017735508,0.00013218648,0.000391298,0.00044339657,0.00058193103,0.0014014996],"category_scores_gemma":[0.00020508842,0.00011114024,0.0002728777,0.00012939272,0.00011083681,0.00014572064,0.00017899963,0.0006294954,0.0012664855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003579141,0.000059971062,0.000071783914,0.000019605639,0.0000042497613,0.000040009618,0.000006661609,0.00024256129,0.9975453,0.000067035966,0.00008182483,0.0018250938],"study_design_scores_gemma":[0.00003689067,0.00080535497,0.00092474965,0.000007827438,0.000022608527,0.00035316715,0.000011939959,0.0031505479,0.98548675,0.00003268136,0.009158629,0.000008857485],"about_ca_topic_score_codex":0.0007629832,"about_ca_topic_score_gemma":0.00087430264,"teacher_disagreement_score":0.0014014996,"about_ca_system_score_codex":0.00033058264,"about_ca_system_score_gemma":0.00026360046,"threshold_uncertainty_score":0.0046885014},"labels":[],"label_agreement":null},{"id":"W3036992533","doi":"10.1158/2326-6074.tumimm18-pr03","title":"Abstract PR03: Immuno-mass spectrometric identification of serum biomarkers of response and toxicity to pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Autoantibody; Pembrolizumab; Immunotherapy; Immunology; Medicine; Immune system; Antigen; Antibody; Immune checkpoint; Cancer; Cancer immunotherapy; Internal medicine","score_opus":0.07018959431744651,"score_gpt":0.3897958769316217,"score_spread":0.31960628261417523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036992533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97087693,0.0034215527,0.018366957,0.00048525602,0.00022471363,0.00026005605,0.00226541,0.000925741,0.0031732675],"genre_scores_gemma":[0.98230445,0.00041325093,0.012704097,0.00051559065,0.000054088003,0.00015711885,0.0015200455,0.000049633043,0.0022816977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937016,0.00011166973,0.000055320026,0.000154686,0.00024995772,0.00005827361],"domain_scores_gemma":[0.9996915,0.000071657065,0.00008135963,0.000021274793,0.00007845058,0.000055823715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006374372,0.0007170693,0.00037429092,0.0011563358,0.00023103414,0.0004081462,0.00043253147,0.00088705454,0.0015947798],"category_scores_gemma":[0.0007465951,0.000198388,0.00029843635,0.0004473583,0.00018498008,0.00021071966,0.00021185365,0.0005854292,0.0007455489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015515791,0.00032484802,0.018922381,0.00014006933,0.000106413805,0.0004596,0.000039069648,0.00022030326,0.9606393,0.000085422274,0.00096265256,0.016548349],"study_design_scores_gemma":[0.0001282968,0.0022344461,0.113695525,0.000023926963,0.00013673818,0.0049818335,0.00007056712,0.009968609,0.86476815,0.00015346844,0.0038071845,0.000031313608],"about_ca_topic_score_codex":0.0005685141,"about_ca_topic_score_gemma":0.0004956604,"teacher_disagreement_score":0.0015947798,"about_ca_system_score_codex":0.0002688589,"about_ca_system_score_gemma":0.00022610754,"threshold_uncertainty_score":0.0053350925},"labels":[],"label_agreement":null},{"id":"W3040953901","doi":"10.1158/2326-6074.tumimm18-a75","title":"Abstract A75: The role of eosinophils in the lung tumor microenvironment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Immune system; Lung cancer; Immunology; Tumor microenvironment; Cytotoxic T cell; Lewis lung carcinoma; Cancer research; Population; Lung; Immunotherapy; Metastasis; Biology; Medicine; Cancer; Pathology; Internal medicine","score_opus":0.037563942209326705,"score_gpt":0.31560181990609054,"score_spread":0.27803787769676386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040953901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9316012,0.041192327,0.0059114886,0.003657777,0.0006875556,0.00020261615,0.0015805176,0.00027523751,0.014891189],"genre_scores_gemma":[0.9709405,0.0088845175,0.0030297025,0.0007051965,0.000388649,0.00009586534,0.0009907058,0.000026321191,0.014938524],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989593,0.000018562689,0.000010160114,0.00002080787,0.000026302208,0.00002823589],"domain_scores_gemma":[0.9998907,0.000020259293,0.000018003668,0.000005712239,0.000021047255,0.000044264973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016804646,0.0004046913,0.00013514771,0.00032942236,0.00020719308,0.0004400885,0.00019212783,0.00042080498,0.0038727408],"category_scores_gemma":[0.000109536464,0.000081507205,0.00014657658,0.00011844153,0.00024953118,0.0002507293,0.0002824638,0.0006559513,0.0008750624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072707364,0.00013196097,0.0042774053,0.00046793686,0.000019636034,0.0012821244,0.000057519435,0.00013871977,0.9668386,0.0011390506,0.0027101084,0.02220988],"study_design_scores_gemma":[0.00034096398,0.0022319597,0.12211408,0.00033439623,0.00019452698,0.0072350684,0.0005864355,0.0026053141,0.78245795,0.0018835136,0.07998183,0.00003408854],"about_ca_topic_score_codex":0.00041862528,"about_ca_topic_score_gemma":0.00037465844,"teacher_disagreement_score":0.0038727408,"about_ca_system_score_codex":0.00022609955,"about_ca_system_score_gemma":0.0001924008,"threshold_uncertainty_score":0.012955666},"labels":[],"label_agreement":null},{"id":"W3044111226","doi":"10.1158/2326-6066.cir-20-0196","title":"The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":300,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal","funders":"Cancéropôle Ile de France; Institut National Du Cancer; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Labex Immuno-Oncology; Seerave Foundation; Japan Society for the Promotion of Science London; Association pour la Recherche sur le Cancer","keywords":"Microbiome; Gut microbiome; Lung cancer; Immune system; Immune checkpoint; Medicine; Immunology; Immunotherapy; Pembrolizumab; Cancer; Cancer immunotherapy; Cancer research; Biology; Oncology; Bioinformatics; Gut flora; Internal medicine","score_opus":0.0142274996646788,"score_gpt":0.3081915938968357,"score_spread":0.2939640942321569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044111226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885356,0.000571423,0.000060793725,0.00005049604,0.0000068784957,0.0000050974827,0.00022595948,0.0000021007136,0.00022368038],"genre_scores_gemma":[0.99962866,0.00007530853,0.00004389023,0.000021184254,0.000006655961,0.000004085072,0.0001510314,7.8799326e-7,0.00006824068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983466,0.00004131813,0.000021160187,0.00004148277,0.000020149124,0.000041129537],"domain_scores_gemma":[0.9995472,0.000052344727,0.00021548806,0.000022053102,0.000060732873,0.000102210164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020967209,0.00017737571,0.00031696953,0.00036614423,0.00039742806,0.0004167155,0.00011115328,0.00030135727,0.0010142665],"category_scores_gemma":[0.0008033614,0.00013177532,0.00026592182,0.0005450044,0.00015273118,0.0002964937,0.0003973042,0.0003823668,0.00012098362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020786536,0.000026696995,0.99714464,0.0000122362335,0.000040406096,0.000044282293,0.00002782282,0.000030785635,0.00087139365,0.0000059985487,0.00009160527,0.0014962681],"study_design_scores_gemma":[0.000004357917,0.00010088325,0.9991879,0.000004791602,0.000025355164,0.000106164756,0.0000920766,0.00021587333,0.000087774606,0.000017885086,0.00015485835,0.0000021263334],"about_ca_topic_score_codex":0.0020489867,"about_ca_topic_score_gemma":0.003048919,"teacher_disagreement_score":0.0020489867,"about_ca_system_score_codex":0.000209522,"about_ca_system_score_gemma":0.00016105793,"threshold_uncertainty_score":0.0040740967},"labels":[],"label_agreement":null},{"id":"W3047711886","doi":"10.1158/2326-6074.tumimm18-pr15","title":"Abstract PR15: A novel NK cell-targeted therapeutic strategy against pancreatic cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"","keywords":"Pancreatic cancer; Cancer research; Immunotherapy; Cytotoxic T cell; Tumor microenvironment; Immune system; Immunology; Cancer immunotherapy; CD8; Memory T cell; Medicine; Biology; Cancer; Internal medicine; In vitro","score_opus":0.14931097674022706,"score_gpt":0.4141424449200402,"score_spread":0.2648314681798132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047711886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600317,0.018385835,0.01192813,0.000725446,0.00039838447,0.0004437655,0.0005942476,0.00036675634,0.007125665],"genre_scores_gemma":[0.9789283,0.0071441764,0.0070766686,0.00034513228,0.000055334818,0.00020522159,0.0007377765,0.000020787993,0.005486657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999254,0.000008924321,0.000008182626,0.000020089377,0.000015799025,0.000021540221],"domain_scores_gemma":[0.99997926,0.0000013429304,0.000004405147,0.0000024140818,0.0000031339907,0.000009428772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010772868,0.00038735,0.0004554333,0.00024661442,0.00010341288,0.00033054512,0.00042239027,0.0003506854,0.0012469016],"category_scores_gemma":[0.000045311062,0.000106178486,0.00036899326,0.0001854431,0.0001855848,0.000287904,0.00028218387,0.00068751496,0.00047350916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014645101,0.001003056,0.00047007686,0.0005905192,0.00006734523,0.0004993376,0.00005759706,0.0012544831,0.91870075,0.00085169787,0.0014435619,0.07359713],"study_design_scores_gemma":[0.0014897906,0.018067017,0.004334941,0.00008316813,0.0003580558,0.0032844562,0.00006667622,0.0045817727,0.91986614,0.00040311698,0.047423705,0.00004115441],"about_ca_topic_score_codex":0.00037884768,"about_ca_topic_score_gemma":0.0005327914,"teacher_disagreement_score":0.0012469016,"about_ca_system_score_codex":0.00019889067,"about_ca_system_score_gemma":0.0003095755,"threshold_uncertainty_score":0.004171312},"labels":[],"label_agreement":null},{"id":"W3082159235","doi":"10.1158/2326-6074.tumimm18-b60","title":"Abstract B60: Functional genomic landscape of T-cell mediated cytotoxicity","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; CTL*; Cancer immunotherapy; Immunotherapy; CRISPR; Cytotoxic T cell; Computational biology; Gene; Cancer; Genetics","score_opus":0.10345025057284551,"score_gpt":0.3694555785910577,"score_spread":0.2660053280182122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082159235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97092956,0.003187138,0.0127001405,0.00030128413,0.00006000222,0.000038874543,0.0056934766,0.000657589,0.006432034],"genre_scores_gemma":[0.9831042,0.001136971,0.0048357854,0.00023470202,0.000015588199,0.000040528066,0.0062148934,0.00018435363,0.0042330166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971586,0.000021535132,0.000014234125,0.000106036445,0.00008943276,0.000052981854],"domain_scores_gemma":[0.99982685,0.000027296854,0.00004982881,0.000017707447,0.000022115764,0.000056212204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016633623,0.0003386698,0.000395284,0.00056464213,0.00021318614,0.00068720937,0.0002976748,0.00047545123,0.004903209],"category_scores_gemma":[0.0002447832,0.00018457958,0.00033119842,0.0004743896,0.00032734234,0.00016778645,0.0004941612,0.00052872824,0.0018645135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011950978,0.000009861099,0.0008064803,0.00003840623,0.000008026564,0.0000533087,0.000011225325,0.00025500136,0.99526274,0.00032223697,0.0001431382,0.0029699693],"study_design_scores_gemma":[0.00011692428,0.0011238961,0.089079104,0.00009720525,0.00013573289,0.0018111144,0.00019124892,0.0075456947,0.86532706,0.0035000483,0.031011011,0.000060958762],"about_ca_topic_score_codex":0.0006715162,"about_ca_topic_score_gemma":0.0008237031,"teacher_disagreement_score":0.004903209,"about_ca_system_score_codex":0.0003407765,"about_ca_system_score_gemma":0.00025779297,"threshold_uncertainty_score":0.01640284},"labels":[],"label_agreement":null},{"id":"W3084364727","doi":"10.1158/2326-6074.tumimm18-b85","title":"Abstract B85: Anticancer efficacy of a novel immune-stimulating oncolytic virus: VG161 in gastrointestinal cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Immune system; ELISPOT; Cancer; Cancer research; Virotherapy; Immunotherapy; Herpes simplex virus; Immunology; Immunogenic cell death; Medicine; Cancer immunotherapy; Virus; Biology; T cell; Internal medicine","score_opus":0.09335631015325443,"score_gpt":0.41129960111078084,"score_spread":0.3179432909575264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084364727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729306,0.0012820909,0.00050013326,0.000028609784,0.000018052571,0.000019242114,0.0001454759,0.000023045526,0.0006903601],"genre_scores_gemma":[0.99785113,0.0005125777,0.0005316669,0.000015457677,0.0000049700925,0.000013916149,0.00027294,0.0000058380992,0.00079154473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999387,0.00001200435,0.000006407878,0.000011960845,0.000013547752,0.000017243963],"domain_scores_gemma":[0.99995863,0.000008910815,0.000008701699,0.000005696143,0.000005244081,0.0000127667945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108655964,0.00024631762,0.00019127129,0.00018538088,0.000067111636,0.00015071075,0.0001326443,0.00022277652,0.00064236677],"category_scores_gemma":[0.00007604357,0.000057783967,0.00017111882,0.00013225872,0.0001572898,0.00010805636,0.000099797275,0.0003590894,0.0001488751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030269186,0.00008582283,0.0002769943,0.000060186874,0.000005879273,0.000019716861,0.000012425595,0.00013948153,0.9972282,0.000058225734,0.000040296647,0.0017701375],"study_design_scores_gemma":[0.00005289922,0.0020805094,0.0026831974,0.000006699973,0.00002379532,0.00013367424,0.0000099376675,0.00054423686,0.99330986,0.000017071232,0.0011358708,0.0000022020374],"about_ca_topic_score_codex":0.00086497446,"about_ca_topic_score_gemma":0.00041685355,"teacher_disagreement_score":0.00086497446,"about_ca_system_score_codex":0.00017496223,"about_ca_system_score_gemma":0.00015823482,"threshold_uncertainty_score":0.0021489263},"labels":[],"label_agreement":null},{"id":"W3092226358","doi":"10.1158/2326-6066.cir-20-0527","title":"The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Gary Bennett Family Fund; Suomen Kulttuurirahasto; Stand Up To Cancer; Uehara Memorial Foundation; National Institutes of Health; Orionin Tutkimussäätiö; American Institute for Cancer Research; National Cancer Institute; Entertainment Industry Foundation; Mitsukoshi Health and Welfare Foundation; American Association for Cancer Research; American Society of Clinical Oncology; Japan Society for the Promotion of Science; Cancer Research UK; Conquer Cancer Foundation","keywords":"Tumor microenvironment; Colorectal cancer; Medicine; Cancer research; Macrophage polarization; Cancer; Macrophage; Immunology; Oncology; Immune system; Internal medicine; Biology; In vitro","score_opus":0.027447630629549757,"score_gpt":0.3126443706912673,"score_spread":0.2851967400617176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092226358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867886,0.00040836434,0.0007355636,0.000013699948,0.0000014757092,0.0000033711738,0.00004405862,0.0000070586825,0.00010752459],"genre_scores_gemma":[0.9994647,0.00006560333,0.00038082144,0.0000033499887,0.0000019442944,0.000002733425,0.00003316938,0.0000010900824,0.000046623256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973243,0.00012539022,0.000014900405,0.000044223285,0.0000386058,0.000044380366],"domain_scores_gemma":[0.99929154,0.00026708475,0.00020249982,0.00007735413,0.000081372775,0.00008008638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090705516,0.00014905151,0.00021764857,0.0006223571,0.00018314729,0.00034654306,0.00011730697,0.00022031796,0.00045574192],"category_scores_gemma":[0.001297442,0.000116552,0.00012195844,0.0004178725,0.00020884785,0.00019734171,0.00025940323,0.00023092423,0.00011876022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000770235,0.0000251764,0.94740593,0.000023897306,0.000045399403,0.00007847022,0.000050767783,0.00047321816,0.037614804,0.000048965023,0.00004985826,0.013413277],"study_design_scores_gemma":[0.000009221095,0.00024654926,0.9766174,0.000007869759,0.000065456705,0.00076913874,0.00014258061,0.005004237,0.016526233,0.0001935547,0.0004054124,0.000012388333],"about_ca_topic_score_codex":0.0003651515,"about_ca_topic_score_gemma":0.00077687646,"teacher_disagreement_score":0.00090705516,"about_ca_system_score_codex":0.00015132448,"about_ca_system_score_gemma":0.00009687456,"threshold_uncertainty_score":0.004796982},"labels":[],"label_agreement":null},{"id":"W3105835028","doi":"10.1158/2326-6066.cir-20-0138","title":"A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Academisch Medisch Centrum; Vrije Universiteit Amsterdam","keywords":"CD40; Cancer research; T cell; Chronic lymphocytic leukemia; B cell; Jurkat cells; Antibody; Cytotoxic T cell; Immunology; Biology; Leukemia; Medicine; In vitro; Immune system","score_opus":0.10189720866426633,"score_gpt":0.402953893935271,"score_spread":0.30105668527100465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105835028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672925,0.0006619387,0.0010383654,0.000033060398,0.0000143715315,0.00004110386,0.00012862677,0.000053079344,0.0013000828],"genre_scores_gemma":[0.99749017,0.00030318025,0.00070670433,0.000029451292,0.000009391015,0.000038709488,0.00033529132,0.000009575661,0.001077509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985576,0.000033768865,0.000012262519,0.000023671817,0.000026079035,0.000048381586],"domain_scores_gemma":[0.99995553,0.000012237748,0.00000563312,0.0000075668227,0.00000543096,0.000013601135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016382655,0.00041458104,0.00021202845,0.00020862452,0.00012268394,0.0002266631,0.00019021174,0.00023794205,0.0013214478],"category_scores_gemma":[0.00009213945,0.000107409054,0.00015737354,0.00010417796,0.00010664475,0.00010023849,0.00013640602,0.0005487258,0.00038132264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023785087,0.00014792981,0.00010149959,0.000026227613,0.0000058068567,0.0000349704,0.000012792854,0.00014839468,0.9977488,0.00007246263,0.000055314245,0.0014079135],"study_design_scores_gemma":[0.000101680394,0.0014632945,0.0025833831,0.0000065605764,0.000019274994,0.00034920205,0.000013362863,0.002043179,0.9914055,0.000038258,0.0019734895,0.0000029497521],"about_ca_topic_score_codex":0.00058968074,"about_ca_topic_score_gemma":0.00055760867,"teacher_disagreement_score":0.0013214478,"about_ca_system_score_codex":0.00019450781,"about_ca_system_score_gemma":0.00015902772,"threshold_uncertainty_score":0.004420638},"labels":[],"label_agreement":null},{"id":"W3108724287","doi":"10.1158/2326-6074.tumimm18-pr19","title":"Abstract PR19: Utilizing novel oncolytic vaccinia virus for selective expression of immunotherapeutic payloads in metastatic tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Vaccinia; Immune system; Immune checkpoint; Immunotherapy; Cancer; Medicine; Cancer research; Cancer immunotherapy; Immunology; Virus; Biology; Gene; Internal medicine","score_opus":0.11398960278472821,"score_gpt":0.4195886685095294,"score_spread":0.3055990657248012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108724287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501224,0.0036014423,0.03912885,0.00030678863,0.0002170852,0.0002781396,0.0006789165,0.00034883927,0.0053175283],"genre_scores_gemma":[0.9730883,0.0015811636,0.01912452,0.000089644054,0.000034040168,0.00008075327,0.0007476506,0.000080823236,0.00517316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999006,0.000010377481,0.0000074886684,0.000025209212,0.000027703096,0.000028691837],"domain_scores_gemma":[0.9999502,0.0000063209386,0.000016117132,0.000006072003,0.000009424416,0.0000119623855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001663356,0.00034612868,0.0002089837,0.00017591659,0.00013520816,0.00034734086,0.00026706312,0.0003329577,0.0012411635],"category_scores_gemma":[0.00011335494,0.00012213696,0.00030038,0.000102533355,0.00018650279,0.0002819053,0.00022948592,0.00051607203,0.00054296845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085109496,0.00005054159,0.00010566058,0.000034604007,0.000004651545,0.00007520126,0.000007652903,0.00020579544,0.99595,0.00043087528,0.00013658013,0.0029132536],"study_design_scores_gemma":[0.00003142377,0.00031613276,0.00044705332,0.0000041704657,0.0000101792475,0.00027228033,0.0000044231374,0.0018017418,0.99206734,0.00006297056,0.0049782614,0.0000039530883],"about_ca_topic_score_codex":0.0006324277,"about_ca_topic_score_gemma":0.0004641418,"teacher_disagreement_score":0.0012411635,"about_ca_system_score_codex":0.00039236332,"about_ca_system_score_gemma":0.00021242163,"threshold_uncertainty_score":0.0041521788},"labels":[],"label_agreement":null},{"id":"W3118944735","doi":"10.1158/2326-6074.tumimm18-a26","title":"Abstract A26: Immune profiling and organoids generation of a rare case of prostate cancer liver metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Metastasis; Immunotherapy; Cancer; Pathology; Immunophenotyping; Oncology; Internal medicine; Immunology; Antigen","score_opus":0.15677542524079074,"score_gpt":0.41524590447679954,"score_spread":0.2584704792360088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118944735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96905386,0.0046398477,0.013336083,0.001795243,0.00025090747,0.0003697574,0.0008042265,0.00061017484,0.009139954],"genre_scores_gemma":[0.99319977,0.0006943845,0.0032550218,0.00034914378,0.000112436544,0.000039415674,0.00030024257,0.000042217303,0.0020073804],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99970526,0.00004822433,0.000024209758,0.00009358021,0.00006465719,0.00006399467],"domain_scores_gemma":[0.9994246,0.00013718163,0.00011298112,0.000087189466,0.00005035347,0.00018779282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023247219,0.00056227297,0.00046880753,0.0014176896,0.0007416564,0.0006056986,0.00042022034,0.0011880961,0.0021460678],"category_scores_gemma":[0.00095966365,0.00032342694,0.0006428469,0.0004899454,0.0004776644,0.00047186657,0.0005887067,0.0012788092,0.0007050272],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037605283,0.000109867935,0.009973526,0.00021880584,0.000035453577,0.94890296,0.000434377,0.00032715968,0.030625015,0.0007191397,0.0010149782,0.007262565],"study_design_scores_gemma":[0.000028138329,0.00033416605,0.0130340755,0.00003368973,0.00004445429,0.9615902,0.00028024125,0.0014172596,0.017666,0.00046769608,0.005072493,0.000031610958],"about_ca_topic_score_codex":0.000999426,"about_ca_topic_score_gemma":0.001119501,"teacher_disagreement_score":0.0021460678,"about_ca_system_score_codex":0.00049160497,"about_ca_system_score_gemma":0.00024932736,"threshold_uncertainty_score":0.00717932},"labels":[],"label_agreement":null},{"id":"W3126199907","doi":"10.1158/2326-6074.tumimm20-po081","title":"Abstract PO081: Systematic Generation of Allogeneic Immune-targeting Modalities for Glioblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Population; Haematopoiesis; Immune system; Progenitor cell; Chimeric antigen receptor; Stem cell; Chemoradiotherapy; Oncology; Immunotherapy; Cancer research; Cancer; Immunology; Internal medicine; Biology","score_opus":0.13009358589491676,"score_gpt":0.41780739091948677,"score_spread":0.28771380502457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126199907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96123993,0.0032239119,0.023871856,0.00022783605,0.00017666252,0.00080801395,0.0010196647,0.00032859494,0.009103466],"genre_scores_gemma":[0.9846447,0.0014593148,0.008660423,0.00013447463,0.00002261473,0.0004540484,0.0006421705,0.000059744154,0.003922392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999175,0.000010912803,0.0000052086675,0.000022171327,0.000023489163,0.000020659545],"domain_scores_gemma":[0.9999778,0.0000022472605,0.000006423088,0.0000039470037,0.000003566426,0.0000060061625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013333543,0.00031493118,0.00018949505,0.00035737857,0.00010885965,0.00021586398,0.00024166743,0.00022700419,0.002191889],"category_scores_gemma":[0.00007579655,0.000093989096,0.00021632326,0.0001580391,0.00014137132,0.00015396663,0.00028230174,0.0004252892,0.00048687292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034951724,0.00040711527,0.00030283208,0.00017234244,0.00002063148,0.00014307954,0.000030480418,0.0007394649,0.965998,0.0010692347,0.0008964262,0.029870845],"study_design_scores_gemma":[0.00018598857,0.00418224,0.0018296536,0.000021858985,0.000088059285,0.0006085421,0.000025004583,0.0029552002,0.97158706,0.00024421499,0.018261483,0.000010678913],"about_ca_topic_score_codex":0.00020129052,"about_ca_topic_score_gemma":0.0002817868,"teacher_disagreement_score":0.002191889,"about_ca_system_score_codex":0.0001376562,"about_ca_system_score_gemma":0.00022000792,"threshold_uncertainty_score":0.007332623},"labels":[],"label_agreement":null},{"id":"W3128382343","doi":"10.1158/2326-6074.tumimm20-pr009","title":"Abstract PR009: The functional genomic landscape of recurrent glioblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Cancer research; Biology; Stem cell; Regulator; Glioblastoma; Gene; Medicine; Genetics","score_opus":0.052074732079787474,"score_gpt":0.36706898798161386,"score_spread":0.3149942559018264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128382343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926675,0.0006827628,0.0023124842,0.000079132675,0.000008921149,0.000017916207,0.0029632605,0.00014203879,0.0011260319],"genre_scores_gemma":[0.9934337,0.00026960552,0.0012530339,0.00004677229,0.00000509616,0.000019610618,0.003282678,0.00003702834,0.0016524416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998902,0.000006587691,0.00000541945,0.000039078215,0.000036985384,0.000021746504],"domain_scores_gemma":[0.9999292,0.00000771183,0.000033342647,0.0000052873443,0.000008188488,0.000016158394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005787463,0.00015591248,0.00017475766,0.00033865563,0.00007922858,0.000209072,0.00014010514,0.00016598038,0.0034092532],"category_scores_gemma":[0.00013103355,0.00007880586,0.00016908848,0.000305406,0.00011725307,0.00007395251,0.00018794772,0.00023252028,0.0004489554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020995538,0.000013744276,0.003818348,0.00004862556,0.00001679027,0.0001665312,0.000017365877,0.00014582543,0.9897183,0.000115462186,0.0002013871,0.0055276984],"study_design_scores_gemma":[0.000053103882,0.0010625928,0.43407398,0.000021073749,0.00016056841,0.0056526447,0.00016187331,0.0036370386,0.54277223,0.0005702284,0.011813892,0.000020666143],"about_ca_topic_score_codex":0.0007196506,"about_ca_topic_score_gemma":0.00081230386,"teacher_disagreement_score":0.0034092532,"about_ca_system_score_codex":0.00016338257,"about_ca_system_score_gemma":0.00013208744,"threshold_uncertainty_score":0.01140511},"labels":[],"label_agreement":null},{"id":"W3137608926","doi":"10.1158/2326-6066.cir-20-0800","title":"Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Institute of Health Services and Policy Research; Deutsche Forschungsgemeinschaft; Rosetrees Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Canadian Institutes of Health Research; Melanoma Research Alliance; International Development Research Centre; Government of Canada; Azrieli Foundation; Israel Science Foundation; Israel Cancer Research Fund","keywords":"Cytotoxic T cell; Immune checkpoint; Cancer immunotherapy; Alternative splicing; Biology; Cancer research; Gene isoform; Cell biology; Immune system; T cell; splice; Receptor; Immunotherapy; Effector; Immunology; Genetics; Gene; In vitro","score_opus":0.028152558349800166,"score_gpt":0.3100179988044744,"score_spread":0.2818654404546742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137608926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938764,0.00051930523,0.0036569936,0.0000819187,0.00005331853,0.000020325127,0.00018033144,0.00009212862,0.0015192166],"genre_scores_gemma":[0.99681646,0.00017513381,0.0017009157,0.000040178573,0.000013559641,0.000009643307,0.00013288748,0.000018515333,0.0010927931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998759,0.00002350535,0.000013632594,0.000021525231,0.000034417833,0.000031043815],"domain_scores_gemma":[0.9999205,0.000014901943,0.000018722447,0.000011052683,0.000009251345,0.000025565643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014359193,0.00026454715,0.00014240252,0.00011591073,0.000083303734,0.00023544338,0.00014302619,0.00020521283,0.0011415929],"category_scores_gemma":[0.000091880094,0.00007423648,0.00015907153,0.000071405804,0.00016519787,0.000092833805,0.00010462646,0.00046446134,0.00041244077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029382809,0.000007917293,0.000055604298,0.0000055399273,0.0000011908518,0.000018978297,0.0000024097885,0.000025069467,0.99933726,0.000062644714,0.000018549557,0.00043533513],"study_design_scores_gemma":[0.000018369103,0.00022431224,0.0007739178,0.000002029511,0.00001210274,0.00031828127,0.000008846349,0.00083602895,0.9956285,0.00003893322,0.0021369033,0.0000018616454],"about_ca_topic_score_codex":0.00018101637,"about_ca_topic_score_gemma":0.00028153622,"teacher_disagreement_score":0.0011415929,"about_ca_system_score_codex":0.00019737708,"about_ca_system_score_gemma":0.000119057186,"threshold_uncertainty_score":0.0038189292},"labels":[],"label_agreement":null},{"id":"W3173022732","doi":"10.1158/2326-6074.tumimm18-a38","title":"Abstract A38: Oncogenes drive production of immunosuppressive cytokines to facilitate lung cancer progression","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Cancer research; Carcinogenesis; KRAS; Immune system; Biology; Cytokine; Immunology; Lung cancer; Oncogene; Chemokine; Cancer; Medicine; Cell cycle; Pathology","score_opus":0.13618006315326206,"score_gpt":0.4293497468823965,"score_spread":0.29316968372913443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173022732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956311,0.0009862571,0.0016202412,0.00007595337,0.000020848709,0.000022033733,0.0006429052,0.00012473714,0.0008759601],"genre_scores_gemma":[0.9955558,0.0002625442,0.0016622014,0.000032234708,0.000010651736,0.000032440807,0.0006415588,0.000017389419,0.00178511],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998363,0.00001999653,0.00001356035,0.000034479544,0.00004384935,0.00005172006],"domain_scores_gemma":[0.9998871,0.000016947275,0.000026178956,0.000013105008,0.000016020678,0.000040662424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121590696,0.00026052105,0.00017387756,0.00028609208,0.00012476575,0.00028131035,0.000123306,0.00018005719,0.002174452],"category_scores_gemma":[0.00008764948,0.00009879917,0.00019428687,0.00014079767,0.00014066214,0.00016063372,0.0001495696,0.00041019384,0.0005451322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044924003,0.000014744834,0.00026550665,0.000012465597,0.0000010026562,0.000011555927,0.0000036289794,0.00001411569,0.9991429,0.000029579616,0.000027234822,0.0004324374],"study_design_scores_gemma":[0.000016934102,0.0002369011,0.009270151,0.0000046776468,0.0000062063796,0.0001718357,0.000024358122,0.00081448746,0.9874455,0.000040074672,0.0019663866,0.0000025305708],"about_ca_topic_score_codex":0.00037248,"about_ca_topic_score_gemma":0.00050410355,"teacher_disagreement_score":0.002174452,"about_ca_system_score_codex":0.00034731667,"about_ca_system_score_gemma":0.00016991161,"threshold_uncertainty_score":0.0072743297},"labels":[],"label_agreement":null},{"id":"W3199446885","doi":"10.1158/2326-6066.cir-21-0519","title":"Supporting the Next Generation of Scientists to Lead Cancer Immunology Research","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Engineering ethics; Field (mathematics); Cancer immunotherapy; Publishing; Political science; Immunology; Medicine; Immunotherapy; Engineering; Immune system","score_opus":0.3417155636439009,"score_gpt":0.5241351132805301,"score_spread":0.1824195496366292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199446885","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003934534,0.011397049,0.0103348745,0.9231038,0.021599563,0.0001353247,0.000030107723,0.00017673417,0.029288048],"genre_scores_gemma":[0.26260734,0.033636965,0.059320513,0.5150094,0.03722242,0.0010219209,0.0002910623,0.00039755242,0.09049289],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.937866,0.038322866,0.0014757634,0.003070506,0.009975216,0.009289663],"domain_scores_gemma":[0.85726625,0.022276118,0.0052537983,0.003935202,0.018282754,0.09298598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06649777,0.00083002134,0.000973983,0.0015603557,0.016595902,0.027046572,0.0030479408,0.013079319,0.022169359],"category_scores_gemma":[0.06845948,0.00069449935,0.001205504,0.0010161782,0.016012572,0.017896673,0.023996603,0.024433106,0.00927726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000191604,0.0004672202,0.005263777,0.00073148706,0.00005430675,0.0010538924,0.031241389,0.00035792656,0.0024291284,0.2625078,0.49556112,0.20014034],"study_design_scores_gemma":[0.000056019093,0.00013218059,0.0004540098,0.00056171365,0.000015089732,0.00034170924,0.016432315,0.00023074284,0.0003144933,0.064176634,0.9172385,0.000046584733],"about_ca_topic_score_codex":0.0018684996,"about_ca_topic_score_gemma":0.0050302893,"teacher_disagreement_score":0.06649777,"about_ca_system_score_codex":0.0060640424,"about_ca_system_score_gemma":0.062104397,"threshold_uncertainty_score":0.351678},"labels":[],"label_agreement":null},{"id":"W3212747176","doi":"10.1158/2326-6066.cir-21-0445","title":"Imaging α-GalCer–Activated iNKT Cells in a Hepatic Metastatic Environment","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Canadian Cancer Society; Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Metastasis; Cytokine; Immunotherapy; Liver transplantation; Primary tumor; Cancer; Liver tumor; Colorectal cancer; Immune system","score_opus":0.041644585124124195,"score_gpt":0.3314237682964186,"score_spread":0.28977918317229445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212747176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637874,0.0016201414,0.031499017,0.0002539897,0.000029830007,0.000075632655,0.00018339821,0.00027050375,0.0022800944],"genre_scores_gemma":[0.968453,0.0012429081,0.02695401,0.00012858014,0.000021773807,0.000093021576,0.00019223357,0.000061414,0.002853136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999199,0.00001751522,0.0000042552,0.000017559541,0.00001847779,0.000022313223],"domain_scores_gemma":[0.99994135,0.000011725729,0.000014564627,0.0000055762293,0.000008422191,0.00001833925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018138437,0.00028575867,0.00016472113,0.00035054755,0.00012797548,0.00023790188,0.0001675722,0.00041096058,0.00082074746],"category_scores_gemma":[0.000118451244,0.0001892096,0.0001742324,0.00016441137,0.00014497072,0.0002559652,0.00018641211,0.00046150136,0.00022773324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059609043,0.000018985791,0.00027018308,0.000030517585,0.0000033600015,0.00017353831,0.000012296084,0.00015329022,0.99768424,0.000057140645,0.00003836055,0.0014984511],"study_design_scores_gemma":[0.000032038282,0.00039437972,0.0045945407,0.000010607274,0.000024554603,0.001754979,0.00006225947,0.010422852,0.9806774,0.00011162972,0.0019062875,0.0000084705225],"about_ca_topic_score_codex":0.0006534667,"about_ca_topic_score_gemma":0.0008019827,"teacher_disagreement_score":0.00082074746,"about_ca_system_score_codex":0.00022180665,"about_ca_system_score_gemma":0.00018760144,"threshold_uncertainty_score":0.002745688},"labels":[],"label_agreement":null},{"id":"W4205365572","doi":"10.1158/2326-6074.tumimm21-p008","title":"Abstract P008: Effect of route of Bacillus Calmette Guérin administration on the tumor immune microenvironment in a mouse model of non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Immunotherapy; Immune system; Urology; Tumor microenvironment; Cancer; Flow cytometry; Saline; Internal medicine; Immunology","score_opus":0.049497589969809325,"score_gpt":0.3508672274035879,"score_spread":0.30136963743377854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205365572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512393,0.0021235677,0.0040074857,0.00069291395,0.00039631207,0.00042631276,0.002979025,0.00052738073,0.0037230838],"genre_scores_gemma":[0.97673845,0.001459683,0.0069297887,0.00037716367,0.00010443355,0.00092648744,0.0023496007,0.00014789194,0.010966479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934214,0.00009835746,0.000067507324,0.00016087323,0.0001399629,0.00019108888],"domain_scores_gemma":[0.9993339,0.00006577898,0.00018754473,0.00007213812,0.0000560197,0.0002845841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005106289,0.00090920884,0.00071716506,0.0008531339,0.00030545171,0.0006150453,0.00053229777,0.0013829436,0.0027515208],"category_scores_gemma":[0.00017826859,0.00038773808,0.0008939561,0.00038859455,0.0006623448,0.0005486181,0.00028115805,0.003576528,0.0010275964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026979297,0.0015397987,0.0003076801,0.00016964783,0.000015857035,0.000120824116,0.000055862612,0.0001874018,0.9922225,0.00014948612,0.00030327242,0.0022298128],"study_design_scores_gemma":[0.0003496313,0.015738415,0.0051244134,0.000051984414,0.00006714463,0.00034689458,0.00010135474,0.0015657034,0.97331095,0.00010771174,0.0032137795,0.000022049822],"about_ca_topic_score_codex":0.0009622263,"about_ca_topic_score_gemma":0.0010125716,"teacher_disagreement_score":0.0027515208,"about_ca_system_score_codex":0.00048813346,"about_ca_system_score_gemma":0.00060356007,"threshold_uncertainty_score":0.009204805},"labels":[],"label_agreement":null},{"id":"W4205464259","doi":"10.1158/2326-6074.tumimm21-p001","title":"Abstract P001: The gut microbiome-prostate tumor crosstalk is modulated by dietary polyunsaturated fatty acids","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval","funders":"","keywords":"Prostate cancer; Eicosapentaenoic acid; PTEN; Gut flora; Polyunsaturated fatty acid; Cancer; Gastroenterology; Prostate; Internal medicine; Medicine; Cancer research; Biology; Oncology; Immunology; Fatty acid; Biochemistry; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.02772733896355184,"score_gpt":0.32999613121093146,"score_spread":0.3022687922473796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205464259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91561687,0.010895181,0.0063161016,0.0045133764,0.0016286247,0.0004080738,0.041496687,0.0009277558,0.018197238],"genre_scores_gemma":[0.95210975,0.004207881,0.004426156,0.001266748,0.00043097395,0.0007115004,0.01376354,0.00018607367,0.022897292],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977344,0.000037984624,0.000010608113,0.00006467678,0.00006045921,0.0000528162],"domain_scores_gemma":[0.9997503,0.000040206003,0.00006685161,0.00001593899,0.000040015013,0.00008660454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002497463,0.00046495814,0.00068413815,0.00031816633,0.00031774107,0.00080650044,0.00029198546,0.00056840683,0.03750417],"category_scores_gemma":[0.00032893498,0.00016552568,0.00041014122,0.00042675485,0.00034958488,0.000307361,0.0005384268,0.001013954,0.0030274305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043151654,0.0013848916,0.024960961,0.004819882,0.00073975645,0.00085725967,0.00021311957,0.0008635574,0.79462034,0.0012922639,0.032626897,0.09446951],"study_design_scores_gemma":[0.0031387596,0.017695507,0.5661853,0.00057038537,0.0013249412,0.0031250843,0.000918146,0.0060805315,0.30608723,0.0041780816,0.09058261,0.000113463226],"about_ca_topic_score_codex":0.000407747,"about_ca_topic_score_gemma":0.0005341109,"teacher_disagreement_score":0.03750417,"about_ca_system_score_codex":0.0002326307,"about_ca_system_score_gemma":0.0006456846,"threshold_uncertainty_score":0.12546396},"labels":[],"label_agreement":null},{"id":"W4205606019","doi":"10.1158/2326-6074.tumimm21-p038","title":"Abstract P038: Identification and functional evaluation of monoclonal antibodies specifically targeting human Carbonic Anhydrase IX","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; National Research Council Canada","funders":"","keywords":"Tumor hypoxia; Monoclonal antibody; Cancer research; Hypoxia (environmental); Carbonic anhydrase; Biology; Antibody; Chemistry; Biochemistry; Radiation therapy; Enzyme; Medicine; Immunology; Internal medicine","score_opus":0.09562450883257141,"score_gpt":0.38601229145727783,"score_spread":0.29038778262470644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205606019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797846,0.0023639791,0.006176404,0.00017407723,0.000053461958,0.0002674192,0.0005191794,0.0001289336,0.002338065],"genre_scores_gemma":[0.9882655,0.0011638732,0.0058444724,0.000144511,0.000033793323,0.00019856417,0.0021019033,0.000029642162,0.0022177116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996948,0.000058844835,0.00002735446,0.000060589686,0.00006449523,0.0000939239],"domain_scores_gemma":[0.99985456,0.0000330591,0.000029028073,0.000010823501,0.000037098027,0.00003538116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037822913,0.0007567591,0.00023477203,0.0003805473,0.00015560102,0.0002594438,0.00045528964,0.0006662729,0.0012929856],"category_scores_gemma":[0.00028361718,0.00018456834,0.0003733556,0.00020756322,0.00014649385,0.00018080678,0.00017486868,0.0005993156,0.00045653174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015529229,0.00013467601,0.00018306384,0.000033211316,0.000008393211,0.000040895207,0.000007839241,0.00016095738,0.99706537,0.000050666906,0.00009417902,0.002065434],"study_design_scores_gemma":[0.00014912132,0.0029458632,0.004025957,0.000011898906,0.000072516275,0.00051662716,0.000015364854,0.0022855913,0.98596096,0.000047183912,0.003962259,0.000006609571],"about_ca_topic_score_codex":0.00091265375,"about_ca_topic_score_gemma":0.0006827029,"teacher_disagreement_score":0.0012929856,"about_ca_system_score_codex":0.00051960093,"about_ca_system_score_gemma":0.00019762828,"threshold_uncertainty_score":0.0043254495},"labels":[],"label_agreement":null},{"id":"W4205984988","doi":"10.1158/2326-6074.tumimm21-p045","title":"Abstract P045: Preclinical transcriptome-based evaluation of the translatable potential of new treatments in Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Transcriptome; Cancer research; Gene expression profiling; Gene signature; Triple-negative breast cancer; CD44; Breast cancer; Biology; Cancer; Gene expression; Significance analysis of microarrays; Gene; In vitro; Genetics","score_opus":0.08245404925804785,"score_gpt":0.42460060505243963,"score_spread":0.3421465557943918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205984988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601377,0.0024966993,0.0025283073,0.00030589686,0.00014710627,0.0002975485,0.0044352696,0.0002101354,0.0035651173],"genre_scores_gemma":[0.9827958,0.0017660063,0.0039070654,0.00025738403,0.000036526137,0.0004990904,0.0059140185,0.0000791865,0.0047449986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985695,0.000025702699,0.000007765115,0.000026601827,0.000052039406,0.000030896877],"domain_scores_gemma":[0.99990416,0.00001416022,0.000016585409,0.000012499973,0.000022337847,0.000030339892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035114237,0.00041282154,0.0005255581,0.00028222208,0.00021367903,0.00038308723,0.0002076717,0.000319929,0.0041679936],"category_scores_gemma":[0.00012680473,0.00014751543,0.00035732644,0.00022678527,0.00022726668,0.00020756363,0.00014187569,0.00093113276,0.00064266165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002333168,0.00079572777,0.0005125928,0.00019534424,0.000038028196,0.00003735224,0.000025236222,0.00052440556,0.98493737,0.00010633209,0.0008069216,0.009687567],"study_design_scores_gemma":[0.00044207153,0.023006046,0.014016571,0.00002821838,0.00022055492,0.00021940947,0.00011099266,0.0028771344,0.9495265,0.00011761606,0.009417912,0.000017099796],"about_ca_topic_score_codex":0.0008807108,"about_ca_topic_score_gemma":0.0013392352,"teacher_disagreement_score":0.0041679936,"about_ca_system_score_codex":0.00037181852,"about_ca_system_score_gemma":0.00048478853,"threshold_uncertainty_score":0.013943374},"labels":[],"label_agreement":null},{"id":"W4206062949","doi":"10.1158/2326-6066.cir-21-0332","title":"An <i>In Vivo</i> Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; McGill University","keywords":"Epitope; Immunogenicity; Peptide; Adjuvant; Peptide vaccine; Antigen; Mimotope; Peptide library; Cytotoxic T cell","score_opus":0.04164043390786948,"score_gpt":0.37923803936803574,"score_spread":0.33759760546016626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206062949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954284,0.0027688364,0.034869555,0.0002817595,0.00007610043,0.00054565625,0.0011381801,0.00043447828,0.0056013972],"genre_scores_gemma":[0.9529177,0.0023018399,0.037294038,0.00034587167,0.000035786452,0.00030510288,0.0015060703,0.00006316193,0.0052304086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985254,0.000034374545,0.0000091199345,0.000035014073,0.0000376531,0.000031262556],"domain_scores_gemma":[0.99989355,0.000021298054,0.000027035137,0.00001557168,0.000021428303,0.000021098642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002620741,0.0005061431,0.00030825814,0.00026720116,0.000113488735,0.00024859956,0.00019702301,0.00034963453,0.0009009015],"category_scores_gemma":[0.0001585842,0.00012259962,0.00023608831,0.00016027234,0.00012480536,0.0001579109,0.00019300824,0.0003228345,0.00043822936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045012926,0.000054672557,0.000112942005,0.000031038322,0.0000042165584,0.000026785761,0.0000042016263,0.00011984367,0.99770653,0.00004641841,0.00006303783,0.0017853497],"study_design_scores_gemma":[0.000019543799,0.0014334642,0.000980683,0.000004263191,0.000021406708,0.0001837898,0.000010304891,0.0009262594,0.9940148,0.000035704317,0.0023648385,0.0000049627647],"about_ca_topic_score_codex":0.00010088087,"about_ca_topic_score_gemma":0.0002370555,"teacher_disagreement_score":0.0009009015,"about_ca_system_score_codex":0.00013194545,"about_ca_system_score_gemma":0.00013584293,"threshold_uncertainty_score":0.0030137897},"labels":[],"label_agreement":null},{"id":"W4206202786","doi":"10.1158/2326-6074.tumimm21-p013","title":"Abstract P013: Germinal center hypoxia in tumor-draining lymph nodes negatively regulates humoral immune responses and affects the activation of tumor-infiltrating T cells","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Germinal center; Immune system; Tumor hypoxia; Cancer research; Lymph; Immunology; Antibody; Immunoglobulin class switching; Biology; Hypoxia (environmental); Lymph node; Medicine; B cell; Pathology; Chemistry; Internal medicine; Radiation therapy","score_opus":0.05903517423731405,"score_gpt":0.3599433665381531,"score_spread":0.3009081923008391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206202786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066097,0.0015714291,0.0024746025,0.00023589449,0.00007096386,0.000034772544,0.0010312708,0.00015285044,0.0037671647],"genre_scores_gemma":[0.98957145,0.0004026974,0.00084693026,0.000106691965,0.000032335876,0.000039345086,0.0008433713,0.000038408667,0.008118815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999201,0.000007926945,0.0000045691368,0.000024150157,0.000019622556,0.000023579069],"domain_scores_gemma":[0.9999343,0.000009297732,0.000017623848,0.000004610971,0.000007784164,0.000026342455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005624093,0.00021815051,0.00014104358,0.00011310283,0.00010505995,0.00018793912,0.0001765245,0.00023814607,0.0064619617],"category_scores_gemma":[0.000051407937,0.000079596844,0.000109563,0.00007852336,0.00018289406,0.0001360833,0.00011729846,0.00044069032,0.0008842803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023321855,0.000019607187,0.00032261724,0.000046827787,0.0000029260473,0.000058946363,0.000007306637,0.000028112285,0.9978789,0.00007164463,0.0001546102,0.0011752117],"study_design_scores_gemma":[0.000052097137,0.00053972343,0.015682662,0.0000121960975,0.000018782497,0.0005388134,0.000047941932,0.0005710143,0.977665,0.00010200931,0.0047669783,0.0000028015252],"about_ca_topic_score_codex":0.00041561222,"about_ca_topic_score_gemma":0.0002595915,"teacher_disagreement_score":0.0064619617,"about_ca_system_score_codex":0.00027008617,"about_ca_system_score_gemma":0.0001361456,"threshold_uncertainty_score":0.021617353},"labels":[],"label_agreement":null},{"id":"W4206500679","doi":"10.1158/2326-6066.cir-21-1083","title":"Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; University of Texas MD Anderson Cancer Center; American Association for Cancer Research","keywords":"Melanoma; Immunotherapy; Stromal cell; Cancer; MHC class I; Tumor-infiltrating lymphocytes; Antigen; Cytotoxic T cell; Major histocompatibility complex","score_opus":0.047796247781921916,"score_gpt":0.37120881998169686,"score_spread":0.32341257219977493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206500679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933356,0.00014411632,0.00029069989,0.000014346298,0.0000014650494,0.0000044117296,0.00004544398,0.000008229403,0.00015770238],"genre_scores_gemma":[0.99950707,0.00004707439,0.00019715581,0.000013630022,0.000003255529,0.0000060577927,0.00008070559,0.000003406927,0.00014168648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990916,0.00001933272,0.0000058887013,0.000029222625,0.000016356254,0.000020088515],"domain_scores_gemma":[0.9998759,0.000017833136,0.000055792443,0.000012933277,0.000011781835,0.000025764592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114222,0.00015532457,0.00013392579,0.00031720867,0.00015456561,0.00030258545,0.00007712412,0.00020035416,0.0008922091],"category_scores_gemma":[0.00018197995,0.00009874501,0.00008797286,0.0001557275,0.00018325578,0.00013993918,0.00018168382,0.00033912424,0.0002036055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004850976,0.00005451439,0.07535699,0.000018180172,0.000017190954,0.0001772229,0.00009877439,0.00011898864,0.92050844,0.00003247928,0.000051399267,0.0030807036],"study_design_scores_gemma":[0.000033051114,0.0008343174,0.7893922,0.0000074037275,0.000051866202,0.0025252656,0.00038306086,0.0017927882,0.20372033,0.00015307171,0.0010953364,0.00001123455],"about_ca_topic_score_codex":0.00019977445,"about_ca_topic_score_gemma":0.0002571182,"teacher_disagreement_score":0.0008922091,"about_ca_system_score_codex":0.00008517292,"about_ca_system_score_gemma":0.000054486976,"threshold_uncertainty_score":0.0029847622},"labels":[],"label_agreement":null},{"id":"W4206729345","doi":"10.1158/2326-6074.tumimm21-p014","title":"Abstract P014: Driving immune-dependent metabolic vulnerabilities in the breast tumor microenvironment","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Immune system; Inflammation; Cancer research; Immunology; Immunotherapy; Cancer; Breast cancer; Biology; Medicine; Internal medicine","score_opus":0.030611492571380756,"score_gpt":0.31556064803124484,"score_spread":0.2849491554598641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206729345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414176,0.0008698289,0.0026752953,0.00020027053,0.000042689615,0.00005343989,0.0003530679,0.00010856542,0.0015550449],"genre_scores_gemma":[0.9936547,0.0005140895,0.0027806512,0.00007870385,0.000016512839,0.00005322039,0.00037072925,0.000027274626,0.002504101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998919,0.000017230004,0.000007737193,0.000019605206,0.00002938597,0.000034105],"domain_scores_gemma":[0.9999312,0.000012490468,0.00001788556,0.000008614926,0.000006538876,0.000023288314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011464058,0.00023607479,0.00024164876,0.0002194745,0.00012860696,0.00033206373,0.00018033588,0.00031304886,0.0020774137],"category_scores_gemma":[0.00010565733,0.00009276566,0.00017686113,0.00018447702,0.00020955795,0.00016214025,0.0002720485,0.0005203203,0.00049329194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019297087,0.00004265667,0.00013534198,0.00002163581,0.0000016600895,0.000029854054,0.0000053419803,0.00004498568,0.99812454,0.000058237623,0.000040338025,0.0013023919],"study_design_scores_gemma":[0.000035033052,0.00088594534,0.0024693063,0.0000057228185,0.000010356787,0.00021407282,0.000030726,0.0007797271,0.99362284,0.00005905001,0.0018834833,0.0000037269394],"about_ca_topic_score_codex":0.00025516134,"about_ca_topic_score_gemma":0.00037892262,"teacher_disagreement_score":0.0020774137,"about_ca_system_score_codex":0.00017875183,"about_ca_system_score_gemma":0.00019348011,"threshold_uncertainty_score":0.0069496036},"labels":[],"label_agreement":null},{"id":"W4213219040","doi":"10.1158/2326-6066.cir-20-0973","title":"Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Ubiquitin ligase; Cytotoxic T cell; Cytokine; IL-2 receptor; Function (biology); T cell; Immunotherapy; Interleukin 21; Acquired immune system","score_opus":0.03512501272261518,"score_gpt":0.32311491335468334,"score_spread":0.28798990063206814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213219040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95943636,0.02107561,0.011181182,0.0010024167,0.000274009,0.00007360659,0.0009957665,0.00067886023,0.005282279],"genre_scores_gemma":[0.98078376,0.0051746103,0.00572167,0.00025259724,0.00006683204,0.000055333898,0.00075326115,0.0000752861,0.007116593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985933,0.000015186411,0.000012845823,0.000031340798,0.00004875973,0.000032541386],"domain_scores_gemma":[0.99993575,0.000009015277,0.000020129282,0.000009211112,0.000008425768,0.000017459544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001222726,0.00047660427,0.0002715023,0.0002340385,0.000121682664,0.00034252866,0.0002781638,0.00032992492,0.0011151464],"category_scores_gemma":[0.00006542819,0.00011322714,0.0001852897,0.0001414808,0.00026132408,0.0002113696,0.00017083075,0.0011669975,0.00058763876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095306365,0.000014380014,0.00008840496,0.000029588693,0.0000028542447,0.000030047624,0.00000427019,0.00004261511,0.99762577,0.00006346811,0.00008211677,0.0019212534],"study_design_scores_gemma":[0.00002900247,0.00013897335,0.0011941094,0.000009136274,0.00001492179,0.00018378087,0.000011926053,0.00041251554,0.99415416,0.00009056969,0.0037567262,0.0000042125866],"about_ca_topic_score_codex":0.00045368538,"about_ca_topic_score_gemma":0.0005983422,"teacher_disagreement_score":0.0011151464,"about_ca_system_score_codex":0.00037233287,"about_ca_system_score_gemma":0.00022320302,"threshold_uncertainty_score":0.0037305355},"labels":[],"label_agreement":null},{"id":"W4220853501","doi":"10.1158/2326-6066.cir-22-0112","title":"Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK; Wellcome Trust","keywords":"Immune system; Tumor microenvironment; Immunotherapy; Peripheral blood; Circulating tumor cell; Cancer immunotherapy; Infiltration (HVAC)","score_opus":0.029117328631029907,"score_gpt":0.36399954309347377,"score_spread":0.3348822144624439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220853501","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07719609,0.2292231,0.02849145,0.3688162,0.25512174,0.00021303639,0.00080424664,0.0009788213,0.039155282],"genre_scores_gemma":[0.38188806,0.19626915,0.011956029,0.077202484,0.24142091,0.00020057989,0.00049924717,0.00044865248,0.09011494],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992685,0.000110904235,0.00004658499,0.00015608908,0.00029247085,0.00012545782],"domain_scores_gemma":[0.9989496,0.00036585398,0.00013930825,0.00006657668,0.0002489442,0.00022979658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015617767,0.00052937045,0.0005655659,0.0006362309,0.0007008884,0.003921434,0.0010793544,0.0037309846,0.0034110749],"category_scores_gemma":[0.0015209407,0.00052088307,0.00044079928,0.0002706579,0.0015874493,0.0030222223,0.0009815557,0.0054670447,0.0011955377],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013788035,0.00016818238,0.0038821995,0.0011165055,0.00012872787,0.0020906187,0.00056409923,0.00070409896,0.09732301,0.062539086,0.6132816,0.21682306],"study_design_scores_gemma":[0.000115549985,0.00016632708,0.0048734844,0.00015446909,0.000065648484,0.0016156558,0.0003775321,0.0011037119,0.027104154,0.011405104,0.95298356,0.000034837325],"about_ca_topic_score_codex":0.00028501343,"about_ca_topic_score_gemma":0.000900007,"teacher_disagreement_score":0.003921434,"about_ca_system_score_codex":0.00095011835,"about_ca_system_score_gemma":0.0004996565,"threshold_uncertainty_score":0.01141119},"labels":[],"label_agreement":null},{"id":"W4224217383","doi":"10.1158/2326-6066.cir-21-0171","title":"Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HealthForceOntario","funders":"Imperial Experimental Cancer Medicine Centre; Rosetrees Trust; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK","keywords":"Oncolytic virus; Medicine; Vaccinia; Immunotherapy; Cancer; Melanoma; Oncology; Virus; Internal medicine; Immunology; Cancer research; Biology","score_opus":0.044125128087930884,"score_gpt":0.37026466762813803,"score_spread":0.32613953954020714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224217383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790764,0.0007045652,0.00023245675,0.00008837514,0.000017170545,0.000033165335,0.000038313377,0.00001130077,0.0009671787],"genre_scores_gemma":[0.9991129,0.00022591384,0.00022480958,0.0000612292,0.000020199082,0.000040857125,0.000098518125,0.0000016592077,0.00021379712],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999392,0.000026399322,0.000004172703,0.000010393223,0.000006841878,0.000013007274],"domain_scores_gemma":[0.9998789,0.000034178764,0.000026002252,0.000011023042,0.000005142025,0.000044820237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019215987,0.00008535871,0.00029811388,0.000057213172,0.0001438571,0.0002511583,0.00005567619,0.000109948574,0.0008480832],"category_scores_gemma":[0.00043431658,0.000057659898,0.00010437624,0.00007387174,0.00015315397,0.00013311807,0.00011378781,0.0003169118,0.00015051286],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06736949,0.0083781015,0.2853381,0.00047243852,0.0001571194,0.002176271,0.00074051315,0.0018172461,0.31100285,0.0011017908,0.0049774055,0.31646857],"study_design_scores_gemma":[0.0064831283,0.19227134,0.6862294,0.00014488415,0.00034154707,0.009093217,0.00050507364,0.005996831,0.06824979,0.00089787657,0.029734856,0.00005203349],"about_ca_topic_score_codex":0.00010958808,"about_ca_topic_score_gemma":0.00023249966,"teacher_disagreement_score":0.0008480832,"about_ca_system_score_codex":0.00017452154,"about_ca_system_score_gemma":0.00024921543,"threshold_uncertainty_score":0.0028371215},"labels":[],"label_agreement":null},{"id":"W4225003254","doi":"10.1158/2326-6066.cir-21-0931","title":"Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Immunotherapy; Adjuvant; CD8; Immune system; Immunology; T cell; Immunoediting; Hepatocellular carcinoma; Dendritic cell; Adjuvant therapy; Adoptive cell transfer; Oncology; Internal medicine; Cancer","score_opus":0.0460332441837773,"score_gpt":0.3094296325806096,"score_spread":0.2633963883968323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225003254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797577,0.00059510546,0.0009350317,0.000032364347,0.000028988952,0.00007718092,0.000023819204,0.000041305746,0.00029040984],"genre_scores_gemma":[0.99848974,0.0002652549,0.0008015445,0.00003883688,0.00003793759,0.000061726954,0.00007402813,0.0000058529154,0.00022496887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998037,0.00004193973,0.00002117871,0.000035740526,0.000042535557,0.00005491051],"domain_scores_gemma":[0.9999087,0.000018706234,0.000020037534,0.000019796573,0.000006993196,0.00002576681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026854864,0.00037985356,0.00080890866,0.00023987661,0.00010160939,0.00021681243,0.00024129121,0.00024045527,0.0004450003],"category_scores_gemma":[0.00020881637,0.00015944024,0.00026480935,0.00016794233,0.00019171882,0.00016527901,0.00022874713,0.0006322676,0.00017946328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063215927,0.0057037952,0.0032363483,0.00023322036,0.00016661135,0.00031988017,0.00011264579,0.0022436627,0.8998053,0.00020434939,0.00045599882,0.081196584],"study_design_scores_gemma":[0.006527732,0.17664704,0.03158495,0.00004506225,0.0007175005,0.0026208998,0.00008189375,0.016570002,0.7587411,0.0003247788,0.006097094,0.00004197861],"about_ca_topic_score_codex":0.00018853499,"about_ca_topic_score_gemma":0.0002907041,"teacher_disagreement_score":0.00080890866,"about_ca_system_score_codex":0.00019663172,"about_ca_system_score_gemma":0.00022588925,"threshold_uncertainty_score":0.0014886856},"labels":[],"label_agreement":null},{"id":"W4285672705","doi":"10.1158/2326-6066.723.8.6","title":"A Sampling of Highlights from the Literature","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sampling (signal processing); Medicine; Computer science; Computational biology; Biology","score_opus":0.09914347380315007,"score_gpt":0.3762141187227381,"score_spread":0.277070644919588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285672705","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009317316,0.9113708,0.0012436329,0.027497217,0.033460215,0.00009565439,0.0017462117,0.00028109056,0.023373524],"genre_scores_gemma":[0.0033520488,0.9312043,0.0015255836,0.016359936,0.029866425,0.000111292284,0.0025863661,0.00012158206,0.014872442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923325,0.000112287446,0.00014484725,0.00013224815,0.00027159898,0.00010577472],"domain_scores_gemma":[0.99602145,0.0015624914,0.0004520587,0.000103583654,0.0013549395,0.0005056434],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014390443,0.0010422852,0.0010665837,0.011997828,0.0007507825,0.0035285938,0.00131498,0.0018559555,0.046206754],"category_scores_gemma":[0.00668217,0.00038062202,0.0011562213,0.009888288,0.000609709,0.00333348,0.0018640662,0.0022204923,0.01880074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001132808,0.000039740353,0.00040294422,0.010346272,0.000055905643,0.00038464137,0.00012282415,0.00014723079,0.0004938139,0.0022348345,0.47860858,0.50705],"study_design_scores_gemma":[0.000008499814,0.000024885632,0.0005492621,0.005772853,0.00004029157,0.0007490241,0.00012122399,0.000030420142,0.00010371824,0.0009085203,0.99167717,0.00001420576],"about_ca_topic_score_codex":0.0016172873,"about_ca_topic_score_gemma":0.0037827452,"teacher_disagreement_score":0.9537932,"about_ca_system_score_codex":0.0017394928,"about_ca_system_score_gemma":0.0030789904,"threshold_uncertainty_score":0.15457696},"labels":[],"label_agreement":null},{"id":"W4296301767","doi":"10.1158/2326-6066.cir-22-0434","title":"Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Deutschen Konsortium für Translationale Krebsforschung; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"Bone marrow; Immune system; Antigen; Multiple myeloma; Immunology; Phenotype; Immunotherapy; Medicine; Cancer research; Biology; Gene; Genetics","score_opus":0.05314186102276201,"score_gpt":0.3621803626410768,"score_spread":0.30903850161831475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296301767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991942,0.00029362258,0.00012468205,0.000007034617,0.0000014914734,0.000008363332,0.000023600362,0.000005941042,0.00034103185],"genre_scores_gemma":[0.99951994,0.00010097502,0.00012564794,0.000020769223,0.0000032801597,0.000008005271,0.00007697453,0.000002354302,0.0001418703],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989045,0.000019792285,0.000011431226,0.000030436182,0.000025061967,0.00002284919],"domain_scores_gemma":[0.99989545,0.000029798124,0.000023333945,0.000010246653,0.000016157586,0.000024860181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011381168,0.00020206065,0.00025367778,0.00030243144,0.00016921831,0.0002545973,0.00012744598,0.0003014225,0.0009255004],"category_scores_gemma":[0.00029663366,0.00011898568,0.00013460561,0.00015114178,0.00013874973,0.00013101756,0.00012075472,0.00024383445,0.00015476691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011834394,0.00021525976,0.099522986,0.00008908508,0.00004149642,0.002738773,0.0004736539,0.00034200907,0.8796766,0.000109115805,0.00013784997,0.015469775],"study_design_scores_gemma":[0.00020531226,0.004447727,0.78543377,0.00003066231,0.00026071738,0.025588416,0.0003665912,0.002137747,0.178023,0.0002101731,0.0032717648,0.000024069532],"about_ca_topic_score_codex":0.0005902596,"about_ca_topic_score_gemma":0.0006381068,"teacher_disagreement_score":0.0009255004,"about_ca_system_score_codex":0.00021945628,"about_ca_system_score_gemma":0.000087629596,"threshold_uncertainty_score":0.0030961633},"labels":[],"label_agreement":null},{"id":"W4306721717","doi":"10.1158/2326-6066.cir-22-0095","title":"Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; American Association for Cancer Research; Children's Hospital of Philadelphia; Stand Up To Cancer; Entertainment Industry Foundation; Doris Duke Charitable Foundation","keywords":"CD19; Chimeric antigen receptor; Medicine; Context (archaeology); Immunotherapy; Immunology; Oncology; Cancer research; Antigen; Biology; Immune system","score_opus":0.07989112111024521,"score_gpt":0.3691113198757585,"score_spread":0.2892201987655133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306721717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655163,0.00018967848,0.0024719976,0.000026739732,0.0000015750668,0.000017879182,0.00025253117,0.00003415315,0.00045375855],"genre_scores_gemma":[0.99773896,0.00011453114,0.0013977803,0.000039362014,0.0000016042944,0.000015334768,0.00044650584,0.000011326381,0.00023468932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987864,0.000019256928,0.000008849351,0.00003210999,0.000039105646,0.000022083042],"domain_scores_gemma":[0.99989057,0.00003742865,0.000027077294,0.000015090156,0.00001527447,0.000014608399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015642933,0.00012146912,0.00020939736,0.00024822133,0.00007191785,0.0002538733,0.00013783143,0.00021131501,0.00051218196],"category_scores_gemma":[0.0004272081,0.00008703779,0.00009828555,0.00016068427,0.00012624565,0.000090105714,0.00015020877,0.00021717345,0.00012592548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002823247,0.000051660358,0.021007435,0.000025901849,0.000029686229,0.00022241665,0.00008617416,0.001470848,0.96234685,0.0002008547,0.0000997673,0.014176109],"study_design_scores_gemma":[0.000059179816,0.0014289308,0.17619321,0.000010340282,0.00014115716,0.0051276493,0.00014724427,0.03365571,0.77837616,0.00054985634,0.0042963405,0.000014240807],"about_ca_topic_score_codex":0.0004398299,"about_ca_topic_score_gemma":0.0005580766,"teacher_disagreement_score":0.00051218196,"about_ca_system_score_codex":0.0001404824,"about_ca_system_score_gemma":0.00008864453,"threshold_uncertainty_score":0.0017133951},"labels":[],"label_agreement":null},{"id":"W4309656465","doi":"10.1158/2326-6066.cir-22-0260","title":"CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Vector Institute; Hôpital de l'Enfant-Jésus; Université de Montréal; University of Toronto; University Health Network; Artificial Intelligence in Medicine (Canada); Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal; Terry Fox Research Institute","keywords":"Sting; Pancreatic cancer; Medicine; Cancer; Cancer research; Cancer immunotherapy; Immunotherapy; Immunology; Internal medicine","score_opus":0.04895646800022256,"score_gpt":0.3561988983489186,"score_spread":0.307242430348696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309656465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957314,0.0015533786,0.0008871902,0.00009046035,0.000022545122,0.000024663568,0.000142453,0.000050634113,0.0014973221],"genre_scores_gemma":[0.99716955,0.00066260505,0.00061193114,0.000027149737,0.000008683131,0.000016913951,0.00021573456,0.0000054612005,0.0012818594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990964,0.000015003656,0.000006849301,0.000012700498,0.000023246095,0.00003262568],"domain_scores_gemma":[0.99997175,0.000003485683,0.000006683789,0.0000045889497,0.0000028414174,0.000010630961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081761835,0.0002663379,0.00016328353,0.00016263108,0.00013778714,0.00017768041,0.0001149028,0.00014343989,0.0008855593],"category_scores_gemma":[0.00007051375,0.000059179416,0.00017154602,0.00016881234,0.00012068393,0.000113364775,0.000113339054,0.00030494513,0.00021736156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021320416,0.00010489478,0.00028436995,0.000032524338,0.0000069053904,0.000079354184,0.000009984527,0.00012981887,0.99429154,0.00014553854,0.00011161775,0.0045903213],"study_design_scores_gemma":[0.000038718048,0.00062225596,0.0039005466,0.0000045459255,0.000019262847,0.00034158543,0.000014515711,0.0012653018,0.9884815,0.00005287166,0.0052564605,0.000002413485],"about_ca_topic_score_codex":0.0006149992,"about_ca_topic_score_gemma":0.0013317429,"teacher_disagreement_score":0.0008855593,"about_ca_system_score_codex":0.00028255297,"about_ca_system_score_gemma":0.00027715598,"threshold_uncertainty_score":0.00296247},"labels":[],"label_agreement":null},{"id":"W4311098518","doi":"10.1158/2326-6074.tumimm22-a09","title":"Abstract A09: Immune checkpoint inhibitor-induced polyarthritis: a case series","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nivolumab; Polyarthritis; Prednisone; Ipilimumab; Arthritis; Internal medicine; Cancer; Rash; Synovitis; Dermatology; Surgery; Oncology; Immunotherapy","score_opus":0.06990754541223117,"score_gpt":0.37819605054656996,"score_spread":0.3082885051343388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94777215,0.016739247,0.0062434976,0.0036301056,0.0017329268,0.00057241373,0.00066750485,0.0003923009,0.022249933],"genre_scores_gemma":[0.9935315,0.0016076309,0.00094771513,0.00092820433,0.001247632,0.000050472507,0.00015396863,0.000034243698,0.0014985496],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99839514,0.00016859849,0.0002858836,0.00045670767,0.0002182709,0.00047534192],"domain_scores_gemma":[0.9979621,0.0003402456,0.0005409495,0.00023362401,0.00016793625,0.00075505977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046369008,0.0032285016,0.0014058495,0.0032992724,0.003541046,0.0020586788,0.0016049785,0.0054301536,0.005236906],"category_scores_gemma":[0.002470098,0.0015321282,0.001997474,0.002664519,0.0018730198,0.0023316029,0.002103576,0.0035207423,0.0023774642],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028875873,0.000071755036,0.0068334625,0.00006657244,0.000024500956,0.99056154,0.00013384692,0.000055214547,0.00049172173,0.000092465816,0.0004919086,0.0011481073],"study_design_scores_gemma":[0.000014264769,0.000043925636,0.0034541774,0.00002069967,0.000017933235,0.99563414,0.00009804224,0.00011301286,0.00013431378,0.000057152367,0.00040379495,0.000008497574],"about_ca_topic_score_codex":0.0020379606,"about_ca_topic_score_gemma":0.002124294,"teacher_disagreement_score":0.0054301536,"about_ca_system_score_codex":0.0012367029,"about_ca_system_score_gemma":0.0008901814,"threshold_uncertainty_score":0.017519176},"labels":[],"label_agreement":null},{"id":"W4311098665","doi":"10.1158/2326-6074.tumimm22-a03","title":"Abstract A03: Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Interquartile range; Immunotherapy; Oncology; Internal medicine; Clinical trial; Melanoma; Survival analysis; Targeted therapy; Randomized controlled trial; Cancer","score_opus":0.36514786188021325,"score_gpt":0.477485829104555,"score_spread":0.11233796722434175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098665","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22716421,0.42682272,0.16938867,0.007634031,0.0007148807,0.027275683,0.12021794,0.0012316395,0.019550221],"genre_scores_gemma":[0.8752331,0.025317488,0.06559707,0.0010739918,0.00018076504,0.017420476,0.014706205,0.00006196797,0.00040887512],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9082273,0.06989341,0.014434681,0.0038046767,0.0032859321,0.0003540271],"domain_scores_gemma":[0.6255184,0.34498656,0.022081116,0.0025531612,0.004252812,0.00060794316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07711283,0.0017994016,0.0038187688,0.0065701543,0.00045420206,0.0040056393,0.0020340416,0.0027520745,0.006279146],"category_scores_gemma":[0.25661793,0.0010468195,0.011261447,0.005702332,0.0006820052,0.003134724,0.0016364837,0.001785065,0.0004685518],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023105338,0.0003684074,0.11574392,0.36306217,0.12967995,0.0014794793,0.0019937258,0.17322357,0.0011055707,0.019100532,0.01736084,0.15377659],"study_design_scores_gemma":[0.023498395,0.012145144,0.12940526,0.21869491,0.17171745,0.0058088377,0.0030986553,0.2576386,0.0029108273,0.08931417,0.084727086,0.0010406214],"about_ca_topic_score_codex":0.0029557282,"about_ca_topic_score_gemma":0.0026819878,"teacher_disagreement_score":0.07711283,"about_ca_system_score_codex":0.002889169,"about_ca_system_score_gemma":0.0031590085,"threshold_uncertainty_score":0.40781653},"labels":[],"label_agreement":null},{"id":"W4311098666","doi":"10.1158/2326-6074.tumimm22-a51","title":"Abstract A51: STING activation overcomes immune escape in osteosarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Sting; Stimulator of interferon genes; Cancer research; Metastasis; Immune system; Cancer; Tumor microenvironment; Cancer cell; Immunotherapy; Medicine; Downregulation and upregulation; Innate immune system; Immunology; Biology; Internal medicine; Gene","score_opus":0.0800805621876029,"score_gpt":0.37718980849216177,"score_spread":0.29710924630455887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98938715,0.0038296555,0.0016733349,0.00029584242,0.0002365992,0.000094210365,0.00041334983,0.00022089401,0.0038490212],"genre_scores_gemma":[0.99454653,0.0011654041,0.00059359585,0.00009395383,0.000029397164,0.0000436678,0.0004050123,0.000012751965,0.00310968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998951,0.000015305774,0.000012006344,0.000017563076,0.000021221369,0.000038765676],"domain_scores_gemma":[0.9999361,0.0000072772864,0.000013447031,0.000007796317,0.0000066113125,0.00002884067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001354682,0.0003128782,0.0003205286,0.0002752513,0.00012488417,0.0003051382,0.00019347918,0.00027344257,0.0041325707],"category_scores_gemma":[0.00011745203,0.00009310437,0.00030557957,0.00013335947,0.00018336622,0.00020314613,0.00017846008,0.00085121754,0.000592495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008654267,0.00037698206,0.00037900743,0.00014706895,0.000021212743,0.00009352809,0.000020472422,0.00026728856,0.9844258,0.0004355311,0.0005665721,0.01240101],"study_design_scores_gemma":[0.0004019028,0.011005039,0.007843985,0.000045144265,0.000117343705,0.00051611837,0.00007643234,0.0030691412,0.96145993,0.00031145886,0.015138542,0.000014957556],"about_ca_topic_score_codex":0.0005037426,"about_ca_topic_score_gemma":0.00088447274,"teacher_disagreement_score":0.0041325707,"about_ca_system_score_codex":0.00020445212,"about_ca_system_score_gemma":0.0002993745,"threshold_uncertainty_score":0.0138248205},"labels":[],"label_agreement":null},{"id":"W4311934208","doi":"10.1158/2326-6066.cir-22-0174","title":"Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome–Positive C3 Cancers in Mice","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universiteit Leiden; National Institutes of Health; Eurostars; Bundesministerium für Bildung und Forschung; Institut de recherche en santé mentale; European Commission","keywords":"Medicine; Virology; Cisplatin; Immunotherapy; Genome; Cancer research; Immunology; Biology; Immune system; Internal medicine; Chemotherapy; Gene; Genetics","score_opus":0.026674317863691798,"score_gpt":0.3423913271875536,"score_spread":0.3157170093238618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311934208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699855,0.0009143934,0.00064907636,0.00008909225,0.00005878236,0.00006212687,0.00018150118,0.00006957568,0.0009769051],"genre_scores_gemma":[0.99679416,0.00068994856,0.0008629096,0.000044646007,0.000023388808,0.00005477013,0.00023546425,0.000016313576,0.0012784748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997836,0.00004822089,0.000018560815,0.00003938749,0.000044317927,0.00006584549],"domain_scores_gemma":[0.99981457,0.000035895926,0.000042354754,0.000026583884,0.000019203466,0.000061495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002470034,0.0005252065,0.0005490891,0.00040696378,0.000116570125,0.00031104285,0.00028077714,0.00052000995,0.0006466623],"category_scores_gemma":[0.0001639955,0.00017047959,0.0003315712,0.0001677426,0.00030566467,0.0002719917,0.00015591842,0.0007813516,0.00024265583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026948329,0.001085238,0.00037857977,0.00012056559,0.00003608792,0.000047474103,0.00004280331,0.0010272578,0.9856397,0.00024981107,0.00015333906,0.008524421],"study_design_scores_gemma":[0.00041604874,0.017202856,0.00287529,0.000021344062,0.00009049438,0.0001651856,0.000020370377,0.0030725983,0.9739653,0.000106839456,0.0020475474,0.000016242908],"about_ca_topic_score_codex":0.00066935335,"about_ca_topic_score_gemma":0.00081072334,"teacher_disagreement_score":0.00066935335,"about_ca_system_score_codex":0.0002246508,"about_ca_system_score_gemma":0.00041745364,"threshold_uncertainty_score":0.002163291},"labels":[],"label_agreement":null},{"id":"W4360813826","doi":"10.1158/2326-6066.cir-22-0621","title":"The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Genome British Columbia; Infrastruktura PL-Grid; Imperial Experimental Cancer Medicine Centre; Cancerfonden; Agence Nationale de la Recherche; European Regional Development Fund; Fundacja na rzecz Nauki Polskiej; European Commission; UK Research and Innovation; Horizon 2020 Framework Programme; Cancer Research UK; NuCana; Medical Research Council; Swedish Cancer Foundation; Fundação para a Ciência e a Tecnologia; Genome Canada","keywords":"MHC class I; Computational biology; Biology; Major histocompatibility complex; Human leukocyte antigen; Genome; Cancer immunotherapy; Antigen; Cancer; Genetics; Immunotherapy; Gene","score_opus":0.044769820431042634,"score_gpt":0.34525456298662566,"score_spread":0.300484742555583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360813826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7125849,0.0060888324,0.26115263,0.001104698,0.00020259734,0.00015689436,0.0081587145,0.0028776806,0.007673102],"genre_scores_gemma":[0.792077,0.0026618852,0.19501491,0.00072891364,0.00008833003,0.00015713632,0.0067524905,0.00063625653,0.0018830529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967945,0.000046696463,0.000018147128,0.00012408222,0.00008886525,0.000042831554],"domain_scores_gemma":[0.9993198,0.0002662094,0.00016737753,0.000090496156,0.00009393049,0.00006229837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011496148,0.00059504516,0.0005188509,0.00091109454,0.00029856642,0.0013192156,0.00044999528,0.0005007655,0.0019810484],"category_scores_gemma":[0.0019775971,0.00032401332,0.000555536,0.00079249346,0.0004716275,0.0011686656,0.0009078316,0.0010956143,0.00061277533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079254876,0.00007962394,0.020085528,0.0008481933,0.000261932,0.00056785805,0.00023952663,0.007226359,0.8675636,0.0044448464,0.0030198172,0.094870135],"study_design_scores_gemma":[0.0001295522,0.00067243073,0.080988415,0.00017553418,0.0004111596,0.0038971605,0.00032091333,0.15105522,0.68540406,0.02620119,0.050603025,0.00014131726],"about_ca_topic_score_codex":0.000602821,"about_ca_topic_score_gemma":0.0011212245,"teacher_disagreement_score":0.0019810484,"about_ca_system_score_codex":0.00043656174,"about_ca_system_score_gemma":0.00051334937,"threshold_uncertainty_score":0.0066272616},"labels":[],"label_agreement":null},{"id":"W4380357935","doi":"10.1158/2326-6066.cir-22-0465","title":"Aerobic Exercise Alters the Melanoma Microenvironment and Modulates ERK5 S496 Phosphorylation","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"NHLBI Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Division of Cancer Epidemiology and Genetics, National Cancer Institute; University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas","keywords":"Tumor microenvironment; Immune system; Cancer research; CD8; Cytotoxic T cell; Population; Melanoma; Macrophage polarization; Biology; Phosphorylation; Immunology; Phenotype; Medicine; Endocrinology; Cell biology","score_opus":0.03871444760019662,"score_gpt":0.31733138965066304,"score_spread":0.27861694205046644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380357935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970209,0.0011389386,0.00051499106,0.00012139394,0.00002473645,0.000007997092,0.00019112762,0.000022504524,0.0009574046],"genre_scores_gemma":[0.9979103,0.0006250196,0.00023428659,0.0000509393,0.0000098593555,0.000011632816,0.000111161855,0.0000056334648,0.0010411342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995375,0.000008161098,0.0000026123148,0.000011563365,0.000007207064,0.000016721724],"domain_scores_gemma":[0.99997854,0.0000022579409,0.000009743887,0.0000018146231,0.0000013726171,0.000006214193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041775667,0.00017249095,0.00011529693,0.000098980134,0.000066183355,0.00014646913,0.000069766575,0.00015490096,0.0011752488],"category_scores_gemma":[0.00005049888,0.000068261375,0.0001423986,0.000054713837,0.00012393938,0.00010081566,0.00009947539,0.00023831165,0.00015704073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007863921,0.000085254534,0.0011681559,0.000045152083,0.000012927544,0.000043864642,0.000013149308,0.00010258016,0.99289954,0.00007530075,0.00010798077,0.0046596476],"study_design_scores_gemma":[0.00013914947,0.0020139446,0.23918848,0.000038916598,0.00007323982,0.00034862346,0.00012913939,0.0027400602,0.7515134,0.00046613105,0.003331627,0.0000172163],"about_ca_topic_score_codex":0.0003241026,"about_ca_topic_score_gemma":0.00069698354,"teacher_disagreement_score":0.0011752488,"about_ca_system_score_codex":0.00010054837,"about_ca_system_score_gemma":0.00006134307,"threshold_uncertainty_score":0.0039316416},"labels":[],"label_agreement":null},{"id":"W4380450183","doi":"10.1158/2326-6066.cir-22-0140","title":"HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; McGill University; Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Tumor microenvironment; Immune system; Cancer research; Breast cancer; Biology; Carcinogenesis; Immunotherapy; Cancer; Tumor progression; Tumor initiation; Gene knockdown; Immunology; Cell culture","score_opus":0.049542272113119894,"score_gpt":0.3641174741742652,"score_spread":0.3145752020611453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380450183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364257,0.0034727778,0.0014926755,0.00013508496,0.000021185464,0.000017031769,0.00029587437,0.00003266373,0.0008901896],"genre_scores_gemma":[0.994591,0.0016327988,0.00096977525,0.00008680776,0.000007467929,0.000020485784,0.00039489055,0.0000086415375,0.002288159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999275,0.0000081967955,0.000004052383,0.000018549543,0.000022158254,0.000019518055],"domain_scores_gemma":[0.99997365,0.000002104008,0.0000095734,0.0000022269428,0.0000037890893,0.000008651189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096684715,0.00023872442,0.00016972134,0.00011565503,0.000115875024,0.00024115367,0.00010064065,0.00017099161,0.0007527052],"category_scores_gemma":[0.000041779975,0.00008964283,0.00019678478,0.000101045014,0.00011574769,0.00014180469,0.00017118393,0.00033680318,0.00022856682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058484555,0.000010711774,0.0004307744,0.000031090934,0.0000041514872,0.000058835707,0.000009332654,0.00005338931,0.9986222,0.000044021683,0.000027703372,0.00064936414],"study_design_scores_gemma":[0.000016133215,0.00023802376,0.021452805,0.000010623677,0.000020752812,0.000827387,0.00007769606,0.0012042416,0.9711889,0.000128324,0.0048298836,0.0000053506637],"about_ca_topic_score_codex":0.0002670692,"about_ca_topic_score_gemma":0.0005467948,"teacher_disagreement_score":0.0007527052,"about_ca_system_score_codex":0.00024338876,"about_ca_system_score_gemma":0.00013758641,"threshold_uncertainty_score":0.0025181174},"labels":[],"label_agreement":null},{"id":"W4382240403","doi":"10.1158/2326-6066.cir-23-0189","title":"A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Landsteiner Foundation for Blood Transfusion Research","keywords":"Cancer research; CD8; T cell; Cytotoxic T cell; Immune system; Immunotherapy; In vivo; Effector; Peripheral blood mononuclear cell; CD3; Antibody; Ex vivo; Immunology; Biology; In vitro","score_opus":0.07868281163372867,"score_gpt":0.3782674942303921,"score_spread":0.2995846825966634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382240403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552935,0.0003961286,0.0028271293,0.00002420622,0.0000110591045,0.00006353026,0.00012105477,0.00003031135,0.0009972301],"genre_scores_gemma":[0.9972356,0.00022581883,0.0012723733,0.000041467887,0.0000058183177,0.000042888758,0.00022215782,0.000004751862,0.0009491343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998386,0.000029867073,0.000012717388,0.000039450184,0.0000362315,0.000043028274],"domain_scores_gemma":[0.9999639,0.000008236336,0.000009552806,0.000006862835,0.000005014421,0.000006531205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016924995,0.00045754138,0.00020377427,0.00013852592,0.00006598403,0.00026820347,0.00018465245,0.00029323384,0.00071289425],"category_scores_gemma":[0.00010098442,0.00009460081,0.0001754094,0.00009502121,0.00009092006,0.00015226414,0.0001611206,0.0006138965,0.00020510073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106563435,0.00006772519,0.00020358997,0.00002964015,0.0000053230424,0.000031066404,0.000014389687,0.00020675977,0.9973024,0.00005462681,0.000030225354,0.0019476247],"study_design_scores_gemma":[0.00004249696,0.0016328911,0.0018093938,0.000008975177,0.000020236428,0.0005127219,0.000025480878,0.0014795895,0.9926876,0.00005479574,0.0017225473,0.0000033320903],"about_ca_topic_score_codex":0.00016603214,"about_ca_topic_score_gemma":0.00029909235,"teacher_disagreement_score":0.00071289425,"about_ca_system_score_codex":0.00016709736,"about_ca_system_score_gemma":0.00012132594,"threshold_uncertainty_score":0.002384901},"labels":[],"label_agreement":null},{"id":"W4385064061","doi":"10.1158/2326-6066.cir-22-0912","title":"Tumor Cell–Intrinsic c-Myb Upregulation Stimulates Antitumor Immunity in a Murine Colorectal Cancer Model","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; European Commission; Deutsches Krebsforschungszentrum; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Cancer research; Downregulation and upregulation; Cytotoxic T cell; Biology; Tumor microenvironment; Carcinogenesis; CD8; Tumor progression; Cancer; Immune system; Immunology","score_opus":0.06070083626266562,"score_gpt":0.3709813163964048,"score_spread":0.3102804801337392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385064061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633765,0.0006878424,0.0013443611,0.00014303788,0.000034920908,0.0000875077,0.00036219638,0.00010487573,0.0008976723],"genre_scores_gemma":[0.99471754,0.00051079853,0.0020737138,0.00006840101,0.000015515054,0.00011353097,0.00034507847,0.00001925701,0.0021361713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997328,0.000048804457,0.000022376253,0.00006237115,0.000060572635,0.00007302985],"domain_scores_gemma":[0.9998024,0.000016350612,0.000062912215,0.000028028102,0.000013293042,0.00007692817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025237794,0.0006083826,0.00034424273,0.00052033225,0.00016180093,0.00023271813,0.00020702602,0.0005002741,0.0013086251],"category_scores_gemma":[0.000102269616,0.00024474377,0.00036063837,0.00018176751,0.00029088763,0.00022751382,0.00020483123,0.0013313505,0.00039217653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039756656,0.00021096496,0.00016992023,0.000041723306,0.00000562068,0.000056141096,0.000021970518,0.0000826726,0.9980489,0.00007160635,0.000050322637,0.0008425354],"study_design_scores_gemma":[0.00017561282,0.005442977,0.005796644,0.00002163343,0.000040493112,0.0005165758,0.000049803104,0.0025857503,0.9827586,0.00007636567,0.0025242637,0.000011192919],"about_ca_topic_score_codex":0.000623588,"about_ca_topic_score_gemma":0.0010338125,"teacher_disagreement_score":0.0013086251,"about_ca_system_score_codex":0.0003768805,"about_ca_system_score_gemma":0.000257428,"threshold_uncertainty_score":0.0043777823},"labels":[],"label_agreement":null},{"id":"W4388013818","doi":"10.1158/2326-6066.cir-23-0321","title":"Determinants for Antitumor and Protumor Effects of Programmed Cell Death","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Cancer Research Society","keywords":"Immunosurveillance; Tumor microenvironment; Programmed cell death; Biology; Immune system; Epigenetics; Immunology; Cancer; Context (archaeology); Immunotherapy; Chemokine; Immunogenic cell death; Cancer research; Apoptosis; Genetics; Gene","score_opus":0.07155914524658015,"score_gpt":0.4224807868041451,"score_spread":0.35092164155756495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388013818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913033,0.0021991679,0.0024794505,0.00021597091,0.000023288938,0.000018390505,0.00007408504,0.000026569804,0.003659709],"genre_scores_gemma":[0.99886024,0.00023819284,0.0003606302,0.00002891597,0.000013882678,0.000005797375,0.00004443397,0.000004667291,0.00044320174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979764,0.000043676,0.000012869959,0.00003504545,0.000049284245,0.0000614344],"domain_scores_gemma":[0.99957615,0.0001088898,0.00011088011,0.000040669285,0.000046392746,0.0001169431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002336107,0.00012882789,0.0001239408,0.00026239213,0.00011171028,0.00049393513,0.00014252817,0.00018773727,0.0024949908],"category_scores_gemma":[0.00048975466,0.000078519464,0.00008153892,0.00008748014,0.00029321262,0.00028919146,0.00029036036,0.00038924356,0.00029333396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061452633,0.00013525499,0.03756671,0.00010428865,0.000019775065,0.00057075045,0.00014118303,0.00039439395,0.9229301,0.0081634605,0.00029753588,0.029062029],"study_design_scores_gemma":[0.00008972573,0.00201562,0.3629357,0.00005978344,0.00009652456,0.008326058,0.00087036967,0.006138802,0.5862809,0.013293117,0.01985497,0.000038528404],"about_ca_topic_score_codex":0.00005757342,"about_ca_topic_score_gemma":0.00008425669,"teacher_disagreement_score":0.0024949908,"about_ca_system_score_codex":0.00019456903,"about_ca_system_score_gemma":0.00019997895,"threshold_uncertainty_score":0.008346558},"labels":[],"label_agreement":null},{"id":"W4388041288","doi":"10.1158/2326-6066.cir-23-0522","title":"Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Publishing; Scientific publishing; Engineering ethics; Political science; Engineering","score_opus":0.1869273419889362,"score_gpt":0.4251396820144746,"score_spread":0.2382123400255384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388041288","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088243076,0.015889034,0.0003961188,0.94743323,0.032050177,0.000011801473,0.00001503498,0.00002201093,0.0033000787],"genre_scores_gemma":[0.063535415,0.06933693,0.004831311,0.73013407,0.09350725,0.00022427637,0.00013427438,0.00014008541,0.03815647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892484,0.0053196684,0.00045642542,0.00068342476,0.0026002305,0.0016918862],"domain_scores_gemma":[0.96466064,0.00954652,0.0009257283,0.0009051734,0.007047807,0.016914165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038485773,0.00061382196,0.0007592501,0.000874636,0.007452392,0.013293839,0.0016251496,0.009882794,0.00635933],"category_scores_gemma":[0.032006342,0.00043311965,0.0010443571,0.00049325224,0.006221428,0.009119956,0.0051529994,0.022080781,0.0026977113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007012535,0.000066065804,0.00050677767,0.00017736158,0.000012000067,0.00033302698,0.0026189731,0.00006635328,0.00036133899,0.026402127,0.93576187,0.03362407],"study_design_scores_gemma":[0.000032004355,0.00007762094,0.00064823724,0.0005485141,0.000015401822,0.00030355476,0.0051535387,0.000069222755,0.00028492897,0.024643721,0.9681796,0.000043705317],"about_ca_topic_score_codex":0.003723286,"about_ca_topic_score_gemma":0.013708949,"teacher_disagreement_score":0.038485773,"about_ca_system_score_codex":0.0055143945,"about_ca_system_score_gemma":0.021599809,"threshold_uncertainty_score":0.20353472},"labels":[],"label_agreement":null},{"id":"W4388621780","doi":"10.1158/2326-6066.cir-23-0205","title":"The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","keywords":"Pancreatic cancer; Tumor microenvironment; Cancer research; Macrophage migration inhibitory factor; Exosome; Microvesicles; Tumor progression; Cancer immunotherapy; Cancer; Biology; Immunotherapy; Immune system; Immunology; Cytokine; microRNA; Biochemistry","score_opus":0.04572977854645075,"score_gpt":0.3741826503556524,"score_spread":0.32845287180920163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388621780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974855,0.0009160697,0.00084379496,0.000064149455,0.000018519248,0.000019752968,0.00014046756,0.00005277394,0.00045897232],"genre_scores_gemma":[0.998044,0.00047791816,0.00069426716,0.000030030164,0.0000061199366,0.000022140573,0.00017275925,0.000005458499,0.0005473825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999505,0.0000071837094,0.000006461742,0.000010747352,0.000011165252,0.000013858694],"domain_scores_gemma":[0.99996483,0.0000060476514,0.000011224804,0.0000033399162,0.0000033799374,0.000011176821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008413191,0.00022238836,0.0002040315,0.0001442373,0.00008448856,0.00015117059,0.00009915443,0.00017017589,0.0005295986],"category_scores_gemma":[0.00006508456,0.000070528135,0.000175142,0.000085431835,0.00014851723,0.000123245,0.00010428124,0.00042283247,0.00009145964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019724261,0.00004490544,0.00020232526,0.000035954374,0.000004579459,0.000030412662,0.000009515584,0.000084727806,0.99761343,0.000054446075,0.00004144315,0.0016808478],"study_design_scores_gemma":[0.000033132503,0.0005963319,0.002361837,0.000004206817,0.000014576945,0.00010233286,0.000011739834,0.00089379604,0.99468035,0.000025962212,0.0012731262,0.0000027126564],"about_ca_topic_score_codex":0.00020959952,"about_ca_topic_score_gemma":0.00032983656,"teacher_disagreement_score":0.0005295986,"about_ca_system_score_codex":0.00017028302,"about_ca_system_score_gemma":0.00014263028,"threshold_uncertainty_score":0.0017716289},"labels":[],"label_agreement":null},{"id":"W4389227565","doi":"10.1158/2326-6074.tumimm23-a039","title":"Abstract A039: Detection of immune cell glycosylation as an indicator of metabolic activity in the tumor tissue microenvironment using multimodal mass spectrometry imaging","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Glycan; Tumor microenvironment; Biology; Glycosylation; Cancer research; Immunology; Molecular biology; Biochemistry; Glycoprotein","score_opus":0.02756899991615742,"score_gpt":0.3586619397464903,"score_spread":0.3310929398303329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95159686,0.0019099655,0.03961681,0.00025668618,0.00007618867,0.00008038575,0.0025582549,0.0006706717,0.0032341853],"genre_scores_gemma":[0.9327397,0.0014156752,0.058401063,0.00031420827,0.000037239923,0.00013800149,0.0023777315,0.00015736265,0.0044191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998018,0.00002411876,0.000009933119,0.0000602456,0.00007348525,0.000030390616],"domain_scores_gemma":[0.9998229,0.000035875557,0.000041426385,0.00001479105,0.0000593216,0.000025623804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041814664,0.0004123167,0.00021498099,0.00082152284,0.00030876577,0.0004355386,0.00028483194,0.0006324946,0.0017975022],"category_scores_gemma":[0.00030625798,0.00018660187,0.0002197794,0.0005031832,0.00023144753,0.0003215328,0.00030368654,0.0004426761,0.0006536769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063766456,0.000012923623,0.0010063138,0.000025507787,0.0000072513344,0.000030879997,0.000015267942,0.00006170621,0.99679404,0.00003379342,0.00013513953,0.0018134139],"study_design_scores_gemma":[0.000006521665,0.00013554061,0.021176716,0.000008180157,0.000027308177,0.0005192994,0.000065331726,0.0048980177,0.9710571,0.00010413271,0.0019847087,0.00001722466],"about_ca_topic_score_codex":0.0013664301,"about_ca_topic_score_gemma":0.0020827528,"teacher_disagreement_score":0.0017975022,"about_ca_system_score_codex":0.00025258545,"about_ca_system_score_gemma":0.0002169702,"threshold_uncertainty_score":0.0060132146},"labels":[],"label_agreement":null},{"id":"W4389227574","doi":"10.1158/2326-6074.tumimm23-pr04","title":"Abstract PR04: Temporal single cell profiling identifies B-cell specific checkpoint molecules that regulate anti-tumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Acquired immune system; Cancer immunotherapy; TIGIT; Immune checkpoint; Immunotherapy; Antigen presentation; T cell; Cancer research; B cell; Immunology; Immunity; Antigen; Immune system; Antibody","score_opus":0.11737914931982456,"score_gpt":0.3683198197744457,"score_spread":0.25094067045462115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464889,0.0044718133,0.031111931,0.0006338885,0.00020242388,0.00017424703,0.0062410887,0.0010913219,0.009584337],"genre_scores_gemma":[0.9394142,0.0028341308,0.02416553,0.00037619838,0.00007954165,0.00016072545,0.0051730466,0.00020665304,0.027590035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989426,0.0000071576483,0.000007117949,0.00002756606,0.000040279803,0.000023575849],"domain_scores_gemma":[0.9999291,0.000008125158,0.000017574463,0.000007818078,0.000018314591,0.000019064659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013877897,0.00019826245,0.00025297108,0.00054074835,0.00017555096,0.0005149522,0.00030563874,0.0003653726,0.0043672873],"category_scores_gemma":[0.000093559785,0.00016544867,0.0001734247,0.00027551517,0.00016828746,0.00024372872,0.00020111976,0.00056104787,0.0015994521],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082848455,0.00000828944,0.00018804673,0.00001735623,0.000001737495,0.000016404534,0.0000034550258,0.00003535747,0.997285,0.00008959362,0.0002128314,0.0020590147],"study_design_scores_gemma":[0.000023538449,0.00024444566,0.013415028,0.000006444075,0.000015778525,0.00032761766,0.00002299397,0.0022502397,0.9766565,0.0001532346,0.0068762344,0.000007909856],"about_ca_topic_score_codex":0.00058837404,"about_ca_topic_score_gemma":0.00090156234,"teacher_disagreement_score":0.0043672873,"about_ca_system_score_codex":0.00036277296,"about_ca_system_score_gemma":0.00019932845,"threshold_uncertainty_score":0.014610052},"labels":[],"label_agreement":null},{"id":"W4389227587","doi":"10.1158/2326-6074.tumimm23-b009","title":"Abstract B009: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; FOXP3; Tumor microenvironment; Biology; Cancer stem cell; Glioma; Cancer; T cell; Stem cell; Immunology; Cell biology; Genetics","score_opus":0.05937206859392809,"score_gpt":0.3611547826674185,"score_spread":0.30178271407349044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98455507,0.0028630125,0.0034329768,0.00028392154,0.0001144044,0.00006324642,0.00503395,0.000534772,0.0031185613],"genre_scores_gemma":[0.9747307,0.0018253457,0.00393161,0.00026904754,0.000045614346,0.00012099209,0.0135311475,0.00007638099,0.0054691457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998785,0.000010724954,0.000009197103,0.000024849378,0.000048101312,0.000028566732],"domain_scores_gemma":[0.9999366,0.0000058223814,0.000016589966,0.0000048283837,0.00001487895,0.000021286625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011819444,0.00019884783,0.00033926702,0.0005147752,0.00015061867,0.00041046785,0.00016649537,0.00022257291,0.004339295],"category_scores_gemma":[0.00014944814,0.000081180246,0.00029524663,0.00059610576,0.00009763707,0.00015994455,0.00018573756,0.0004112949,0.0017055302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006227897,0.00012461997,0.0037049074,0.00027911298,0.000030882606,0.00014502108,0.000044880002,0.00018582493,0.9745891,0.00023756106,0.0018828928,0.01815239],"study_design_scores_gemma":[0.00022881565,0.001820066,0.08073156,0.000083006315,0.00021995103,0.0015036573,0.0002726442,0.005458126,0.8673731,0.0007590927,0.04151548,0.0000345717],"about_ca_topic_score_codex":0.0007306398,"about_ca_topic_score_gemma":0.0006535349,"teacher_disagreement_score":0.004339295,"about_ca_system_score_codex":0.00020913678,"about_ca_system_score_gemma":0.00026272732,"threshold_uncertainty_score":0.014516413},"labels":[],"label_agreement":null},{"id":"W4389227629","doi":"10.1158/2326-6074.tumimm23-a036","title":"Abstract A036: Development of a stirred-tank bioreactor scale-up approach to allogeneic natural killer cell culture","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Immunology; Immunotherapy; K562 cells; Immune system; Flow cytometry; Transplantation; Cell therapy; Cancer immunotherapy; Biology; Cancer research; Medicine; Stem cell; Cell biology; Leukemia; Internal medicine","score_opus":0.061332372972011086,"score_gpt":0.3458579716181284,"score_spread":0.2845255986461173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60158867,0.003020365,0.37053782,0.00068380695,0.0007171643,0.0023968366,0.003198665,0.0033404573,0.014516174],"genre_scores_gemma":[0.67303,0.0023022736,0.30695,0.00022690013,0.000111154826,0.0014883605,0.005017069,0.00033821212,0.010535975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994118,0.00007492075,0.000065127664,0.00010873151,0.0002894081,0.000049924925],"domain_scores_gemma":[0.9997737,0.00003514827,0.000032771415,0.00003193262,0.00009014989,0.00003641489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085580564,0.0005355699,0.00045769883,0.0004943779,0.0002765096,0.0009187015,0.000946717,0.0005776401,0.0021249298],"category_scores_gemma":[0.0003983217,0.00019900981,0.0005900732,0.00035316075,0.00017403747,0.00035715685,0.0004727735,0.0010517756,0.0026244675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059031834,0.00013037243,0.00014510499,0.00006358342,0.000005617581,0.000057144178,0.000024844669,0.00045704728,0.9925424,0.0001600319,0.0002695435,0.0060854387],"study_design_scores_gemma":[0.000028293758,0.0004353429,0.00075805886,0.00001854782,0.000024217117,0.00014455468,0.000023826573,0.004078756,0.9866334,0.00008085941,0.0077588065,0.000015221632],"about_ca_topic_score_codex":0.00088666327,"about_ca_topic_score_gemma":0.001308392,"teacher_disagreement_score":0.0021249298,"about_ca_system_score_codex":0.00038584284,"about_ca_system_score_gemma":0.00048812554,"threshold_uncertainty_score":0.0071086287},"labels":[],"label_agreement":null},{"id":"W4389227639","doi":"10.1158/2326-6074.tumimm23-a006","title":"Abstract A006: Understanding the Potential of Human IL-12 and Chimeric IL-15 Combination for Cancer Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Interleukin 15; Cancer immunotherapy; Immunology; Cytotoxic T cell; Chimeric antigen receptor; CD8; T cell; Cancer research; STAT4; Biology; Immune system; Medicine; Cytokine; Interleukin; In vitro; stat; STAT3; Cell biology; Signal transduction","score_opus":0.15433649951523956,"score_gpt":0.4428773898484035,"score_spread":0.288540890333164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8376667,0.07986133,0.0657643,0.0017978543,0.00030468882,0.00030259634,0.0007095877,0.0003216291,0.013271283],"genre_scores_gemma":[0.9784848,0.0070087044,0.010616525,0.00029508478,0.000059121507,0.00006774715,0.00022209791,0.0000115513385,0.0032342835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993956,0.00001162134,0.000004056944,0.00001168278,0.000018648298,0.000014511845],"domain_scores_gemma":[0.9999826,0.0000035736266,0.000005159113,0.0000013090864,0.0000029591927,0.0000043874525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001709396,0.00024863085,0.00015323973,0.00016072165,0.00005490812,0.00029067448,0.000209066,0.00028320646,0.0017406108],"category_scores_gemma":[0.000078134646,0.000081997874,0.00022482671,0.00009301368,0.00012728093,0.00028662034,0.000092252696,0.00031801045,0.00046190427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028842597,0.00010009009,0.0005103594,0.00020685262,0.000015665864,0.000091791,0.000012485628,0.0017632799,0.97828513,0.0011816163,0.00045229268,0.017091997],"study_design_scores_gemma":[0.00008235666,0.001732266,0.0024318616,0.000045629295,0.00006280667,0.00071417826,0.000026678912,0.019393014,0.952861,0.0013166842,0.021319326,0.000014132142],"about_ca_topic_score_codex":0.0003847466,"about_ca_topic_score_gemma":0.0003000863,"teacher_disagreement_score":0.0017406108,"about_ca_system_score_codex":0.00030420293,"about_ca_system_score_gemma":0.00019079333,"threshold_uncertainty_score":0.005822897},"labels":[],"label_agreement":null},{"id":"W4389227651","doi":"10.1158/2326-6074.tumimm23-b047","title":"Abstract B047: Tertiary lymphoid structures and B cells signatures determine clinically relevant T cell phenotype in ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germinal center; CD8; Immunotherapy; Biology; Follicular dendritic cells; Immunosurveillance; Cancer research; Immunology; T cell; Immune system; B cell; Antigen-presenting cell; Antibody","score_opus":0.050372601418938595,"score_gpt":0.38741373420365127,"score_spread":0.3370411327847127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97194684,0.009470998,0.0026548607,0.0011753778,0.00036491247,0.0001291553,0.0018925879,0.00033609782,0.012029217],"genre_scores_gemma":[0.9843614,0.0021582958,0.0012889617,0.00025777883,0.00017827573,0.000082455204,0.0013346258,0.00006718191,0.010270959],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998889,0.000020099547,0.000012528998,0.000028406579,0.000021798593,0.000028285038],"domain_scores_gemma":[0.99982303,0.00002943387,0.000038701346,0.000014213606,0.0000394761,0.00005519077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023057727,0.00017735288,0.0002988885,0.0010327927,0.00025952962,0.0005826242,0.00017763366,0.00042939652,0.010144226],"category_scores_gemma":[0.00036493034,0.00014729715,0.00017309694,0.00041793624,0.00025904735,0.00023129686,0.00040077112,0.00043115963,0.0016352176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004726364,0.00026766703,0.15328659,0.0009894302,0.00008374532,0.0037387975,0.000447478,0.00035358677,0.6567545,0.0013590349,0.020028785,0.15796404],"study_design_scores_gemma":[0.00015952587,0.001115933,0.83474267,0.00015602214,0.00010850836,0.018438516,0.00066811085,0.0011433007,0.09633451,0.001289741,0.04579195,0.00005124101],"about_ca_topic_score_codex":0.0005003781,"about_ca_topic_score_gemma":0.00041293766,"teacher_disagreement_score":0.010144226,"about_ca_system_score_codex":0.00034451013,"about_ca_system_score_gemma":0.00016119912,"threshold_uncertainty_score":0.033935845},"labels":[],"label_agreement":null},{"id":"W4389227659","doi":"10.1158/2326-6074.tumimm23-a041","title":"Abstract A041: Rejuvenation: Innovative technology to improve T-cell antitumor properties through partial reprogramming","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reprogramming; Induced pluripotent stem cell; Epigenetics; Biology; Cell potency; Immunotherapy; Embryonic stem cell; T cell; Cytotoxic T cell; Stem cell; Cell therapy; Cell; Phenotype; Cancer research; Immunology; Cell biology; Immune system; Genetics; In vitro","score_opus":0.06679651810333476,"score_gpt":0.38924516370498413,"score_spread":0.3224486456016494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8406524,0.017176893,0.11740258,0.00090190925,0.00078285066,0.00026197618,0.0017371753,0.0017047317,0.01937952],"genre_scores_gemma":[0.9506614,0.006039686,0.025024569,0.0004839431,0.00013019973,0.00016116098,0.001034483,0.0002791581,0.016185341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998373,0.00001743553,0.000014026032,0.000046108817,0.0000569426,0.000028062834],"domain_scores_gemma":[0.99989223,0.000016352438,0.000029383962,0.000018026201,0.000023427296,0.000020467349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024232084,0.00035120247,0.0002834485,0.00028759564,0.00016969466,0.00050768786,0.00035138265,0.00050009676,0.0034070848],"category_scores_gemma":[0.00015553339,0.00014678329,0.00043290766,0.00020602076,0.00021181385,0.00035537544,0.00033576138,0.0008642911,0.0011655516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006361006,0.000028111199,0.00010501568,0.00010781808,0.000008016904,0.00006502327,0.00002686096,0.00026773172,0.98531264,0.00053092465,0.000297609,0.013186686],"study_design_scores_gemma":[0.000009632079,0.00028220908,0.0005703108,0.000012829752,0.00003023886,0.00032786696,0.000012255834,0.00088214537,0.98412836,0.0002131429,0.013522462,0.00000843701],"about_ca_topic_score_codex":0.0001770994,"about_ca_topic_score_gemma":0.00014127805,"teacher_disagreement_score":0.0034070848,"about_ca_system_score_codex":0.00017497758,"about_ca_system_score_gemma":0.00017471367,"threshold_uncertainty_score":0.011397839},"labels":[],"label_agreement":null},{"id":"W4389227671","doi":"10.1158/2326-6074.tumimm23-b046","title":"Abstract B046: Analyzing heterogeneity of tumor microenvironment of TNBC patients by meta-analysis of 7 breast cancer scRNAseq studies","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Stromal cell; Breast cancer; Triple-negative breast cancer; Cancer research; Immunotherapy; Immune system; CD8; Medicine; Estrogen receptor; Immune checkpoint; Cancer; T cell; Oncology; Biology; Internal medicine; Immunology","score_opus":0.16784164586879086,"score_gpt":0.43705841957133656,"score_spread":0.2692167737025457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6879952,0.17989065,0.019076405,0.002426069,0.0009151868,0.00036558,0.10455218,0.00052482437,0.0042538857],"genre_scores_gemma":[0.95805216,0.0067074085,0.00443675,0.001054099,0.0001661437,0.0002607705,0.028180286,0.0002328758,0.00090941094],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933863,0.00203549,0.000938287,0.002396347,0.0008528047,0.0003908629],"domain_scores_gemma":[0.9917532,0.0051828683,0.0009718027,0.0009809908,0.0007543517,0.00035667495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065397085,0.0010489563,0.00292474,0.0037556654,0.00096203375,0.0021967962,0.0013044905,0.0011392143,0.004190641],"category_scores_gemma":[0.010681002,0.000577448,0.007967816,0.005071188,0.00041768374,0.0007046893,0.0014090027,0.0012076584,0.00064081425],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031035363,0.000047408692,0.7981057,0.006915722,0.15268618,0.00089516444,0.00027397217,0.0018101971,0.0077595883,0.0003815327,0.0068647056,0.021156313],"study_design_scores_gemma":[0.0003714845,0.0004797962,0.75274146,0.0013602154,0.20702797,0.0022512388,0.00058949646,0.0064713336,0.0033401516,0.0017184487,0.023506304,0.00014206702],"about_ca_topic_score_codex":0.0056332853,"about_ca_topic_score_gemma":0.009882719,"teacher_disagreement_score":0.0065397085,"about_ca_system_score_codex":0.0005580822,"about_ca_system_score_gemma":0.00091687526,"threshold_uncertainty_score":0.034585655},"labels":[],"label_agreement":null},{"id":"W4389227682","doi":"10.1158/2326-6074.tumimm23-b028","title":"Abstract B028: WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wee1; Cancer research; Immune checkpoint; Cell cycle checkpoint; Blockade; Immunotherapy; Cell cycle; Medicine; Biology; Immunology; Immune system; Cancer; Cyclin-dependent kinase 1; Internal medicine","score_opus":0.07118017525727223,"score_gpt":0.4046953547627054,"score_spread":0.3335151795054332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949793,0.0013643433,0.0006897934,0.0001617705,0.000058479647,0.00004876814,0.00051344605,0.00013589523,0.0020482547],"genre_scores_gemma":[0.99517196,0.00055431953,0.0007112447,0.0000758713,0.000011478212,0.00007346962,0.00088674587,0.000015143612,0.002499676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991786,0.000012527331,0.000007169103,0.000011138001,0.000017754735,0.000033584332],"domain_scores_gemma":[0.99994814,0.0000059238027,0.000008896211,0.0000041512394,0.0000057037155,0.000027071028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010526191,0.00040841478,0.00030535532,0.00025071637,0.00013446424,0.00026210985,0.00023185016,0.0002658237,0.003767797],"category_scores_gemma":[0.000073429546,0.00010714942,0.00027527413,0.0001699633,0.000183181,0.0001996979,0.00014016233,0.0009343614,0.00061395945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017693794,0.0005809328,0.00022974682,0.00013288765,0.000018939441,0.000046887686,0.000018703638,0.00022248678,0.991706,0.00011075914,0.00048437068,0.004678917],"study_design_scores_gemma":[0.0003765243,0.0071556806,0.0038611132,0.000016190577,0.000043393655,0.00020713548,0.000032577736,0.0018151655,0.9823499,0.000052915613,0.0040819715,0.000007382942],"about_ca_topic_score_codex":0.0006548695,"about_ca_topic_score_gemma":0.0011294483,"teacher_disagreement_score":0.003767797,"about_ca_system_score_codex":0.00022922765,"about_ca_system_score_gemma":0.00036288332,"threshold_uncertainty_score":0.012604535},"labels":[],"label_agreement":null},{"id":"W4389227694","doi":"10.1158/2326-6074.tumimm23-b025","title":"Abstract B025: Neutrophil depletion enhances the anti-tumor activity of CAR-T cells in an autochthonous model of non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; T cell; CD8; Immunotherapy; Medicine; Infiltration (HVAC); Cell; Lung cancer; Cancer immunotherapy; Immune system; Immunology; Pathology; Biology","score_opus":0.08007744742955278,"score_gpt":0.4022435364212251,"score_spread":0.3221660889916723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548584,0.00078935,0.0011724856,0.00012480233,0.0000615081,0.000097341064,0.0006148716,0.00013747255,0.0015163956],"genre_scores_gemma":[0.99356127,0.0003838471,0.0012621717,0.00007962942,0.000021468604,0.00011928829,0.0007275876,0.000033057026,0.0038118612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996055,0.00007974003,0.00003293759,0.00007352346,0.000096365526,0.00011198049],"domain_scores_gemma":[0.9997706,0.00004353451,0.000046162055,0.00003356709,0.000019212548,0.000087011955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003492466,0.00047913415,0.0005415161,0.00036140447,0.00015886569,0.0003542933,0.00042769298,0.00054486643,0.002765721],"category_scores_gemma":[0.00012590794,0.00020066446,0.0003652293,0.00016994854,0.0002822627,0.00026901992,0.00020273804,0.0014682359,0.0006838611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007749476,0.00073334086,0.00010760733,0.0000680994,0.000008531291,0.00007883886,0.00002436154,0.00021409012,0.99548066,0.00016186807,0.00020227104,0.0021453507],"study_design_scores_gemma":[0.0002069881,0.0065747374,0.0022523836,0.000011108988,0.000019335583,0.00021500769,0.000027110436,0.0026644075,0.98638815,0.00004514704,0.0015885053,0.000007117717],"about_ca_topic_score_codex":0.001591235,"about_ca_topic_score_gemma":0.0018858596,"teacher_disagreement_score":0.002765721,"about_ca_system_score_codex":0.00035621034,"about_ca_system_score_gemma":0.00038232215,"threshold_uncertainty_score":0.00925225},"labels":[],"label_agreement":null},{"id":"W4389227697","doi":"10.1158/2326-6074.tumimm23-a017","title":"Abstract A017: Exploring the interplay between macrophage subtypes and colorectal cancer cell growth","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Cancer research; Stromal cell; Immune system; Biology; Macrophage; Colorectal cancer; Cell culture; Tumor progression; Cell; Cancer cell; Cancer; Immunology; In vitro","score_opus":0.07314657446558576,"score_gpt":0.3727645151303189,"score_spread":0.29961794066473313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946365,0.0019832621,0.0013929135,0.000096356765,0.000020545533,0.00003635653,0.0007985644,0.000025758914,0.0010097154],"genre_scores_gemma":[0.9904469,0.0013997013,0.0028216129,0.00010509991,0.000022332377,0.00008125986,0.0014101426,0.000011232028,0.0037017034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999206,0.00001563943,0.000006002618,0.000014822629,0.000016233365,0.000026699161],"domain_scores_gemma":[0.99993753,0.000014878653,0.000011366538,0.0000044983,0.000015892789,0.000015900507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013882741,0.00022404286,0.00017857022,0.00022575424,0.00014690946,0.00021012739,0.00010792363,0.00020586858,0.0023048336],"category_scores_gemma":[0.000078584184,0.00007206786,0.00020988169,0.00027755369,0.000112905094,0.00013640849,0.00011440928,0.0003068612,0.0005517693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038329145,0.000046659334,0.0013119704,0.00009504389,0.000003598733,0.000058716396,0.00002353704,0.000036344703,0.99618846,0.00004170702,0.00006205586,0.0017487159],"study_design_scores_gemma":[0.00004013334,0.00139824,0.032062177,0.0000192192,0.000029566909,0.0004105413,0.00019345837,0.0011175725,0.9604874,0.00010076818,0.0041340725,0.0000067771393],"about_ca_topic_score_codex":0.00068589195,"about_ca_topic_score_gemma":0.0006176646,"teacher_disagreement_score":0.0023048336,"about_ca_system_score_codex":0.00012501405,"about_ca_system_score_gemma":0.00019004385,"threshold_uncertainty_score":0.0077103972},"labels":[],"label_agreement":null},{"id":"W4389227701","doi":"10.1158/2326-6074.tumimm23-a029","title":"Abstract A029: Treatment-Specific Immune Phenotypes Identified by nELISA High-Throughput Proteomics Reveal Actionable Insights for Drug Discovery","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Proteomics; Immune system; Biology; Cytokine; Phenotype; Computational biology; Proteases; Immunotherapy; Tumor microenvironment; Chemokine; Peripheral blood mononuclear cell; Drug discovery; Immunology; Bioinformatics; Gene; Genetics; In vitro; Enzyme; Biochemistry","score_opus":0.04862144729291532,"score_gpt":0.3739854669666774,"score_spread":0.32536401967376205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97834146,0.001274385,0.010194215,0.0003612633,0.0000617804,0.00018386249,0.0066357674,0.00051307783,0.0024341],"genre_scores_gemma":[0.9665736,0.00080996985,0.018446362,0.00044935502,0.00002798627,0.0002088908,0.0074419756,0.00010763354,0.0059342985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981624,0.000021393995,0.000014255987,0.00003307032,0.000083627034,0.00003138449],"domain_scores_gemma":[0.9998548,0.000027787688,0.00003508364,0.000014775463,0.000037220223,0.000030358276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023850623,0.00042612886,0.00046342757,0.00034610974,0.00020578342,0.0005148003,0.00017237717,0.000340181,0.0024952237],"category_scores_gemma":[0.0002347212,0.00013880557,0.00034433152,0.00029685433,0.00013449168,0.00017390093,0.0001743454,0.0005287807,0.0008702696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025055304,0.000041952513,0.0008274786,0.00003307806,0.000008419045,0.000025281392,0.0000051227785,0.0001238584,0.99597,0.000019743622,0.00024139104,0.0024530806],"study_design_scores_gemma":[0.00002486898,0.00050599815,0.020538656,0.0000066606462,0.00003151815,0.0002307073,0.000023041674,0.0030877644,0.97272927,0.00005020238,0.0027630092,0.000008402159],"about_ca_topic_score_codex":0.0005201644,"about_ca_topic_score_gemma":0.00092820526,"teacher_disagreement_score":0.0024952237,"about_ca_system_score_codex":0.0003472435,"about_ca_system_score_gemma":0.00027017167,"threshold_uncertainty_score":0.008347392},"labels":[],"label_agreement":null},{"id":"W4389227707","doi":"10.1158/2326-6074.tumimm23-a034","title":"Abstract A034: VV-iVP55: A Superior Vaccinia Virus Platform with Enhanced Oncolytic Potency and Immunogenicity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Vaccinia; Biology; Immunogenicity; Virology; Population; Immune system; CD8; Virus; Immunology; Cancer research; Medicine","score_opus":0.04840830391638313,"score_gpt":0.37576277820827836,"score_spread":0.32735447429189524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859833,0.0013726127,0.009325415,0.00008073895,0.00008000528,0.00004993737,0.0005868638,0.0001251877,0.002395932],"genre_scores_gemma":[0.9891199,0.00046369253,0.006158793,0.0000373227,0.000015333488,0.000025770905,0.00079713436,0.000035530255,0.0033465924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998958,0.000011127171,0.0000084663725,0.000022885863,0.000032210402,0.000029532148],"domain_scores_gemma":[0.99994695,0.0000046463692,0.000017099992,0.0000067030596,0.000010533845,0.000014206436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013407145,0.00041998268,0.00018382279,0.0001842745,0.000109461915,0.00037671367,0.00021009332,0.00034795085,0.0011884521],"category_scores_gemma":[0.00008722583,0.000096493226,0.00026762337,0.00012662071,0.00013416007,0.00022186336,0.00020651086,0.00048158842,0.00051367463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000475297,0.000014114267,0.00004943014,0.000022387105,0.000003119005,0.00002339642,0.0000044445906,0.00008865603,0.99825937,0.000121574994,0.00005005379,0.0013160269],"study_design_scores_gemma":[0.000009850005,0.0003613977,0.0007491013,0.000005007292,0.00001641543,0.00023399763,0.0000060983825,0.0007470769,0.993291,0.00003957834,0.004535367,0.00000502971],"about_ca_topic_score_codex":0.00051546784,"about_ca_topic_score_gemma":0.0002798327,"teacher_disagreement_score":0.0011884521,"about_ca_system_score_codex":0.00030347236,"about_ca_system_score_gemma":0.0001602786,"threshold_uncertainty_score":0.0039758086},"labels":[],"label_agreement":null},{"id":"W4389227714","doi":"10.1158/2326-6074.tumimm23-a020","title":"Abstract A020: Neutralizing oxidative damage at telomeres prevents T cell dysfunction and improves adoptive cell therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telomere; DNA damage; Reactive oxygen species; Oxidative stress; Tumor microenvironment; Biology; Cancer research; Cell; Adoptive cell transfer; Cell biology; T cell; Immune system; Immunology; DNA; Genetics; Biochemistry","score_opus":0.04674682155867603,"score_gpt":0.34355372245467763,"score_spread":0.2968069008960016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394406,0.002798013,0.006546327,0.00043807682,0.00025130273,0.00014708952,0.0011395812,0.00055703666,0.004178654],"genre_scores_gemma":[0.98591423,0.0012242706,0.0032887238,0.0002484442,0.00006779106,0.00015859056,0.0011718626,0.000056345718,0.007869757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984837,0.000016672751,0.000015223772,0.00003232908,0.000046634705,0.00004072764],"domain_scores_gemma":[0.99987185,0.000015633448,0.00003354674,0.000012602315,0.000020238096,0.00004619563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019792229,0.00054617104,0.0003200373,0.0003910724,0.00017549121,0.00031762416,0.0003904689,0.00063359534,0.0047704205],"category_scores_gemma":[0.00012164589,0.0001105049,0.00030492333,0.00020385765,0.0002527088,0.0002450417,0.00018916612,0.0011458015,0.00094717764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058771117,0.00032960533,0.00012227599,0.00009638388,0.0000144428295,0.000039262974,0.000016563588,0.00012090607,0.9929931,0.000123364,0.00041497048,0.005141518],"study_design_scores_gemma":[0.0001915936,0.004291569,0.0020161308,0.000015464675,0.000053770076,0.00028314325,0.000021239348,0.0007782853,0.9861822,0.00010593506,0.0060541457,0.000006477227],"about_ca_topic_score_codex":0.0003764668,"about_ca_topic_score_gemma":0.00034059718,"teacher_disagreement_score":0.0047704205,"about_ca_system_score_codex":0.00020088845,"about_ca_system_score_gemma":0.0003311662,"threshold_uncertainty_score":0.015958667},"labels":[],"label_agreement":null},{"id":"W4389227721","doi":"10.1158/2326-6074.tumimm23-b024","title":"Abstract B024: TrkB.T1 receptor promotes an immunosuppressive microenvironment driven by neutrophil recruitment in gliomas","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tropomyosin receptor kinase B; Glioma; Tumor microenvironment; Cancer research; Immune system; Neurotrophic factors; Biology; Paracrine signalling; Downregulation and upregulation; Brain-derived neurotrophic factor; Immunology; Tropomyosin receptor kinase A; Medicine; Receptor; Neurotrophin; Internal medicine","score_opus":0.18318923831139722,"score_gpt":0.4003265696749317,"score_spread":0.21713733136353447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963103,0.0014777282,0.00090648344,0.00011287175,0.000033312044,0.000021448903,0.00023451535,0.0000568377,0.00084661],"genre_scores_gemma":[0.99616134,0.0005134779,0.0006927957,0.000065765795,0.000019613162,0.000029720384,0.00032519022,0.000015987902,0.00217609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987257,0.000021576192,0.000010043464,0.000022844553,0.000026682428,0.000046315643],"domain_scores_gemma":[0.99988925,0.000012640209,0.00003796501,0.000007811098,0.000013722127,0.00003860033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001131039,0.00026118234,0.00022613253,0.00024293225,0.0001008722,0.00025891498,0.00013544469,0.00027748756,0.002014507],"category_scores_gemma":[0.000082232,0.00010877227,0.00020923332,0.00011087687,0.00016815544,0.0001365101,0.000107517175,0.00054760353,0.00068998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002513748,0.000045183835,0.00019933857,0.000030241146,0.000002609973,0.00011191237,0.000007421584,0.00001879767,0.9986602,0.000035822253,0.000050041857,0.00058697636],"study_design_scores_gemma":[0.00010604034,0.0016441111,0.01730093,0.000013529133,0.00003230986,0.0020461977,0.00009474587,0.0010288791,0.97510344,0.00007871093,0.0025431558,0.0000078827325],"about_ca_topic_score_codex":0.00042829706,"about_ca_topic_score_gemma":0.00037080064,"teacher_disagreement_score":0.002014507,"about_ca_system_score_codex":0.00019358733,"about_ca_system_score_gemma":0.00012487572,"threshold_uncertainty_score":0.0067392588},"labels":[],"label_agreement":null},{"id":"W4389227733","doi":"10.1158/2326-6074.tumimm23-b027","title":"Abstract B027: ATR inhibition upregulates PD-L1 and potentiates the antitumor immune response to chemoimmunotherapy in small-cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Blockade; Lung cancer; Immune system; Medicine; Immunology; Chemoimmunotherapy; Immunotherapy; Biology; Pharmacology; Oncology; Internal medicine; Receptor","score_opus":0.05111201229879783,"score_gpt":0.4114197291463439,"score_spread":0.36030771684754603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908925,0.003740161,0.0010743558,0.00030307833,0.00009813788,0.00007450728,0.00062045665,0.00021505823,0.0029816607],"genre_scores_gemma":[0.99341315,0.0012987555,0.0011026186,0.0001521869,0.000033384953,0.00008838395,0.0011354327,0.000021527192,0.0027545362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000021883496,0.000011079445,0.000020219712,0.000032013886,0.000034275105],"domain_scores_gemma":[0.99994206,0.000007039291,0.0000134000275,0.000006865166,0.000006329514,0.000024344792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015771558,0.00039172065,0.00040794045,0.00029027928,0.00013745512,0.00035169133,0.00027331253,0.00027640734,0.002460885],"category_scores_gemma":[0.000077525314,0.00012429409,0.0002970392,0.00017831872,0.00020801832,0.00015871838,0.00016986884,0.0011102511,0.00072719686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010571933,0.00064834266,0.0003011843,0.000114466995,0.00002348812,0.000052603395,0.00001475875,0.00015519334,0.9897928,0.0000978444,0.0005429449,0.0071991747],"study_design_scores_gemma":[0.0004055453,0.00924261,0.0074980007,0.000024060886,0.00007435253,0.00044620578,0.000031633896,0.0014805497,0.9742775,0.000064248205,0.0064470675,0.000008163485],"about_ca_topic_score_codex":0.00037269527,"about_ca_topic_score_gemma":0.00066702423,"teacher_disagreement_score":0.002460885,"about_ca_system_score_codex":0.0002252391,"about_ca_system_score_gemma":0.00030323956,"threshold_uncertainty_score":0.008232534},"labels":[],"label_agreement":null},{"id":"W4389227749","doi":"10.1158/2326-6074.tumimm23-a023","title":"Abstract A023: Nicotinamide Phosphoribosyltransferase (NAMPT) is required for trained macrophage-mediated antitumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; Cancer research; NAD+ kinase; Immune system; Innate immune system; Nicotinamide mononucleotide; Nicotinamide adenine dinucleotide; Immunity; Cancer immunotherapy; PI3K/AKT/mTOR pathway; Medicine; Immunotherapy; Immunology; Biology; Biochemistry; Apoptosis; Enzyme","score_opus":0.07881101901085927,"score_gpt":0.39078295239183025,"score_spread":0.31197193338097096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8859806,0.038574528,0.0229716,0.0040066238,0.004155724,0.0002381517,0.0051868362,0.002337034,0.036548857],"genre_scores_gemma":[0.89474136,0.013034061,0.007117435,0.0008154656,0.0005345901,0.00017189462,0.004967282,0.00021734675,0.07840061],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992275,0.000006772215,0.0000075893036,0.00002391662,0.000024147801,0.000014666985],"domain_scores_gemma":[0.999933,0.0000045254474,0.000016971506,0.0000045828856,0.000012843463,0.000028103741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013051019,0.0003611379,0.000324153,0.000204223,0.00033052466,0.00039022887,0.00035964148,0.00046736724,0.0058570174],"category_scores_gemma":[0.0000749568,0.00013744281,0.00025167174,0.00014937349,0.0002862716,0.00025236473,0.00024288964,0.00064786983,0.0016077703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032712845,0.000023837114,0.00026969792,0.00011923923,0.0000076154793,0.00020808031,0.00001261554,0.000036241134,0.9931859,0.00024531368,0.0009943144,0.004570044],"study_design_scores_gemma":[0.000078520636,0.00032824033,0.025943443,0.000034957684,0.000055100783,0.0013979041,0.00008455514,0.0008949585,0.9339848,0.00043476882,0.03674437,0.000018308683],"about_ca_topic_score_codex":0.00069928257,"about_ca_topic_score_gemma":0.0008853531,"teacher_disagreement_score":0.0058570174,"about_ca_system_score_codex":0.00039468924,"about_ca_system_score_gemma":0.00040722938,"threshold_uncertainty_score":0.019593716},"labels":[],"label_agreement":null},{"id":"W4389227750","doi":"10.1158/2326-6074.tumimm23-b034","title":"Abstract B034: CD27 is a new promising T cell co-stimulatory target for cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer immunotherapy; Monoclonal antibody; T cell; Immunotherapy; CD8; Immunology; Cancer research; Immune system; Biology; Tumor necrosis factor alpha; Antibody; Cell biology","score_opus":0.09209846402742795,"score_gpt":0.4146756453279528,"score_spread":0.3225771813005249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466918,0.020664696,0.009896659,0.0009328963,0.00020224265,0.00024316355,0.0018768653,0.00033708283,0.019154571],"genre_scores_gemma":[0.95015246,0.007681422,0.009418825,0.0004943978,0.00010738026,0.00017908552,0.004936038,0.000075883836,0.026954487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999523,0.000007718844,0.0000023530395,0.000008138438,0.000012327799,0.000017218004],"domain_scores_gemma":[0.9999685,0.0000028844288,0.0000038828816,0.000001756655,0.000007796496,0.000015175531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008254036,0.00035759856,0.00017271462,0.00026952513,0.00013167007,0.00024855195,0.00024084716,0.00027373654,0.0058391746],"category_scores_gemma":[0.000054425174,0.00007929933,0.00019361262,0.00018664903,0.000081245686,0.000107876396,0.00014758283,0.00038741852,0.0021037443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030656595,0.00011064945,0.00042921846,0.00010490466,0.0000117569525,0.00009502144,0.0000073500196,0.00033082173,0.98174083,0.00027099389,0.0016118366,0.014980204],"study_design_scores_gemma":[0.00011565299,0.001509678,0.0037471233,0.000026213573,0.000053855434,0.0007833659,0.00001907924,0.0014591882,0.9387041,0.00022831322,0.05334419,0.000009143718],"about_ca_topic_score_codex":0.0005079742,"about_ca_topic_score_gemma":0.0005496651,"teacher_disagreement_score":0.0058391746,"about_ca_system_score_codex":0.00031755783,"about_ca_system_score_gemma":0.00029744473,"threshold_uncertainty_score":0.019533992},"labels":[],"label_agreement":null},{"id":"W4389227754","doi":"10.1158/2326-6074.tumimm23-b001","title":"Abstract B001: Harnessing invariant natural killer T cell cytotoxicity for cancer therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cytotoxic T cell; Biology; Natural killer T cell; Immunology; Adoptive cell transfer; Cancer research; Population; Interleukin 21; Lymphokine-activated killer cell; Antigen; T cell; CD8; Immune system; Medicine; In vitro","score_opus":0.09172463458641776,"score_gpt":0.3831439119877658,"score_spread":0.29141927740134804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9133518,0.022524148,0.04590117,0.00104546,0.0005524924,0.0003565778,0.0026447854,0.0010160689,0.012607564],"genre_scores_gemma":[0.96372354,0.006133866,0.016665483,0.0005480876,0.00013387657,0.00020341894,0.002387687,0.000107318214,0.010096739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998976,0.00001542618,0.0000065068252,0.000020378102,0.000037150392,0.000022854581],"domain_scores_gemma":[0.99996066,0.0000066893963,0.000010022178,0.0000036768583,0.000007658562,0.000011322098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013914377,0.000326052,0.00023295276,0.00034266795,0.0000871973,0.0003970668,0.00016155305,0.00028410213,0.003295508],"category_scores_gemma":[0.00010473946,0.000062149986,0.00021211419,0.00023028023,0.00018175451,0.00018510163,0.00021704492,0.0005933308,0.0011018593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021090108,0.00008661556,0.00032527908,0.00018198781,0.000008518309,0.000049051236,0.000009629357,0.00017307464,0.9781341,0.00024916927,0.00055067986,0.020020993],"study_design_scores_gemma":[0.000089636924,0.0012049952,0.0037433214,0.000037809903,0.000049083876,0.0005373991,0.00002569057,0.0022338787,0.9697751,0.00054921315,0.021741955,0.000011985833],"about_ca_topic_score_codex":0.00015762434,"about_ca_topic_score_gemma":0.00012579381,"teacher_disagreement_score":0.003295508,"about_ca_system_score_codex":0.00017822864,"about_ca_system_score_gemma":0.0002164683,"threshold_uncertainty_score":0.011024594},"labels":[],"label_agreement":null},{"id":"W4389227756","doi":"10.1158/2326-6074.tumimm23-a050","title":"Abstract A050: Enhancing immune checkpoint inhibitor efficacy by targeting neurotrophic receptor tyrosine kinase 1 signaling in immune resistant non-small cell lung cancer patients","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Medicine; Cancer; Receptor tyrosine kinase; Immunotherapy; Lung cancer; Immunology; Receptor; Internal medicine","score_opus":0.028009205499139326,"score_gpt":0.3293710504655176,"score_spread":0.3013618449663783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584395,0.001452747,0.0001850928,0.00031128473,0.00007006663,0.00007078526,0.00029120102,0.00007872718,0.0016961899],"genre_scores_gemma":[0.99674135,0.0005691191,0.00056559587,0.0003171669,0.000046527,0.000059414007,0.0004888359,0.0000079845695,0.0012040245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992204,0.000013031039,0.000007888755,0.000020737136,0.000016690605,0.00001957906],"domain_scores_gemma":[0.99987745,0.00001514769,0.000023924707,0.0000063081584,0.000012151307,0.00006493475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024018536,0.00022247469,0.00036261062,0.0002129446,0.00017165353,0.00039930484,0.0002653573,0.00026193223,0.003026127],"category_scores_gemma":[0.00020624738,0.0000815607,0.00033709628,0.0001306722,0.00015639549,0.00021758904,0.00014066871,0.00049618067,0.00060478254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048186027,0.010653819,0.067089856,0.0007281488,0.0004549177,0.0006978665,0.00016794229,0.00174447,0.45123664,0.0005594826,0.016319329,0.4021615],"study_design_scores_gemma":[0.028868467,0.26593107,0.43103382,0.0002017518,0.0013402399,0.0043980624,0.00032134927,0.012831355,0.21020876,0.0007324656,0.044031013,0.00010163833],"about_ca_topic_score_codex":0.0007474971,"about_ca_topic_score_gemma":0.0018792044,"teacher_disagreement_score":0.003026127,"about_ca_system_score_codex":0.00044038793,"about_ca_system_score_gemma":0.00043951874,"threshold_uncertainty_score":0.010123432},"labels":[],"label_agreement":null},{"id":"W4389227764","doi":"10.1158/2326-6074.tumimm23-b026","title":"Abstract B026: The senescent tumor cells evade the immune system by secreting SASPs in colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Immunotherapy; CD8; Biology; Colorectal cancer; Cancer cell; Tumor microenvironment; Cytokine; Cancer; Cancer immunotherapy; Tumor progression; Immunology","score_opus":0.037296221061185346,"score_gpt":0.33998373927142556,"score_spread":0.3026875182102402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7876107,0.12005139,0.01652441,0.012744594,0.015008431,0.0006121555,0.014601274,0.0021770373,0.030670078],"genre_scores_gemma":[0.8305821,0.053696834,0.008907212,0.0013080921,0.0017960727,0.0002813827,0.008241018,0.00016233399,0.09502498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999889,0.000016130078,0.00001169068,0.000015177914,0.000046148994,0.000021794773],"domain_scores_gemma":[0.9998864,0.000009475082,0.000017985332,0.000006694796,0.00003550241,0.00004392856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022464692,0.0004113851,0.00047304854,0.0007578452,0.00022074774,0.000494948,0.0003942699,0.0007191895,0.009913548],"category_scores_gemma":[0.00017908585,0.00015579953,0.00030489484,0.0005635851,0.00017972666,0.0004347863,0.00028384113,0.0005908607,0.0033897834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012119369,0.00009444161,0.00075720024,0.0010212134,0.000025709094,0.0007149392,0.000046350928,0.00013446255,0.9631645,0.00085218955,0.009574356,0.022402659],"study_design_scores_gemma":[0.0003997742,0.0023853348,0.052919578,0.00020921665,0.00011888699,0.0034937914,0.00025694421,0.0017387614,0.7474564,0.0010123856,0.18994163,0.00006735416],"about_ca_topic_score_codex":0.00107832,"about_ca_topic_score_gemma":0.0008720277,"teacher_disagreement_score":0.009913548,"about_ca_system_score_codex":0.0003902012,"about_ca_system_score_gemma":0.00045285255,"threshold_uncertainty_score":0.033164084},"labels":[],"label_agreement":null},{"id":"W4389227766","doi":"10.1158/2326-6074.tumimm23-a031","title":"Abstract A031: Discovery and characterization of a novel, immunoproteasome activator that modulates the immunopeptidome, increases MHC class I antigenic presentation and enhances antitumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MHC class I; Cytotoxic T cell; Antigen presentation; Biology; Cancer immunotherapy; Antigen processing; CD8; Antigen; Immunotherapy; Major histocompatibility complex; Antigen-presenting cell; T cell; Immune system; Cell biology; Immunology; Biochemistry; In vitro","score_opus":0.053643369274040585,"score_gpt":0.33869999929725747,"score_spread":0.2850566300232169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96822697,0.008949678,0.014193099,0.00041353697,0.00017514257,0.0004034409,0.0026960636,0.00022794063,0.004714184],"genre_scores_gemma":[0.9741599,0.0032332365,0.0115622785,0.00038566536,0.000052368912,0.00014422955,0.005038703,0.000055851837,0.005367696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991906,0.000011009817,0.000008795983,0.000016523707,0.00002589029,0.000018730205],"domain_scores_gemma":[0.9999443,0.0000069028324,0.000010631785,0.0000045100137,0.000010800343,0.000022817669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015658156,0.00042251253,0.0002930712,0.00021698468,0.00011274339,0.00034809898,0.0002786315,0.0004535407,0.001865577],"category_scores_gemma":[0.00010571094,0.00009494694,0.00040128626,0.00020579733,0.0001078511,0.00014886545,0.00013695745,0.00048061326,0.0009361315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000129373,0.00007545275,0.00009759619,0.000044183664,0.000007787167,0.00007648419,0.0000039928623,0.0000905819,0.9965,0.0000461123,0.00012355,0.0028048032],"study_design_scores_gemma":[0.00010248296,0.0013408116,0.0017032857,0.000009776628,0.000031970478,0.0005680013,0.000012569851,0.00092298636,0.989537,0.0000663089,0.005696181,0.000008568069],"about_ca_topic_score_codex":0.000191905,"about_ca_topic_score_gemma":0.00023845394,"teacher_disagreement_score":0.001865577,"about_ca_system_score_codex":0.00021177347,"about_ca_system_score_gemma":0.00022605645,"threshold_uncertainty_score":0.006240964},"labels":[],"label_agreement":null},{"id":"W4389227770","doi":"10.1158/2326-6074.tumimm23-b003","title":"Abstract B003: Communication is key: Understanding the modulating effect of immune cell crosstalk on T cell therapy function","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Crosstalk; T cell; Immune system; Interactome; CD8; Immunotherapy; Cancer immunotherapy; Cancer research; Cell; Biology; Computational biology; Cell biology; Immunology; Genetics","score_opus":0.15349428235421014,"score_gpt":0.42722960022174505,"score_spread":0.2737353178675349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5840418,0.05942954,0.10869078,0.017460316,0.003869271,0.00037662327,0.013368771,0.004039185,0.20872378],"genre_scores_gemma":[0.8607757,0.01652853,0.020719888,0.001461265,0.00043276054,0.0003169319,0.0038560862,0.00044553058,0.09546335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969494,0.000033679018,0.000015573516,0.000087336404,0.000094223295,0.000074160824],"domain_scores_gemma":[0.999828,0.000039768503,0.000037940677,0.000014906819,0.000032171014,0.000047251902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027673354,0.00061399397,0.00036572144,0.00043229488,0.00046684628,0.0014107756,0.00034997583,0.0011650964,0.05520948],"category_scores_gemma":[0.00024050569,0.00020613396,0.00034338885,0.00036989807,0.00048196132,0.0010559412,0.00063117273,0.0013670836,0.012681818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023460189,0.000047326725,0.0002384957,0.00031974266,0.000009534989,0.00015637634,0.000025778843,0.00027446865,0.97096485,0.0032462985,0.0031277044,0.021354802],"study_design_scores_gemma":[0.00007820902,0.00038560864,0.0077635744,0.00011687567,0.00004139564,0.0006220314,0.0001389411,0.0052681654,0.8388541,0.0052596843,0.1414466,0.000024812276],"about_ca_topic_score_codex":0.00053961796,"about_ca_topic_score_gemma":0.0003748998,"teacher_disagreement_score":0.05520948,"about_ca_system_score_codex":0.0008115597,"about_ca_system_score_gemma":0.0004936982,"threshold_uncertainty_score":0.18469411},"labels":[],"label_agreement":null},{"id":"W4389227786","doi":"10.1158/2326-6074.tumimm23-b021","title":"Abstract B021: In vivo gain-of-function screen identifies CREB5, a novel ECM modulator that promotes immunotherapy resistance via the Collagen-Lair1 axis","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Immune system; Cancer immunotherapy; Cancer research; In vivo; Biology; Immune checkpoint; Stromal cell; Cancer cell; Downregulation and upregulation; Cell biology; Cancer; Immunology; Medicine; Gene; Genetics","score_opus":0.08539948952769882,"score_gpt":0.3718062214813789,"score_spread":0.28640673195368005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734678,0.0020295668,0.010758178,0.00057288096,0.00017835584,0.000317471,0.007508786,0.0006267124,0.0045401542],"genre_scores_gemma":[0.9771598,0.0009445501,0.0072870487,0.00026685096,0.000022991211,0.00010244432,0.0043842904,0.00011938649,0.009712689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982387,0.000016602435,0.00001256614,0.00003475915,0.00007371175,0.000038622915],"domain_scores_gemma":[0.9998883,0.000016882108,0.000033420936,0.0000075236094,0.0000125936795,0.000041261002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001439065,0.0005963939,0.000365807,0.00040539287,0.00018599756,0.00025648528,0.0003857678,0.0005430533,0.0030524097],"category_scores_gemma":[0.00008284648,0.00017140916,0.0004009062,0.00020107068,0.000248068,0.000105023086,0.00020363444,0.00070296245,0.0008344249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003983941,0.000018807734,0.00008090205,0.000018755754,0.0000026595303,0.000052458487,0.0000026748328,0.00003548324,0.9991997,0.000026204703,0.00005282361,0.0004698137],"study_design_scores_gemma":[0.00003680135,0.00036232616,0.0052940557,0.000007679601,0.00003642349,0.0005122081,0.000026248223,0.0016307881,0.9880484,0.000034868615,0.003998334,0.000011954351],"about_ca_topic_score_codex":0.0015290712,"about_ca_topic_score_gemma":0.0020649256,"teacher_disagreement_score":0.0030524097,"about_ca_system_score_codex":0.00040978304,"about_ca_system_score_gemma":0.0003167946,"threshold_uncertainty_score":0.0102113485},"labels":[],"label_agreement":null},{"id":"W4389227791","doi":"10.1158/2326-6074.tumimm23-pr03","title":"Abstract PR03: Hypoxia promotes inflammatory fibroblast formation in pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Stromal cell; Pancreatic cancer; Cancer research; Hypoxia (environmental); Cancer-Associated Fibroblasts; Immune system; Chemokine; Cancer cell; Stroma; Immunotherapy; Biology; Cancer immunotherapy; Cancer; Medicine; Immunology; Chemistry; Internal medicine; Immunohistochemistry","score_opus":0.03971138302073033,"score_gpt":0.3450460202357461,"score_spread":0.30533463721501575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665128,0.011153642,0.0041774833,0.0015540658,0.0004421436,0.00011928978,0.0023958746,0.0002955673,0.013349226],"genre_scores_gemma":[0.96908486,0.0050663655,0.0020597517,0.0005038847,0.0001630964,0.00012934784,0.0026247124,0.00004984825,0.020318149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998809,0.000016876238,0.000011094888,0.000026877722,0.000033974226,0.000030265839],"domain_scores_gemma":[0.9999044,0.000015171548,0.000021076308,0.000008132851,0.000015067471,0.000036153568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015218314,0.00018203582,0.00018333284,0.00027677996,0.00027127462,0.0004020747,0.00016095645,0.00029378204,0.006241818],"category_scores_gemma":[0.00012191356,0.00010970319,0.00020236605,0.00025243618,0.00015014819,0.00019616057,0.0002739295,0.00041907025,0.0011554313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067754794,0.00008877558,0.0019409946,0.00021313527,0.000008088171,0.00072068494,0.000050778646,0.000056285528,0.9833829,0.00024934107,0.002043547,0.010567876],"study_design_scores_gemma":[0.00024703817,0.0020267286,0.14603533,0.00009733902,0.000067357156,0.0072412454,0.0005833647,0.0017324091,0.7939415,0.00062654365,0.04737505,0.000026135927],"about_ca_topic_score_codex":0.0005678875,"about_ca_topic_score_gemma":0.0007122176,"teacher_disagreement_score":0.006241818,"about_ca_system_score_codex":0.0002415541,"about_ca_system_score_gemma":0.00024731373,"threshold_uncertainty_score":0.020880997},"labels":[],"label_agreement":null},{"id":"W4389227797","doi":"10.1158/2326-6074.tumimm23-a047","title":"Abstract A047: Tumor specific γδ T cells expand and respond to PD-1 blockade","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; TIGIT; T cell; T-cell receptor; Blockade; Immunology; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Immunotherapy; Biology; Cancer research; Medicine; Immune system; Receptor; Internal medicine","score_opus":0.12411425987828946,"score_gpt":0.4345827140921795,"score_spread":0.3104684542138901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944924,0.0006830369,0.0009212723,0.00017743812,0.00003357738,0.000036872334,0.0002609323,0.0000693687,0.0033251948],"genre_scores_gemma":[0.99753416,0.00010185607,0.00047380396,0.0001713106,0.000015759482,0.000022735292,0.00026311312,0.000012431233,0.001404763],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999285,0.000010627702,0.0000065789086,0.0000181238,0.000013140806,0.000023123377],"domain_scores_gemma":[0.99991906,0.000021634829,0.000009004987,0.000010377,0.0000149985035,0.000024821418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008163391,0.0002251824,0.00018362606,0.00021468685,0.00020113357,0.00028550078,0.00011288453,0.00033202005,0.0033768083],"category_scores_gemma":[0.00017364495,0.00008257319,0.000175905,0.00008852592,0.00013161471,0.000113172195,0.00015376459,0.0007082543,0.00070094055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055485906,0.00010472014,0.007906327,0.00003952626,0.000010191769,0.0010668514,0.00010457214,0.00022884217,0.9797355,0.00011867467,0.00086556416,0.009264371],"study_design_scores_gemma":[0.00035032147,0.004181511,0.19613689,0.000051967552,0.00014784496,0.024083309,0.0005453879,0.0061718,0.74181145,0.00068873377,0.025804367,0.000026395539],"about_ca_topic_score_codex":0.0006066238,"about_ca_topic_score_gemma":0.00034898848,"teacher_disagreement_score":0.0033768083,"about_ca_system_score_codex":0.00020499613,"about_ca_system_score_gemma":0.00010416723,"threshold_uncertainty_score":0.01129657},"labels":[],"label_agreement":null},{"id":"W4389227799","doi":"10.1158/2326-6074.tumimm23-b039","title":"Abstract B039: T cell recruitment dynamics at different stages of primary and metastatic colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Metastasis; Tumor microenvironment; KRAS; FOXP3; Cancer research; Oncology; Immunotherapy; Cancer; Pathology; Internal medicine; Immune system; Immunology","score_opus":0.129604609222508,"score_gpt":0.410922813002028,"score_spread":0.28131820377952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952577,0.0006315593,0.0011662052,0.00006217664,0.00002963054,0.000027972977,0.0009516428,0.0000702855,0.00180294],"genre_scores_gemma":[0.993952,0.00024107315,0.00086170476,0.000081131555,0.00001175683,0.000060795923,0.0009654874,0.000021839409,0.0038042176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998772,0.000011166519,0.0000063911098,0.000032457414,0.000029094694,0.00004361662],"domain_scores_gemma":[0.9998946,0.000011626571,0.000017082522,0.000006590152,0.000020157693,0.000049971197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009280486,0.00016791192,0.00020629713,0.00022460068,0.000149349,0.00021947469,0.00009771968,0.00027205033,0.00362858],"category_scores_gemma":[0.000088987275,0.00009222912,0.0001948828,0.0001465162,0.00011457708,0.00013376013,0.00013993372,0.0005939057,0.0008688106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053477613,0.00004470345,0.0010859717,0.00003852296,0.000002370229,0.00006304016,0.000032645723,0.00008680564,0.99602365,0.00003775312,0.00015505047,0.0018946232],"study_design_scores_gemma":[0.00009456724,0.0028301936,0.08549397,0.00003064424,0.00004247696,0.0009361246,0.0003686192,0.0035800433,0.89934033,0.00017023773,0.0070929215,0.000019792504],"about_ca_topic_score_codex":0.0010674003,"about_ca_topic_score_gemma":0.0009503007,"teacher_disagreement_score":0.00362858,"about_ca_system_score_codex":0.00023821762,"about_ca_system_score_gemma":0.00015507077,"threshold_uncertainty_score":0.012138844},"labels":[],"label_agreement":null},{"id":"W4389227813","doi":"10.1158/2326-6074.tumimm23-b035","title":"Abstract B035: The contribution of inflammasomes and cGAS-STING in RT-induced cell fate","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Inflammasome; AIM2; Pyrin domain; Biology; Innate immune system; Cytokine; Cancer research; Pyroptosis; Cell biology; Immunology; Immune system; Inflammation","score_opus":0.06907600309833052,"score_gpt":0.3741322705198751,"score_spread":0.30505626742154457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981368,0.0072731567,0.004184072,0.00030247663,0.00012526855,0.000055386714,0.0011966447,0.00014539821,0.0053495346],"genre_scores_gemma":[0.992934,0.0010911612,0.0013652593,0.000081945676,0.000015756497,0.00004056609,0.00066156086,0.000020126248,0.0037896251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999861,0.000026569935,0.000017950637,0.000025757769,0.00003606818,0.000032579323],"domain_scores_gemma":[0.99986136,0.000025601776,0.000039831324,0.00002005968,0.000018446988,0.000034689354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018975214,0.00018923792,0.0002496211,0.00018439876,0.0001638728,0.00039999804,0.00015709137,0.00039114399,0.003547004],"category_scores_gemma":[0.00013495712,0.00007505092,0.0002552533,0.00015929664,0.00018950245,0.00026228133,0.0001944494,0.00058814755,0.0011074187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044237127,0.000033042885,0.000259894,0.000055863104,0.000004009306,0.00008760409,0.000013317902,0.00006561518,0.9966192,0.0002639223,0.00009537225,0.002059837],"study_design_scores_gemma":[0.00004467578,0.00068765006,0.011147876,0.000022538597,0.000017927352,0.0006413104,0.000047994425,0.0010383949,0.98012346,0.00029725922,0.0059240204,0.0000070977076],"about_ca_topic_score_codex":0.00025362262,"about_ca_topic_score_gemma":0.000167473,"teacher_disagreement_score":0.003547004,"about_ca_system_score_codex":0.0002587415,"about_ca_system_score_gemma":0.00016292847,"threshold_uncertainty_score":0.011865914},"labels":[],"label_agreement":null},{"id":"W4389227919","doi":"10.1158/2326-6074.tumimm23-a026","title":"Abstract A026: Administration of preoperative ketorolac prevents osteosarcoma recurrence by promoting T cell memory and inhibiting immunosuppression","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketorolac; Medicine; Immune system; Immunosuppression; Osteosarcoma; Cyclooxygenase; Metastasis; Immunotherapy; Cancer; Immunology; Pharmacology; Cancer research; Internal medicine; Biology; Analgesic","score_opus":0.03980411047910442,"score_gpt":0.3754176781044063,"score_spread":0.33561356762530187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769944,0.000863996,0.0003930552,0.00007462303,0.000056221776,0.000039944465,0.0001581138,0.00009155629,0.0006229644],"genre_scores_gemma":[0.99570066,0.00055721524,0.0009013485,0.000059422375,0.000054239994,0.00006839043,0.00043708074,0.000009871903,0.002211753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999192,0.000009037577,0.000008983759,0.000012510906,0.000020577367,0.000029760806],"domain_scores_gemma":[0.9998628,0.000011229344,0.000046311703,0.000013337478,0.000012132624,0.00005409045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096042044,0.0003809095,0.00046176187,0.00021785556,0.00012918217,0.00020701872,0.0002826796,0.0002575284,0.0024176028],"category_scores_gemma":[0.00013472927,0.000106509375,0.00020141837,0.00011974647,0.00022400804,0.00017997515,0.00013355353,0.0007187768,0.00039399884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010084233,0.0025582986,0.00096874574,0.00027454377,0.000029898874,0.000114554314,0.000034460485,0.00015663917,0.9649801,0.00006294107,0.0006007328,0.02013472],"study_design_scores_gemma":[0.00220113,0.085609496,0.02268961,0.000055461343,0.00013363105,0.0011641306,0.00009187639,0.0017007488,0.8810854,0.000079634185,0.005162474,0.000026478121],"about_ca_topic_score_codex":0.0006033829,"about_ca_topic_score_gemma":0.0008004267,"teacher_disagreement_score":0.0024176028,"about_ca_system_score_codex":0.00013307264,"about_ca_system_score_gemma":0.00037670322,"threshold_uncertainty_score":0.008087635},"labels":[],"label_agreement":null},{"id":"W4389227931","doi":"10.1158/2326-6074.tumimm23-b008","title":"Abstract B008: GPR64-targeting single-domain CAR-T cells for immunotherapy in Ewing sarcoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer research; Cancer; FLI1; Context (archaeology); Transcriptome; Medicine; Sarcoma; Mesenchymal stem cell; Cancer immunotherapy; Biology; Computational biology; Bioinformatics; Transcription factor; Internal medicine; Pathology; Gene expression; Genetics; Gene","score_opus":0.12010739287825663,"score_gpt":0.42062158504169206,"score_spread":0.30051419216343545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735213,0.0039957697,0.0040786364,0.00032267126,0.00014245338,0.00013302692,0.0012508986,0.00022738338,0.0024970714],"genre_scores_gemma":[0.9864608,0.0016830802,0.004201008,0.00023081157,0.00003232326,0.00015327228,0.0028246215,0.00003853821,0.004375632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988747,0.000013901634,0.0000068899244,0.000029665161,0.000030227415,0.000031793003],"domain_scores_gemma":[0.999977,0.0000025282154,0.0000043382447,0.0000024652443,0.0000052165137,0.000008507887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015715968,0.00026169233,0.00034307342,0.0002794927,0.00013472671,0.00030639025,0.00018555224,0.00042171055,0.002801421],"category_scores_gemma":[0.000086247936,0.00008919602,0.00032049287,0.00026007905,0.00013547647,0.00017910189,0.0002494705,0.00058895815,0.0010512072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033169347,0.00008868966,0.00036479026,0.00009205034,0.000013616405,0.00008485689,0.000015606165,0.00022274815,0.99099606,0.0001322338,0.0005745487,0.007083183],"study_design_scores_gemma":[0.00019016418,0.0026058194,0.009126532,0.000029710334,0.00011830399,0.0012523229,0.00007785648,0.0046539805,0.95536715,0.0002899862,0.026269713,0.00001835608],"about_ca_topic_score_codex":0.00021133173,"about_ca_topic_score_gemma":0.00020231222,"teacher_disagreement_score":0.002801421,"about_ca_system_score_codex":0.00019854015,"about_ca_system_score_gemma":0.00016654396,"threshold_uncertainty_score":0.009371698},"labels":[],"label_agreement":null},{"id":"W4389227944","doi":"10.1158/2326-6074.tumimm23-a028","title":"Abstract A028: Defining immune pathways involved in the depletion of B-cell precursor acute lymphoblastic leukemia-initiating cells following early-life cytomegalovirus (CMV) infection in mice","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunology; Immune system; Biology; Leukemia; B cell; Antibody; Chemokine; Medicine; Cancer research; Virology","score_opus":0.053619627169509645,"score_gpt":0.3394182277089818,"score_spread":0.28579860053947215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98618615,0.0025743588,0.005479224,0.00019737578,0.000049702456,0.00012257959,0.002566698,0.0002812363,0.0025426904],"genre_scores_gemma":[0.9799381,0.0016294525,0.007725131,0.0002894312,0.00003379541,0.00029025102,0.0031410016,0.00013267045,0.006820123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996687,0.000038857303,0.000027279835,0.000092515875,0.00009061439,0.00008205877],"domain_scores_gemma":[0.99980193,0.000019010167,0.00007272332,0.0000180773,0.000020295223,0.000068006644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024619882,0.00053683715,0.00027931345,0.0007436285,0.00020395953,0.0004381312,0.0003024271,0.0005588383,0.0019203915],"category_scores_gemma":[0.000118996795,0.00025198603,0.00043609928,0.0002378411,0.00035120515,0.0003398233,0.00027852124,0.0014212014,0.00084356335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014605524,0.00003617414,0.00025801352,0.000034606634,0.0000026429361,0.000024525834,0.000016175285,0.000025115545,0.9985727,0.00006244212,0.00003218902,0.0007893835],"study_design_scores_gemma":[0.000062618616,0.00091210706,0.014608565,0.00003042254,0.000034837423,0.00044239464,0.00007779892,0.0007423303,0.9796832,0.000119549346,0.0032777428,0.00000845515],"about_ca_topic_score_codex":0.00042312313,"about_ca_topic_score_gemma":0.00056453346,"teacher_disagreement_score":0.0019203915,"about_ca_system_score_codex":0.00034061164,"about_ca_system_score_gemma":0.00022580763,"threshold_uncertainty_score":0.0064243674},"labels":[],"label_agreement":null},{"id":"W4389227945","doi":"10.1158/2326-6074.tumimm23-a022","title":"Abstract A022: Immunotherapy of IL-6R Prevents Relapse and Metastasis of Triple-Negative Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Cancer research; Triple-negative breast cancer; Metastasis; Breast cancer; Tumor microenvironment; Cancer; Cytotoxic T cell; Immunology; Oncology; Internal medicine; Biology","score_opus":0.04981593190187377,"score_gpt":0.40484699882325814,"score_spread":0.35503106692138436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994362,0.0015130558,0.00089291285,0.0003475158,0.00020094305,0.00007690651,0.00064260024,0.0001907725,0.001773263],"genre_scores_gemma":[0.9936087,0.0005333606,0.00087932975,0.00017938574,0.00006688156,0.000089347835,0.0010037986,0.000020909438,0.0036183493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990296,0.000016862727,0.000008265435,0.000017296017,0.000026316444,0.00002826942],"domain_scores_gemma":[0.9999484,0.0000045750085,0.000011413315,0.0000066878533,0.0000054849074,0.000023416413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012499152,0.00028221429,0.00034906634,0.00017027376,0.000110050525,0.00024963325,0.00019176451,0.00026477198,0.002402148],"category_scores_gemma":[0.00009403661,0.00007825679,0.00021450473,0.00012223647,0.00016851613,0.00013663512,0.00010474855,0.0010054364,0.0005395763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035155283,0.0017880964,0.0006644711,0.00012738064,0.000031440282,0.00006919175,0.000024146413,0.0002469515,0.97637284,0.00014385938,0.0012183773,0.015797738],"study_design_scores_gemma":[0.0024518787,0.030100668,0.017158918,0.000035957506,0.0001378019,0.0007347861,0.00009104987,0.0032055397,0.9325398,0.00019670525,0.013326,0.000020775135],"about_ca_topic_score_codex":0.00036598774,"about_ca_topic_score_gemma":0.0007024274,"teacher_disagreement_score":0.002402148,"about_ca_system_score_codex":0.00014027879,"about_ca_system_score_gemma":0.00030343593,"threshold_uncertainty_score":0.008036017},"labels":[],"label_agreement":null},{"id":"W4389227987","doi":"10.1158/2326-6074.tumimm23-a010","title":"Abstract A010: Assay development to assess the efficiency and stability of candidate molecules for transcriptional gene silencing of FOXP3, using a human tumor-derived cell line","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene silencing; Biology; FOXP3; Transcription factor; Cell biology; Transcriptional regulation; Epigenetics; Effector; Cancer research; Therapeutic gene modulation; Gene expression; Immune system; Gene; Immunology; Genetics; Regulator gene","score_opus":0.22277501408679942,"score_gpt":0.4421814979584126,"score_spread":0.21940648387161318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227987","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7352291,0.0043802117,0.24885906,0.0001735248,0.00025914906,0.0009392304,0.0022785584,0.0017928696,0.006088267],"genre_scores_gemma":[0.7588189,0.0024743124,0.21183611,0.00020863845,0.00008414728,0.0022309392,0.0073128096,0.00027840608,0.016755756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986584,0.00030715283,0.00013092607,0.0003475294,0.00047444494,0.00008152381],"domain_scores_gemma":[0.999368,0.00025439513,0.00009706067,0.00008822991,0.00013250412,0.000059772374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009638669,0.0010434417,0.00046379195,0.00083729177,0.00029819008,0.0005847029,0.0004775749,0.00064769015,0.0027206023],"category_scores_gemma":[0.00066321203,0.00037473883,0.0004867247,0.00054678414,0.00037458487,0.00030989645,0.0003208738,0.0008673692,0.0013247429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006406212,0.00006031691,0.0003242774,0.000045643235,0.000007655399,0.000012675105,0.00002275046,0.00005287911,0.9972958,0.000048672584,0.000038447924,0.0020268508],"study_design_scores_gemma":[0.000007805432,0.00039875924,0.00094147,0.0000046408195,0.000022784301,0.00006263816,0.000010521251,0.0006989572,0.99671245,0.000025384585,0.0011098009,0.0000046327978],"about_ca_topic_score_codex":0.00043800194,"about_ca_topic_score_gemma":0.00048066795,"teacher_disagreement_score":0.0027206023,"about_ca_system_score_codex":0.00035169834,"about_ca_system_score_gemma":0.00031525863,"threshold_uncertainty_score":0.009101272},"labels":[],"label_agreement":null},{"id":"W4389228010","doi":"10.1158/2326-6074.tumimm23-a003","title":"Abstract A003: High-throughput TCR sequencing demonstrates induction of long-lasting HPV16-specific T cell responses in VB10.16 vaccinated advanced cervical cancer patients","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ELISPOT; T-cell receptor; Peripheral blood mononuclear cell; T cell; Immunotherapy; Medicine; Immunology; Biology; Immune system; Genetics","score_opus":0.05035878388481703,"score_gpt":0.347053994624171,"score_spread":0.296695210739354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976082,0.00019638998,0.0007010693,0.000032004158,0.0000068893396,0.00002248336,0.0005351309,0.000047601723,0.0008501466],"genre_scores_gemma":[0.99764746,0.000051157,0.00045858655,0.00005609428,0.000005342514,0.000022042801,0.00096669194,0.000013120574,0.0007796283],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998833,0.000017901562,0.000006981963,0.00004083828,0.000021339514,0.000029579045],"domain_scores_gemma":[0.9998134,0.00007092388,0.00002471645,0.000023015029,0.000030000203,0.00003802746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019860131,0.00019722657,0.00027047994,0.00015726042,0.00014599365,0.00033018264,0.00010889992,0.00029958264,0.00364786],"category_scores_gemma":[0.0004241103,0.00009990821,0.00013755308,0.00011455938,0.00012238306,0.00011403645,0.00012971467,0.00042838525,0.0006567386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042132847,0.00027844845,0.04694291,0.00010372204,0.000036689547,0.0003936907,0.0002424558,0.00087175163,0.91887224,0.00005729714,0.0009424435,0.027045073],"study_design_scores_gemma":[0.0005494536,0.015136023,0.5340741,0.00004857696,0.00020098926,0.0066030775,0.00037781315,0.010405813,0.4231577,0.00032946724,0.009080558,0.00003654824],"about_ca_topic_score_codex":0.0008495188,"about_ca_topic_score_gemma":0.0005103345,"teacher_disagreement_score":0.00364786,"about_ca_system_score_codex":0.00019961737,"about_ca_system_score_gemma":0.00013774983,"threshold_uncertainty_score":0.012203336},"labels":[],"label_agreement":null},{"id":"W4389228033","doi":"10.1158/2326-6074.tumimm23-a018","title":"Abstract A018: Characterization of macrophage population in head and neck squamous cell carcinoma and renal cell carcinoma and their role in modulating immune checkpoint blockade response","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Tumor microenvironment; Medicine; Nivolumab; Renal cell carcinoma; Immune system; Cancer research; Population; Immune checkpoint; Immunotherapy; Cytokine; Tumor necrosis factor alpha; Cancer; Internal medicine; Head and neck cancer; Immunology","score_opus":0.03612479526620541,"score_gpt":0.31801589618779136,"score_spread":0.2818911009215859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745375,0.00090516935,0.00059702137,0.00001825772,0.000010197621,0.000034872282,0.000262804,0.000008549309,0.00070940546],"genre_scores_gemma":[0.995943,0.00042642077,0.0011883957,0.00003707708,0.000013796651,0.0000667033,0.0005732403,0.0000034972168,0.0017478467],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999913,0.000011847093,0.0000113234255,0.00001946667,0.000020578023,0.000023762697],"domain_scores_gemma":[0.9999244,0.000012222449,0.000011106731,0.0000064430637,0.000028427534,0.000017460263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014784228,0.00010182073,0.00015450799,0.00034560345,0.0001624406,0.000195535,0.00007157016,0.00013653563,0.00204561],"category_scores_gemma":[0.000102173704,0.00005623321,0.00015742051,0.00020457458,0.00009196136,0.000097092074,0.00010704036,0.00016774517,0.0003741994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082443876,0.000080881495,0.022499012,0.000119246586,0.000009334922,0.00025080531,0.000108694185,0.000039902967,0.9697501,0.000050892468,0.00009608388,0.0061704875],"study_design_scores_gemma":[0.00007155187,0.0025259845,0.32914945,0.000040735213,0.000083919585,0.0032254127,0.0009288498,0.0012046822,0.6568,0.000109932866,0.0058447747,0.000014704465],"about_ca_topic_score_codex":0.0007819273,"about_ca_topic_score_gemma":0.00087221916,"teacher_disagreement_score":0.00204561,"about_ca_system_score_codex":0.0000976989,"about_ca_system_score_gemma":0.00015497158,"threshold_uncertainty_score":0.0068432093},"labels":[],"label_agreement":null},{"id":"W4389228053","doi":"10.1158/2326-6074.tumimm23-a004","title":"Abstract A004: Immune response to sub-ablative radiation before surgery in pleural mesothelioma – Results from the SMARTER trial","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Mesothelioma; Radiology; Surgery; Nuclear medicine; Pathology","score_opus":0.08277757359573512,"score_gpt":0.38857470126811866,"score_spread":0.30579712767238354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892055,0.003764081,0.00060943776,0.0011731642,0.00035706934,0.0007359697,0.0019747256,0.00009321908,0.0020868338],"genre_scores_gemma":[0.98249406,0.0017455291,0.0014323196,0.0019143155,0.00062948244,0.00160756,0.005289772,0.000051547948,0.004835315],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993309,0.00039049034,0.000047565383,0.000106762775,0.000059403224,0.00006486751],"domain_scores_gemma":[0.99870586,0.00039859672,0.00031328193,0.00023112609,0.00009552846,0.0002557013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430174,0.00055564195,0.001297971,0.00014746368,0.00022499633,0.00085237133,0.00041093392,0.0007573344,0.004522288],"category_scores_gemma":[0.0013634267,0.00019637804,0.0018262967,0.00018964615,0.0005349164,0.00056670525,0.00033909242,0.0023241055,0.00092772255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8483497,0.0064623165,0.009619737,0.0017515951,0.0039651776,0.00015506726,0.00013641482,0.0020647103,0.043688748,0.0004562755,0.008942051,0.07440819],"study_design_scores_gemma":[0.49574095,0.41665697,0.05762193,0.00020403309,0.0042399624,0.00038434606,0.000094897056,0.0018186095,0.0101597635,0.0014349732,0.011571276,0.00007220627],"about_ca_topic_score_codex":0.00014788851,"about_ca_topic_score_gemma":0.0003160582,"teacher_disagreement_score":0.004522288,"about_ca_system_score_codex":0.00035192238,"about_ca_system_score_gemma":0.00043548667,"threshold_uncertainty_score":0.015128553},"labels":[],"label_agreement":null},{"id":"W4389228096","doi":"10.1158/2326-6074.tumimm23-a002","title":"Abstract A002: Analysis of tumor microenvironments in ovarian cancer patients receiving anti-BTN1A1 immunotherapy combined with standard-of-care therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Immune system; Medicine; Tumor microenvironment; Cancer; Ovarian cancer; Multiplex; Antibody; Oncology; Immunofluorescence; Clinical trial; Cancer research; Cancer immunotherapy; Mass cytometry; Internal medicine; Immunology; Bioinformatics; Biology","score_opus":0.030192311363762055,"score_gpt":0.33452821421615886,"score_spread":0.3043359028523968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829394,0.00064600847,0.00018973903,0.00003730995,0.000008902804,0.000018803163,0.00019750444,0.000013218591,0.00059455505],"genre_scores_gemma":[0.9991617,0.00010370224,0.00015595648,0.000025676747,0.0000078657995,0.000018882321,0.0002716396,0.0000016472962,0.0002528186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989235,0.000021225562,0.000009008818,0.000025817799,0.00002370951,0.000027790586],"domain_scores_gemma":[0.999882,0.000021217487,0.000036684523,0.00000699449,0.00002023946,0.000032871754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015913162,0.00009949711,0.00020918305,0.00040767086,0.00017398171,0.00025105916,0.00008398972,0.00017288794,0.0013313574],"category_scores_gemma":[0.00026395885,0.00007021977,0.00014638186,0.00025289776,0.000114194016,0.00015741224,0.00014480438,0.00021161765,0.00013010178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012889328,0.0005622411,0.6862581,0.00019703113,0.00013268397,0.0021881077,0.00034403297,0.00057513185,0.24409331,0.00014757231,0.0013273442,0.05128517],"study_design_scores_gemma":[0.00012198847,0.0020852978,0.96036845,0.000011623731,0.00010350086,0.0030242582,0.0003439903,0.002454052,0.027755573,0.000105675776,0.003613691,0.00001194773],"about_ca_topic_score_codex":0.00051774894,"about_ca_topic_score_gemma":0.0005693378,"teacher_disagreement_score":0.0013313574,"about_ca_system_score_codex":0.00020561396,"about_ca_system_score_gemma":0.000120633995,"threshold_uncertainty_score":0.004453838},"labels":[],"label_agreement":null},{"id":"W4389239891","doi":"10.1158/2326-6074.tumimm23-b030","title":"Abstract B030: Characterizing MAIT cells in lung cancer: Insights from NSCLC and murine models","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Granzyme B; Cytotoxic T cell; Granzyme; Immune system; Biology; T-cell receptor; Cancer research; Ex vivo; Tumor microenvironment; Immunology; Lung cancer; T cell; In vivo; Immunotherapy; CD8; Pathology; Medicine; In vitro; Perforin","score_opus":0.05391378213233809,"score_gpt":0.3382651749986699,"score_spread":0.2843513928663318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904131,0.0032755022,0.0033105558,0.0001377173,0.000024995703,0.00017458542,0.0007987217,0.000089298526,0.0017755339],"genre_scores_gemma":[0.9900462,0.002007631,0.0038112514,0.00010033493,0.000025724828,0.00017319928,0.0017612042,0.00002323783,0.0020512654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975437,0.000042437914,0.000026277978,0.00005037532,0.00006347471,0.00006306525],"domain_scores_gemma":[0.999881,0.000018000765,0.000026356984,0.000015121894,0.000016879814,0.000042598604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040629526,0.000611308,0.00026810146,0.00089656503,0.00026687374,0.0003051752,0.00027073667,0.0005050053,0.0013085471],"category_scores_gemma":[0.00014019215,0.00016164903,0.0003030612,0.00026087003,0.00032355922,0.00037319123,0.0003334259,0.000796262,0.000589563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029999053,0.00014245778,0.0014817355,0.00007254774,0.0000045391134,0.00012834933,0.000029404804,0.000059421604,0.9957552,0.00006574588,0.000047496,0.0019131601],"study_design_scores_gemma":[0.0001088214,0.0039739995,0.038106505,0.000051393494,0.00005772768,0.0040187584,0.00015857174,0.0020085468,0.9468465,0.0001802935,0.0044770064,0.00001205709],"about_ca_topic_score_codex":0.00045901616,"about_ca_topic_score_gemma":0.0006392231,"teacher_disagreement_score":0.0013085471,"about_ca_system_score_codex":0.00033675786,"about_ca_system_score_gemma":0.00019548317,"threshold_uncertainty_score":0.004377544},"labels":[],"label_agreement":null},{"id":"W4389239901","doi":"10.1158/2326-6074.tumimm23-b033","title":"Abstract B033: Multiplex analysis of the tumor immune microenvironment during treatment with atezolizumab/pelareorep/letrozole reveals novel immune-tumor interactions","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Tumor microenvironment; Immune system; Cancer research; Immunotherapy; Medicine; Cytotoxic T cell; Immunology; Biology; Nivolumab","score_opus":0.03899828271051024,"score_gpt":0.3539340456493098,"score_spread":0.31493576293879955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570763,0.0012670583,0.0015773284,0.00003954476,0.000017705912,0.000026711838,0.0005072266,0.00005929717,0.0007975271],"genre_scores_gemma":[0.9962675,0.00031745087,0.0016611797,0.000052993266,0.000009505847,0.000036170815,0.0006505012,0.0000089637715,0.0009958973],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993384,0.000008036726,0.0000032065811,0.000017238257,0.000017786728,0.000019849118],"domain_scores_gemma":[0.9999665,0.000006609257,0.000006631759,0.0000024504864,0.000007482116,0.000010213331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008507048,0.00014326192,0.00020897014,0.00018994276,0.00009902753,0.000235779,0.0000745974,0.00020228657,0.0016920811],"category_scores_gemma":[0.00006305206,0.00006580243,0.00012275533,0.00011803304,0.00006941101,0.000082725455,0.00006850187,0.00028984895,0.0003740152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004321761,0.00003249014,0.0016405964,0.000019887266,0.0000047114836,0.000037977872,0.000012149181,0.00004611795,0.99466044,0.00000892921,0.000069929585,0.0030345814],"study_design_scores_gemma":[0.000034948906,0.00090453756,0.065697856,0.0000064953765,0.00003688757,0.0005570258,0.00007184055,0.003029226,0.92777467,0.000042681677,0.0018372562,0.000006518343],"about_ca_topic_score_codex":0.00033871696,"about_ca_topic_score_gemma":0.00041275012,"teacher_disagreement_score":0.0016920811,"about_ca_system_score_codex":0.00012474527,"about_ca_system_score_gemma":0.00007884434,"threshold_uncertainty_score":0.0056605935},"labels":[],"label_agreement":null},{"id":"W4389239913","doi":"10.1158/2326-6074.tumimm23-a013","title":"Abstract A013: Targeting perivascular macrophages with an orally bioavailable heme oxygenase-1 inhibitor improves responses to chemotherapeutic drugs in cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Tumor microenvironment; Stromal cell; Heme oxygenase; Immune system; Angiogenesis; Cancer; Cancer cell; Immunotherapy; Cancer immunotherapy; Ferroportin; Biology; Immunology; Chemistry; Heme; Medicine; Inflammation; Internal medicine; Biochemistry; Enzyme","score_opus":0.037996206869306375,"score_gpt":0.3591688728274037,"score_spread":0.3211726659580973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804784,0.005546514,0.0018259953,0.0004871495,0.000372974,0.0002222092,0.000499986,0.0003608466,0.0026364364],"genre_scores_gemma":[0.988787,0.002206568,0.0019984874,0.00026283495,0.000094709765,0.00017161912,0.00072288775,0.00003557389,0.0057204138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994147,0.000010961661,0.0000058720284,0.0000114193335,0.000011563466,0.000018723034],"domain_scores_gemma":[0.99995136,0.0000062342647,0.000009339874,0.0000053907293,0.0000068175364,0.000020920515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011331258,0.0003101542,0.0005213413,0.00029017357,0.0001248094,0.0002513092,0.00025275434,0.00034827887,0.004667676],"category_scores_gemma":[0.00009810455,0.00008096323,0.0002104803,0.00017406154,0.00016629451,0.00022112104,0.00012253171,0.0007199613,0.0007018051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00865537,0.0038874347,0.0003998934,0.0002835266,0.000058767324,0.00012346922,0.000029687486,0.00026897577,0.93069446,0.00025557764,0.0019430781,0.05339977],"study_design_scores_gemma":[0.0063851667,0.067349724,0.013097164,0.00006400282,0.00033222997,0.0008510645,0.00007283835,0.0029332493,0.8878562,0.0002632872,0.020764073,0.000030960666],"about_ca_topic_score_codex":0.000560567,"about_ca_topic_score_gemma":0.00067385007,"teacher_disagreement_score":0.004667676,"about_ca_system_score_codex":0.00014386451,"about_ca_system_score_gemma":0.00028402658,"threshold_uncertainty_score":0.015614927},"labels":[],"label_agreement":null},{"id":"W4389239921","doi":"10.1158/2326-6074.tumimm23-a015","title":"Abstract A015: Rapid mitochondrial reactive oxygen species production precedes NF-κB activation and pro-inflammatory responses in macrophages","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reactive oxygen species; Proinflammatory cytokine; Chemistry; Cell biology; Mitochondrial ROS; Lipopolysaccharide; Inflammation; NF-κB; Context (archaeology); Pharmacology; Signal transduction; Biochemistry; Immunology; Biology","score_opus":0.0801465144568929,"score_gpt":0.34463482955673336,"score_spread":0.26448831509984044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86501217,0.0380951,0.036956146,0.0039837197,0.011475996,0.0006020876,0.021425078,0.0026607641,0.019788979],"genre_scores_gemma":[0.9321095,0.0076839933,0.009073773,0.00061169575,0.0011024667,0.00037480737,0.008452119,0.00015873233,0.040432975],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997379,0.000021072015,0.000035206256,0.000065456945,0.00009339817,0.00004693897],"domain_scores_gemma":[0.9997507,0.000028772802,0.00006495408,0.000023245593,0.0000726852,0.00005961442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030421017,0.00048775505,0.0004903133,0.00064707565,0.00042286672,0.00058120384,0.0004596876,0.00073156157,0.021387523],"category_scores_gemma":[0.0002736802,0.00020844341,0.0005573717,0.0005193804,0.00024824878,0.00071580964,0.00033757897,0.00080016017,0.0051747174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000842738,0.000080514685,0.0005411352,0.0004418376,0.000013801539,0.00021890002,0.000028092914,0.000043591153,0.99181753,0.00034962696,0.001560105,0.004062007],"study_design_scores_gemma":[0.00016006209,0.0012296127,0.032662895,0.00009266378,0.00006834932,0.0014931291,0.00018032634,0.00096587394,0.9280583,0.0014669261,0.03357697,0.000044826033],"about_ca_topic_score_codex":0.00031589827,"about_ca_topic_score_gemma":0.00022215482,"teacher_disagreement_score":0.021387523,"about_ca_system_score_codex":0.00031511558,"about_ca_system_score_gemma":0.0004208062,"threshold_uncertainty_score":0.0715484},"labels":[],"label_agreement":null},{"id":"W4389239946","doi":"10.1158/2326-6074.tumimm23-a024","title":"Abstract A024: Systemic administration of CD3-redirected lentiviral vector efficiently targets CD19-CAR delivery to human T cells in vivo","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD19; IL-2 receptor; Tropism; CD3; In vivo; Ex vivo; T cell; LDL receptor; Viral vector; Antibody; Biology; Cell biology; Molecular biology; Immunology; Antigen; Recombinant DNA; Immune system; CD8; Virus; Lipoprotein","score_opus":0.04491017351373862,"score_gpt":0.37345859563846934,"score_spread":0.32854842212473073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96982735,0.0021570127,0.015723372,0.00031827806,0.0002136337,0.00043338106,0.0018096255,0.0009949924,0.00852241],"genre_scores_gemma":[0.97714806,0.00070391624,0.009472165,0.00016134493,0.00005221056,0.00022401207,0.0014260802,0.00012526549,0.010686912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998265,0.000021705817,0.000014177591,0.000041860207,0.00004133356,0.000054423672],"domain_scores_gemma":[0.99995065,0.0000071840186,0.0000111207155,0.00000839326,0.000008025649,0.000014671577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017519662,0.00041684086,0.00027237734,0.0002645416,0.0001727581,0.00036602106,0.00023899131,0.0004888412,0.0032848467],"category_scores_gemma":[0.00007906714,0.00013743823,0.00026631812,0.00014716812,0.00022169291,0.00016193074,0.00012936114,0.0009905207,0.0011591177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023266711,0.00013692542,0.00007212889,0.000036801066,0.0000067661153,0.00006315914,0.000015243083,0.00006254416,0.9958983,0.000150452,0.00036126634,0.0029637346],"study_design_scores_gemma":[0.00008411707,0.00080696226,0.00083000225,0.000005154869,0.000017289725,0.00022752039,0.000007370276,0.00092498434,0.9926692,0.000039608898,0.004383515,0.000004266573],"about_ca_topic_score_codex":0.0011147923,"about_ca_topic_score_gemma":0.0009581001,"teacher_disagreement_score":0.0032848467,"about_ca_system_score_codex":0.00033017667,"about_ca_system_score_gemma":0.00037551948,"threshold_uncertainty_score":0.010988891},"labels":[],"label_agreement":null},{"id":"W4389239965","doi":"10.1158/2326-6074.tumimm23-b020","title":"Abstract B020: Hypoxia as tumor-intrinsic regulator of Flt3L production by NK cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Immunotherapy; Cancer research; Lymphokine-activated killer cell; Cytokine; Tumor microenvironment; Natural killer cell; Chemokine; Immune system; Cell biology; Cancer immunotherapy; Interleukin 12; Interleukin 21; Immunology; Cytotoxic T cell; T cell; In vitro","score_opus":0.03968215534722751,"score_gpt":0.33277334051829544,"score_spread":0.2930911851710679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626046,0.0011881392,0.00118855,0.00006182541,0.00001126108,0.00000976899,0.00046659503,0.000032256474,0.00078110496],"genre_scores_gemma":[0.99717134,0.0003092672,0.00057595625,0.000035918707,0.0000073598594,0.000015819636,0.00048376952,0.0000077772675,0.0013927892],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999361,0.0000080297505,0.0000045833367,0.000017914756,0.000015166184,0.000018243803],"domain_scores_gemma":[0.9999503,0.0000049198943,0.000020414987,0.0000028530349,0.000006020156,0.000015475887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005029525,0.00013683748,0.000110843466,0.00010124717,0.00008725162,0.00016043517,0.00007216551,0.00011096001,0.0011466399],"category_scores_gemma":[0.000043113225,0.00006006769,0.0000894925,0.000077235985,0.00009894927,0.00010015717,0.00009803684,0.00017238835,0.00017255395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009126631,0.000005139557,0.0004816966,0.000009895727,9.0287534e-7,0.000015273235,0.000003293108,0.000014517407,0.99893194,0.000017468217,0.000021474008,0.0004070838],"study_design_scores_gemma":[0.000016972153,0.00028165197,0.05792452,0.000005176219,0.000009841923,0.00027505142,0.000034277367,0.0007007814,0.9388907,0.000051730633,0.0018057738,0.0000034787367],"about_ca_topic_score_codex":0.00075268367,"about_ca_topic_score_gemma":0.00073952647,"teacher_disagreement_score":0.0011466399,"about_ca_system_score_codex":0.00024065135,"about_ca_system_score_gemma":0.00008969225,"threshold_uncertainty_score":0.0038359165},"labels":[],"label_agreement":null},{"id":"W4389239981","doi":"10.1158/2326-6074.tumimm23-a045","title":"Abstract A045: Development of automated deep learning-based off-target distribution prediction system for CRISPR-Cas13 system","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Genome editing; Computational biology; Computer science; RNA; Gene; Biology; Genetics","score_opus":0.027281087744333306,"score_gpt":0.3724679905078316,"score_spread":0.3451869027634983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239981","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04012736,0.00035768378,0.9005752,0.00035852237,0.00015069141,0.0003275396,0.0013974257,0.049757633,0.006947841],"genre_scores_gemma":[0.53253627,0.0003795619,0.44251204,0.00076991913,0.00004616718,0.0006098786,0.0047993455,0.00095361815,0.01739328],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995716,0.000040006827,0.000027841243,0.00014947144,0.00014023663,0.00007078647],"domain_scores_gemma":[0.99965525,0.000055874316,0.000029505085,0.000042255862,0.00017624281,0.000040798055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068032736,0.0009023653,0.0005872057,0.0006111509,0.00043434097,0.00075117894,0.001914745,0.0007505328,0.0067862733],"category_scores_gemma":[0.00086050376,0.00045869028,0.0006729567,0.00030062153,0.0002947935,0.0009580362,0.000869261,0.0013230256,0.0021144946],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006467717,0.000614337,0.00874891,0.00029617,0.00020968297,0.0003805006,0.00015559862,0.2079075,0.07105949,0.0052263257,0.035468746,0.66928595],"study_design_scores_gemma":[0.000024034976,0.000070605536,0.00074746483,0.000010018618,0.000017502349,0.000047172143,0.000009665734,0.9756575,0.018879723,0.0012684666,0.003248758,0.000019033478],"about_ca_topic_score_codex":0.012066574,"about_ca_topic_score_gemma":0.0076179504,"teacher_disagreement_score":0.012066574,"about_ca_system_score_codex":0.0011828807,"about_ca_system_score_gemma":0.001378476,"threshold_uncertainty_score":0.023992658},"labels":[],"label_agreement":null},{"id":"W4389239988","doi":"10.1158/2326-6074.tumimm23-b052","title":"Abstract B052: Single-cell analysis of multiple cancers in the upper gastrointestinal tract uncovers immune characteristics of tumor microenvironments linked to the predictive biomarkers for immunotherapy in esophageal cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer; Immune system; Medicine; Stromal cell; Cancer research; Adenocarcinoma; Esophageal cancer; Cell; Cancer cell; Oncology; Internal medicine; Immunology; Biology","score_opus":0.04764231119001107,"score_gpt":0.35189254125083835,"score_spread":0.3042502300608273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96878964,0.0012763946,0.012684293,0.0002046254,0.000076354496,0.00005014083,0.0154076535,0.00026814162,0.0012427218],"genre_scores_gemma":[0.95589155,0.00041845252,0.013540787,0.00030346258,0.000052628682,0.0001236178,0.028299192,0.00012670412,0.0012435167],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99959916,0.00005127683,0.000027595797,0.00017744483,0.000078926365,0.000065559245],"domain_scores_gemma":[0.99964094,0.00008288656,0.00006054934,0.00005754716,0.00009269232,0.00006541041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062648935,0.0003642211,0.000534255,0.00078801764,0.00051389035,0.0007322368,0.00029206675,0.00044812376,0.0018867977],"category_scores_gemma":[0.00065920077,0.00021708733,0.00072580314,0.00065724325,0.00025219852,0.00021382415,0.0005523254,0.0006008023,0.00069551705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095803617,0.00016391535,0.18884248,0.0003995872,0.0005637276,0.0004062004,0.00028682104,0.0036092554,0.77118343,0.0006014169,0.00506199,0.027923144],"study_design_scores_gemma":[0.00010189485,0.00047700468,0.7931995,0.000077544435,0.0006255356,0.0015804685,0.00068125833,0.040921245,0.13943844,0.0013697214,0.02144605,0.00008128401],"about_ca_topic_score_codex":0.0028023578,"about_ca_topic_score_gemma":0.004496866,"teacher_disagreement_score":0.0028023578,"about_ca_system_score_codex":0.0002693931,"about_ca_system_score_gemma":0.00042766344,"threshold_uncertainty_score":0.006311953},"labels":[],"label_agreement":null},{"id":"W4389240018","doi":"10.1158/2326-6074.tumimm23-a033","title":"Abstract A033: Secretogranin V as a Potential Biomarker for Esophageal Squamous Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene knockdown; Biomarker; Cancer research; Medicine; Cancer; Esophageal squamous cell carcinoma; Esophageal cancer; Small interfering RNA; Oncology; Immunotherapy; Cell; Cell culture; Transcription factor; Internal medicine; Biology; Gene; Transfection","score_opus":0.036486499083017765,"score_gpt":0.3538197098311396,"score_spread":0.3173332107481218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637995,0.026408782,0.0032190466,0.0009126387,0.0003297533,0.00008457808,0.0014590867,0.00016839604,0.0036182324],"genre_scores_gemma":[0.9939493,0.0022072636,0.0012781401,0.00016437411,0.000090602516,0.000020974374,0.0007826594,0.000005265849,0.0015015363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985254,0.000030034986,0.000025652727,0.000022537402,0.00005609364,0.000013141287],"domain_scores_gemma":[0.99984145,0.000028249624,0.000053697346,0.000006658965,0.000047335485,0.000022551278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003502118,0.0003339244,0.00027457427,0.00079766545,0.00012901647,0.0005556605,0.00019666378,0.0004169416,0.0021746682],"category_scores_gemma":[0.00042264708,0.00006842026,0.00030228612,0.00062576344,0.0001551496,0.0002233086,0.00022797198,0.00024431804,0.0005803768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031731639,0.00021601643,0.4781863,0.0011445493,0.0004696314,0.0022333749,0.000105902225,0.0009355341,0.3502514,0.00052800693,0.0051513566,0.15760468],"study_design_scores_gemma":[0.00010349103,0.0016687209,0.7955104,0.00020134693,0.0005721401,0.00724072,0.00024991663,0.0055931704,0.17397168,0.00068261137,0.014164745,0.000041117313],"about_ca_topic_score_codex":0.000707496,"about_ca_topic_score_gemma":0.00042385605,"teacher_disagreement_score":0.0021746682,"about_ca_system_score_codex":0.00030588682,"about_ca_system_score_gemma":0.00027702286,"threshold_uncertainty_score":0.0072749853},"labels":[],"label_agreement":null},{"id":"W4389240026","doi":"10.1158/2326-6074.tumimm23-a011","title":"Abstract A011: Targeting the FES tyrosine kinase in antigen presenting cells to enhance anti-tumor cytotoxic lymphocyte responses","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Cytotoxic T cell; CTL*; Immune system; Immunology; Cancer research; Immunotherapy; Cancer immunotherapy; Innate immune system; Inflammation; Medicine; Biology; CD8","score_opus":0.06120850725847581,"score_gpt":0.4099252004221392,"score_spread":0.3487166931636634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515499,0.009862319,0.017353997,0.0019539555,0.0011072482,0.00028981036,0.0011287421,0.0006076311,0.016146414],"genre_scores_gemma":[0.9537315,0.0036735164,0.007227739,0.0003812223,0.00014524827,0.000108619744,0.0010350473,0.000044584427,0.0336525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999387,0.0000076263764,0.0000051833968,0.000010010849,0.0000199032,0.000018571753],"domain_scores_gemma":[0.9999554,0.000004788451,0.000008205206,0.000002579992,0.000007933033,0.000020945694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013571179,0.00037806173,0.00016932694,0.00020098903,0.00010675403,0.0003268808,0.00024457255,0.00039260724,0.0064280904],"category_scores_gemma":[0.000068259615,0.000093438975,0.00024697278,0.00011533695,0.00015019086,0.00023786783,0.00016795579,0.0006243789,0.0016037083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006586952,0.00016847484,0.00012778727,0.00014251174,0.0000082785255,0.0000734375,0.0000069581392,0.00014782895,0.98956966,0.00040099813,0.0008688481,0.007826556],"study_design_scores_gemma":[0.00023613841,0.0019898175,0.0014117894,0.000014322812,0.000028166316,0.00030085072,0.000014755188,0.001348704,0.9804067,0.00017990025,0.014061413,0.000007400705],"about_ca_topic_score_codex":0.00022510254,"about_ca_topic_score_gemma":0.0002003855,"teacher_disagreement_score":0.0064280904,"about_ca_system_score_codex":0.00026159504,"about_ca_system_score_gemma":0.00020194353,"threshold_uncertainty_score":0.021504104},"labels":[],"label_agreement":null},{"id":"W4389240058","doi":"10.1158/2326-6074.tumimm23-b036","title":"Abstract B036: cGAS-STING activation promotes anti-tumor inflammatory response in osteosarcoma: Implications for tumor microenvironment reprogramming and tumor progression in patients","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Tumor microenvironment; Sting; Stimulator of interferon genes; Innate immune system; Cancer research; Immune system; Tumor necrosis factor alpha; Macrophage polarization; Immunology; Macrophage; Reprogramming; Biology; Medicine; Cell; In vitro","score_opus":0.04514764148239905,"score_gpt":0.365085682048669,"score_spread":0.31993804056626995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981067,0.00046206146,0.00050133944,0.000057455058,0.0000115867815,0.00002031363,0.00032544052,0.000020535505,0.00049448066],"genre_scores_gemma":[0.99824274,0.00018877652,0.0004765388,0.00004745775,0.0000070884043,0.000025037378,0.00044807125,0.00000405958,0.00056011474],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998996,0.00002026164,0.000010571173,0.000018248149,0.000022160679,0.000029106253],"domain_scores_gemma":[0.99993324,0.000009597229,0.000016139871,0.000005653311,0.000008521432,0.000026954032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016583483,0.00016951708,0.00021765045,0.00016028761,0.00011009209,0.00022673857,0.000070650116,0.00016789751,0.0021201256],"category_scores_gemma":[0.000112382746,0.00006600536,0.00018829461,0.0001714149,0.0001378831,0.000091776856,0.00010237968,0.00043096114,0.00031570497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010172346,0.00013209341,0.0041649044,0.00004315754,0.0000064806322,0.00009272738,0.00003273404,0.000099373574,0.99087805,0.00006731523,0.00012907569,0.0033368508],"study_design_scores_gemma":[0.00016035058,0.006006384,0.10937875,0.000022825747,0.000054991717,0.0013596601,0.0003023306,0.00241894,0.87516654,0.00014898115,0.0049705305,0.000009654379],"about_ca_topic_score_codex":0.000436194,"about_ca_topic_score_gemma":0.00050248136,"teacher_disagreement_score":0.0021201256,"about_ca_system_score_codex":0.00017007126,"about_ca_system_score_gemma":0.00018485595,"threshold_uncertainty_score":0.007092595},"labels":[],"label_agreement":null},{"id":"W4389240069","doi":"10.1158/2326-6074.tumimm23-a053","title":"Abstract A053: Notch completes CD4 T cell help in CD8 T cells and ensures timely departure","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Priming (agriculture); Cytotoxic T cell; CD8; Antigen-presenting cell; T cell; Cell biology; CD40; IL-2 receptor; Lymph node; Biology; Immunology; Chemistry; Antigen; Immune system; Biochemistry","score_opus":0.10310504523726723,"score_gpt":0.4104980381016099,"score_spread":0.3073929928643427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705038,0.0012578081,0.012631742,0.00037560487,0.00016785967,0.00007752376,0.0013970714,0.00056819775,0.013020351],"genre_scores_gemma":[0.9739396,0.00025807353,0.006884633,0.00016026504,0.000045072717,0.00005443163,0.0010472453,0.00011161245,0.017499123],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998186,0.000020390915,0.00001578651,0.000043294054,0.0000572375,0.000044817232],"domain_scores_gemma":[0.99983644,0.000018151122,0.00003816935,0.000023769171,0.00002651461,0.000057039622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011129178,0.0002334172,0.0001640659,0.00021805736,0.00023400481,0.00045130137,0.0003968834,0.00042014083,0.007948147],"category_scores_gemma":[0.0001331408,0.00014103095,0.00020206739,0.000116952906,0.00019962993,0.00026185007,0.00028795752,0.0007312413,0.003173713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002070777,0.000029339151,0.00016680708,0.000025224099,0.0000021960254,0.00006035081,0.000008980157,0.000069520414,0.99677294,0.00039892131,0.00020868093,0.0020498661],"study_design_scores_gemma":[0.00002758929,0.00016291978,0.0015278786,0.000007630979,0.000007093731,0.0002209463,0.000018961986,0.0009877557,0.98980635,0.00016109175,0.0070678107,0.000003990932],"about_ca_topic_score_codex":0.00044221975,"about_ca_topic_score_gemma":0.00045643924,"teacher_disagreement_score":0.007948147,"about_ca_system_score_codex":0.00048353113,"about_ca_system_score_gemma":0.0003024663,"threshold_uncertainty_score":0.026589274},"labels":[],"label_agreement":null},{"id":"W4389240132","doi":"10.1158/2326-6074.tumimm23-b013","title":"Abstract B013: Investigating the role of LINE-1 ORF1 protein in a syngeneic mouse melanoma model","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transposable element; Biology; Cancer research; Cell culture; Cancer; Melanoma; Cell growth; Genome; Genetics; Gene","score_opus":0.0704131324677263,"score_gpt":0.34318599144591855,"score_spread":0.27277285897819226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98635954,0.0026559075,0.005631381,0.00044045292,0.00017955256,0.00021988628,0.0017029707,0.00022487908,0.0025854325],"genre_scores_gemma":[0.9761963,0.0021216434,0.005471699,0.00026601463,0.00004257565,0.00044826034,0.0027606434,0.00008438352,0.012608424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967086,0.00004615142,0.000026433949,0.00009584536,0.00008996079,0.0000707364],"domain_scores_gemma":[0.9997328,0.000027439813,0.000068061505,0.000027506416,0.000040276987,0.00010393274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034040515,0.0006292219,0.00035072787,0.0007967174,0.00028746433,0.0003624971,0.00033123346,0.0009128607,0.002684475],"category_scores_gemma":[0.00014782255,0.00018753849,0.0005475669,0.00031658568,0.0003064408,0.0004808497,0.00020892851,0.0016004628,0.0012335171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002525104,0.00026903825,0.00022528412,0.00006356013,0.0000069367647,0.00015138269,0.000021404163,0.00004670594,0.9976572,0.00013905307,0.00012864856,0.0010383279],"study_design_scores_gemma":[0.00010698815,0.0036501018,0.003934139,0.000023315568,0.00006253061,0.0010912634,0.00010849785,0.001500136,0.98192376,0.00014675978,0.00744055,0.0000120036575],"about_ca_topic_score_codex":0.0006637448,"about_ca_topic_score_gemma":0.0005086523,"teacher_disagreement_score":0.002684475,"about_ca_system_score_codex":0.00044589734,"about_ca_system_score_gemma":0.00023285394,"threshold_uncertainty_score":0.008980453},"labels":[],"label_agreement":null},{"id":"W4389240136","doi":"10.1158/2326-6074.tumimm23-a025","title":"Abstract A025: Combination of anti-CTLA4 and radiation induce synergistic tumor control in radiorecurrent prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Tramp; Immune system; Cancer; Immunotherapy; Cancer research; Radiation therapy; Immune checkpoint; Oncology; Immunology; Internal medicine","score_opus":0.05905890052005738,"score_gpt":0.4087926179580436,"score_spread":0.34973371743798626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541616,0.0011957615,0.0009865818,0.00006246715,0.000058226124,0.00009751663,0.00033233705,0.00010585229,0.0017451094],"genre_scores_gemma":[0.9960317,0.0004886404,0.0010043774,0.00005674356,0.00002295951,0.000074561896,0.0005921186,0.000012535945,0.0017163724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987364,0.000022167289,0.00000979685,0.000020950292,0.000031168904,0.000042374224],"domain_scores_gemma":[0.9999291,0.000009333976,0.000013216411,0.0000111246545,0.000007783315,0.000029515362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018439577,0.00043193757,0.00041651892,0.0003919704,0.00013028701,0.0002604227,0.00038364422,0.00027367444,0.002109973],"category_scores_gemma":[0.00007745593,0.00012490751,0.0004617764,0.00024033539,0.00021279846,0.00015897768,0.00017815812,0.0006415686,0.00034401438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020862145,0.0014666907,0.0004146354,0.00016090412,0.00005674067,0.00007509595,0.000022711305,0.00045811536,0.9861769,0.00010408356,0.00040238808,0.008575418],"study_design_scores_gemma":[0.00047424287,0.021431966,0.00553403,0.000012761291,0.00012578652,0.00041073328,0.000025479063,0.0015920582,0.96739787,0.00003509113,0.002950222,0.000009660419],"about_ca_topic_score_codex":0.0008092418,"about_ca_topic_score_gemma":0.00083076826,"teacher_disagreement_score":0.002109973,"about_ca_system_score_codex":0.00021033104,"about_ca_system_score_gemma":0.00028464737,"threshold_uncertainty_score":0.007058561},"labels":[],"label_agreement":null},{"id":"W4389240145","doi":"10.1158/2326-6074.tumimm23-a035","title":"Abstract A035: Comparing the clinical and genomic landscapes of acral, mucosal, and cutaneous metastatic melanomas treated with immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Melanoma; Mucosal melanoma; Oncology; Malignancy; Internal medicine; Metastatic melanoma; Cancer; Immunotherapy; Immune checkpoint; Cohort; Pembrolizumab; Cancer research","score_opus":0.10236977837228804,"score_gpt":0.402273994166284,"score_spread":0.29990421579399595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970493,0.00024689204,0.000113893286,0.000026728858,0.0000016795072,0.0000059889558,0.0022095519,0.0000070602014,0.0003389572],"genre_scores_gemma":[0.99778026,0.00006554994,0.00012915792,0.0000207128,0.0000031284742,0.000008012958,0.0018848177,0.0000027710507,0.00010559281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987316,0.000023572025,0.00001192853,0.000045720277,0.000022199902,0.000023392913],"domain_scores_gemma":[0.9996692,0.00007790347,0.00015551751,0.000019900415,0.000029423585,0.00004805951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001801848,0.00009588419,0.00022250776,0.0005318814,0.00016304705,0.00035694888,0.00014765603,0.00014401975,0.002073197],"category_scores_gemma":[0.0004923616,0.00006558442,0.000272055,0.00080690783,0.00009492766,0.00013240408,0.0002122477,0.00014622074,0.00020687585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014022226,0.000052603984,0.97964007,0.00006521714,0.00012553408,0.00024140601,0.000042367326,0.00025408788,0.010050348,0.00003867881,0.0004961553,0.0075911516],"study_design_scores_gemma":[0.000016768505,0.00013302702,0.9971687,0.0000065629793,0.00007082254,0.0005962648,0.00007267276,0.00040037048,0.0009602548,0.000045426517,0.0005269855,0.0000021941669],"about_ca_topic_score_codex":0.0011514144,"about_ca_topic_score_gemma":0.0013722151,"teacher_disagreement_score":0.002073197,"about_ca_system_score_codex":0.00017779175,"about_ca_system_score_gemma":0.0001348353,"threshold_uncertainty_score":0.006935537},"labels":[],"label_agreement":null},{"id":"W4389240156","doi":"10.1158/2326-6074.tumimm23-b051","title":"Abstract B051: GSTT2 modulates the bladder tumor environment and response to BCG Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Bladder cancer; Cancer research; Immunology; Gene expression; Gene; Immune system; Cancer; Biology; Internal medicine","score_opus":0.06729804768618665,"score_gpt":0.3874945738633544,"score_spread":0.32019652617716776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786204,0.0007081078,0.00042381533,0.00014033055,0.000022037115,0.000008989307,0.00046987346,0.000024596562,0.00034019834],"genre_scores_gemma":[0.9970304,0.0002725868,0.00023926454,0.00007409483,0.000012586939,0.000022673674,0.00063473993,0.000016514668,0.0016969998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998721,0.000029827823,0.000007642117,0.00002627977,0.00002712942,0.000037001086],"domain_scores_gemma":[0.9998771,0.000013219141,0.00004006052,0.000009249285,0.000009702722,0.00005075104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001289112,0.00021601944,0.0002633862,0.00017064337,0.0001254998,0.00029487838,0.00013242278,0.00028435848,0.0023427454],"category_scores_gemma":[0.00012634524,0.00010715821,0.00018151102,0.00016802755,0.00021987454,0.00012994741,0.00012599585,0.0005270073,0.00049028615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009578528,0.00007243089,0.0018338496,0.000027531258,0.0000075013886,0.000036264537,0.000010425399,0.00004586611,0.9960751,0.000022332286,0.00009940972,0.0008113624],"study_design_scores_gemma":[0.000113348295,0.0031546669,0.14588265,0.000024391955,0.00007380006,0.00067683903,0.00018359035,0.0017957237,0.8443092,0.000102262384,0.003671534,0.000012044577],"about_ca_topic_score_codex":0.00042977632,"about_ca_topic_score_gemma":0.00050090824,"teacher_disagreement_score":0.0023427454,"about_ca_system_score_codex":0.00020527879,"about_ca_system_score_gemma":0.00017457179,"threshold_uncertainty_score":0.007837236},"labels":[],"label_agreement":null},{"id":"W4389240203","doi":"10.1158/2326-6074.tumimm23-a005","title":"Abstract A005: Synergistically Engaging a b-Selective IL-2 Agonist with PD1/PDL-1 Blockade in a Bifunctional Superkine, MDNA223","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; In vivo; Cancer research; Pharmacology; Flow cytometry; Cancer immunotherapy; Peripheral blood mononuclear cell; Tumor-infiltrating lymphocytes; Chemistry; Immunotherapy; Agonist; Blockade; T cell; In vitro; Medicine; Receptor; Immunology; Immune system; Biology; Biochemistry","score_opus":0.03985302018752771,"score_gpt":0.34393564231748563,"score_spread":0.3040826221299579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929363,0.0010556639,0.0033459065,0.00009278876,0.000042487867,0.0000811393,0.0002857065,0.00009079486,0.002069136],"genre_scores_gemma":[0.9944478,0.00025017702,0.0034795338,0.000048340364,0.000009905324,0.000051000563,0.00026416325,0.000007265851,0.0014416203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999201,0.000014240591,0.0000076050633,0.000016552933,0.000023664537,0.00001772081],"domain_scores_gemma":[0.99996364,0.000006531129,0.000009364694,0.0000032431612,0.0000028932332,0.000014312229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103958744,0.00027589948,0.00016796237,0.00012979397,0.000072517265,0.00022925608,0.00017795202,0.00023341655,0.0013377729],"category_scores_gemma":[0.000057556124,0.00005887023,0.00016849636,0.00006977948,0.0001302028,0.00011278307,0.00015377221,0.00031170814,0.00032867354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031636888,0.00008785321,0.00013481037,0.000047344147,0.000006758522,0.000037914895,0.000008497069,0.0002599187,0.9959273,0.00010027279,0.00011902999,0.0029537978],"study_design_scores_gemma":[0.0000706256,0.001382007,0.0007620338,0.000005606124,0.000018349949,0.0002020776,0.000008568315,0.0015372183,0.99342716,0.000028499151,0.0025524972,0.0000053845074],"about_ca_topic_score_codex":0.00022039106,"about_ca_topic_score_gemma":0.00027021058,"teacher_disagreement_score":0.0013377729,"about_ca_system_score_codex":0.00019317024,"about_ca_system_score_gemma":0.00015856439,"threshold_uncertainty_score":0.0044752955},"labels":[],"label_agreement":null},{"id":"W4389240410","doi":"10.1158/2326-6074.tumimm23-pr05","title":"Abstract PR05: Dgat1 camouflages sexual dimorphism in anti-tumor CD8+ T cell immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; Tumor microenvironment; Biology; Cytotoxic T cell; T cell; Immunotherapy; Cancer immunotherapy; Immunology; Immune system; Cancer research; Biochemistry; In vitro","score_opus":0.04975814404255782,"score_gpt":0.3622263831629061,"score_spread":0.31246823912034827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98228776,0.0021763563,0.0046857945,0.00090349297,0.00028007064,0.00004787657,0.0038343614,0.000500677,0.0052835625],"genre_scores_gemma":[0.9839881,0.0005925961,0.0013495176,0.0003007315,0.00003305059,0.000054770728,0.0016310356,0.00014858978,0.011901492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999688,0.000044582775,0.000024202416,0.00009585615,0.000060675084,0.00008664499],"domain_scores_gemma":[0.9997224,0.000033449218,0.00009239977,0.000033214754,0.00001799542,0.000100552235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015908049,0.00036670265,0.00025764186,0.00046420752,0.00023351648,0.00042707942,0.00037695668,0.00059961475,0.0068682553],"category_scores_gemma":[0.00012930948,0.00018161022,0.00024972347,0.0002472694,0.00041206606,0.00022631092,0.00033491306,0.0013348109,0.0020415033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020197265,0.000038686583,0.00022330743,0.000034197914,0.0000034961568,0.00006703403,0.000013060365,0.00004594176,0.9973346,0.0002156851,0.00021529586,0.001606762],"study_design_scores_gemma":[0.000068581154,0.0004774229,0.011640137,0.000015708949,0.000020463804,0.00071694853,0.00011898183,0.00118464,0.9723025,0.00016644786,0.013276243,0.000011820218],"about_ca_topic_score_codex":0.0003064738,"about_ca_topic_score_gemma":0.0005636756,"teacher_disagreement_score":0.0068682553,"about_ca_system_score_codex":0.0004174286,"about_ca_system_score_gemma":0.00019652245,"threshold_uncertainty_score":0.022976577},"labels":[],"label_agreement":null},{"id":"W4389240413","doi":"10.1158/2326-6074.tumimm23-b014","title":"Abstract B014: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Ovarian cancer; Immunotherapy; Cancer research; Cancer; Immune system; Biology; Immune checkpoint; Cancer immunotherapy; T cell; CRISPR; Immunology; Gene; Genetics","score_opus":0.06805472660407133,"score_gpt":0.3542901432539164,"score_spread":0.2862354166498451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9278882,0.0018635032,0.055233393,0.00069647277,0.0001271745,0.00012434596,0.005355319,0.0013697925,0.0073417565],"genre_scores_gemma":[0.96693355,0.00075265823,0.022412585,0.00023358574,0.00001956334,0.00009600529,0.0027113738,0.0002576473,0.006583068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983156,0.000014784463,0.000007855535,0.000048328588,0.000057053545,0.000040288494],"domain_scores_gemma":[0.9998894,0.000018644108,0.000042109492,0.0000104632245,0.000013844148,0.00002564472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012426659,0.00031430458,0.00027785925,0.00045808926,0.00021966833,0.0005159973,0.00023765408,0.0004170211,0.0033304968],"category_scores_gemma":[0.00011605881,0.00021203168,0.00031436063,0.00024417692,0.0003352571,0.00021629973,0.00039834314,0.0007657895,0.0008861185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004851501,0.000009425229,0.00018390307,0.000025488172,0.0000021202388,0.0000154068,0.000009949503,0.00013689864,0.9978606,0.00022632959,0.000098963996,0.0013822735],"study_design_scores_gemma":[0.000036318892,0.0002443555,0.01116126,0.000017426375,0.000027940081,0.00030005522,0.000110265784,0.004459566,0.9690675,0.0004017496,0.0141563555,0.00001719127],"about_ca_topic_score_codex":0.0010862206,"about_ca_topic_score_gemma":0.0014470904,"teacher_disagreement_score":0.0033304968,"about_ca_system_score_codex":0.00045778765,"about_ca_system_score_gemma":0.0002769827,"threshold_uncertainty_score":0.011141658},"labels":[],"label_agreement":null},{"id":"W4389240415","doi":"10.1158/2326-6074.tumimm23-b041","title":"Abstract B041: Defining the Determinants of Immune Response in DNA Homologous Recombination Deficient Tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune checkpoint; CXCL10; Tumor microenvironment; Immune system; Immunotherapy; Cancer research; Chemokine; CXCR3; Cancer immunotherapy; Biology; Cancer; Immunology; Chemokine receptor; Medicine; Genetics","score_opus":0.06969010939385277,"score_gpt":0.40386602749732037,"score_spread":0.3341759181034676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917691,0.0005290819,0.00481501,0.00010798865,0.000019663981,0.000050116618,0.0013446372,0.00011360433,0.0012509079],"genre_scores_gemma":[0.98964685,0.0002535799,0.0046370537,0.00010813322,0.000008529322,0.00007648739,0.0020129567,0.00008167937,0.0031746936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997211,0.000047791607,0.000023259428,0.00006397481,0.00007879805,0.00006507088],"domain_scores_gemma":[0.999843,0.000021404201,0.000057775695,0.000012190211,0.000017286471,0.000048239574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023209123,0.00031392637,0.00021162652,0.00048289713,0.000135493,0.0003434183,0.00020506515,0.00038389335,0.0020858531],"category_scores_gemma":[0.0001343954,0.00014444817,0.00021486868,0.000170129,0.00022115391,0.00016044956,0.00020782105,0.0008172577,0.00071726623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077621364,0.000019432691,0.00023116509,0.0000080570735,0.0000011772892,0.000008412001,0.000004500267,0.000047870275,0.9991049,0.000038167076,0.000027795539,0.0004308177],"study_design_scores_gemma":[0.00002024867,0.00059796363,0.011467662,0.00000787923,0.0000093090475,0.00029682738,0.00004356001,0.0021055597,0.98350304,0.00006735996,0.0018739233,0.0000067070373],"about_ca_topic_score_codex":0.00053481135,"about_ca_topic_score_gemma":0.00056802557,"teacher_disagreement_score":0.0020858531,"about_ca_system_score_codex":0.0004726546,"about_ca_system_score_gemma":0.00014808564,"threshold_uncertainty_score":0.0069779158},"labels":[],"label_agreement":null},{"id":"W4389240416","doi":"10.1158/2326-6074.tumimm23-b031","title":"Abstract B031: A tale of cancer cell death and immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Necroptosis; Pyroptosis; Programmed cell death; Immunogenic cell death; Cytotoxic T cell; Immunotherapy; Cancer; Cancer research; Cancer immunotherapy; Biology; Immune system; Cancer cell; Apoptosis; Immunology; In vitro","score_opus":0.06960302290979067,"score_gpt":0.385671473663472,"score_spread":0.3160684507536813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240416","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07978618,0.11907959,0.044901982,0.43573844,0.07379644,0.00025628027,0.0020396467,0.002026996,0.24237444],"genre_scores_gemma":[0.37995672,0.06519999,0.032778397,0.09966785,0.014803762,0.00031770548,0.0014170608,0.00094054505,0.40491793],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995646,0.00010186541,0.000017617298,0.00007862441,0.00016533617,0.000071842216],"domain_scores_gemma":[0.9995328,0.0000729336,0.000033157507,0.000037779042,0.00010172656,0.00022159259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095583434,0.00048338718,0.0003332314,0.0007604894,0.0012127819,0.0026016703,0.0006844658,0.0017736211,0.013211217],"category_scores_gemma":[0.0008017971,0.00024410128,0.00048128827,0.00034938147,0.0015758032,0.0017869974,0.0014762981,0.0049761417,0.0044757104],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000659019,0.00026715186,0.0018305858,0.00042488315,0.00007155961,0.00086552504,0.0007581053,0.00066552527,0.087858506,0.16487505,0.54402274,0.19770136],"study_design_scores_gemma":[0.00006328548,0.00026866936,0.0016374439,0.00020857985,0.000029733925,0.0009478597,0.00048549712,0.000536223,0.019435307,0.04631893,0.9300351,0.00003333206],"about_ca_topic_score_codex":0.00080184743,"about_ca_topic_score_gemma":0.0008025293,"teacher_disagreement_score":0.013211217,"about_ca_system_score_codex":0.0016972675,"about_ca_system_score_gemma":0.0010183322,"threshold_uncertainty_score":0.04419595},"labels":[],"label_agreement":null},{"id":"W4389240426","doi":"10.1158/2326-6074.tumimm23-b004","title":"Abstract B004: Neoantigen adenoviral cancer vaccine generates improved CD8+ T-cell responses compared to adjuvanted peptide vaccine","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peptide vaccine; Immune system; CD8; Immunology; Cancer vaccine; T cell; Cancer immunotherapy; Vaccination; Epitope; Virology; Immunotherapy; Biology; Antigen; Medicine","score_opus":0.06228367985435414,"score_gpt":0.3741527830259748,"score_spread":0.3118691031716207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909739,0.0010547683,0.0039029873,0.00012280639,0.00010625575,0.000071731316,0.00078974623,0.00016907745,0.002808688],"genre_scores_gemma":[0.9840719,0.0004544551,0.0047771987,0.000056422974,0.000019082194,0.000046427947,0.0018162088,0.000045554312,0.008712646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999106,0.000010648249,0.000008697813,0.000016829905,0.00003064183,0.000022627337],"domain_scores_gemma":[0.9999422,0.000008741912,0.0000131588195,0.0000069711764,0.000011742614,0.000017207749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008912231,0.00040123521,0.00019608765,0.0001692648,0.00006706154,0.00019371917,0.0001597187,0.0002725389,0.004092372],"category_scores_gemma":[0.0000794867,0.00008605496,0.0001478465,0.00012340881,0.0001108553,0.00013336353,0.00010167191,0.0005043835,0.0007959931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012791721,0.000049309525,0.00008175888,0.00003529633,0.0000026315681,0.000011495293,0.0000043017694,0.000102929356,0.9980568,0.000045455832,0.00008615757,0.001396017],"study_design_scores_gemma":[0.000027970103,0.000904004,0.0012284976,0.0000057199213,0.000009807929,0.00010986084,0.000006976686,0.0007183516,0.99423814,0.000026923864,0.00272133,0.0000024374203],"about_ca_topic_score_codex":0.0003930008,"about_ca_topic_score_gemma":0.00029930743,"teacher_disagreement_score":0.004092372,"about_ca_system_score_codex":0.00023097642,"about_ca_system_score_gemma":0.00017198216,"threshold_uncertainty_score":0.013690352},"labels":[],"label_agreement":null},{"id":"W4389240480","doi":"10.1158/2326-6074.tumimm23-b049","title":"Abstract B049: Lipid nanoparticle-delivered toll-like receptor agonists are highly effective in cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Tumor microenvironment; Cancer; Immune system; Melanoma; CpG Oligodeoxynucleotide; Cancer immunotherapy; Cancer research; CpG site; Dosing; Immunology; Pharmacology; Internal medicine; Chemistry","score_opus":0.03809409247362991,"score_gpt":0.3372456088245331,"score_spread":0.2991515163509032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800632,0.0061115916,0.007006453,0.00029975572,0.00019440312,0.00011038782,0.00064936583,0.00030808142,0.005256737],"genre_scores_gemma":[0.98165923,0.0019138182,0.005917469,0.00012681121,0.00004675386,0.00008521956,0.0008797647,0.000052498588,0.009318288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989116,0.000018159022,0.000009654978,0.000018494182,0.00004018587,0.000022402966],"domain_scores_gemma":[0.9999449,0.0000074840527,0.000015843407,0.0000038897097,0.000012524265,0.000015328478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016468234,0.00044120307,0.0002889762,0.000273232,0.000102750855,0.00021539154,0.00018343286,0.00041814102,0.003257564],"category_scores_gemma":[0.000084634514,0.00011137237,0.00021113154,0.00012438906,0.00015303325,0.00018315777,0.00016305296,0.00044965371,0.0010705541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019691103,0.0000543856,0.000043081793,0.00003968124,0.0000032041924,0.00001727195,0.0000027449992,0.000058548176,0.9974942,0.00003312884,0.00012756269,0.001929294],"study_design_scores_gemma":[0.000048095262,0.0007964602,0.00068111724,0.000006488892,0.000012179175,0.000107650165,0.0000034902475,0.00061130465,0.99542207,0.000024894069,0.0022831568,0.000003052615],"about_ca_topic_score_codex":0.0003266624,"about_ca_topic_score_gemma":0.000257387,"teacher_disagreement_score":0.003257564,"about_ca_system_score_codex":0.00019924714,"about_ca_system_score_gemma":0.00016933371,"threshold_uncertainty_score":0.010897636},"labels":[],"label_agreement":null},{"id":"W4389240568","doi":"10.1158/2326-6074.tumimm23-pr01","title":"Abstract PR01: Regulation of exhausted CD8+ T cell differentiation by IKZF transcription factors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Immunology; Cancer immunotherapy; CD8; Biology; Immunotherapy; T cell; Cytokine; Progenitor cell; Transcription factor; Cancer research; Stem cell; Immune system; Cell biology; Genetics; Gene","score_opus":0.06386997535943507,"score_gpt":0.34039160081341263,"score_spread":0.27652162545397757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97453237,0.0029943495,0.013716186,0.00030988824,0.00011663834,0.000068938,0.002481726,0.00061191514,0.005167951],"genre_scores_gemma":[0.9823208,0.00086327514,0.003633609,0.000099853045,0.000023897905,0.000055490633,0.001604571,0.00011083103,0.011287668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985313,0.000013026861,0.000013079693,0.000048115962,0.000029568873,0.000043078995],"domain_scores_gemma":[0.9998826,0.0000134644815,0.000041233943,0.000011668618,0.000013730386,0.000037350048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011064799,0.00037497593,0.00014719745,0.00022161324,0.00016190989,0.00032227178,0.00022743727,0.00022322069,0.0036933601],"category_scores_gemma":[0.000096785174,0.000109666384,0.00021988251,0.00012263774,0.00026458522,0.00023519657,0.0002525958,0.0007491012,0.0013516853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013053424,0.000014055932,0.0001410311,0.000039454157,0.0000015253227,0.000040679482,0.000010830438,0.00003759404,0.997874,0.0000921296,0.000089204426,0.0015288444],"study_design_scores_gemma":[0.000030522675,0.0002577883,0.004385202,0.000011784824,0.0000118014805,0.00026760658,0.000052811833,0.00070342014,0.98896885,0.00010795139,0.0051965727,0.000005693982],"about_ca_topic_score_codex":0.00043949755,"about_ca_topic_score_gemma":0.00047344348,"teacher_disagreement_score":0.0036933601,"about_ca_system_score_codex":0.00030632134,"about_ca_system_score_gemma":0.00021373444,"threshold_uncertainty_score":0.012355566},"labels":[],"label_agreement":null},{"id":"W4389241326","doi":"10.1158/2326-6074.tumimm23-b043","title":"Abstract B043: A core inflammatory gene network associated with poor prognosis serves chemokine production in cancer associated fibroblasts in pancreatic ductal adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Transcriptome; Chemokine; Cancer-Associated Fibroblasts; Cancer research; Pancreatic cancer; Cancer; Pancreatic ductal adenocarcinoma; Gene signature; Adenocarcinoma; Biology; Gene expression; Gene; Medicine; Inflammation; Immunology; Internal medicine; Tumor cells","score_opus":0.09791905113859348,"score_gpt":0.38460295732029376,"score_spread":0.28668390618170025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721737,0.0018941944,0.0037404143,0.000121846846,0.000031091917,0.000040298062,0.020167347,0.00020651674,0.0016246062],"genre_scores_gemma":[0.974935,0.0007860609,0.0057475483,0.00014280734,0.000019857178,0.00015612134,0.016444277,0.00006675466,0.001701534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99978954,0.000024341822,0.000014779034,0.00007902953,0.000052975705,0.000039369177],"domain_scores_gemma":[0.9998086,0.000044547774,0.000054585344,0.000013419927,0.000037464648,0.000041415522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021468377,0.0002522656,0.00038988196,0.0009485987,0.00041976414,0.00048111586,0.00014185325,0.00020664462,0.003422995],"category_scores_gemma":[0.00032778174,0.00011988985,0.0003858627,0.0013068215,0.0001603662,0.00016281479,0.000361297,0.00026991114,0.0006703055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025291804,0.00013790569,0.3550019,0.0012382795,0.0003635128,0.0008397409,0.00039257517,0.0020871314,0.5931438,0.00039713524,0.004195951,0.03967293],"study_design_scores_gemma":[0.0000607305,0.0002688686,0.9468551,0.00007988967,0.00035862945,0.0011625503,0.00045124494,0.0051194862,0.037977725,0.0006633191,0.0069671045,0.000035225436],"about_ca_topic_score_codex":0.0018136563,"about_ca_topic_score_gemma":0.0022331583,"teacher_disagreement_score":0.003422995,"about_ca_system_score_codex":0.00023993975,"about_ca_system_score_gemma":0.000407761,"threshold_uncertainty_score":0.011451066},"labels":[],"label_agreement":null},{"id":"W4389241345","doi":"10.1158/2326-6074.tumimm23-a037","title":"Abstract A037: Prostate Specific Membrane Antigen Targeted Photodynamic Therapy Agent for the Treatment of Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Photodynamic therapy; Breast cancer; Cancer; Prostate; Cancer research; Glutamate carboxypeptidase II; Immunotherapy; Antigen; Pathology; Oncology; Internal medicine; Immunology; Chemistry","score_opus":0.06213209408112459,"score_gpt":0.3445584552434887,"score_spread":0.28242636116236414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81317747,0.106486924,0.030351624,0.002553558,0.0008963187,0.00095976156,0.0039637634,0.0014273687,0.04018328],"genre_scores_gemma":[0.90800244,0.035336807,0.023731425,0.00083968916,0.00017240833,0.00044497373,0.00239559,0.00008931563,0.028987268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993753,0.000005907098,0.0000022708439,0.000012017909,0.000028663797,0.000013697697],"domain_scores_gemma":[0.99997747,0.0000025517515,0.0000049897735,0.000001528395,0.000005373972,0.000008129971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011848614,0.00033977616,0.00022991518,0.00048294547,0.00017433775,0.0002060801,0.00033318822,0.00041055903,0.003946929],"category_scores_gemma":[0.000036680092,0.00009098511,0.00027706116,0.0002650981,0.00013231297,0.00020794851,0.00013768877,0.0006581233,0.0010370056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033390892,0.00038619823,0.00029800297,0.0002851246,0.000026328746,0.00013177197,0.000013916626,0.00019366566,0.9650203,0.0006619491,0.0027498037,0.029898845],"study_design_scores_gemma":[0.00017732714,0.0028953536,0.003373294,0.00005359212,0.00009354327,0.0013368803,0.000015558937,0.0013505663,0.95037955,0.00017173833,0.04013905,0.000013459438],"about_ca_topic_score_codex":0.00091989635,"about_ca_topic_score_gemma":0.00091044075,"teacher_disagreement_score":0.003946929,"about_ca_system_score_codex":0.00030276724,"about_ca_system_score_gemma":0.00035477016,"threshold_uncertainty_score":0.0132038},"labels":[],"label_agreement":null},{"id":"W4389241358","doi":"10.1158/2326-6074.tumimm23-a016","title":"Abstract A016: Reprogramming of immune-enhancing neutrophils by subclinical low-dose endotoxin for the treatment of cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Innate immune system; Reprogramming; Immunotherapy; Immunology; Cancer immunotherapy; Medicine; Cancer; Cancer research; Cancer cell; Subclinical infection; Biology; Cell; Internal medicine","score_opus":0.08005832439318357,"score_gpt":0.4560578932807521,"score_spread":0.3759995688875685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793162,0.005684974,0.009766206,0.0006910104,0.0003064035,0.00016005208,0.00057485513,0.00023241357,0.0032678768],"genre_scores_gemma":[0.9869675,0.00254827,0.004662506,0.00026735812,0.000049009766,0.00010298721,0.0005666934,0.000023281113,0.0048123104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999225,0.000013040555,0.0000075781636,0.000014677182,0.000025267991,0.00001689678],"domain_scores_gemma":[0.9999548,0.0000049001706,0.000011966241,0.0000051489324,0.000009244466,0.000013900554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011335657,0.00021651763,0.00017483966,0.00013257767,0.00010794256,0.00022633896,0.0001287029,0.0002302583,0.0020555465],"category_scores_gemma":[0.00008229813,0.00005329581,0.00022932472,0.00009148082,0.0001562819,0.00014720195,0.00020179206,0.0006259844,0.00032121415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034143537,0.00009610946,0.0003240485,0.00011029182,0.0000071733657,0.000051414896,0.000015039269,0.00008067174,0.99133,0.00019667849,0.00027371256,0.007173288],"study_design_scores_gemma":[0.000080956415,0.0025727737,0.004536705,0.000021410113,0.00003832793,0.00044437285,0.000049748298,0.0008074342,0.9805375,0.0001858454,0.0107155265,0.00000937244],"about_ca_topic_score_codex":0.0001858669,"about_ca_topic_score_gemma":0.00026178767,"teacher_disagreement_score":0.0020555465,"about_ca_system_score_codex":0.00014481832,"about_ca_system_score_gemma":0.00023656328,"threshold_uncertainty_score":0.0068765283},"labels":[],"label_agreement":null},{"id":"W4389241389","doi":"10.1158/2326-6074.tumimm23-b002","title":"Abstract B002: Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; T cell; CD8; Biology; Population; Immune system; Cytotoxic T cell; Splenocyte; Cancer research; Molecular biology; Immunology; Medicine; In vitro","score_opus":0.07310221273367039,"score_gpt":0.3595919720579775,"score_spread":0.2864897593243071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881811,0.0026492209,0.0026769773,0.00020448868,0.0001730287,0.00007367724,0.0006799964,0.00021207969,0.005149464],"genre_scores_gemma":[0.9877246,0.0007888043,0.0023297484,0.00014614809,0.00005751804,0.000069093556,0.0012558824,0.00003705606,0.007591151],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991477,0.0000145359045,0.0000060778593,0.000016777474,0.000022278196,0.0000256008],"domain_scores_gemma":[0.9999399,0.000015714817,0.000012734819,0.0000058091505,0.0000067720594,0.000019027882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117717536,0.00033253516,0.0001911076,0.00022619465,0.00009160836,0.00021878126,0.00027308357,0.00050995813,0.0034515876],"category_scores_gemma":[0.00010471628,0.00009374251,0.0001682305,0.00011629888,0.00015393535,0.00017164403,0.00008375441,0.00064208155,0.00070933066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010679829,0.00026097475,0.00015503571,0.0000824826,0.000006064709,0.000041211395,0.000008574196,0.00007575015,0.9929548,0.00009885591,0.0003448433,0.0049036383],"study_design_scores_gemma":[0.0001739256,0.0044535077,0.002455159,0.000010859956,0.00001729521,0.00024257597,0.000012155524,0.00072023016,0.9880399,0.000033714055,0.0038373023,0.0000032690575],"about_ca_topic_score_codex":0.00045773966,"about_ca_topic_score_gemma":0.00031985276,"teacher_disagreement_score":0.0034515876,"about_ca_system_score_codex":0.00019063932,"about_ca_system_score_gemma":0.00017113921,"threshold_uncertainty_score":0.011546731},"labels":[],"label_agreement":null},{"id":"W4389241392","doi":"10.1158/2326-6074.tumimm23-b007","title":"Abstract B007: Phenotypic Signatures of Circulating Neoantigen-Reactive CD8+ T Cells in Patients with Metastatic Cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; T-cell receptor; Cytotoxic T cell; Immunotherapy; T cell; Biology; Antigen; Cancer immunotherapy; Immunology; Circulating tumor cell; Cancer research; Phenotype; Cancer; Immune system; Metastasis; Gene; In vitro; Genetics","score_opus":0.06538773514156315,"score_gpt":0.38750745095334577,"score_spread":0.3221197158117826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999209,0.00009898267,0.0001905321,0.000013373689,0.0000019880206,0.000006300125,0.00011062859,0.000009848865,0.00035932],"genre_scores_gemma":[0.999323,0.000029958106,0.00021003344,0.000016040143,0.000004235802,0.000009542231,0.00020375941,0.0000028873235,0.00020065073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999926,0.000010428889,0.0000060862794,0.00002325956,0.000018007067,0.000016231068],"domain_scores_gemma":[0.99987495,0.000034400568,0.000027031487,0.000007849181,0.000023589539,0.000032172124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008289081,0.0001311383,0.00017084199,0.0002851325,0.00011619203,0.00021483365,0.000078740886,0.00024641628,0.001587597],"category_scores_gemma":[0.000288708,0.00006610306,0.000071810326,0.00020227114,0.000092135844,0.00010465739,0.0001053758,0.00024834136,0.00031641757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017009452,0.00016419205,0.47807187,0.000087245244,0.000026948841,0.0008741131,0.00030211842,0.00033904036,0.49538162,0.000058024212,0.0004429346,0.022551017],"study_design_scores_gemma":[0.00003919645,0.0013926405,0.95191413,0.000010124392,0.00004145082,0.0045990567,0.0002464231,0.0011905326,0.039089542,0.00007845269,0.0013913123,0.000007020509],"about_ca_topic_score_codex":0.00024750645,"about_ca_topic_score_gemma":0.00022695138,"teacher_disagreement_score":0.001587597,"about_ca_system_score_codex":0.000096559874,"about_ca_system_score_gemma":0.000054893568,"threshold_uncertainty_score":0.005311072},"labels":[],"label_agreement":null},{"id":"W4389241393","doi":"10.1158/2326-6074.tumimm23-a030","title":"Abstract A030: Blood-based screening panel for lung cancer based on clonal hematopoietic mutations in tumor infiltrating immune cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Cancer; Immune system; Medicine; Circulating tumor cell; Somatic evolution in cancer; Haematopoiesis; Immunology; Oncology; Cancer research; Internal medicine; Biology; Metastasis; Stem cell; Genetics","score_opus":0.0600768943612152,"score_gpt":0.3735269915377564,"score_spread":0.3134500971765412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639906,0.0010767699,0.024238138,0.0005439266,0.00007069553,0.00020515666,0.0055571278,0.0009764459,0.003341163],"genre_scores_gemma":[0.9835624,0.00011702122,0.012222601,0.00021122336,0.000028122184,0.00007525628,0.0026373062,0.00002897785,0.0011169965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990388,0.00031934376,0.00009586335,0.00018946276,0.00028028752,0.00007627696],"domain_scores_gemma":[0.9982374,0.0007998481,0.00027789513,0.00008301952,0.0004320414,0.00016979905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001474553,0.00060195266,0.0005065717,0.0016142942,0.00020804828,0.00065851037,0.0004459613,0.00055715657,0.0021158352],"category_scores_gemma":[0.003070571,0.00015646574,0.00047468414,0.000696216,0.00015623884,0.00020183073,0.00028897732,0.00052104646,0.0010433313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017154665,0.00038071178,0.8082403,0.00012269494,0.00016401653,0.0006813315,0.00005734375,0.005012348,0.12591378,0.00020258901,0.0053293435,0.05218011],"study_design_scores_gemma":[0.00015194391,0.0017617475,0.70704037,0.00007528443,0.00028740763,0.0036498236,0.000108483735,0.122826666,0.15739916,0.00058780634,0.006047541,0.00006379588],"about_ca_topic_score_codex":0.0021832795,"about_ca_topic_score_gemma":0.0023929544,"teacher_disagreement_score":0.0021832795,"about_ca_system_score_codex":0.00034308273,"about_ca_system_score_gemma":0.00031569714,"threshold_uncertainty_score":0.007798314},"labels":[],"label_agreement":null},{"id":"W4389241397","doi":"10.1158/2326-6074.tumimm23-a032","title":"Abstract A032: Antitumor activities of different RIG-I agonists in a murine model of kidney adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kidney; Adjuvant; TLR9; CpG site; Cancer research; CpG Oligodeoxynucleotide; Internal medicine; Pharmacology; Immunology; Biology; Gene; Gene expression","score_opus":0.06922599686079035,"score_gpt":0.3876212511225661,"score_spread":0.3183952542617758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528813,0.0010075758,0.001236949,0.00010811262,0.00007868917,0.00010458358,0.00057288684,0.00008767233,0.0015153964],"genre_scores_gemma":[0.991497,0.0008252327,0.0021236427,0.00007920318,0.00003582036,0.00019465604,0.00091749855,0.000019323157,0.0043076174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997496,0.00005241338,0.000029401634,0.00004059984,0.000062851555,0.000065081986],"domain_scores_gemma":[0.9998357,0.000025089532,0.000034769775,0.000022609851,0.000016091546,0.00006565291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003740762,0.0006468037,0.000486724,0.00051092665,0.000168501,0.0002589994,0.00029750288,0.00047986984,0.001462133],"category_scores_gemma":[0.00012832423,0.00015935194,0.0005050987,0.00022016131,0.00026828938,0.000268585,0.0001574073,0.00087452057,0.00039175354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025414994,0.001161798,0.0002358891,0.00008574771,0.000015224517,0.00007276509,0.000024868006,0.00018479585,0.9929055,0.00007526832,0.00010498638,0.002591532],"study_design_scores_gemma":[0.00024096857,0.015017703,0.0020203057,0.00001060736,0.000042812288,0.0002082305,0.000027708675,0.0007801457,0.9805572,0.000031570813,0.0010556997,0.0000071484305],"about_ca_topic_score_codex":0.000598947,"about_ca_topic_score_gemma":0.0007839899,"teacher_disagreement_score":0.001462133,"about_ca_system_score_codex":0.00020463858,"about_ca_system_score_gemma":0.00043652076,"threshold_uncertainty_score":0.004891336},"labels":[],"label_agreement":null},{"id":"W4389241441","doi":"10.1158/2326-6074.tumimm23-b029","title":"Abstract B029: Investigating therapeutic strategies to promote immune rejection of KRAS G12C inhibitor-resistant sub-populations in lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Immune system; Cancer research; Cancer; Lung cancer; Tumor microenvironment; Immunotherapy; Population; Immunology; Cancer cell; Biology; Medicine; Oncology; Colorectal cancer; Internal medicine","score_opus":0.16407142773062766,"score_gpt":0.46741755157289805,"score_spread":0.3033461238422704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845553,0.0042119874,0.0037485866,0.0004317968,0.00008460917,0.00027258418,0.00029236928,0.00012830622,0.0023741883],"genre_scores_gemma":[0.99259526,0.0017753066,0.002595192,0.00018095603,0.00003096826,0.0001672424,0.0002571001,0.000021792197,0.0023762244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998803,0.000022558994,0.0000065844292,0.000021531281,0.00002966512,0.000039386643],"domain_scores_gemma":[0.999944,0.0000070869073,0.000011144284,0.0000047194617,0.0000081736525,0.000024965906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025794763,0.00031641728,0.00035683863,0.00023897947,0.0001353627,0.0003583316,0.00033499094,0.00037670755,0.0020367992],"category_scores_gemma":[0.00009453011,0.00011510447,0.0002564816,0.00011166203,0.00018255468,0.00021278975,0.00020113049,0.0007739972,0.00048907095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071944797,0.0006107445,0.00033375522,0.0001590998,0.00002021778,0.00005351748,0.000024022536,0.0005223003,0.98349655,0.0002753989,0.00033390947,0.013451099],"study_design_scores_gemma":[0.000551251,0.019668587,0.0057308767,0.000028114964,0.000109508284,0.00047299845,0.000073984535,0.0046094027,0.9579034,0.00019941696,0.010638119,0.00001450469],"about_ca_topic_score_codex":0.0004978286,"about_ca_topic_score_gemma":0.0007709567,"teacher_disagreement_score":0.0020367992,"about_ca_system_score_codex":0.00025656453,"about_ca_system_score_gemma":0.0002982566,"threshold_uncertainty_score":0.006813824},"labels":[],"label_agreement":null},{"id":"W4389241446","doi":"10.1158/2326-6074.tumimm23-b012","title":"Abstract B012: Transcriptional activation of mouse LINE-1 promoter by transcription factor YY1","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"YY1; Transcription factor; Biology; Promoter; Molecular biology; Response element; Transcription (linguistics); Gene knockdown; Chromatin immunoprecipitation; Electrophoretic mobility shift assay; General transcription factor; Genetics; Gene; Gene expression","score_opus":0.11607551148955102,"score_gpt":0.3437398097800102,"score_spread":0.22766429829045914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95786923,0.008819425,0.01956439,0.00034705072,0.0002951266,0.00009576754,0.007032413,0.0006293858,0.0053470912],"genre_scores_gemma":[0.9536702,0.002370141,0.011922211,0.00020314558,0.00008021215,0.00015536933,0.013486368,0.0001749033,0.017937442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981767,0.00002133079,0.000014584521,0.000060055365,0.000045988687,0.00004045565],"domain_scores_gemma":[0.999884,0.000014952249,0.00003383255,0.000008961545,0.000017130027,0.00004107293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011689638,0.0005685973,0.00024687388,0.00036570156,0.00015900694,0.00025970463,0.00027115876,0.00028574234,0.004498113],"category_scores_gemma":[0.000124885,0.00019207507,0.00040699285,0.0002685645,0.00014886644,0.00018674677,0.00023172155,0.0005703853,0.0018577973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010675414,0.000014026406,0.00013632762,0.000036218225,0.000002125606,0.00002352754,0.0000064038427,0.000015687465,0.9986908,0.00005890061,0.00011629757,0.0007928196],"study_design_scores_gemma":[0.000026649597,0.0001700845,0.0053741285,0.000019348412,0.00001247664,0.00020037011,0.000023974268,0.0006941396,0.98774034,0.000061609564,0.005670306,0.000006589033],"about_ca_topic_score_codex":0.0007368511,"about_ca_topic_score_gemma":0.00073244545,"teacher_disagreement_score":0.004498113,"about_ca_system_score_codex":0.0003960495,"about_ca_system_score_gemma":0.00024935495,"threshold_uncertainty_score":0.015047729},"labels":[],"label_agreement":null},{"id":"W4389241501","doi":"10.1158/2326-6074.tumimm23-b010","title":"Abstract B010: Revealing the Influence of the Infantile Immune System on the Developmental Origins of Childhood Ependymoma: An Integrative Multi-Omic Investigation of Supratentorial Ependymoma Tumorigenesis Driven by ZFTA-RELA Fusion","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ependymoma; Biology; Immune system; Neuroscience; Cancer research; Immunology; Pathology; Medicine","score_opus":0.043145817827848765,"score_gpt":0.33973470422725477,"score_spread":0.296588886399406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704442,0.0030988443,0.019134277,0.00030548274,0.00010725448,0.000103681145,0.0020871179,0.00039141023,0.00432767],"genre_scores_gemma":[0.9763541,0.0018897419,0.012639635,0.00017955225,0.000020167387,0.00012323499,0.0017955732,0.000117802556,0.006880212],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982446,0.000014361177,0.000009947621,0.000049002534,0.00005581826,0.000046564175],"domain_scores_gemma":[0.99989295,0.000012250048,0.000029067307,0.00001170657,0.000013028348,0.000040955954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025923288,0.00037087649,0.00028058095,0.0004977467,0.0002069743,0.0003771995,0.00026507862,0.00035939147,0.0020585633],"category_scores_gemma":[0.00009967706,0.00015753208,0.00033521937,0.0001600625,0.00029237152,0.00027423626,0.0004884115,0.0012498226,0.00050054124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046307436,0.000023543143,0.00038761907,0.00004263348,0.000004874841,0.00008343602,0.00002517653,0.0000415311,0.99734133,0.00018502564,0.00006960491,0.0017490849],"study_design_scores_gemma":[0.000022331547,0.00050256983,0.018571997,0.00002376215,0.000050796058,0.001190112,0.0001678286,0.0019950974,0.96902686,0.00018271981,0.008254242,0.000011753687],"about_ca_topic_score_codex":0.00048624247,"about_ca_topic_score_gemma":0.00089712266,"teacher_disagreement_score":0.0020585633,"about_ca_system_score_codex":0.0003298614,"about_ca_system_score_gemma":0.00030365877,"threshold_uncertainty_score":0.0068866014},"labels":[],"label_agreement":null},{"id":"W4389241535","doi":"10.1158/2326-6074.tumimm23-a001","title":"Abstract A001: Reshaping the immune microenvironment after temozolomide priming in metastatic colorectal cancer patients in ARETHUSA clinical trial","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Immune system; Immune checkpoint; Immunotherapy; MSH6; Medicine; DNA mismatch repair; Colorectal cancer; Cancer research; Oncology; Tumor microenvironment; Cancer; Immunology; Internal medicine; Biology; Chemotherapy","score_opus":0.08686040538991975,"score_gpt":0.4098916356056458,"score_spread":0.32303123021572605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503654,0.0011915029,0.0001719736,0.00047776004,0.000111830035,0.0005686349,0.00060321076,0.000044175147,0.0017942984],"genre_scores_gemma":[0.9949262,0.00067948137,0.00043650327,0.00043322513,0.00013820571,0.0007351252,0.0013486398,0.0000122536285,0.0012904211],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997129,0.00013589117,0.000014908913,0.00003312915,0.000033693148,0.00006949471],"domain_scores_gemma":[0.9996575,0.00005927616,0.00008714179,0.000030223517,0.00003075509,0.00013514893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009905886,0.0004337582,0.000968642,0.00023733346,0.00034089977,0.00059493596,0.00028713892,0.0004693833,0.00376083],"category_scores_gemma":[0.00073507533,0.00015765514,0.0006763445,0.00028372317,0.00035750994,0.000389202,0.00021881922,0.0017108651,0.0003691683],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7736501,0.015417798,0.021256272,0.0010628607,0.0014299639,0.00033257378,0.0001908221,0.001062733,0.06425501,0.00045537692,0.007996956,0.11288948],"study_design_scores_gemma":[0.2850582,0.5306164,0.1522644,0.00014349804,0.0015635986,0.00051417644,0.00017874141,0.0021759945,0.013135752,0.00038199418,0.013917446,0.000049751183],"about_ca_topic_score_codex":0.0003733631,"about_ca_topic_score_gemma":0.0010584783,"teacher_disagreement_score":0.00376083,"about_ca_system_score_codex":0.000329466,"about_ca_system_score_gemma":0.000762076,"threshold_uncertainty_score":0.012581289},"labels":[],"label_agreement":null},{"id":"W4389241566","doi":"10.1158/2326-6074.tumimm23-b054","title":"Abstract B054: Immunological control by PARP inhibitors for successful immunotherapy in metastatic ovarian carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Immunotherapy; Cytotoxic T cell; DNA repair; DNA damage; Cancer; Immunology; Biology; Ovarian cancer; Immune system; Medicine; Internal medicine; DNA; In vitro; Genetics","score_opus":0.10298796408779382,"score_gpt":0.43308032806995667,"score_spread":0.33009236398216285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601099,0.02375742,0.0069346954,0.0007532276,0.00024473903,0.0002718481,0.0009010528,0.0002491953,0.006777924],"genre_scores_gemma":[0.98809063,0.0046588997,0.0034595977,0.00022218513,0.000065149914,0.00013069215,0.0005937253,0.000020313712,0.0027587288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999373,0.000010176049,0.0000055117357,0.0000125491215,0.000015744268,0.000018814564],"domain_scores_gemma":[0.99997425,0.0000028327665,0.00000654174,0.000002396412,0.0000037922152,0.000010118729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013861894,0.00025545468,0.00024676236,0.00022206016,0.00014558273,0.0003689479,0.00019125143,0.00024029575,0.0021711178],"category_scores_gemma":[0.000065611006,0.00008387326,0.00022328881,0.00016050725,0.00011750389,0.00017234102,0.00018970766,0.00061445433,0.0004587673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011385683,0.00041605512,0.00046860587,0.00030318,0.000026487405,0.00011947892,0.000024144327,0.00073129643,0.94885373,0.00051565154,0.0010117056,0.04639109],"study_design_scores_gemma":[0.00048554133,0.0063062613,0.0065745944,0.000060114995,0.00009770906,0.0007722464,0.000040811567,0.0036982712,0.95107824,0.0004197574,0.03045059,0.00001576636],"about_ca_topic_score_codex":0.0001458655,"about_ca_topic_score_gemma":0.00023093194,"teacher_disagreement_score":0.0021711178,"about_ca_system_score_codex":0.00022244883,"about_ca_system_score_gemma":0.00017616904,"threshold_uncertainty_score":0.007263124},"labels":[],"label_agreement":null},{"id":"W4389241582","doi":"10.1158/2326-6074.tumimm23-b048","title":"Abstract B048: Multiplex analysis of pancreatic, oesophageal and rectal adenocarcinoma: A cross-cancer approach on the impact of neoadjuvant therapy on the tumour microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Medicine; FOXP3; Stromal cell; Pancreatic cancer; Immune system; Cancer research; CD8; Immunotherapy; Tumor-infiltrating lymphocytes; Colorectal cancer; Pathology; Cancer; Immunology; Internal medicine","score_opus":0.11217253789018335,"score_gpt":0.4123460487443221,"score_spread":0.3001735108541388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975486,0.00100962,0.0075649647,0.000036021585,0.000014664884,0.00005176375,0.000234229,0.00009117682,0.0012426795],"genre_scores_gemma":[0.9778886,0.0007976183,0.01765932,0.000075450145,0.000012847794,0.00014243314,0.0006567001,0.000027288936,0.0027398004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998116,0.000034562643,0.000016286052,0.000050068313,0.000047410555,0.000040089235],"domain_scores_gemma":[0.9999088,0.000015110823,0.000019851195,0.000011801544,0.000027063252,0.00001735282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000322403,0.00031589103,0.00019620621,0.00043117767,0.00019752712,0.00032418047,0.000114114875,0.00024899334,0.0014691938],"category_scores_gemma":[0.00012488263,0.00016200147,0.00019182102,0.000297114,0.00013865346,0.00012987742,0.00021112086,0.00022863048,0.0003397279],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010402625,0.000021476328,0.0020497811,0.000028033312,0.000009224424,0.000027323089,0.000016125481,0.000042244228,0.995783,0.000021903796,0.000020441636,0.0018764393],"study_design_scores_gemma":[0.000009007941,0.0006184835,0.0577709,0.000008242818,0.00008701034,0.00089010346,0.00007445761,0.002443246,0.9355177,0.00004066252,0.0025335501,0.0000065999607],"about_ca_topic_score_codex":0.00045787884,"about_ca_topic_score_gemma":0.0007979159,"teacher_disagreement_score":0.0014691938,"about_ca_system_score_codex":0.00014321315,"about_ca_system_score_gemma":0.00014607846,"threshold_uncertainty_score":0.0049149394},"labels":[],"label_agreement":null},{"id":"W4389241592","doi":"10.1158/2326-6074.tumimm23-b038","title":"Abstract B038: Targeting a Treg-specific deubiquitinase module for antitumor immune therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FOXP3; Cancer research; Immune system; Cancer immunotherapy; Tumor microenvironment; Immunotherapy; Deubiquitinating enzyme; Effector; Biology; Regulatory T cell; Immunology; Immune checkpoint; T cell; Medicine; Gene; IL-2 receptor; Ubiquitin","score_opus":0.10759420896632486,"score_gpt":0.37443864192431087,"score_spread":0.266844432957986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206653,0.01187996,0.049202852,0.0010688986,0.00065925263,0.00035013977,0.0031720237,0.002040783,0.010960752],"genre_scores_gemma":[0.963138,0.0029067036,0.018445883,0.0005411315,0.00006992971,0.00017231105,0.0021703392,0.00016654514,0.012389251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998938,0.000010524167,0.000007501362,0.00002644161,0.00003600228,0.000025702544],"domain_scores_gemma":[0.9999472,0.0000033491328,0.000013314418,0.0000049289806,0.000009632702,0.00002147923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022730653,0.0003472382,0.00025844565,0.0002005233,0.00013179945,0.00034154014,0.0002662153,0.00037971724,0.002950059],"category_scores_gemma":[0.00006469484,0.00011775671,0.00032426888,0.00012140184,0.0001425381,0.00015253181,0.00019619911,0.0006663536,0.0010438204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013618352,0.00004401786,0.00010401935,0.00005127657,0.0000087559465,0.00003075478,0.0000045710153,0.000130301,0.9927776,0.00022517345,0.00055097573,0.0059363646],"study_design_scores_gemma":[0.00006002687,0.00041054894,0.00071269774,0.0000083403975,0.000023129138,0.00015843913,0.0000071785807,0.0017385609,0.98291403,0.00012043269,0.0138392225,0.000007401687],"about_ca_topic_score_codex":0.00037791397,"about_ca_topic_score_gemma":0.00045567175,"teacher_disagreement_score":0.002950059,"about_ca_system_score_codex":0.0002865698,"about_ca_system_score_gemma":0.00024526936,"threshold_uncertainty_score":0.009868979},"labels":[],"label_agreement":null},{"id":"W4389241602","doi":"10.1158/2326-6074.tumimm23-pr06","title":"Abstract PR06: Hallmarks of CD8 T cell dysfunction are established within hours of tumor antigen encounter prior to cell division","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immunology; T cell; CD8; Cytotoxic T cell; Epigenetics; Immunotherapy; Cancer; Biology; Cancer research; Cancer immunotherapy; Antigen; Context (archaeology); Medicine; Immune system; Genetics; In vitro","score_opus":0.04536079984949287,"score_gpt":0.35569516336923906,"score_spread":0.3103343635197462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824087,0.0015171827,0.007932816,0.00023061264,0.000088190944,0.000046930323,0.0018146745,0.0004941437,0.005466845],"genre_scores_gemma":[0.9805531,0.00066664047,0.0028679906,0.00012609245,0.000029096145,0.00006464034,0.0013733121,0.000105112726,0.01421403],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998035,0.000016168755,0.000013984581,0.000062366875,0.00006612501,0.000037912298],"domain_scores_gemma":[0.9998248,0.000018430452,0.00005187165,0.000024982817,0.000031008647,0.00004900082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011585259,0.00023824691,0.00024323032,0.00037775314,0.00022945573,0.00058450445,0.00019237639,0.0003904179,0.004926632],"category_scores_gemma":[0.00017161081,0.00013986528,0.00015484692,0.0002188547,0.0002999662,0.00034604705,0.00035718037,0.0009002545,0.0017361632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024885012,0.000025459147,0.00200918,0.000040292693,0.000003303586,0.00015697115,0.000054761542,0.000057342717,0.9920993,0.00027388375,0.00032719402,0.004703524],"study_design_scores_gemma":[0.00001909632,0.00062503066,0.049772043,0.000017799302,0.000012432139,0.0012761744,0.0001983395,0.0007735404,0.938128,0.0003000924,0.008865375,0.0000121345165],"about_ca_topic_score_codex":0.00034719336,"about_ca_topic_score_gemma":0.00049563916,"teacher_disagreement_score":0.004926632,"about_ca_system_score_codex":0.00024369873,"about_ca_system_score_gemma":0.00013451657,"threshold_uncertainty_score":0.01648122},"labels":[],"label_agreement":null},{"id":"W4389241634","doi":"10.1158/2326-6074.tumimm23-b032","title":"Abstract B032: CD161+ TRM cells counteract HPV-associated clinical benefits in oropharyngeal cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer; Medicine; Cancer immunotherapy; CD8; Immunology; Cancer research; Context (archaeology); Immune system; Oncology; Biology; Internal medicine","score_opus":0.14820406812954517,"score_gpt":0.46991587073285385,"score_spread":0.32171180260330867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692386,0.0013661516,0.00038961222,0.000099178775,0.000036905003,0.000050088565,0.0001763158,0.000050565402,0.0009071853],"genre_scores_gemma":[0.99732625,0.00026712543,0.00048058532,0.00015597107,0.000036886602,0.00005703876,0.00031669877,0.000016884682,0.0013426347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978596,0.000053809654,0.000014897381,0.000039759172,0.0000349265,0.00007062698],"domain_scores_gemma":[0.99985695,0.000027510041,0.000026434887,0.000021945325,0.000017191243,0.00005000783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027842436,0.00026468287,0.00052775827,0.0002204905,0.00015175321,0.00039970907,0.00019494878,0.00035812755,0.0035810883],"category_scores_gemma":[0.00027597128,0.00010694986,0.00024884954,0.00013318485,0.0002166684,0.00018591511,0.00025325487,0.0007849307,0.0008497398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020277759,0.0006687347,0.0028916753,0.0001590435,0.00002384728,0.000061203566,0.00004756254,0.00018549846,0.9768802,0.0000799641,0.00038582942,0.016588543],"study_design_scores_gemma":[0.0012717829,0.03701803,0.102833375,0.00012461214,0.00022099292,0.0017902228,0.00040748977,0.0049601095,0.8287703,0.0006067334,0.021967115,0.000029208939],"about_ca_topic_score_codex":0.00022169459,"about_ca_topic_score_gemma":0.0002948899,"teacher_disagreement_score":0.0035810883,"about_ca_system_score_codex":0.0001792109,"about_ca_system_score_gemma":0.00024170314,"threshold_uncertainty_score":0.011979878},"labels":[],"label_agreement":null},{"id":"W4389241701","doi":"10.1158/2326-6074.tumimm23-a040","title":"Abstract A040: Spatially resolved immune cell networks in renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Mass cytometry; Immune system; Immunotherapy; Cell; Renal cell carcinoma; Clear cell renal cell carcinoma; Tumor microenvironment; Antibody; Computational biology; Medicine; Cancer research; Biology; Immunology; Oncology; Phenotype; Genetics; Gene","score_opus":0.045366380144374725,"score_gpt":0.3139700469654124,"score_spread":0.2686036668210377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97578794,0.00086842466,0.01999427,0.00023226124,0.00002492259,0.000045362725,0.0012625409,0.00033352675,0.0014506135],"genre_scores_gemma":[0.9869559,0.00020119692,0.010895674,0.0000865149,0.00002222308,0.00004617438,0.0008934226,0.000035559253,0.00086329004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999706,0.000046089135,0.0000122881665,0.00010729901,0.00009360054,0.000034826815],"domain_scores_gemma":[0.99964404,0.00008449446,0.00007855713,0.000035573645,0.00011115488,0.00004616374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052377745,0.00017774836,0.00034204178,0.0010071266,0.00037754234,0.0007081156,0.00033750417,0.00042525172,0.001438138],"category_scores_gemma":[0.00072392763,0.00016242993,0.0003094539,0.0006950519,0.00023804254,0.00027353878,0.0004049454,0.00039074,0.00046162016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000446761,0.00010428175,0.12172048,0.00021513981,0.00012194877,0.00025969627,0.00030767298,0.009255987,0.83508754,0.0009143715,0.0014983248,0.030067755],"study_design_scores_gemma":[0.00004153589,0.00035942058,0.59802234,0.000038819348,0.0001399144,0.0010105268,0.00088095886,0.12280083,0.26536945,0.0026691242,0.008606524,0.000060553564],"about_ca_topic_score_codex":0.0040266756,"about_ca_topic_score_gemma":0.004362386,"teacher_disagreement_score":0.0040266756,"about_ca_system_score_codex":0.0007620081,"about_ca_system_score_gemma":0.00045741358,"threshold_uncertainty_score":0.008006513},"labels":[],"label_agreement":null},{"id":"W4389241714","doi":"10.1158/2326-6074.tumimm23-a009","title":"Abstract A009: CD103+CD56+ innate lymphoid cells are associated with an immunosuppressive microenvironment in ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"CD8; Biology; Ovarian cancer; Tumor microenvironment; Cancer research; CD16; Immunology; Antigen; Cancer; CD3; Immune system","score_opus":0.04907335634722679,"score_gpt":0.32257049648452607,"score_spread":0.2734971401372993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971275,0.00092490605,0.0003262263,0.0000653947,0.000010857763,0.00001438191,0.0004463556,0.000024887206,0.0010594381],"genre_scores_gemma":[0.99828017,0.0002497363,0.00022884287,0.000036614896,0.000014128029,0.000013059813,0.000495028,0.0000055040605,0.00067686226],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994075,0.0000069872603,0.0000068663226,0.000018110926,0.000011232468,0.000016030815],"domain_scores_gemma":[0.9999137,0.000013392595,0.00003581577,0.000006808593,0.00001000159,0.000020286054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006331222,0.000101412785,0.00013858682,0.00024155778,0.00013276198,0.00027796073,0.00007879083,0.00016434725,0.004549978],"category_scores_gemma":[0.000120647914,0.000060256676,0.00009832173,0.00024525487,0.00014024563,0.000099821744,0.00014276922,0.00020177418,0.00048675528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015526431,0.0000738133,0.104679264,0.00027019414,0.000027696573,0.0013790372,0.00014603151,0.000082966006,0.8772089,0.00014239181,0.00058415974,0.013852846],"study_design_scores_gemma":[0.00007748289,0.00069112587,0.8584562,0.00004995172,0.00007785308,0.0133057125,0.0006829509,0.0007376189,0.117616825,0.00027638848,0.008016347,0.000011517857],"about_ca_topic_score_codex":0.00018116987,"about_ca_topic_score_gemma":0.00017673688,"teacher_disagreement_score":0.004549978,"about_ca_system_score_codex":0.000118037206,"about_ca_system_score_gemma":0.00008851014,"threshold_uncertainty_score":0.0152211785},"labels":[],"label_agreement":null},{"id":"W4389241744","doi":"10.1158/2326-6074.tumimm23-a043","title":"Abstract A043: Identifying critical vulnerabilities that sensitise <i>Lkb1</i>-mutant lung adenocarcinoma to T cell mediated killing","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Cancer research; Immune checkpoint; STK11; Biology; Adenocarcinoma; CD8; CRISPR; Immunotherapy; Cancer; Memory T cell; T cell; Immune system; Immunology; Gene; Genetics; Colorectal cancer","score_opus":0.11875345147917762,"score_gpt":0.4189211730398104,"score_spread":0.30016772156063276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743988,0.0019135076,0.012573283,0.0006235461,0.00012996783,0.00024935443,0.0039017838,0.0005878514,0.005621935],"genre_scores_gemma":[0.97747314,0.0010375959,0.010178642,0.0004620993,0.000021571695,0.00016482362,0.0035210713,0.00010925734,0.0070318985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998085,0.000024187586,0.00002059863,0.00004318974,0.000055415276,0.00004809455],"domain_scores_gemma":[0.9998952,0.000018442932,0.000027910213,0.000013857597,0.000016845508,0.00002779268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018699371,0.0004024271,0.00032780797,0.0003181536,0.00023929343,0.0003878895,0.00033889787,0.000536896,0.003756609],"category_scores_gemma":[0.00014793477,0.00018968286,0.0003956732,0.00019379861,0.00023348621,0.00014624403,0.00025569493,0.00084978837,0.0011928605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012225457,0.0000343042,0.0002880512,0.000029192386,0.000007768035,0.000045693916,0.0000065487634,0.00013821693,0.9977235,0.00006572172,0.0002201254,0.0013186058],"study_design_scores_gemma":[0.00004477698,0.0009480106,0.004698548,0.000008031532,0.000044480672,0.00071467797,0.00003503863,0.0018026411,0.9855078,0.000079997204,0.0061053587,0.000010532451],"about_ca_topic_score_codex":0.0009521192,"about_ca_topic_score_gemma":0.0011827128,"teacher_disagreement_score":0.003756609,"about_ca_system_score_codex":0.0003946674,"about_ca_system_score_gemma":0.0003352798,"threshold_uncertainty_score":0.012567103},"labels":[],"label_agreement":null},{"id":"W4389241748","doi":"10.1158/2326-6074.tumimm23-a044","title":"Abstract A044: Screening and characterization of CD38 chimeric antigen receptors for the development of natural killer cell-based therapies","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD38; Jurkat cells; Epitope; Monoclonal antibody; Antigen; Chimeric antigen receptor; Biology; Molecular biology; T cell; Antibody; Chemistry; Immunology; Immune system; Cell biology; CD34; Stem cell","score_opus":0.058183982660818534,"score_gpt":0.33942677344880046,"score_spread":0.2812427907879819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98580325,0.000868305,0.009912114,0.00012248877,0.000018847657,0.00023141675,0.0008449226,0.00010696037,0.002091788],"genre_scores_gemma":[0.9691422,0.0008442731,0.01938322,0.00008771062,0.00001213116,0.00019134792,0.0036982694,0.000049734288,0.006590973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997807,0.000035090878,0.000017050628,0.00003166362,0.00008330074,0.000052237163],"domain_scores_gemma":[0.9998946,0.000017701272,0.000019339815,0.000014374571,0.00003131875,0.000022582824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027006018,0.000432278,0.00021101217,0.00035093105,0.00013407477,0.00031079032,0.00045492782,0.0003473743,0.002873185],"category_scores_gemma":[0.00021718486,0.00014099221,0.00033392885,0.0002481241,0.00012243583,0.0001700103,0.00020726617,0.00044688646,0.0010187455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074598625,0.000065207954,0.0001809257,0.000022792578,0.000004489897,0.000036166024,0.000007637522,0.00017517783,0.9976205,0.000053367152,0.0000663616,0.0016927139],"study_design_scores_gemma":[0.000031430744,0.000617828,0.0013585899,0.0000053276685,0.000019965739,0.00026415204,0.000015196784,0.0014169452,0.9926878,0.00003564441,0.0035427012,0.0000043806194],"about_ca_topic_score_codex":0.00047868473,"about_ca_topic_score_gemma":0.00037623203,"teacher_disagreement_score":0.002873185,"about_ca_system_score_codex":0.00032384502,"about_ca_system_score_gemma":0.00023831576,"threshold_uncertainty_score":0.009611726},"labels":[],"label_agreement":null},{"id":"W4389241775","doi":"10.1158/2326-6074.tumimm23-a054","title":"Abstract A054: Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Memory T cell; Immunotherapy; Cancer immunotherapy; CD8; Immunology; Immune system; T cell; CTLA-4; Cancer research; Cancer; Antigen; Medicine; Biology; In vitro; Internal medicine; Biochemistry","score_opus":0.08523785618377776,"score_gpt":0.36477024238039285,"score_spread":0.2795323861966151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837445,0.0022918899,0.004684431,0.00051320944,0.00045860908,0.00006802899,0.000877051,0.00038174257,0.0069805034],"genre_scores_gemma":[0.9699392,0.00074283057,0.0034918985,0.0003049135,0.00011688723,0.00008195107,0.0012861202,0.00006176241,0.023974493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998629,0.00002111273,0.000011830874,0.000027374535,0.00003997645,0.000036910344],"domain_scores_gemma":[0.99990237,0.00002216543,0.000021993588,0.000010466195,0.000016057358,0.00002683371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019876308,0.00031548442,0.00022291335,0.00038163937,0.00014253362,0.00031861346,0.00028843177,0.00040279632,0.008613748],"category_scores_gemma":[0.00012791948,0.00012130232,0.00030273432,0.00013452003,0.00020772757,0.00021997814,0.00016289648,0.000697211,0.0010115635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075115496,0.00016419888,0.00029671335,0.00007799844,0.000012279557,0.00007476184,0.000008508883,0.00010001911,0.99147886,0.00019583652,0.0007638456,0.0060758516],"study_design_scores_gemma":[0.00013907618,0.001578773,0.0022444346,0.000008478703,0.00003643438,0.00038717806,0.000011911976,0.00058216066,0.98956513,0.00010144346,0.0053406223,0.0000043004297],"about_ca_topic_score_codex":0.00033549726,"about_ca_topic_score_gemma":0.00028770615,"teacher_disagreement_score":0.008613748,"about_ca_system_score_codex":0.0003015027,"about_ca_system_score_gemma":0.00023697392,"threshold_uncertainty_score":0.028815806},"labels":[],"label_agreement":null},{"id":"W4389241782","doi":"10.1158/2326-6074.tumimm23-b011","title":"Abstract B011: Dynamics of predicted tumor neoepitope burden in a pan-cancer solid tumor pediatric cohort","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Context (archaeology); Cohort; Cancer; Pediatric cancer; Germline; Internal medicine; Disease; Human leukocyte antigen; Immunology; Biology; Genetics; Antigen; Gene","score_opus":0.055717692292938714,"score_gpt":0.38698924339892876,"score_spread":0.33127155110599005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314535,0.00015067321,0.00095074985,0.00007614867,0.000006346131,0.000014976127,0.0051904456,0.000046055826,0.0004192437],"genre_scores_gemma":[0.9852122,0.00022552717,0.0011011802,0.00006294536,0.000014665364,0.0000386263,0.012900402,0.00006807101,0.00037633377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996038,0.000056790755,0.00002117581,0.00018965144,0.00007051317,0.000057964062],"domain_scores_gemma":[0.99864346,0.00028933925,0.0003208031,0.00018706267,0.00026739915,0.00029189908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074289326,0.00029393836,0.00037446117,0.0005469418,0.0005121876,0.0008787581,0.00042729467,0.0003057734,0.0020821304],"category_scores_gemma":[0.0026716944,0.00022519229,0.0002826257,0.00083459186,0.00022349946,0.00044422157,0.0007966909,0.0007181222,0.0005592219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036441913,0.000025094087,0.98798126,0.000017463799,0.000054592518,0.00019132376,0.00016244453,0.00059331406,0.0027709631,0.00007956463,0.0015406144,0.006218993],"study_design_scores_gemma":[0.000022044129,0.0002038559,0.9889921,0.000013679315,0.000060528553,0.0016434077,0.0004166439,0.0034017374,0.0017729187,0.0001292032,0.00332955,0.0000144258765],"about_ca_topic_score_codex":0.0058888574,"about_ca_topic_score_gemma":0.005160291,"teacher_disagreement_score":0.0058888574,"about_ca_system_score_codex":0.00046011966,"about_ca_system_score_gemma":0.00050482,"threshold_uncertainty_score":0.011709154},"labels":[],"label_agreement":null},{"id":"W4389241815","doi":"10.1158/2326-6074.tumimm23-ia015","title":"Abstract IA015: Obesity and immunometabolism in cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Adipokine; Inflammation; Immunotherapy; Leptin; Immunology; Tumor microenvironment; Biology; Macrophage; Cancer immunotherapy; Adipose tissue; Cancer; Cancer research; Immunity; T cell; Internal medicine; Endocrinology; Medicine; Obesity","score_opus":0.07229591227182185,"score_gpt":0.40847689797416753,"score_spread":0.33618098570234567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241815","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039115965,0.19576825,0.0078106523,0.17934418,0.10825074,0.00034541808,0.0019646944,0.0010468735,0.46635318],"genre_scores_gemma":[0.11170013,0.05625658,0.0023844177,0.011819414,0.017025184,0.00009274488,0.00079187745,0.00010750595,0.79982215],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9998387,0.000033895383,0.00001666833,0.000032704356,0.00005619277,0.000021845448],"domain_scores_gemma":[0.99971026,0.000040847804,0.000036130456,0.00001612658,0.00009908184,0.000097568605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006067921,0.0003892842,0.00026744942,0.00093500986,0.0005328506,0.0016626725,0.0005335662,0.0012509348,0.042230923],"category_scores_gemma":[0.00054763193,0.00013273983,0.0001954394,0.0005290078,0.00060274435,0.0007446028,0.0006808275,0.0010593912,0.0071252426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036053165,0.00016364008,0.0020907472,0.0012376917,0.000032031887,0.00043798873,0.00022429685,0.00036730428,0.012740803,0.034388117,0.6779057,0.27005112],"study_design_scores_gemma":[0.000028261567,0.00015006892,0.008020824,0.0004232457,0.000026044494,0.000556889,0.00017741426,0.00040248604,0.004093416,0.005517049,0.9805844,0.000019792169],"about_ca_topic_score_codex":0.0021516688,"about_ca_topic_score_gemma":0.00265901,"teacher_disagreement_score":0.042230923,"about_ca_system_score_codex":0.0014389257,"about_ca_system_score_gemma":0.0008150922,"threshold_uncertainty_score":0.14127654},"labels":[],"label_agreement":null},{"id":"W4389241834","doi":"10.1158/2326-6074.tumimm23-b005","title":"Abstract B005: Molecular, metabolic and functional CD4 T cell paralysis in lymph node impedes tumor control","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Biology; T cell; Lymph node; Adoptive cell transfer; Cancer research; Tumor-infiltrating lymphocytes; Epitope; Antigen; Immunology; Cell biology; Immune system","score_opus":0.053916213096303046,"score_gpt":0.3794539962917979,"score_spread":0.3255377831954948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877664,0.0011521673,0.003476763,0.0003430287,0.000074054245,0.00006462317,0.00058724784,0.00018551924,0.0063501545],"genre_scores_gemma":[0.986283,0.00033173276,0.0022470835,0.00008118033,0.000016823082,0.000057502813,0.0005535126,0.000036174755,0.010392907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998889,0.0000109077455,0.0000068066383,0.000021448852,0.000033998385,0.000037991256],"domain_scores_gemma":[0.9999261,0.000011673667,0.000015148195,0.000008179705,0.000010713586,0.000028192855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010361987,0.00032367217,0.00015362304,0.0001841698,0.00013743548,0.00028126047,0.00032073402,0.0003467344,0.005674663],"category_scores_gemma":[0.00009316468,0.00011160093,0.00016007059,0.00008975248,0.00030332137,0.00018609637,0.0002069084,0.001075636,0.0011196748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038454184,0.00006724746,0.00017400118,0.000053313834,0.0000031440213,0.000035285106,0.000014203911,0.00012335894,0.99613357,0.00039905743,0.00015732158,0.0024550853],"study_design_scores_gemma":[0.00005269516,0.0006259159,0.0023448656,0.000014582682,0.000010987219,0.0001907223,0.000029250641,0.0018872013,0.9898113,0.00014815411,0.004880948,0.0000034314305],"about_ca_topic_score_codex":0.0008180365,"about_ca_topic_score_gemma":0.00064357946,"teacher_disagreement_score":0.005674663,"about_ca_system_score_codex":0.00052102533,"about_ca_system_score_gemma":0.00034362648,"threshold_uncertainty_score":0.018983603},"labels":[],"label_agreement":null},{"id":"W4389244652","doi":"10.1158/2326-6074.tumimm23-a012","title":"Abstract A012: STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Stimulator of interferon genes; Sting; Immunology; Interferon; Antigen; Antigen presentation; Biology; Immune system; Cancer research; Immunotherapy; Chemokine; Agonist; T cell; Innate immune system; Receptor","score_opus":0.1160784814119432,"score_gpt":0.41451720734726144,"score_spread":0.2984387259353182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319465,0.0030195455,0.0055234777,0.000503634,0.00024822887,0.00009330223,0.0036552371,0.00027996613,0.0034819213],"genre_scores_gemma":[0.989684,0.0007054618,0.0024479006,0.00026442608,0.000053175303,0.00008749802,0.0014605175,0.00003941792,0.005257497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977916,0.00003089483,0.000022718934,0.00005669113,0.00004566909,0.00006480681],"domain_scores_gemma":[0.9998596,0.000011968319,0.00003372439,0.000012764666,0.000018793826,0.00006308915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013743652,0.00028427257,0.0003207585,0.00014402978,0.00017998801,0.00045589657,0.00012358381,0.00034642778,0.0062973513],"category_scores_gemma":[0.00009328415,0.00012342753,0.00028103153,0.000117384734,0.00018760754,0.00018961595,0.00019600877,0.00095511664,0.0016639734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003653713,0.000026733163,0.00021672466,0.000060254108,0.0000027563372,0.00003147123,0.000011289433,0.000026654297,0.99781775,0.000085828695,0.0001766261,0.0011785425],"study_design_scores_gemma":[0.00007352622,0.00076389976,0.008797751,0.000026063419,0.000024773755,0.00023013097,0.00007728922,0.00094351795,0.9818735,0.000102352344,0.0070794467,0.000007664414],"about_ca_topic_score_codex":0.00033808965,"about_ca_topic_score_gemma":0.00047263788,"teacher_disagreement_score":0.0062973513,"about_ca_system_score_codex":0.00029217842,"about_ca_system_score_gemma":0.00023153251,"threshold_uncertainty_score":0.021066725},"labels":[],"label_agreement":null},{"id":"W4389244706","doi":"10.1158/2326-6074.tumimm23-b045","title":"Abstract B045: EV-mediated immune modulation of CD8+ T cells in renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Renal cell carcinoma; Flow cytometry; CD8; Immunotherapy; Cytotoxic T cell; Biology; Downregulation and upregulation; Cell culture; Immunology; Medicine; Chemistry; Pathology; In vitro","score_opus":0.03481382890091826,"score_gpt":0.3363016341544896,"score_spread":0.30148780525357133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907656,0.004603673,0.0014479654,0.00013494829,0.00013165122,0.000043586424,0.00044891075,0.00006165134,0.0023620587],"genre_scores_gemma":[0.99248874,0.001559974,0.001377315,0.00010536099,0.000056387762,0.000057931215,0.0010493625,0.000016362956,0.003288409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999895,0.000023388715,0.000010288891,0.000018285518,0.000024623789,0.00002841759],"domain_scores_gemma":[0.99996376,0.000008568061,0.0000059778154,0.0000040543737,0.000007793344,0.000009935286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014517392,0.00024333282,0.00029606943,0.00017604664,0.00013794278,0.00024391098,0.00018509105,0.00034103013,0.0033428688],"category_scores_gemma":[0.0000868346,0.00006859141,0.00031581937,0.00014663304,0.000107016676,0.00013997495,0.00013512645,0.000397915,0.00072742836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000964843,0.00019267271,0.00054652384,0.00025822912,0.000017903383,0.000100165315,0.00002723517,0.0002099516,0.9887798,0.000089748995,0.00035522203,0.00845771],"study_design_scores_gemma":[0.00014408266,0.0043892493,0.00999442,0.000027517544,0.00006664701,0.0008093543,0.000059606824,0.0010539328,0.97379905,0.00008099234,0.009567324,0.000007920753],"about_ca_topic_score_codex":0.0003916574,"about_ca_topic_score_gemma":0.00025311316,"teacher_disagreement_score":0.0033428688,"about_ca_system_score_codex":0.00017540606,"about_ca_system_score_gemma":0.00016812001,"threshold_uncertainty_score":0.011183023},"labels":[],"label_agreement":null},{"id":"W4389244746","doi":"10.1158/2326-6074.tumimm23-a052","title":"Abstract A052: Comprehensive EBV-specific T cell profiling and multi-omics analysis of nasopharyngeal carcinoma CD8 T cells reveals novel cancer-associated phenotype","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD38; Antigen; Nasopharyngeal carcinoma; Biology; CD8; Immunology; Immune system; TIGIT; Cytotoxic T cell; Cancer research; Medicine; Internal medicine; Stem cell","score_opus":0.10563327961360386,"score_gpt":0.3765125474396494,"score_spread":0.27087926782604554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720784,0.0010486396,0.013796301,0.00011480586,0.000036857877,0.00011026418,0.011055681,0.00043910998,0.0013198268],"genre_scores_gemma":[0.96104544,0.00047528054,0.018337369,0.00015999185,0.00003432531,0.00025033607,0.01755101,0.0000861459,0.0020601454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997594,0.000025511039,0.000019225108,0.000098016775,0.000059310023,0.000038593585],"domain_scores_gemma":[0.999908,0.00001714848,0.000017428334,0.00001352735,0.000026323754,0.00001756201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023262293,0.00042710468,0.00050395366,0.0009187305,0.0003915135,0.0007395656,0.00019389177,0.00033111696,0.0017595675],"category_scores_gemma":[0.00025458494,0.00012007121,0.00048708095,0.0008727845,0.00013336404,0.00016914347,0.00029978695,0.0003546821,0.0008225517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044474046,0.0000879215,0.018411594,0.00016141302,0.00008396476,0.00012030735,0.00008652143,0.0007478225,0.96483177,0.000085035885,0.0009703746,0.013968633],"study_design_scores_gemma":[0.00007252328,0.00094257767,0.46477333,0.00005336507,0.0003913605,0.0016355764,0.0005831438,0.038485613,0.47242787,0.0007866516,0.019783046,0.00006495541],"about_ca_topic_score_codex":0.00070577476,"about_ca_topic_score_gemma":0.0008333474,"teacher_disagreement_score":0.0017595675,"about_ca_system_score_codex":0.00020213811,"about_ca_system_score_gemma":0.00023948583,"threshold_uncertainty_score":0.0058863163},"labels":[],"label_agreement":null},{"id":"W4389244749","doi":"10.1158/2326-6074.tumimm23-a027","title":"Abstract A027: Exploring autoantibody response to proteins encoded by prostate cancer driver genes","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KEGG; Prostate cancer; Gene; Cancer; Biology; Computational biology; Autoantibody; Immunogenicity; Candidate gene; Genetics; Immune system; Transcriptome; Antibody; Gene expression","score_opus":0.15501005347750768,"score_gpt":0.44437593238393897,"score_spread":0.2893658789064313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883492,0.0031715333,0.0021437043,0.00011534029,0.000036302576,0.000051497158,0.0048380727,0.0001083029,0.0011860261],"genre_scores_gemma":[0.98374605,0.0013487135,0.005411795,0.00019771305,0.000036585378,0.000049586903,0.008155012,0.000034767938,0.0010197677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999747,0.000042973727,0.000017648463,0.00008008766,0.00007549911,0.000036826572],"domain_scores_gemma":[0.99956006,0.00013258912,0.00013109541,0.000019401225,0.00007838,0.00007845044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039478127,0.00035806812,0.00044149734,0.0014721544,0.0002835355,0.0006565058,0.00021373732,0.00034634472,0.0022135833],"category_scores_gemma":[0.00054901064,0.00012335129,0.00063089246,0.0015398968,0.000118007505,0.0001650198,0.0003432452,0.00028001601,0.0006332745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019586096,0.00024462282,0.39137468,0.0010929349,0.0007245142,0.0018364987,0.00013225652,0.0015919557,0.55221665,0.00034842544,0.003320133,0.045158718],"study_design_scores_gemma":[0.00011930202,0.0012595057,0.87454724,0.00009743818,0.0011046875,0.006054149,0.00022285237,0.00658448,0.09467617,0.0006270456,0.014665391,0.00004170864],"about_ca_topic_score_codex":0.0010099515,"about_ca_topic_score_gemma":0.0012299101,"teacher_disagreement_score":0.0022135833,"about_ca_system_score_codex":0.00027309058,"about_ca_system_score_gemma":0.00039996597,"threshold_uncertainty_score":0.0074052215},"labels":[],"label_agreement":null},{"id":"W4389244753","doi":"10.1158/2326-6074.tumimm23-pr02","title":"Abstract PR02: Lyn kinase regulates myeloid-cell responses to mammary tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"LYN; Cancer research; Tumor microenvironment; Mammary tumor; Metastasis; Chemokine; Myeloid; Macrophage polarization; Biology; Src family kinase; Immunology; Medicine; Kinase; Macrophage; Cancer; Breast cancer; Immune system; Proto-oncogene tyrosine-protein kinase Src; Internal medicine; Cell biology","score_opus":0.07701884497399324,"score_gpt":0.39625133368253135,"score_spread":0.3192324887085381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930207,0.0019394425,0.0018790391,0.00022969647,0.000061016817,0.000030936004,0.00091088586,0.00009150279,0.0018368395],"genre_scores_gemma":[0.99322915,0.0006166843,0.00089747837,0.00009514432,0.000017673618,0.000050030405,0.0011345595,0.000043105298,0.0039161397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998276,0.000024442405,0.000017367967,0.000046133755,0.00003380307,0.00005050062],"domain_scores_gemma":[0.99984944,0.000017561651,0.00004660181,0.00001311867,0.000012818725,0.00006042063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014191738,0.00028050714,0.00025819542,0.00019241472,0.0002454275,0.0004789711,0.00024254968,0.00033326226,0.0023687931],"category_scores_gemma":[0.00014155138,0.0001563676,0.00023843325,0.00016746309,0.00027825663,0.0001900897,0.00026835848,0.00076897524,0.0010687012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038883608,0.00004073539,0.00024813227,0.000025768957,0.0000021266671,0.000061135084,0.00000777456,0.000038211165,0.99820924,0.00012296051,0.00009304908,0.00076186954],"study_design_scores_gemma":[0.00013206228,0.000763062,0.018910611,0.000016553748,0.00002527284,0.0008910649,0.00012595452,0.0024712211,0.97229755,0.00017153894,0.004183113,0.000012039974],"about_ca_topic_score_codex":0.00035131903,"about_ca_topic_score_gemma":0.00046400313,"teacher_disagreement_score":0.0023687931,"about_ca_system_score_codex":0.00038087412,"about_ca_system_score_gemma":0.00026214833,"threshold_uncertainty_score":0.0079244375},"labels":[],"label_agreement":null},{"id":"W4389244767","doi":"10.1158/2326-6074.tumimm23-b017","title":"Abstract B017: Single-cell proteogenomic profiling reveals immune cell networks in renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clear cell renal cell carcinoma; Immune system; Stromal cell; Myeloid; T cell; CD8; Cancer research; Cell; Flow cytometry; Renal cell carcinoma; Biology; Phenotype; Medicine; Immunology; Pathology; Genetics","score_opus":0.05663824027177373,"score_gpt":0.3094583303966602,"score_spread":0.2528200901248865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96383536,0.0018630563,0.011374964,0.0005354749,0.00006306161,0.00006412889,0.018731508,0.00041954505,0.0031128176],"genre_scores_gemma":[0.9682907,0.00065957,0.009670603,0.0002993053,0.000039761533,0.00008288738,0.018837243,0.00011745492,0.0020025778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976426,0.000022018608,0.000013424171,0.00008197344,0.00007756873,0.00004064518],"domain_scores_gemma":[0.99978155,0.000055049128,0.00003707848,0.000021091973,0.00006524291,0.000040113042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003562102,0.00021153131,0.00032058026,0.00079346896,0.00044519082,0.0007037266,0.00020576693,0.00030281313,0.003014885],"category_scores_gemma":[0.0005093271,0.00013999765,0.0002514892,0.00070881104,0.00021818839,0.0002137638,0.0003499043,0.00040146054,0.0011092969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040549706,0.000056172008,0.07607151,0.0003129283,0.000123367,0.000268931,0.0002129033,0.0013139308,0.8913395,0.00041847271,0.003970661,0.0255062],"study_design_scores_gemma":[0.000040352727,0.00026080664,0.7134806,0.00006491192,0.00017529864,0.0017166763,0.00058271823,0.017292125,0.24484392,0.001323298,0.02016552,0.000053784264],"about_ca_topic_score_codex":0.0026237958,"about_ca_topic_score_gemma":0.0037394806,"teacher_disagreement_score":0.003014885,"about_ca_system_score_codex":0.00037360983,"about_ca_system_score_gemma":0.00052078575,"threshold_uncertainty_score":0.010085821},"labels":[],"label_agreement":null},{"id":"W4389244788","doi":"10.1158/2326-6074.tumimm23-a021","title":"Abstract A021: Nutrient competition in the tumor microenvironment alters NK cell metabolism in Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glycogen; Tumor microenvironment; Pancreatic cancer; Biology; Cancer research; Cytotoxic T cell; Cell culture; Cancer cell; Organoid; Cell biology; Immune system; Endocrinology; Internal medicine; Cancer; Immunology; Biochemistry; In vitro; Medicine","score_opus":0.029300270878236865,"score_gpt":0.32090771148354424,"score_spread":0.29160744060530736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216753,0.0027574322,0.0014594364,0.00024732697,0.00009552615,0.000022340664,0.0020564606,0.000058505895,0.0011354797],"genre_scores_gemma":[0.990862,0.0010769371,0.0010697998,0.00019344412,0.000020788932,0.00008559507,0.0021776801,0.000036777627,0.0044769403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983966,0.00002863441,0.000014169154,0.0000494189,0.000032964224,0.000035056688],"domain_scores_gemma":[0.99990857,0.000013417967,0.000022816199,0.000009963079,0.000013551337,0.0000316829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012052132,0.00021297242,0.00040580097,0.00018519555,0.00019696479,0.0005071974,0.00019895515,0.00036181195,0.0054539414],"category_scores_gemma":[0.0001346336,0.00013767248,0.00037266023,0.00027079525,0.00020205948,0.00022445338,0.00028334663,0.00082202244,0.00087093364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019472553,0.000075253876,0.002454983,0.00013670113,0.000017785685,0.00012836691,0.000033281984,0.000108951586,0.99172145,0.00007007352,0.00027315607,0.0030327977],"study_design_scores_gemma":[0.00018467245,0.002426366,0.101140946,0.00005738486,0.000116760275,0.0014670811,0.0005157235,0.0018112353,0.87912506,0.00041709514,0.012708564,0.000029107618],"about_ca_topic_score_codex":0.00063545373,"about_ca_topic_score_gemma":0.0005831576,"teacher_disagreement_score":0.0054539414,"about_ca_system_score_codex":0.00029812183,"about_ca_system_score_gemma":0.00024377124,"threshold_uncertainty_score":0.01824528},"labels":[],"label_agreement":null},{"id":"W4389244809","doi":"10.1158/2326-6074.tumimm23-a038","title":"Abstract A038: Targeting TCTP overcomes resistance to T cell-mediated immunotherapy by reversing the multi-malignant phenotypes of immune-refractory tumor cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Immune checkpoint; Immune system; Medicine; Cancer research; Cancer; Targeted therapy; Immunology; Cancer immunotherapy; Internal medicine","score_opus":0.03711075864348952,"score_gpt":0.34290584805681174,"score_spread":0.30579508941332223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98474425,0.003829963,0.0059634116,0.0003908058,0.0001425535,0.0001268134,0.00047494503,0.00027424475,0.0040530823],"genre_scores_gemma":[0.99339795,0.0008544555,0.0018127982,0.00015210564,0.000022302083,0.00006025354,0.00045291416,0.000025846948,0.0032214967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992216,0.000009798894,0.000006577512,0.000016263639,0.000023637698,0.000021659835],"domain_scores_gemma":[0.99994767,0.000006735078,0.000010431185,0.0000068821696,0.0000117944965,0.000016394742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080930426,0.0002796793,0.00023056431,0.00020484511,0.00014714625,0.0002477142,0.0002437336,0.00037208587,0.0018925618],"category_scores_gemma":[0.000088634464,0.00006725123,0.0002319822,0.0001433133,0.00014292327,0.00015793138,0.00013371614,0.00073075783,0.000572435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019025446,0.00009668772,0.00018962155,0.000059550082,0.000008756154,0.00007572247,0.000011739544,0.000108055894,0.993576,0.00018991076,0.00034175007,0.005151996],"study_design_scores_gemma":[0.00009201195,0.001242044,0.0022821224,0.000011839668,0.000042255175,0.0006948769,0.000023128545,0.0027923281,0.98303324,0.00015655074,0.0096210595,0.000008485576],"about_ca_topic_score_codex":0.00061471824,"about_ca_topic_score_gemma":0.0006063409,"teacher_disagreement_score":0.0018925618,"about_ca_system_score_codex":0.00021036554,"about_ca_system_score_gemma":0.00024998648,"threshold_uncertainty_score":0.006331265},"labels":[],"label_agreement":null},{"id":"W4389261506","doi":"10.1158/2326-6074.tumimm23-a042","title":"Abstract A042: Quantitative multiplex immunoprecipitation reveals distinct protein interaction networks responsible for discrepant <i>in vivo</i> activity exhibited by two second generation CD22-targeted chimeric antigen receptors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Multiplex; CD19; Antigen; CD22; Immunoprecipitation; In vivo; Cancer research; MUC1; CD28; Immunotherapy; Biology; Computational biology; Immunology; Antibody; CD8; Immune system; Bioinformatics; Genetics","score_opus":0.11106423132623436,"score_gpt":0.43683583407814675,"score_spread":0.3257716027519124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389261506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027294,0.0006095796,0.00554398,0.0002309466,0.000044488643,0.00003650083,0.0011547738,0.00022590504,0.0018808588],"genre_scores_gemma":[0.99148303,0.00026961914,0.003504067,0.00015950763,0.000027349923,0.000059689715,0.0019377324,0.000049450307,0.0025095763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997379,0.000035625133,0.000014436801,0.00009670146,0.000060408012,0.000054882446],"domain_scores_gemma":[0.9998772,0.000035615012,0.000026447955,0.000014126079,0.000018702574,0.000027884835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031596815,0.00038188722,0.0002781455,0.00038414518,0.00022387823,0.0007835388,0.0002800115,0.00035568626,0.0033319565],"category_scores_gemma":[0.00027229244,0.00017056936,0.000324225,0.00026962385,0.0001874863,0.00019062367,0.00012567009,0.0006451067,0.0008634166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005943182,0.00009025708,0.0009839479,0.000026826085,0.000021225775,0.00004139003,0.000012043806,0.00015501995,0.99578387,0.0001355073,0.00041929615,0.0017361783],"study_design_scores_gemma":[0.00012379324,0.00052988343,0.02722113,0.0000069384946,0.000060606217,0.00063931476,0.000048689268,0.015167235,0.95260096,0.00023004701,0.003353086,0.000018360712],"about_ca_topic_score_codex":0.00046175395,"about_ca_topic_score_gemma":0.0005751158,"teacher_disagreement_score":0.0033319565,"about_ca_system_score_codex":0.00039375047,"about_ca_system_score_gemma":0.00018830753,"threshold_uncertainty_score":0.011146486},"labels":[],"label_agreement":null},{"id":"W4389261533","doi":"10.1158/2326-6074.tumimm23-b037","title":"Abstract B037: Single-cell analysis reveals immune characteristics linked to poor prognosis in <i>Fusobacterium nucleatum</i>-infected colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusobacterium nucleatum; Immune system; Transcriptome; Colorectal cancer; Biology; Cancer research; Cell; Cancer; Immunology; Gene expression; Gene; Genetics","score_opus":0.04287220124879889,"score_gpt":0.356041591496834,"score_spread":0.31316939024803514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389261533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528164,0.0005307287,0.001353593,0.00005203329,0.000015027076,0.000017331127,0.0023837257,0.000044507662,0.0003212535],"genre_scores_gemma":[0.99471587,0.00020748844,0.001509486,0.000073083065,0.000015399943,0.000037171085,0.0031037203,0.000012743705,0.00032504587],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987936,0.0000140609345,0.000007823134,0.000042399126,0.000025714333,0.00003058173],"domain_scores_gemma":[0.9998234,0.00003106946,0.000045180714,0.000015157072,0.00004453144,0.00004069828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002033306,0.00017978768,0.0003763468,0.0005029869,0.00024824668,0.00044451468,0.00015066421,0.00029068752,0.0009825011],"category_scores_gemma":[0.0003185934,0.000090494235,0.00024506648,0.00049170427,0.00015388311,0.00012461914,0.00019515131,0.00024236196,0.00031780315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013815588,0.00007480297,0.2609249,0.00019785643,0.00010012875,0.0003387916,0.00014785615,0.00083991425,0.7223528,0.000076713484,0.00097234093,0.0125922775],"study_design_scores_gemma":[0.000019641835,0.00044102533,0.9261603,0.000027124426,0.0001079926,0.00081579346,0.00041527412,0.0082407035,0.06097371,0.00022376244,0.0025502509,0.000024354977],"about_ca_topic_score_codex":0.0018480952,"about_ca_topic_score_gemma":0.0022939185,"teacher_disagreement_score":0.0018480952,"about_ca_system_score_codex":0.00021311807,"about_ca_system_score_gemma":0.00016984894,"threshold_uncertainty_score":0.003674686},"labels":[],"label_agreement":null},{"id":"W4389892676","doi":"10.1158/2326-6066.cir-23-0498","title":"Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Legend Biotech; Juno Therapeutics; Genentech; National Institutes of Health; National Cancer Institute; Natera; Regeneron Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Amgen; Society of Memorial Sloan Kettering; Seres Therapeutics; Da Volterra; BeiGene; Cycle for Survival; Daiichi Sankyo Europe; Sanofi; Eli Lilly and Company; AstraZeneca; National Institute on Aging; Parker Institute for Cancer Immunotherapy","keywords":"Dysbiosis; Fecal bacteriotherapy; Microbiome; Medicine; Feces; Gut flora; Context (archaeology); Colitis; Transplantation; Immunology; Internal medicine; Inflammatory bowel disease; Gastroenterology; Antibiotics; Clostridium difficile; Disease; Biology; Microbiology; Bioinformatics","score_opus":0.03188858580801742,"score_gpt":0.3309719139326852,"score_spread":0.2990833281246678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389892676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968209,0.0017493939,0.0006737247,0.00009657796,0.00001444975,0.000018783763,0.00004534312,0.000023878496,0.00055685994],"genre_scores_gemma":[0.99850345,0.0006392362,0.00052660116,0.00010537177,0.00001813152,0.000008099867,0.00009128599,0.0000048815223,0.00010296785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998362,0.000046394372,0.00001755787,0.000030935305,0.000029335053,0.000039575047],"domain_scores_gemma":[0.999624,0.000047490164,0.00018333856,0.000031606076,0.000025358393,0.00008815072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032547925,0.00023219042,0.00045720694,0.0002628185,0.00023638585,0.00035824106,0.000073352145,0.00012185615,0.0007298764],"category_scores_gemma":[0.0006127161,0.000083747465,0.0002565095,0.0002552312,0.00025622008,0.00018123812,0.00024850122,0.00033319523,0.00010918972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035777849,0.000619648,0.57190514,0.0004306373,0.0003958834,0.0030109065,0.00021415157,0.00057984,0.27576408,0.00016203285,0.0006744034,0.14266549],"study_design_scores_gemma":[0.00012033065,0.00517256,0.95661724,0.00007391593,0.00019201718,0.008093839,0.0002860101,0.0009364129,0.025453933,0.00016657259,0.0028731578,0.000014092485],"about_ca_topic_score_codex":0.00028844582,"about_ca_topic_score_gemma":0.00056113204,"teacher_disagreement_score":0.0007298764,"about_ca_system_score_codex":0.00017072506,"about_ca_system_score_gemma":0.00021010774,"threshold_uncertainty_score":0.0024417043},"labels":[],"label_agreement":null},{"id":"W4390706751","doi":"10.1158/2326-6066.cir-23-0480","title":"Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"University of Pittsburgh; Leids Universitair Medisch Centrum; National Institutes of Health; Universiteit Leiden; Istituto Pasteur-Fondazione Cenci Bolognetti; Oncolytics Biotech","keywords":"Oncolytic virus; Medicine; Immunotherapy; Antibody; Cancer immunotherapy; Regimen; Cancer; Neutralizing antibody; Cancer research; Immunology; Internal medicine","score_opus":0.031371503910255456,"score_gpt":0.37407636577103637,"score_spread":0.3427048618607809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927543,0.002261524,0.002987761,0.00006689182,0.00006402359,0.00010435991,0.00021507633,0.00009846874,0.001447624],"genre_scores_gemma":[0.9950009,0.0010399095,0.00218884,0.00006816018,0.000018804227,0.000079523496,0.0003197549,0.000022135757,0.0012619054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958664,0.00006256445,0.000027208953,0.000069449765,0.00010219881,0.0001519114],"domain_scores_gemma":[0.9998599,0.000038462502,0.000030462896,0.00003207701,0.000013224778,0.000025815485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020512578,0.0006350209,0.00052599754,0.00023876331,0.00009697881,0.0003724191,0.0003289497,0.00048334108,0.000712721],"category_scores_gemma":[0.00019966648,0.00018825028,0.00039969746,0.00014561924,0.00021729233,0.00028732733,0.0002006547,0.0011902988,0.0002255335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022681977,0.00018834638,0.00009728529,0.000035020566,0.000013996027,0.000025205343,0.000013607928,0.00019569784,0.99576974,0.0001189433,0.000061869905,0.0032534976],"study_design_scores_gemma":[0.000058037116,0.0020527984,0.0015583949,0.000008373951,0.00003642859,0.0002306925,0.00001156539,0.0012604144,0.992361,0.000040893094,0.0023753182,0.0000060271027],"about_ca_topic_score_codex":0.0005698954,"about_ca_topic_score_gemma":0.0009621709,"teacher_disagreement_score":0.000712721,"about_ca_system_score_codex":0.00024109324,"about_ca_system_score_gemma":0.0002326722,"threshold_uncertainty_score":0.002384305},"labels":[],"label_agreement":null},{"id":"W4400002746","doi":"10.1158/2326-6066.cir-23-1114","title":"Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; Queen's University","funders":"Canada Foundation for Innovation; Bladder Cancer Canada; Cancer Research Society","keywords":"Bladder cancer; Immune system; Immunotherapy; Cancer; Medicine; Tumor microenvironment; Inflammation; Immunology; Cancer research; Cancer immunotherapy; Internal medicine","score_opus":0.05586856429779632,"score_gpt":0.4219470691131157,"score_spread":0.3660785048153194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400002746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983322,0.0010465209,0.00016855603,0.000033140423,0.000005223562,0.0000074892537,0.000077450524,0.000016559967,0.00031282325],"genre_scores_gemma":[0.9988661,0.00034679702,0.00015361063,0.00002465343,0.0000053219496,0.000010268643,0.000116863026,0.000003935598,0.00047245988],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999925,0.000016686661,0.0000057711895,0.000013898629,0.000019211266,0.00001942727],"domain_scores_gemma":[0.99983764,0.000011248611,0.00007117685,0.000010153961,0.000015583986,0.000054206255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013182698,0.00013026116,0.0001760149,0.0003131999,0.00017590469,0.00025481393,0.000066471526,0.00016825457,0.0013848282],"category_scores_gemma":[0.00015248512,0.00011244524,0.000119237826,0.00018648537,0.00012560024,0.00010836572,0.00021860443,0.0003275459,0.00019833524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019339797,0.000180984,0.08282601,0.0001654741,0.00003862957,0.00052382145,0.00014306176,0.00012895263,0.9028354,0.00010114767,0.00027825043,0.010844309],"study_design_scores_gemma":[0.00004534737,0.0011352516,0.90324336,0.000025064486,0.00007372773,0.00212957,0.0002400709,0.0010730878,0.087777354,0.00011142475,0.004134889,0.000010753066],"about_ca_topic_score_codex":0.00042280884,"about_ca_topic_score_gemma":0.0005393467,"teacher_disagreement_score":0.0013848282,"about_ca_system_score_codex":0.00012525746,"about_ca_system_score_gemma":0.0001394054,"threshold_uncertainty_score":0.0046327114},"labels":[],"label_agreement":null},{"id":"W4401879340","doi":"10.1158/2326-6066.cir-24-0463","title":"Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Ludwig Center at Harvard; Fondation pour la Recherche Médicale; Glenn Foundation for Medical Research; Canadian Institutes of Health Research; American Cancer Society","keywords":"Immune system; Immunotherapy; CD8; Immunology; Cytotoxic T cell; Antigen; T cell; Cancer; Medicine; Immunity; Cancer research; Biology; Internal medicine","score_opus":0.05197326157117774,"score_gpt":0.34573866911676804,"score_spread":0.29376540754559033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401879340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984999,0.000658397,0.0004940665,0.000018635732,0.000007471598,0.0000044454405,0.00006371812,0.000013276825,0.00024003458],"genre_scores_gemma":[0.99856526,0.00034736207,0.0003457097,0.000036426205,0.000009504419,0.000009736651,0.000083470004,0.0000048171055,0.0005978599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990857,0.000016921056,0.000010174883,0.000021591564,0.0000149574935,0.000027888475],"domain_scores_gemma":[0.999841,0.00001591223,0.00006616912,0.00001796175,0.000009223328,0.000049789895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019710568,0.00023032504,0.0002663227,0.00015715968,0.000060247654,0.00016427362,0.00009337351,0.00017463007,0.00064308837],"category_scores_gemma":[0.00012990876,0.00009941403,0.00016108465,0.00007225255,0.00015435102,0.00016426438,0.00013165789,0.00032401085,0.00012472435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001984111,0.000029331157,0.0011999152,0.000014930271,0.0000039634806,0.000052257587,0.000011284167,0.00005461162,0.99711454,0.000051913157,0.000019290386,0.0012495761],"study_design_scores_gemma":[0.00005972497,0.0055850544,0.13288482,0.000015288811,0.000062610154,0.002373948,0.00011567855,0.0017148582,0.85285056,0.0002869668,0.0040384987,0.000011993071],"about_ca_topic_score_codex":0.00013194306,"about_ca_topic_score_gemma":0.00022810658,"teacher_disagreement_score":0.00064308837,"about_ca_system_score_codex":0.00012543914,"about_ca_system_score_gemma":0.00011153262,"threshold_uncertainty_score":0.0021513104},"labels":[],"label_agreement":null},{"id":"W4403222422","doi":"10.1158/2326-6066.cir-23-0639","title":"Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T Cells","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative; Terry Fox Research Institute; Canadian Cancer Society","keywords":"Immunogenicity; CD8; Cancer immunotherapy; Immunotherapy; T cell; Cancer; Cytotoxic T cell; Antigen; Cancer research; Biology; Immunology; T-cell receptor; Immune system; In vitro; Genetics","score_opus":0.10180865058364161,"score_gpt":0.3742992026682734,"score_spread":0.2724905520846318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403222422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990502,0.00009999327,0.00028962997,0.000015791897,0.0000049023292,0.000005140342,0.000039080438,0.000006798439,0.0004885651],"genre_scores_gemma":[0.9990275,0.000073455645,0.00031288862,0.000020937874,0.0000042004294,0.000007534062,0.000076230426,0.000008342669,0.00046895418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999798,0.00005573901,0.00001886435,0.000030130976,0.000030734955,0.000066523],"domain_scores_gemma":[0.99973375,0.00011819441,0.000040401977,0.000019135865,0.000025856723,0.00006262715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017367674,0.00015368896,0.00016956736,0.00010047917,0.00007389034,0.00046219013,0.00009188167,0.00023778509,0.0009617978],"category_scores_gemma":[0.00029292845,0.00010686178,0.00009045584,0.00009573344,0.00018119681,0.00019583186,0.0001170098,0.00057551445,0.00026051037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011862351,0.000036736077,0.00031251553,0.000007560694,0.0000014775075,0.000011452839,0.0000069429943,0.000054263826,0.99916375,0.000019375986,0.0000068032136,0.00026061395],"study_design_scores_gemma":[0.000018023116,0.0010864376,0.011743283,0.000004000393,0.000020547388,0.00011590242,0.000055425597,0.0022016892,0.98420864,0.00005682467,0.00048402324,0.0000051754128],"about_ca_topic_score_codex":0.00017964853,"about_ca_topic_score_gemma":0.00024171121,"teacher_disagreement_score":0.0009617978,"about_ca_system_score_codex":0.0001695077,"about_ca_system_score_gemma":0.00010995633,"threshold_uncertainty_score":0.003217578},"labels":[],"label_agreement":null},{"id":"W4403429512","doi":"10.1158/2326-6066.cir-24-0138","title":"Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Cancer research; Immunotherapy; Antigen; Chimeric antigen receptor; Cytotoxicity; Immunology; Cytotoxic T cell; In vivo; Medicine; In vitro; Chemistry; Immune system; Biology; Biochemistry","score_opus":0.09737323653413922,"score_gpt":0.4412458670481349,"score_spread":0.3438726305139957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403429512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867683,0.0011378431,0.0067405845,0.00021488922,0.00016543356,0.0015716917,0.00084991386,0.00018820814,0.0023631426],"genre_scores_gemma":[0.9860961,0.0015534784,0.006309843,0.00015909628,0.0000576108,0.0011664386,0.0014458789,0.000042139356,0.0031694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996394,0.000089673245,0.000029392673,0.000060064925,0.000076908735,0.00010459387],"domain_scores_gemma":[0.99977165,0.000032913234,0.00005407113,0.000028480714,0.000040541494,0.000072310744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065961713,0.00081840844,0.0005450722,0.00052645826,0.00027363843,0.00062805664,0.0006044913,0.0008658411,0.0014172737],"category_scores_gemma":[0.00031152926,0.0002931567,0.0004665409,0.00023157576,0.00031592205,0.0004394599,0.00021795489,0.0020300932,0.0005330627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019364597,0.00565931,0.00042378248,0.00014741597,0.000044474116,0.00019284953,0.000120261415,0.0016427437,0.98107177,0.0004836493,0.00059732626,0.00767994],"study_design_scores_gemma":[0.00157486,0.076427534,0.0018324462,0.000027847731,0.00016898924,0.0006011059,0.00008979017,0.0036410084,0.90748763,0.00016838001,0.007963621,0.000016736332],"about_ca_topic_score_codex":0.0006787307,"about_ca_topic_score_gemma":0.00083230034,"teacher_disagreement_score":0.0014172737,"about_ca_system_score_codex":0.00038993955,"about_ca_system_score_gemma":0.0005320074,"threshold_uncertainty_score":0.0047412515},"labels":[],"label_agreement":null},{"id":"W4403519928","doi":"10.1158/2326-6074.tumimm24-a038","title":"Abstract A038: Antigen Presentation By Cancer-Associated Fibroblasts","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Cancer; Antigen; Cancer immunotherapy; Presentation (obstetrics); Antigen presentation; Immunology; Immunotherapy; Cancer research; Immune system; Internal medicine; T cell; Surgery","score_opus":0.11191344090386023,"score_gpt":0.48049826228805137,"score_spread":0.36858482138419113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403519928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913011,0.0021346163,0.0033929173,0.00011119972,0.000044401037,0.000032557655,0.0014620573,0.00009550783,0.0014255972],"genre_scores_gemma":[0.992015,0.00086183054,0.003006617,0.000054781754,0.00003842717,0.000034421395,0.0020764987,0.000020930742,0.0018915806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998896,0.000011214084,0.000009486658,0.000039279206,0.000031763953,0.000018693945],"domain_scores_gemma":[0.9998485,0.000032639055,0.00004045238,0.000014076816,0.000032061987,0.00003230763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001627271,0.0002864081,0.00018950806,0.00026891116,0.00018533687,0.00035022068,0.0001209452,0.00019460576,0.0023570342],"category_scores_gemma":[0.00019874262,0.00006372082,0.00015355654,0.00022678677,0.0001045397,0.00013337396,0.00012533883,0.00022187033,0.00063576904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014623725,0.000020821135,0.0024597922,0.000056708257,0.000007744247,0.00008558463,0.000011102922,0.000044510907,0.99372756,0.000033686923,0.00014079387,0.003265469],"study_design_scores_gemma":[0.000028590177,0.00041833802,0.06649452,0.000016853075,0.00003983133,0.0020053454,0.000064947664,0.002110436,0.9226666,0.00018046025,0.005964974,0.000009201616],"about_ca_topic_score_codex":0.00047426054,"about_ca_topic_score_gemma":0.00028852114,"teacher_disagreement_score":0.0023570342,"about_ca_system_score_codex":0.00015609575,"about_ca_system_score_gemma":0.00011912577,"threshold_uncertainty_score":0.007885098},"labels":[],"label_agreement":null},{"id":"W4403519959","doi":"10.1158/2326-6074.tumimm24-b028","title":"Abstract B028: Claudin-18 expression (using the 43-14A antibody kit) in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for immunotherapy with zolbetuximab","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Immunotherapy; Pancreatic ductal adenocarcinoma; Biomarker; Medicine; Claudin; Adenocarcinoma; Antibody; Immunology; Cancer research; Cancer; Pancreatic cancer; Immune system; Internal medicine; Biology; Tight junction","score_opus":0.13943216474690143,"score_gpt":0.5130102213733195,"score_spread":0.3735780566264181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403519959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933877,0.0006730718,0.00039772806,0.00015031107,0.000010133508,0.00006333153,0.0013144135,0.000031122774,0.0039720954],"genre_scores_gemma":[0.9944199,0.00059373025,0.0012560444,0.0001283438,0.000008233488,0.000029919003,0.0012506543,0.000015284833,0.0022978715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997552,0.000010324663,0.000012391274,0.000042979493,0.00011434057,0.00006480661],"domain_scores_gemma":[0.99954635,0.0000289376,0.000060136423,0.000019404157,0.00024615755,0.000098892095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039933054,0.00020499261,0.000206427,0.0011720179,0.001065936,0.00066483405,0.0004757207,0.00031191442,0.0020693117],"category_scores_gemma":[0.0004936643,0.00014110519,0.00021373996,0.00122232,0.0004587393,0.00015384496,0.00034195147,0.0003700118,0.00040918382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005741002,0.00006521054,0.9375099,0.00007754793,0.00005377169,0.002258302,0.00033696817,0.00024107994,0.043665122,0.0001274613,0.0016770172,0.013413406],"study_design_scores_gemma":[0.00002516269,0.00013304844,0.98209757,0.000020053069,0.000057416662,0.005133463,0.00054989156,0.0006948149,0.0067057586,0.000045138386,0.004516894,0.000020729456],"about_ca_topic_score_codex":0.6103773,"about_ca_topic_score_gemma":0.68250835,"teacher_disagreement_score":0.6103773,"about_ca_system_score_codex":0.0048482064,"about_ca_system_score_gemma":0.0032155914,"threshold_uncertainty_score":0.7838345},"labels":[],"label_agreement":null},{"id":"W4403520007","doi":"10.1158/2326-6074.tumimm24-a049","title":"Abstract A049: NKG2D and NKp30 activating receptors drive allogeneic natural killer cell responsiveness against pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"NKG2D; Medicine; Receptor; Pancreatic cancer; Immunotherapy; Immunology; Natural killer cell; Cancer; Immune system; Cancer research; Cytotoxic T cell; Biology; Internal medicine","score_opus":0.033934821150558694,"score_gpt":0.34384930452207874,"score_spread":0.30991448337152006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520007","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608683,0.0004195619,0.0008073643,0.00017070422,0.000029740027,0.000060450646,0.03407858,0.00025860762,0.003306524],"genre_scores_gemma":[0.924584,0.00014772637,0.0011699516,0.000091646085,0.000006559936,0.00006922277,0.07145875,0.000044237553,0.0024279198],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980694,0.000037930073,0.00001470917,0.000053719923,0.000048188635,0.000038580405],"domain_scores_gemma":[0.9998561,0.00003510916,0.000027424569,0.00002233096,0.000023359185,0.000035702815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024475754,0.00018820021,0.00026941058,0.0004407869,0.00019803818,0.00035459892,0.00017622583,0.0001665473,0.004648469],"category_scores_gemma":[0.0004001582,0.00006353061,0.00032259303,0.00046402393,0.00010715136,0.00008593023,0.00026250398,0.000283082,0.0006396375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008286122,0.0007494744,0.13742508,0.0009188872,0.0008444024,0.0004308818,0.0001330684,0.012747951,0.7477522,0.0013741603,0.0381001,0.051237714],"study_design_scores_gemma":[0.0014953496,0.003384478,0.5678374,0.00011088246,0.0008470504,0.001410888,0.0006025089,0.05764916,0.26879066,0.0012284021,0.096598744,0.00004446494],"about_ca_topic_score_codex":0.007628412,"about_ca_topic_score_gemma":0.009971277,"teacher_disagreement_score":0.007628412,"about_ca_system_score_codex":0.00046971848,"about_ca_system_score_gemma":0.00041589577,"threshold_uncertainty_score":0.015550733},"labels":[],"label_agreement":null},{"id":"W4403520012","doi":"10.1158/2326-6074.tumimm24-b007","title":"Abstract B007: Upregulation of PD-L1 as a mechanism of resistance to CD47 inhibition in non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Downregulation and upregulation; Mechanism (biology); Cancer; PD-L1; CD47; Cancer research; Medicine; Lung cancer; Acquired resistance; Immunotherapy; Immunology; Immune system; Biology; Oncology; Internal medicine; Biochemistry","score_opus":0.031904079087619795,"score_gpt":0.3501959446331875,"score_spread":0.3182918655455677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520012","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866397,0.0031680486,0.0022336051,0.000614197,0.00010539024,0.00008539923,0.001547078,0.00030154997,0.0053051007],"genre_scores_gemma":[0.9910952,0.0007098925,0.0011359764,0.00014329702,0.000016582884,0.00007268342,0.0014049024,0.00002494231,0.005396549],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998393,0.000015939722,0.00001111601,0.000030611256,0.000060205584,0.000042801978],"domain_scores_gemma":[0.99992,0.000013721763,0.000015349908,0.000008156093,0.000013085383,0.000029640902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014228512,0.0002348291,0.00030504953,0.00031243227,0.00018386626,0.00041534627,0.00024008805,0.000464858,0.004759577],"category_scores_gemma":[0.00010290264,0.00013451811,0.00031081104,0.00022073828,0.00022191158,0.00018446277,0.00015101212,0.00094383775,0.0011360883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005799216,0.00016439818,0.00070154725,0.0001069074,0.000009844251,0.000105093684,0.000017018228,0.000085284664,0.9923775,0.00017797819,0.0007852676,0.0048892945],"study_design_scores_gemma":[0.00010860219,0.0012849141,0.013126444,0.000011038424,0.00002230093,0.0007090213,0.000051848794,0.0013234778,0.977494,0.0001334195,0.0057281507,0.000006907393],"about_ca_topic_score_codex":0.0005164271,"about_ca_topic_score_gemma":0.00035744417,"teacher_disagreement_score":0.004759577,"about_ca_system_score_codex":0.00044219528,"about_ca_system_score_gemma":0.00026060478,"threshold_uncertainty_score":0.015922368},"labels":[],"label_agreement":null},{"id":"W4403520103","doi":"10.1158/2326-6074.tumimm24-b032","title":"Abstract B032: Novel immunotherapy approach for metastatic triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Immunotherapy; Medicine; Breast cancer; Cancer immunotherapy; Cancer; Metastatic breast cancer; Oncology; Internal medicine; Cancer research","score_opus":0.08897110372185572,"score_gpt":0.3986291801122491,"score_spread":0.3096580763903934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520103","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580015,0.01901134,0.011655274,0.00083809794,0.00042770864,0.0004074065,0.00063293666,0.00033377984,0.008692002],"genre_scores_gemma":[0.9764246,0.0071414867,0.009316672,0.000433991,0.00011258743,0.0002686941,0.0007193528,0.000026263193,0.0055564335],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999379,0.00000842626,0.000003003049,0.000013349054,0.000020647045,0.000016753767],"domain_scores_gemma":[0.99997663,0.0000026242128,0.000004177785,0.0000017620653,0.0000041056232,0.0000107992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001407974,0.00038917142,0.00037269044,0.00039129876,0.00018820325,0.00020751514,0.00025439836,0.00043912613,0.0020048812],"category_scores_gemma":[0.000053443353,0.00010831592,0.00041134452,0.00022599782,0.0001336775,0.00020785612,0.00018882698,0.0005059027,0.00060099474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004038321,0.00042480603,0.00023338733,0.00021632691,0.00002158981,0.00014397169,0.000026588003,0.00050487823,0.97537076,0.0002860514,0.0009681001,0.021399671],"study_design_scores_gemma":[0.0005111802,0.014022997,0.00805677,0.00006626616,0.00018310954,0.0020910827,0.000060881554,0.0063936263,0.93696946,0.00036261432,0.031235535,0.000046435343],"about_ca_topic_score_codex":0.0007284446,"about_ca_topic_score_gemma":0.000914104,"teacher_disagreement_score":0.0020048812,"about_ca_system_score_codex":0.00021396956,"about_ca_system_score_gemma":0.00024631948,"threshold_uncertainty_score":0.0067070127},"labels":[],"label_agreement":null},{"id":"W4403520141","doi":"10.1158/2326-6074.tumimm24-pr-07","title":"Abstract PR-07: Optimally designed mRNA vaccine encoding tumor-specific antigens identified in a colorectal cancer model leads to complete tumor rejection in mice","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Colorectal cancer; Medicine; Antigen; Cancer; Messenger RNA; Cancer immunotherapy; Immunology; Immunotherapy; Cancer research; Gene; Immune system; Biology; Genetics; Internal medicine","score_opus":0.06872976233229297,"score_gpt":0.38325896576257934,"score_spread":0.31452920343028634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300957,0.00045992894,0.0047320095,0.00012254616,0.000063132335,0.000079120095,0.0005040247,0.00011878896,0.00091101765],"genre_scores_gemma":[0.98690414,0.00042845262,0.0077454005,0.00009775536,0.000018064482,0.00010994516,0.001216812,0.000054576594,0.0034248682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997545,0.0000319801,0.000024293542,0.000065457534,0.000056491772,0.00006727541],"domain_scores_gemma":[0.9998534,0.000021571932,0.000055496723,0.000013123752,0.000015477279,0.000040892784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017181186,0.0004315303,0.00030510625,0.000271166,0.00010236864,0.00020717709,0.00022468441,0.00045064086,0.0015126776],"category_scores_gemma":[0.000117092284,0.00014184485,0.0002815803,0.00013202561,0.00023736402,0.00017276451,0.00011497009,0.00081472215,0.00041493052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018018448,0.00011014362,0.000066956774,0.000030608717,0.000004939049,0.00001984347,0.0000060233865,0.00014473799,0.9987404,0.00006879261,0.00003565971,0.0005919132],"study_design_scores_gemma":[0.00004044948,0.002013913,0.0008299873,0.0000061652067,0.000018188524,0.000107334454,0.0000141265455,0.0011586114,0.9943615,0.000029505914,0.0014160239,0.0000042719803],"about_ca_topic_score_codex":0.00027476178,"about_ca_topic_score_gemma":0.00037289018,"teacher_disagreement_score":0.0015126776,"about_ca_system_score_codex":0.0003139078,"about_ca_system_score_gemma":0.00020813894,"threshold_uncertainty_score":0.0050604343},"labels":[],"label_agreement":null},{"id":"W4403520195","doi":"10.1158/2326-6074.tumimm24-b022","title":"Abstract B022: Tumoral GLI1 controls the resident innate and adaptive tumor immune microenvironment in triple negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Triple-negative breast cancer; Immune system; Tumor microenvironment; Cancer; Breast cancer; Innate immune system; Medicine; Immunotherapy; Immunology; Cancer immunotherapy; Acquired immune system; Cancer research; Internal medicine","score_opus":0.04032041317806927,"score_gpt":0.36141426816272637,"score_spread":0.3210938549846571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520195","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984504,0.002862314,0.0032120293,0.00040403762,0.00006261862,0.000045705412,0.0031033834,0.00024741475,0.005558459],"genre_scores_gemma":[0.98622024,0.0010676739,0.0015437732,0.00016379409,0.000012587695,0.00005490073,0.0022822407,0.000051346648,0.008603482],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999168,0.00000739228,0.000005559541,0.000020329227,0.000026326197,0.000023557075],"domain_scores_gemma":[0.99994636,0.000004227653,0.000013759288,0.000005129882,0.000006858259,0.000023677958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008592557,0.00020640122,0.0001945872,0.00020174377,0.00018193103,0.0003161067,0.00018126491,0.00024112516,0.0032832313],"category_scores_gemma":[0.000056386783,0.00011401503,0.0001402055,0.00014898501,0.00020553419,0.00012040553,0.00021601738,0.0005089675,0.0011812825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001785341,0.000017227987,0.0006313372,0.00007574685,0.000003796448,0.00006708181,0.000018812189,0.0000415701,0.996908,0.00011220514,0.0002516102,0.0016941559],"study_design_scores_gemma":[0.000085429776,0.0005000677,0.052850887,0.00004522725,0.00005336579,0.0016756521,0.0002821831,0.0018934697,0.9269806,0.00025711273,0.0153620355,0.000013965632],"about_ca_topic_score_codex":0.0011435836,"about_ca_topic_score_gemma":0.0013088599,"teacher_disagreement_score":0.0032832313,"about_ca_system_score_codex":0.00029475024,"about_ca_system_score_gemma":0.00026689487,"threshold_uncertainty_score":0.010983527},"labels":[],"label_agreement":null},{"id":"W4403520285","doi":"10.1158/2326-6074.tumimm24-b012","title":"Abstract B012: Reviving exhausted T cells in pediatric B-cell acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Cancer research; Immunology; Leukemia","score_opus":0.05261392441516446,"score_gpt":0.3874645670991617,"score_spread":0.3348506426839973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520285","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953939,0.0019279994,0.0016537632,0.00004232388,0.000014106836,0.000030897496,0.0002890192,0.00004331071,0.00060463796],"genre_scores_gemma":[0.99558157,0.0012611592,0.001784044,0.00007220546,0.000012042187,0.000046373425,0.00061859045,0.000016486929,0.0006076173],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998373,0.000029645063,0.000012100077,0.000025802863,0.000053485634,0.000041595624],"domain_scores_gemma":[0.99993074,0.000012901241,0.000023857127,0.0000058837986,0.000010007199,0.000016645177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023833413,0.00027238825,0.0003047667,0.0002445898,0.0001090244,0.00033414477,0.00016018799,0.0003094716,0.00080766826],"category_scores_gemma":[0.00015975253,0.00009772491,0.00014321916,0.00030837188,0.00020756027,0.00028771767,0.00022241507,0.0007638304,0.0002846718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061369705,0.0001002455,0.004041322,0.00012225528,0.000008883839,0.00011034991,0.00006392254,0.00025394632,0.9881493,0.0001337431,0.000112046735,0.0062903673],"study_design_scores_gemma":[0.00007781093,0.0034108406,0.052920364,0.0000280732,0.000051060077,0.0012676278,0.00027573376,0.002395364,0.9322365,0.000181484,0.0071422462,0.000012933114],"about_ca_topic_score_codex":0.00042794686,"about_ca_topic_score_gemma":0.0004771274,"teacher_disagreement_score":0.00080766826,"about_ca_system_score_codex":0.0002585965,"about_ca_system_score_gemma":0.00016621746,"threshold_uncertainty_score":0.0027019382},"labels":[],"label_agreement":null},{"id":"W4407578969","doi":"10.1158/2326-6066.cir-24-0151","title":"CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Artificial Intelligence in Medicine (Canada); Vector Institute; University of Toronto; University Health Network; Structural Genomics Consortium; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Cancer Society; Princess Margaret Cancer Foundation","keywords":"Tumor microenvironment; CD8; Cytotoxic T cell; Immunotherapy; Biology; Cancer research; Immunology; Antigen; Immune system; Genetics","score_opus":0.03959988273125058,"score_gpt":0.3094242174564884,"score_spread":0.2698243347252378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407578969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611133,0.0006058218,0.0018596792,0.00005410435,0.000009363913,0.00001833769,0.00028768944,0.000047607464,0.0010060654],"genre_scores_gemma":[0.99761677,0.00019491743,0.0008931212,0.00003438883,0.0000074784784,0.000019128625,0.0002607632,0.00001255156,0.000960821],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986565,0.000011946975,0.000012476007,0.000040506966,0.000026889822,0.000042410113],"domain_scores_gemma":[0.9999099,0.000010734234,0.00003661634,0.000011176814,0.000009099858,0.000022504437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059139584,0.00014805459,0.00018168919,0.00024984256,0.00015995723,0.00043743718,0.000058641406,0.00017053747,0.0015300368],"category_scores_gemma":[0.00010644369,0.00007511593,0.00009229889,0.00020768518,0.00016496443,0.00014997635,0.0001598665,0.0003579751,0.00028815665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010584835,0.0000124588405,0.003091257,0.000021419475,0.00000369954,0.000085379615,0.000027883669,0.000036309837,0.9941685,0.000055051776,0.000031163312,0.0023610415],"study_design_scores_gemma":[0.00003630324,0.00026844876,0.2209146,0.000028445786,0.00007267371,0.0027018217,0.00058751466,0.0020272967,0.7671141,0.0002934597,0.005939035,0.000016319782],"about_ca_topic_score_codex":0.00029384394,"about_ca_topic_score_gemma":0.00069281994,"teacher_disagreement_score":0.0015300368,"about_ca_system_score_codex":0.00016375253,"about_ca_system_score_gemma":0.00011846446,"threshold_uncertainty_score":0.005118549},"labels":[],"label_agreement":null},{"id":"W4407863592","doi":"10.1158/2326-6074.io2025-a116","title":"Abstract A116: Single cell analyses of syngeneic ovarian cancer models implicates macrophage skewing as key to evoking anti-tumor immunity via coordinated TGF-β and PD-L1 blockade","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Blockade; Ovarian cancer; Immunotherapy; Immunology; Cancer; Immunity; Medicine; Cancer research; Macrophage; Cancer immunotherapy; Immune system; Biology; Receptor; Internal medicine; In vitro","score_opus":0.0755580791581171,"score_gpt":0.3952990855604798,"score_spread":0.3197410064023627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407863592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526693,0.002212511,0.02798951,0.00033236644,0.00022347718,0.0003587679,0.008461244,0.00080987305,0.0069429353],"genre_scores_gemma":[0.96164113,0.001128503,0.016466053,0.0002570671,0.00003529921,0.00048231008,0.005672451,0.00018926887,0.014127936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963427,0.00002899982,0.00004057093,0.00011751651,0.0001221694,0.00005656449],"domain_scores_gemma":[0.9997824,0.000028696844,0.000062550214,0.000037790065,0.00003442633,0.000054176082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027253813,0.0004550881,0.00033275175,0.00056566537,0.00030238385,0.0004078557,0.00021981627,0.00041457292,0.0035059152],"category_scores_gemma":[0.00010614711,0.00020189887,0.0003123861,0.00035007746,0.00032965545,0.00023874898,0.00024179397,0.0009880931,0.0010611078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102761274,0.00003089711,0.00029201273,0.000034352473,0.000004813929,0.000023154198,0.000020749116,0.000034657285,0.99850935,0.00008914637,0.00009418985,0.0007639903],"study_design_scores_gemma":[0.000027922908,0.00027904208,0.004481481,0.000007788566,0.00001959465,0.00016281362,0.000034490517,0.0007544173,0.99018365,0.000055426946,0.00398863,0.00000474026],"about_ca_topic_score_codex":0.0010157988,"about_ca_topic_score_gemma":0.0016139454,"teacher_disagreement_score":0.0035059152,"about_ca_system_score_codex":0.000282129,"about_ca_system_score_gemma":0.00025386433,"threshold_uncertainty_score":0.011728466},"labels":[],"label_agreement":null},{"id":"W4407863613","doi":"10.1158/2326-6074.io2025-a015","title":"Abstract A015: GPNMB CAR T cells target both Glioblastoma and its immunosuppressive niche to relieve immune evasion","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Evasion (ethics); Glioblastoma; Niche; Immune system; Immunotherapy; Immunology; Cancer immunotherapy; Biology; Cancer research; Medicine; Ecology","score_opus":0.03854279659123545,"score_gpt":0.39178252174718603,"score_spread":0.3532397251559506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407863613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776289,0.0036699225,0.006739311,0.0011938476,0.0002713743,0.00012281792,0.000989489,0.00041367087,0.008970781],"genre_scores_gemma":[0.971374,0.0020198277,0.0051826364,0.00052175194,0.0000743956,0.00008438814,0.0008290629,0.000050248604,0.019863809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999194,0.0000077501445,0.00000495527,0.000019351772,0.000029355657,0.00001914055],"domain_scores_gemma":[0.99995804,0.00000474083,0.000008003803,0.0000029867376,0.000011302704,0.000014948593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104661485,0.00022398094,0.00021084184,0.0002964126,0.00021110657,0.00044158727,0.0002017534,0.00031888543,0.00768352],"category_scores_gemma":[0.00008963556,0.00009658123,0.00018149527,0.00018587576,0.00022352845,0.0002148357,0.00021471715,0.00051399716,0.0012701282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018691488,0.000048261965,0.00089720817,0.00008443929,0.000009442977,0.00016248463,0.000031858406,0.00013142644,0.98682284,0.00046202756,0.0012639281,0.009899106],"study_design_scores_gemma":[0.000059542384,0.0009738352,0.013158184,0.00002636486,0.000043226635,0.0015996466,0.00018539092,0.0021546916,0.9545148,0.00053757726,0.026734065,0.0000127320445],"about_ca_topic_score_codex":0.00068450265,"about_ca_topic_score_gemma":0.0009865754,"teacher_disagreement_score":0.00768352,"about_ca_system_score_codex":0.00028898584,"about_ca_system_score_gemma":0.0003723648,"threshold_uncertainty_score":0.025703907},"labels":[],"label_agreement":null},{"id":"W4407866429","doi":"10.1158/2326-6074.io2025-b034","title":"Abstract B034: The immune checkpoint molecule B7-H3 is a driver of tumor immune exclusion by mediating TGF-β activation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"Immune system; Cancer research; Immune checkpoint; Cancer immunotherapy; Medicine; Immunotherapy; Immunology","score_opus":0.022527636315242603,"score_gpt":0.36444219741222433,"score_spread":0.3419145610969817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98264784,0.0037787703,0.0044814777,0.00029304897,0.000094185394,0.00011796315,0.0058421623,0.00017435686,0.0025702193],"genre_scores_gemma":[0.9841501,0.0010704696,0.0035237698,0.00036909195,0.000033035736,0.00016603546,0.007134644,0.000070521004,0.0034822982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973696,0.000031921645,0.0000126038,0.00005737081,0.000112632304,0.00004843761],"domain_scores_gemma":[0.99985456,0.000018584133,0.000050578907,0.000012006716,0.00003072565,0.00003357804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029473926,0.0003059183,0.0003500027,0.00039024747,0.0002405729,0.0005157563,0.00023940297,0.00025314215,0.0038160237],"category_scores_gemma":[0.00014931183,0.000121654935,0.00029222888,0.00034781088,0.0002887033,0.00018396902,0.00020714055,0.0006834545,0.00096988963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008380865,0.0000463596,0.0018451905,0.000078336394,0.000027575972,0.000020571615,0.000007498361,0.00011192494,0.9929705,0.000062864485,0.00028502478,0.0037060492],"study_design_scores_gemma":[0.00018894157,0.0016061136,0.042822193,0.000025888809,0.0001247398,0.00027309672,0.00009255114,0.0015167968,0.94561803,0.00031096258,0.007409806,0.000010745682],"about_ca_topic_score_codex":0.0008703147,"about_ca_topic_score_gemma":0.0009182789,"teacher_disagreement_score":0.0038160237,"about_ca_system_score_codex":0.0004503976,"about_ca_system_score_gemma":0.000424772,"threshold_uncertainty_score":0.012765944},"labels":[],"label_agreement":null},{"id":"W4407866505","doi":"10.1158/2326-6074.io2025-b016","title":"Abstract B016: Prime-Boost: mRNA Tumor Vaccines in Combination with Oncolytic Virotherapy for Durable Anti-Tumor Immunity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunity; Immunotherapy; Immunology; Virology; Cancer research; Immune system","score_opus":0.03169217769698976,"score_gpt":0.38019406700288555,"score_spread":0.34850188930589576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97237396,0.0037686867,0.017796041,0.0003580298,0.0003419837,0.0002757823,0.00038538792,0.00057525624,0.004124816],"genre_scores_gemma":[0.9803971,0.001243839,0.01256662,0.00009005503,0.0000751371,0.00014013328,0.00030715734,0.00008800752,0.0050919834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979645,0.000031449905,0.000014184914,0.000042267475,0.00005948863,0.000056155735],"domain_scores_gemma":[0.99992096,0.000014591997,0.000018653445,0.000012027547,0.000009291846,0.000024537598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022910027,0.0006329951,0.00058324484,0.0003671502,0.00011918395,0.00045032977,0.00027773847,0.00040760462,0.0024895451],"category_scores_gemma":[0.00014663528,0.00022073196,0.00033024905,0.00024542774,0.00027227242,0.0002600932,0.00024052498,0.0011434588,0.00075598207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054791616,0.00036152138,0.00013903441,0.00011026873,0.000011904605,0.00004697688,0.000013638431,0.0005409188,0.9872651,0.00030063867,0.00025523105,0.010406847],"study_design_scores_gemma":[0.00013393062,0.0037821713,0.0007741274,0.000012920648,0.000036562356,0.00019728231,0.000007773478,0.0023470197,0.9891101,0.000077108765,0.0035121178,0.000008936967],"about_ca_topic_score_codex":0.0004997615,"about_ca_topic_score_gemma":0.00042564308,"teacher_disagreement_score":0.0024895451,"about_ca_system_score_codex":0.00029854933,"about_ca_system_score_gemma":0.00041855525,"threshold_uncertainty_score":0.008328319},"labels":[],"label_agreement":null},{"id":"W4407866525","doi":"10.1158/2326-6074.io2025-a0","title":"Abstract A089: Methotrexate preserves anti-PD1 anti-tumor benefits while reducing arthritic inflammation in a tumor and ICI-arthritis combination mouse model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Inflammation; Methotrexate; Arthritis; Rheumatoid arthritis; Immunology; Cancer research","score_opus":0.056128609333595925,"score_gpt":0.36372974049113727,"score_spread":0.30760113115754134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97893804,0.0026178805,0.0048896438,0.0006032787,0.00028924228,0.00020588071,0.0065468894,0.00057462003,0.0053343675],"genre_scores_gemma":[0.97006154,0.0013852664,0.0057076616,0.0002940662,0.000077178374,0.00031876384,0.004136097,0.00012383821,0.017895695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994604,0.00006898712,0.000060187936,0.00013057739,0.00015151693,0.00012837631],"domain_scores_gemma":[0.9995484,0.00004768316,0.0001309111,0.000062886276,0.00004183332,0.00016830843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002588508,0.00077621127,0.00058032316,0.00093539385,0.0002992384,0.0004527349,0.00040493155,0.0007659077,0.0033699502],"category_scores_gemma":[0.00015126231,0.0002864324,0.0006073502,0.00035347213,0.00041165398,0.00037093466,0.00015131223,0.0025131293,0.001340699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006398638,0.0002863878,0.00015592657,0.00005720932,0.000011038754,0.000072519855,0.00001952713,0.00013145358,0.9969381,0.00009315206,0.0002459734,0.0013488537],"study_design_scores_gemma":[0.00018511692,0.005129006,0.0038578096,0.000024389603,0.00004598552,0.00045290825,0.000048208036,0.0014979627,0.9837368,0.00008024194,0.004926164,0.000015323689],"about_ca_topic_score_codex":0.001233832,"about_ca_topic_score_gemma":0.0020362476,"teacher_disagreement_score":0.0033699502,"about_ca_system_score_codex":0.00046826756,"about_ca_system_score_gemma":0.00042369709,"threshold_uncertainty_score":0.0112736225},"labels":[],"label_agreement":null},{"id":"W4407866526","doi":"10.1158/2326-6074.io2025-a089","title":"Abstract A089: Methotrexate preserves anti-PD1 anti-tumor benefits while reducing arthritic inflammation in a tumor and ICI-arthritis combination mouse model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Arthritis; Methotrexate; Inflammation; Cancer research; Inflammatory arthritis; Immunology","score_opus":0.056128609333595925,"score_gpt":0.36372974049113727,"score_spread":0.30760113115754134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97893804,0.0026178805,0.0048896438,0.0006032787,0.00028924228,0.00020588071,0.0065468894,0.00057462003,0.0053343675],"genre_scores_gemma":[0.97006154,0.0013852664,0.0057076616,0.0002940662,0.000077178374,0.00031876384,0.004136097,0.00012383821,0.017895695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994604,0.00006898712,0.000060187936,0.00013057739,0.00015151693,0.00012837631],"domain_scores_gemma":[0.9995484,0.00004768316,0.0001309111,0.000062886276,0.00004183332,0.00016830843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002588508,0.00077621127,0.00058032316,0.00093539385,0.0002992384,0.0004527349,0.00040493155,0.0007659077,0.0033699502],"category_scores_gemma":[0.00015126231,0.0002864324,0.0006073502,0.00035347213,0.00041165398,0.00037093466,0.00015131223,0.0025131293,0.001340699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006398638,0.0002863878,0.00015592657,0.00005720932,0.000011038754,0.000072519855,0.00001952713,0.00013145358,0.9969381,0.00009315206,0.0002459734,0.0013488537],"study_design_scores_gemma":[0.00018511692,0.005129006,0.0038578096,0.000024389603,0.00004598552,0.00045290825,0.000048208036,0.0014979627,0.9837368,0.00008024194,0.004926164,0.000015323689],"about_ca_topic_score_codex":0.001233832,"about_ca_topic_score_gemma":0.0020362476,"teacher_disagreement_score":0.0033699502,"about_ca_system_score_codex":0.00046826756,"about_ca_system_score_gemma":0.00042369709,"threshold_uncertainty_score":0.0112736225},"labels":[],"label_agreement":null},{"id":"W4407866599","doi":"10.1158/2326-6074.io2025-b108","title":"Abstract B108: nELISA high-throughput proteomics enables scalable biomarker discovery: identification of IL-1 pathway intermediates as novel CRC biomarkers","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biomarker discovery; Proteomics; Computational biology; Biomarker; Identification (biology); Throughput; Biology; Computer science; Gene; Genetics","score_opus":0.031611479988859104,"score_gpt":0.37022501254226203,"score_spread":0.33861353255340293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90515155,0.0025317431,0.07664949,0.0013166026,0.000364855,0.00027384682,0.0051648077,0.0023774568,0.0061697536],"genre_scores_gemma":[0.8924277,0.001075827,0.088447176,0.00057959714,0.00006540188,0.0002953585,0.0056114984,0.00016013342,0.011337301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997172,0.00004126634,0.000015818785,0.000057704554,0.00013582036,0.000032175667],"domain_scores_gemma":[0.99978536,0.000049475682,0.000049720555,0.000022386457,0.00005195585,0.000041144343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053841417,0.0004965111,0.00029680083,0.00038871515,0.00024147074,0.0005778794,0.00034350282,0.00043494592,0.004220675],"category_scores_gemma":[0.00037330916,0.00018083815,0.00031703903,0.000230329,0.0002734048,0.00038173673,0.00037280557,0.0007364047,0.0014239182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018468298,0.000041685784,0.000461591,0.00005703561,0.000008616725,0.0000468504,0.000010976349,0.00013753142,0.99454725,0.00015489226,0.00073076005,0.0036180594],"study_design_scores_gemma":[0.000043818094,0.00023855896,0.003284858,0.0000091936845,0.000013167435,0.00020214556,0.00001139389,0.0043469993,0.9852504,0.00011204794,0.006472289,0.000015180942],"about_ca_topic_score_codex":0.0004505889,"about_ca_topic_score_gemma":0.0006535003,"teacher_disagreement_score":0.004220675,"about_ca_system_score_codex":0.00036965235,"about_ca_system_score_gemma":0.00044460152,"threshold_uncertainty_score":0.014119506},"labels":[],"label_agreement":null},{"id":"W4407866624","doi":"10.1158/2326-6074.io2025-a016","title":"Abstract A016: Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Cancer research; Medicine; Immunotherapy; Computational biology; Cancer; Biology; Internal medicine","score_opus":0.041151855758443136,"score_gpt":0.38099791652814474,"score_spread":0.3398460607697016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953967,0.0006755424,0.002216878,0.00009410896,0.000025704388,0.00004760113,0.00041298996,0.00015281585,0.0009776284],"genre_scores_gemma":[0.9952583,0.0003587283,0.0015326219,0.000039362072,0.000006495662,0.00004949787,0.00058079057,0.000024739084,0.0021494366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990046,0.000009763841,0.000008075541,0.000023832574,0.00002593738,0.00003187971],"domain_scores_gemma":[0.9999571,0.0000042126944,0.000012057326,0.000005121671,0.0000069836237,0.000014484156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010676665,0.00036590715,0.0002755086,0.00025018462,0.00009913845,0.0003352571,0.00020599464,0.0002673426,0.0012907542],"category_scores_gemma":[0.000073789015,0.00011312407,0.00022116721,0.00015782932,0.00017534218,0.0001304619,0.0001476152,0.00056685327,0.00036642168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015085052,0.0000692745,0.00020358247,0.0000349453,0.000008310415,0.000039873867,0.000013527305,0.00017117975,0.9970983,0.000092823015,0.00011465863,0.0020026534],"study_design_scores_gemma":[0.00006521774,0.0015789228,0.0026039437,0.0000055287505,0.000046219808,0.00038796963,0.000029084184,0.0014832587,0.9907092,0.000044629545,0.003040454,0.0000057138677],"about_ca_topic_score_codex":0.001425693,"about_ca_topic_score_gemma":0.0014167724,"teacher_disagreement_score":0.001425693,"about_ca_system_score_codex":0.00026619527,"about_ca_system_score_gemma":0.00026305192,"threshold_uncertainty_score":0.0043180585},"labels":[],"label_agreement":null},{"id":"W4407866625","doi":"10.1158/2326-6074.io2025-a067","title":"Abstract A067: PRMT7 deficiency in T cells enhances immune response and fosters an anti-tumor microenvironment in melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto; McGill University","funders":"","keywords":"Immune system; Tumor microenvironment; Melanoma; Immunology; Cancer research; Immunotherapy; Medicine; Cancer immunotherapy; Tumor immunology; Biology","score_opus":0.017046726403289213,"score_gpt":0.3290419966659493,"score_spread":0.3119952702626601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165803,0.0013861008,0.0026880787,0.00034331557,0.0001200112,0.00008177999,0.0012453279,0.00022131193,0.002256172],"genre_scores_gemma":[0.99135196,0.00051863084,0.0016926461,0.0001370557,0.000036004745,0.00007393523,0.00091905834,0.000072866904,0.0051978673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997578,0.000039473194,0.000028059532,0.00004713567,0.00006804478,0.000059469196],"domain_scores_gemma":[0.9997937,0.000023348573,0.00005758148,0.000019202222,0.000020568252,0.00008561757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001280072,0.00041871064,0.00033984517,0.0003092796,0.00017298557,0.00034124285,0.00025021945,0.0005355671,0.0035595957],"category_scores_gemma":[0.00011964181,0.00016420393,0.0003455624,0.00017696418,0.00033843194,0.00022245261,0.00018317698,0.0013475469,0.0012986715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021170586,0.000046531604,0.00009545944,0.00003064496,0.0000033973242,0.000043822634,0.0000066650045,0.000039312745,0.9987765,0.00004810249,0.0000709,0.0006269405],"study_design_scores_gemma":[0.00009795999,0.0012946606,0.0025301275,0.000011417616,0.00002677541,0.00039906832,0.00004346625,0.0008307127,0.99167305,0.000072448485,0.0030155883,0.000004746575],"about_ca_topic_score_codex":0.0004017136,"about_ca_topic_score_gemma":0.00047867192,"teacher_disagreement_score":0.0035595957,"about_ca_system_score_codex":0.00023321634,"about_ca_system_score_gemma":0.00023270813,"threshold_uncertainty_score":0.011907995},"labels":[],"label_agreement":null},{"id":"W4407866630","doi":"10.1158/2326-6074.io2025-b054","title":"Abstract B054: Immune checkpoint inhibitor-induced myocarditis and myocarditis-myositis overlap syndrome: identifying distinct molecular pathways for targeted therapeutic interventions","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Christie (Canada); McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Myocarditis; Myositis; Medicine; Immunotherapy; Immune checkpoint; Immunology; Immune system; Internal medicine","score_opus":0.08281328274867114,"score_gpt":0.39597794455155993,"score_spread":0.3131646618028888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845695,0.0064609214,0.0034012697,0.0005651844,0.000066446584,0.00013326202,0.0013817938,0.00017349278,0.0032480643],"genre_scores_gemma":[0.9917916,0.0009973145,0.0034716881,0.00035647213,0.00009255416,0.00007228522,0.0020478147,0.000027471277,0.0011427845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959797,0.000069706344,0.00003578098,0.000113347385,0.0001112453,0.000071960225],"domain_scores_gemma":[0.99967134,0.000055280416,0.00014641408,0.000017027982,0.000041276176,0.00006865943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006710917,0.00055395823,0.00061034854,0.00094600115,0.00035725627,0.00087541935,0.00037803952,0.00049405004,0.0038122279],"category_scores_gemma":[0.0006099455,0.00018051841,0.00044569166,0.00065598515,0.0003981237,0.00029761804,0.00050441816,0.00058676314,0.0006317779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007337959,0.0007555844,0.6157249,0.00084651104,0.0005093016,0.0045641144,0.00019244381,0.0011332782,0.2605745,0.00081721146,0.004022193,0.10352195],"study_design_scores_gemma":[0.0004308199,0.00170373,0.9471841,0.00014175399,0.00031725553,0.009164732,0.00017757056,0.0038740085,0.029773418,0.0006300408,0.0065773437,0.00002532023],"about_ca_topic_score_codex":0.0018091291,"about_ca_topic_score_gemma":0.0014244452,"teacher_disagreement_score":0.0038122279,"about_ca_system_score_codex":0.00069722097,"about_ca_system_score_gemma":0.00058801385,"threshold_uncertainty_score":0.012753129},"labels":[],"label_agreement":null},{"id":"W4407866729","doi":"10.1158/2326-6074.io2025-b122","title":"Abstract B122: Genetically engineered Vaccinia Virus expressing MHC-I as a precision medicine cancer vaccine","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Vaccinia; Virology; Genetically engineered; Cancer; Virus; Cancer vaccine; Genetically modified organism; Cancer immunotherapy; Medicine; Major histocompatibility complex; Biology; Immunology; Immunotherapy; Immune system; Recombinant DNA; Genetics; Gene","score_opus":0.03941943681818824,"score_gpt":0.4162353845623751,"score_spread":0.3768159477441868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825806,0.0026384806,0.00918185,0.00036238338,0.00020636241,0.00018355338,0.0005196601,0.00012653116,0.004200535],"genre_scores_gemma":[0.98357403,0.0007996257,0.008552413,0.00014325457,0.0000310337,0.00008205865,0.0007681233,0.00002087844,0.0060285777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000016557391,0.000008214705,0.000021639149,0.000042506294,0.00003059518],"domain_scores_gemma":[0.99996424,0.0000048495563,0.000010993506,0.0000033369918,0.0000074424315,0.000009158206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001273131,0.00030809533,0.00019140521,0.0001483563,0.00009421666,0.0003104107,0.00021512104,0.0004592212,0.001527655],"category_scores_gemma":[0.00008950821,0.00010833597,0.00018754635,0.00010167908,0.00011543334,0.00014863566,0.000117742005,0.0007544276,0.0004622968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009783142,0.00009416596,0.00016146942,0.00003164982,0.00000458634,0.000030649684,0.000005350145,0.00030913219,0.9969252,0.00024962408,0.00018846695,0.0019017885],"study_design_scores_gemma":[0.00006178245,0.0017977061,0.0012124777,0.000012684354,0.000016553473,0.00025811887,0.000012379632,0.003041252,0.98370206,0.000089260095,0.009789253,0.0000063793045],"about_ca_topic_score_codex":0.00043882485,"about_ca_topic_score_gemma":0.00030387074,"teacher_disagreement_score":0.001527655,"about_ca_system_score_codex":0.00033509513,"about_ca_system_score_gemma":0.00015232411,"threshold_uncertainty_score":0.005110562},"labels":[],"label_agreement":null},{"id":"W4407866806","doi":"10.1158/2326-6074.io2025-a060","title":"Abstract A060: Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioblastoma; Glioma; Stem cell; Cancer research; CCL5; Temozolomide; Medicine; Biology; T cell; Immunology; Immune system; Cell biology","score_opus":0.021816199533360496,"score_gpt":0.35325700406390054,"score_spread":0.33144080453054003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9102325,0.012346801,0.021811405,0.001899378,0.0012631202,0.00030965358,0.035674203,0.0027302557,0.013732687],"genre_scores_gemma":[0.9536703,0.004125288,0.0073439595,0.0006776505,0.00011791954,0.00017737306,0.012992352,0.00022275612,0.020672351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980086,0.0000134769225,0.000016950144,0.00004791344,0.000072237526,0.00004861481],"domain_scores_gemma":[0.99987686,0.0000071498007,0.00002702141,0.00000839336,0.000038717455,0.00004176318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017220977,0.0003103216,0.0003068697,0.0004822152,0.00035879304,0.00066726265,0.00024903324,0.0004106101,0.0072486578],"category_scores_gemma":[0.00014422012,0.00013423007,0.00036207747,0.00042761432,0.00020461672,0.00034393536,0.0003267739,0.0006340031,0.0017267129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002806938,0.000027727221,0.0006925515,0.0002379554,0.000014325387,0.00009479729,0.00005183176,0.0001242008,0.98931956,0.00056215725,0.002755024,0.0058391895],"study_design_scores_gemma":[0.00008266657,0.00041966702,0.025021749,0.00007625311,0.00007840774,0.00046038337,0.00028955186,0.0024773618,0.92597556,0.00047246704,0.044613417,0.000032565702],"about_ca_topic_score_codex":0.0026739761,"about_ca_topic_score_gemma":0.0030518307,"teacher_disagreement_score":0.0072486578,"about_ca_system_score_codex":0.00045056656,"about_ca_system_score_gemma":0.00057239627,"threshold_uncertainty_score":0.024249196},"labels":[],"label_agreement":null},{"id":"W4407866822","doi":"10.1158/2326-6074.io2025-a058","title":"Abstract A058: nELISA high-throughput protein profiling captures immune secretomes for high-resolution phenotypic screens","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Profiling (computer programming); Computational biology; Phenotype; Immune system; High resolution; Throughput; Biology; Computer science; Genetics; Gene; Geography; Remote sensing","score_opus":0.03600245217277007,"score_gpt":0.38102337572036243,"score_spread":0.34502092354759234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8529091,0.0013838778,0.11415839,0.0006424224,0.000083630366,0.00053717726,0.019049374,0.004669557,0.0065664365],"genre_scores_gemma":[0.8168594,0.0009056034,0.15504257,0.00041480764,0.000034716286,0.0006982801,0.014509172,0.0005352557,0.01100016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996245,0.00006724986,0.000029659737,0.000060243303,0.00017536592,0.000042882006],"domain_scores_gemma":[0.9996778,0.00009966353,0.00006335833,0.000049235965,0.00006722035,0.000042681593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052786194,0.0005802673,0.0005731666,0.00065171963,0.00027201427,0.00076424464,0.0004964853,0.00049170427,0.0033404122],"category_scores_gemma":[0.00043771687,0.00023902186,0.00043504356,0.00044168616,0.00018098443,0.00028185235,0.00034878476,0.0007239546,0.0018322077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009551702,0.00005069331,0.00046947718,0.000033447966,0.000007480865,0.000028180251,0.000007759945,0.00024799132,0.99602497,0.000048849804,0.00040943452,0.0025761868],"study_design_scores_gemma":[0.000018025688,0.00019753735,0.005379434,0.000006033417,0.000014882069,0.00015408317,0.000015035136,0.00738938,0.9816399,0.00008048884,0.005093744,0.000011428893],"about_ca_topic_score_codex":0.0006216342,"about_ca_topic_score_gemma":0.0015129008,"teacher_disagreement_score":0.0033404122,"about_ca_system_score_codex":0.00041551914,"about_ca_system_score_gemma":0.00021102607,"threshold_uncertainty_score":0.011174858},"labels":[],"label_agreement":null},{"id":"W4408362108","doi":"10.1158/2326-6066.cir-24-0758","title":"IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; Congressionally Directed Medical Research Programs; National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada; American Cancer Society; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Pancreatic Cancer Action Network","keywords":"CD8; CD40; T cell; Cancer research; Cytotoxic T cell; Biology; Immunology; Antigen; Immune system; Genetics; In vitro","score_opus":0.06724943435714295,"score_gpt":0.39998855345792045,"score_spread":0.33273911910077747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408362108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899083,0.00026040414,0.00034777753,0.000022139608,0.000012244377,0.0000119837205,0.00003963472,0.000026997079,0.0002879499],"genre_scores_gemma":[0.998596,0.00011649398,0.0005411809,0.000026298821,0.0000066779107,0.00001384882,0.00009905639,0.000007047873,0.00059342507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998173,0.000036281974,0.00002317657,0.000030801042,0.000035808018,0.0000568076],"domain_scores_gemma":[0.99992657,0.0000101711275,0.000014675716,0.000010258959,0.0000066676917,0.000031635456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014342552,0.00019095713,0.00023287191,0.00017110023,0.00008384671,0.00030077173,0.00013007807,0.0001558163,0.0007855832],"category_scores_gemma":[0.00012520098,0.0000913898,0.00017033417,0.00007778627,0.00013191387,0.00014263559,0.0001631245,0.00051069877,0.00018477911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046776177,0.00014089092,0.00068724336,0.000028199069,0.0000075197986,0.000027225413,0.00001889329,0.00014586918,0.9950879,0.000041734587,0.000041513682,0.0033053355],"study_design_scores_gemma":[0.00009285092,0.0026395908,0.0068319966,0.0000064351075,0.000042069558,0.00025366788,0.000029990157,0.0012563472,0.9867007,0.0000365106,0.0021067415,0.0000031233594],"about_ca_topic_score_codex":0.00024507233,"about_ca_topic_score_gemma":0.0005376708,"teacher_disagreement_score":0.0007855832,"about_ca_system_score_codex":0.00020098001,"about_ca_system_score_gemma":0.0001531074,"threshold_uncertainty_score":0.0026280284},"labels":[],"label_agreement":null},{"id":"W4408812473","doi":"10.1158/2326-6066.cir-24-0743","title":"Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Parker Institute for Cancer Immunotherapy","keywords":"PDGFRB; Mesenchymal stem cell; Stromal cell; Cancer research; Glioma; Endoglin; Biology; Angiogenesis; Cancer stem cell; Stem cell; Pathology; Medicine; Cell biology; CD34; Gene","score_opus":0.012996252969319317,"score_gpt":0.31219995113242266,"score_spread":0.2992036981631033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408812473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984028,0.00077665295,0.00034200607,0.000021066262,0.000003586389,0.0000044095377,0.00013271134,0.000012841431,0.00030394248],"genre_scores_gemma":[0.9992822,0.00021973021,0.00015084405,0.000011641988,0.0000049886057,0.0000056800022,0.00013443975,0.0000018465748,0.00018874182],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989736,0.000017124177,0.0000097212105,0.000016550915,0.000035250778,0.000023882918],"domain_scores_gemma":[0.9997756,0.000023415894,0.00012875316,0.000010676216,0.00002070916,0.000040898187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013049177,0.00013532978,0.00012631922,0.0007541828,0.00012189996,0.00023052582,0.00006778053,0.00012722742,0.00059844344],"category_scores_gemma":[0.00030239194,0.000078452926,0.00007849041,0.0003566876,0.00014661263,0.00008263306,0.00015468679,0.00015389192,0.000097480966],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080277905,0.00004986444,0.8294356,0.00007828918,0.0001010635,0.00068108697,0.00014384348,0.0003114246,0.14527866,0.00023358836,0.00024811155,0.022635695],"study_design_scores_gemma":[0.0000042103115,0.00009223935,0.98729056,0.000007853762,0.000036323152,0.001054719,0.000110622954,0.0005817319,0.010029279,0.00024206511,0.00054557656,0.0000047541303],"about_ca_topic_score_codex":0.00067011354,"about_ca_topic_score_gemma":0.0013682714,"teacher_disagreement_score":0.0007541828,"about_ca_system_score_codex":0.0001067923,"about_ca_system_score_gemma":0.00011184191,"threshold_uncertainty_score":0.0020019412},"labels":[],"label_agreement":null},{"id":"W4412825944","doi":"10.1158/2326-6066.cir-24-0897","title":"Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Sarcoma Foundation of America","keywords":"Chimeric antigen receptor; Cancer research; Metastasis; Sarcoma; Cytotoxic T cell; Stromal cell; Tumor microenvironment; Immunotherapy; Cancer; Antigen; Medicine; Immunology; Biology; Immune system; Pathology; In vitro; Internal medicine","score_opus":0.053936030644522716,"score_gpt":0.4012525384342819,"score_spread":0.34731650778975914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882448,0.0011452069,0.008113094,0.00013588312,0.000029496934,0.000074648706,0.00017405309,0.0001739628,0.0019088975],"genre_scores_gemma":[0.9937412,0.00065820693,0.0036608542,0.00007542699,0.000012960893,0.000051773663,0.00020670831,0.00001576973,0.0015770429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.000009302539,0.000005527711,0.000016280535,0.000017202692,0.000021287431],"domain_scores_gemma":[0.9999628,0.0000065249974,0.000007813235,0.000003910198,0.000004378141,0.000014428844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008507551,0.00025802018,0.00021478572,0.00015621411,0.00006690824,0.00020217648,0.00013135631,0.0002564914,0.0010156323],"category_scores_gemma":[0.000052421463,0.0000853789,0.00018546787,0.000071468814,0.00016792487,0.00013802345,0.00018932547,0.00051187474,0.00033424067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009549011,0.000049450406,0.00024444234,0.000048942948,0.0000056685194,0.00014086842,0.000025514091,0.00078623014,0.99451536,0.00031815926,0.00015938524,0.0036105467],"study_design_scores_gemma":[0.00008102314,0.0009160524,0.0018335468,0.000010147727,0.000045425553,0.00090113765,0.000033729666,0.004187347,0.9838974,0.0001634549,0.007924266,0.0000064101578],"about_ca_topic_score_codex":0.00034451194,"about_ca_topic_score_gemma":0.00047404927,"teacher_disagreement_score":0.0010156323,"about_ca_system_score_codex":0.00016832084,"about_ca_system_score_gemma":0.00021501954,"threshold_uncertainty_score":0.0033976436},"labels":[],"label_agreement":null},{"id":"W4414458510","doi":"10.1158/2326-6074.cimm25-pr-01","title":"Abstract PR-01: Targeting the ApoE-LDLR pathway disrupts MDSC-mediated systemic immunosuppression and enhances the efficacy of NK cell immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunosuppression; Immunotherapy; Cancer immunotherapy; Tumor microenvironment; T cell; Immune tolerance; Ex vivo; Myeloid-derived Suppressor Cell","score_opus":0.021941002524156625,"score_gpt":0.3261121331413621,"score_spread":0.30417113061720547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414458510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332196,0.0005368761,0.0034810547,0.00015199625,0.000050505667,0.000061359475,0.00065657345,0.00021348186,0.0015260573],"genre_scores_gemma":[0.9921422,0.00030918175,0.0020864066,0.00006441957,0.000013521384,0.00007440927,0.0006646544,0.00004660638,0.0045986697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981624,0.000025073732,0.000022162827,0.000045987916,0.000039818053,0.00005074713],"domain_scores_gemma":[0.99987125,0.000011625456,0.000044177614,0.000016963304,0.000012900044,0.000043028325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015886902,0.00044432507,0.00036247514,0.00020677627,0.00013237342,0.00033344785,0.00023851125,0.00031181244,0.0019497381],"category_scores_gemma":[0.0000776965,0.00011792886,0.00023436209,0.000112535774,0.00035326023,0.0001772653,0.00016035856,0.00092209666,0.0005819793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047626536,0.00012883561,0.00012669954,0.00003521337,0.0000061180976,0.00004936916,0.000009438178,0.00007258874,0.99760336,0.00009848896,0.000081347556,0.0013122754],"study_design_scores_gemma":[0.00007682886,0.0010238519,0.0014573105,0.0000064558662,0.000019301728,0.0001868146,0.000021091317,0.00080118154,0.9947384,0.000044166758,0.0016214623,0.0000031514971],"about_ca_topic_score_codex":0.00036730108,"about_ca_topic_score_gemma":0.00044939894,"teacher_disagreement_score":0.0019497381,"about_ca_system_score_codex":0.00026655002,"about_ca_system_score_gemma":0.00035776326,"threshold_uncertainty_score":0.0065224767},"labels":[],"label_agreement":null},{"id":"W4414465146","doi":"10.1158/2326-6074.cimm25-pr-16","title":"Abstract PR-16: Therapeutic inhibition of TREX1 elicits type I interferon–mediated antitumor immunity with minimal autoimmune toxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Knockout mouse; Immunotherapy; Cancer immunotherapy; Immunity; Downregulation and upregulation; Inflammation; Cancer; Interferon; Cytotoxic T cell","score_opus":0.07872362776945517,"score_gpt":0.39940011158254946,"score_spread":0.32067648381309427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829522,0.0030082432,0.005452776,0.00022035449,0.00011277556,0.00016997628,0.0020094903,0.00038649823,0.0056878156],"genre_scores_gemma":[0.98538357,0.0012473786,0.003292866,0.00010726697,0.000015073517,0.000095499345,0.0017563812,0.00003337318,0.008068699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989426,0.000011488329,0.000010402445,0.000027075715,0.000030152762,0.000026578118],"domain_scores_gemma":[0.9999399,0.000005708539,0.000016721031,0.000008762802,0.000008218933,0.000020677591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013574286,0.0005261718,0.00034833368,0.00017880279,0.0000890428,0.00023095308,0.00030364312,0.00032418448,0.002976852],"category_scores_gemma":[0.000072369636,0.00010529374,0.00025387958,0.00014451814,0.00017141768,0.00022162929,0.00012583412,0.001067131,0.0008085303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058034254,0.00018117268,0.00009149027,0.000107831904,0.000011182581,0.000059685015,0.00000928695,0.0003724686,0.9941923,0.000114909795,0.00025173253,0.0040276707],"study_design_scores_gemma":[0.0001248166,0.002549189,0.00060850626,0.000008165404,0.000017346454,0.0002770012,0.000007641147,0.00073052966,0.99287355,0.000039546463,0.0027591393,0.0000044562294],"about_ca_topic_score_codex":0.00019600707,"about_ca_topic_score_gemma":0.00026551544,"teacher_disagreement_score":0.002976852,"about_ca_system_score_codex":0.00019059624,"about_ca_system_score_gemma":0.00024678354,"threshold_uncertainty_score":0.009958625},"labels":[],"label_agreement":null},{"id":"W4414465149","doi":"10.1158/2326-6074.cimm25-b014","title":"Abstract B014: SYNCRIP drives therapy resistance via ferroptosis suppression and metabolic activation in Glioblastoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Downregulation and upregulation; Glioblastoma; Reprogramming; Cancer; Regulator; Cancer cell; Immunotherapy; Mechanism (biology)","score_opus":0.042119258215151736,"score_gpt":0.3829273282088889,"score_spread":0.3408080699937372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989405,0.002652402,0.0017868192,0.00057939143,0.00010776679,0.00005410773,0.0013305773,0.00028217604,0.0038016448],"genre_scores_gemma":[0.99418604,0.0007877535,0.0006028061,0.00020113734,0.000013812588,0.000030329978,0.0007452534,0.000029127777,0.0034036434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998976,0.00001488967,0.000008163513,0.000018376068,0.00002945325,0.00003154218],"domain_scores_gemma":[0.9999193,0.000005426694,0.000025563859,0.0000068561635,0.000013312498,0.000029544335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012602999,0.00022095558,0.0002797065,0.00033916984,0.00017661693,0.000318251,0.00014302251,0.0002762851,0.0030328769],"category_scores_gemma":[0.000077989265,0.00010574774,0.0001842376,0.00024058805,0.0002639206,0.00011647589,0.00018474228,0.00048314044,0.0006596762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005576604,0.00008807307,0.0016598064,0.00008545809,0.000014735876,0.00035854155,0.00003498737,0.00008134731,0.9891734,0.00026563677,0.0013771462,0.006303231],"study_design_scores_gemma":[0.00026401825,0.0026082774,0.07274388,0.000048071022,0.00009463882,0.003868768,0.00037042418,0.002980522,0.8955253,0.0005562266,0.020917984,0.000021914582],"about_ca_topic_score_codex":0.0011274737,"about_ca_topic_score_gemma":0.0017637878,"teacher_disagreement_score":0.0030328769,"about_ca_system_score_codex":0.0004958114,"about_ca_system_score_gemma":0.0003620661,"threshold_uncertainty_score":0.010145962},"labels":[],"label_agreement":null},{"id":"W4414465151","doi":"10.1158/2326-6074.cimm25-pr-11","title":"Abstract PR-11: B cell infiltration and clonal expansion in tertiary lymphoid structures: Insights from intravital microscopy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"High endothelial venules; Immune system; Lymph; Lymphatic system; B cell; Intravital microscopy; Infiltration (HVAC); Tumor microenvironment; Lymphocyte","score_opus":0.016223602725056893,"score_gpt":0.31025442311668533,"score_spread":0.2940308203916284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9435944,0.004796148,0.04132046,0.00034154486,0.00003438486,0.00008576354,0.0010097972,0.00051013386,0.008307337],"genre_scores_gemma":[0.96909404,0.0013847806,0.02300979,0.00011652773,0.00001619001,0.00007662099,0.00059664325,0.00007623542,0.0056291874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985576,0.00002690269,0.000007466084,0.000041330746,0.000028431221,0.000040000687],"domain_scores_gemma":[0.99988604,0.000025407144,0.000031120933,0.000012705965,0.00002137797,0.00002344494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002555577,0.00019303159,0.000108746855,0.0005386814,0.00022290126,0.0003119849,0.00020272545,0.00041013004,0.0018234348],"category_scores_gemma":[0.0000910515,0.00017804113,0.00015014118,0.00019360025,0.00020367403,0.0002657971,0.00025236688,0.0007259996,0.0005323671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004215677,0.000020476988,0.00061213184,0.000030751355,0.0000031939976,0.00006035132,0.000027399645,0.000078346886,0.99662834,0.00026241055,0.00008780646,0.002146529],"study_design_scores_gemma":[0.000017078693,0.00019282535,0.02169681,0.000024441946,0.000017061666,0.0011124273,0.00015426292,0.007848123,0.961947,0.00035527078,0.0066237617,0.000010862578],"about_ca_topic_score_codex":0.0014268891,"about_ca_topic_score_gemma":0.0012678403,"teacher_disagreement_score":0.0018234348,"about_ca_system_score_codex":0.00037536828,"about_ca_system_score_gemma":0.00012498305,"threshold_uncertainty_score":0.0060999393},"labels":[],"label_agreement":null},{"id":"W4414465152","doi":"10.1158/2326-6074.cimm25-a002","title":"Abstract A002: Comprehensive blood profiling for immunotherapy outcome prediction and longitudinal immune trajectory characterisation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adjuvant; Immunotherapy; Immune system; Peripheral blood mononuclear cell; Antibody; Clinical trial; Adverse effect; Univariate","score_opus":0.10022597285674148,"score_gpt":0.41030359151371626,"score_spread":0.3100776186569748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8279117,0.002485488,0.110452205,0.0011847563,0.00026009823,0.0005696997,0.045436352,0.004728441,0.0069712955],"genre_scores_gemma":[0.9191565,0.0006199349,0.041617416,0.00042417497,0.00023987792,0.0007021936,0.033578835,0.00022475254,0.003436353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994548,0.00016240582,0.000041506893,0.00017980766,0.00011809924,0.00004345374],"domain_scores_gemma":[0.9985921,0.000431431,0.0002456509,0.00022143217,0.0003355505,0.00017379069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001342934,0.000617301,0.00053730945,0.0011236646,0.00027614317,0.0013841274,0.00049514143,0.00063120347,0.0061471337],"category_scores_gemma":[0.002875395,0.00021412669,0.00046349806,0.0010126223,0.00019210584,0.00043623,0.0006359969,0.0009064781,0.0023239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077490527,0.0012752942,0.4269748,0.00070123555,0.00074618234,0.00045087736,0.00028267823,0.020181058,0.18339574,0.0016776002,0.03742839,0.31913713],"study_design_scores_gemma":[0.000561017,0.0045793895,0.60828614,0.00020050643,0.00063129014,0.0023472896,0.00027376306,0.24281164,0.0857707,0.0062378966,0.04811836,0.0001819753],"about_ca_topic_score_codex":0.00095964177,"about_ca_topic_score_gemma":0.0010939775,"teacher_disagreement_score":0.0061471337,"about_ca_system_score_codex":0.0002746955,"about_ca_system_score_gemma":0.0005737735,"threshold_uncertainty_score":0.020564258},"labels":[],"label_agreement":null},{"id":"W4414465153","doi":"10.1158/2326-6074.cimm25-pr-10","title":"Abstract PR-10: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blockade; Cytotoxic T cell; Immune checkpoint; T cell; CD8; Immune system; Cancer immunotherapy; Immunotherapy; Effector","score_opus":0.08873159915895826,"score_gpt":0.40836903552775927,"score_spread":0.31963743636880104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465153","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514069,0.012101064,0.02443325,0.0011790053,0.0005868643,0.0004936588,0.0005018486,0.0016908469,0.0076066675],"genre_scores_gemma":[0.98646146,0.0023884298,0.0051699765,0.00039988084,0.00007478339,0.00017616896,0.0003146628,0.000086311884,0.004928291],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998598,0.000021843513,0.000008008482,0.000028765762,0.00003535079,0.00004615024],"domain_scores_gemma":[0.9998865,0.000013381366,0.000025864792,0.000011230873,0.000013567667,0.000049438426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026651344,0.00037803053,0.00036999452,0.00022681877,0.00010422526,0.00043358273,0.00038459332,0.00028614033,0.003577694],"category_scores_gemma":[0.00023251207,0.00011477533,0.0002219793,0.000115615105,0.00016473809,0.000400584,0.00032369714,0.0014604602,0.0010496785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043678973,0.002413841,0.0009286593,0.0005069551,0.000072524876,0.00017897003,0.000045554414,0.002784622,0.8013905,0.0007988441,0.005401297,0.18111044],"study_design_scores_gemma":[0.001814862,0.033549175,0.0052649085,0.00013417524,0.00017779433,0.001281294,0.00005759984,0.019356068,0.9075272,0.0009807163,0.029815586,0.000040778235],"about_ca_topic_score_codex":0.00027643345,"about_ca_topic_score_gemma":0.00045253322,"teacher_disagreement_score":0.003577694,"about_ca_system_score_codex":0.00023750821,"about_ca_system_score_gemma":0.00036207936,"threshold_uncertainty_score":0.011968553},"labels":[],"label_agreement":null},{"id":"W4414465155","doi":"10.1158/2326-6074.cimm25-b010","title":"Abstract B010: α-Synuclein preformed fibrils suppress cell cycle progression and glycolytic flux in glioblastoma cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cell cycle; Cancer cell; Flux (metallurgy); Glycolysis; Neurodegeneration; Tumor progression; Cyclin; Cell","score_opus":0.04064383925663431,"score_gpt":0.3710928370987603,"score_spread":0.330448997842126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465155","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855096,0.0033092415,0.0014799738,0.00033707777,0.00020075422,0.000076529206,0.0020499516,0.00017024421,0.0038251837],"genre_scores_gemma":[0.986375,0.0016107019,0.0019789245,0.00018906589,0.000023497372,0.00012756168,0.0023301467,0.000021801305,0.007343448],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992144,0.000008696331,0.000011769963,0.000014530624,0.00002036161,0.000023173568],"domain_scores_gemma":[0.9999665,0.0000051422503,0.00000565674,0.000003975522,0.000007821063,0.000010852601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077013574,0.00027994366,0.00022824625,0.00023395351,0.00019344967,0.00019760209,0.00013913382,0.0002755543,0.002739119],"category_scores_gemma":[0.000049753522,0.000084571504,0.00024225039,0.00026079814,0.00012031073,0.00012429396,0.00011777053,0.00047165205,0.00050765375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004712422,0.00017875484,0.00031779063,0.0001274433,0.00001044633,0.00008785461,0.000036745314,0.00008114344,0.99386334,0.00015131237,0.00083098875,0.0038430435],"study_design_scores_gemma":[0.00009733633,0.0008789535,0.008309429,0.0000133834965,0.000020295949,0.00021847396,0.00006242478,0.0008555103,0.9833,0.000063593616,0.0061749276,0.000005718177],"about_ca_topic_score_codex":0.0021990133,"about_ca_topic_score_gemma":0.00205849,"teacher_disagreement_score":0.002739119,"about_ca_system_score_codex":0.00021059594,"about_ca_system_score_gemma":0.00031867632,"threshold_uncertainty_score":0.00916332},"labels":[],"label_agreement":null},{"id":"W4414465159","doi":"10.1158/2326-6074.cimm25-b017","title":"Abstract B017: Impact of gut microbiota on response to Bacillus Calmette-Guérin immunotherapy in bladder cancer: Towards a predictive molecular model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Gut flora; Bladder cancer; Antibiotics; Bacteria; Probiotic; Cancer","score_opus":0.051216184011676304,"score_gpt":0.4408723039258178,"score_spread":0.38965611991414145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465159","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728574,0.004970722,0.013845088,0.001070388,0.00013298422,0.0001042993,0.004696097,0.000213683,0.0021093294],"genre_scores_gemma":[0.9893818,0.0013005511,0.0050795176,0.00020570809,0.00004021595,0.0000738363,0.0031591791,0.000035088717,0.0007240655],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997031,0.00010244892,0.000014528559,0.00007650776,0.000056917477,0.00004645602],"domain_scores_gemma":[0.9993875,0.0001791532,0.00019378083,0.000043862197,0.00011095215,0.00008470227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087972695,0.00074292225,0.00065423566,0.00070939655,0.00029196375,0.001278055,0.00036142205,0.0005282654,0.0025224355],"category_scores_gemma":[0.0013856159,0.00020356511,0.00088535517,0.0006392018,0.0003157146,0.00047419503,0.000830648,0.001018498,0.0007218124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035913982,0.0007936774,0.77177364,0.0008021632,0.0011710188,0.00022082125,0.00016874711,0.013295825,0.12993494,0.0012970665,0.0029824295,0.07396826],"study_design_scores_gemma":[0.00007917224,0.0020308646,0.81754893,0.00023855836,0.0006782842,0.0003396224,0.00038042272,0.15624602,0.015227394,0.0032041268,0.003973816,0.000052867843],"about_ca_topic_score_codex":0.004399033,"about_ca_topic_score_gemma":0.0021713853,"teacher_disagreement_score":0.004399033,"about_ca_system_score_codex":0.00056295935,"about_ca_system_score_gemma":0.00073360675,"threshold_uncertainty_score":0.008746862},"labels":[],"label_agreement":null},{"id":"W4414465161","doi":"10.1158/2326-6074.cimm25-b023","title":"Abstract B023: A scalable, proteome-wide protein profiling platform with absolute quantification of 1000 proteins","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ouranos","funders":"","keywords":"Profiling (computer programming); Proteomics; KEGG; Biomarker; Quantitative proteomics; Redundancy (engineering)","score_opus":0.050840511920718076,"score_gpt":0.37482568781807757,"score_spread":0.3239851758973595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465161","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20376202,0.00318563,0.6217178,0.0016070638,0.0004877566,0.0014440977,0.07972799,0.06875803,0.019309573],"genre_scores_gemma":[0.20800905,0.0017402761,0.6771597,0.0015673079,0.00013983903,0.002743921,0.09331633,0.004749143,0.010574406],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980368,0.0002212029,0.00011149735,0.0005670162,0.00094361947,0.00011989901],"domain_scores_gemma":[0.9991233,0.0001569247,0.00015192485,0.00012503231,0.00026153383,0.00018126857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026109894,0.0015506832,0.0013057807,0.0023382818,0.00094322645,0.002209914,0.0016281239,0.0011340987,0.0052759508],"category_scores_gemma":[0.0013865967,0.0008931626,0.0008993342,0.0018424646,0.0006899369,0.0016011395,0.0021963248,0.0019183882,0.005898135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016827432,0.0002789159,0.0033052017,0.00043365645,0.00020472723,0.00015546705,0.000105469306,0.0022776253,0.9205631,0.0023579684,0.023112876,0.045522284],"study_design_scores_gemma":[0.00039360658,0.0011229576,0.014317256,0.00018456379,0.00023028953,0.0009052839,0.000109986846,0.14389974,0.7120661,0.009539957,0.116865166,0.00036508276],"about_ca_topic_score_codex":0.0012104794,"about_ca_topic_score_gemma":0.002220446,"teacher_disagreement_score":0.0052759508,"about_ca_system_score_codex":0.000807299,"about_ca_system_score_gemma":0.0016030067,"threshold_uncertainty_score":0.017649889},"labels":[],"label_agreement":null},{"id":"W4414465163","doi":"10.1158/2326-6074.cimm25-a004","title":"Abstract A004: Modulating chromatin remodeling as a strategy to reverse immune evasion in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Immune system; Chromatin remodeling; Antigen presentation; Immunotherapy; Chromatin; Immunogenicity; Ovarian cancer; Immune checkpoint; Downregulation and upregulation","score_opus":0.09923062220342622,"score_gpt":0.4569732006418941,"score_spread":0.3577425784384679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465163","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976794,0.008474194,0.0065074395,0.0008197976,0.0003001798,0.0001702792,0.0006386478,0.00048558085,0.0058099297],"genre_scores_gemma":[0.98545444,0.002364498,0.003952044,0.00021266799,0.000051902556,0.00006342185,0.00047669318,0.000030203986,0.007394125],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999502,0.0000073500673,0.0000041229314,0.000010936601,0.000015474765,0.000011882805],"domain_scores_gemma":[0.9999596,0.000005449369,0.000011369196,0.0000045295096,0.0000058387022,0.000013211825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109819266,0.0002323844,0.00017831806,0.00026367715,0.00012574752,0.0002404979,0.00027512063,0.00032512788,0.0039304383],"category_scores_gemma":[0.000084596104,0.00009410245,0.00022670288,0.00018013772,0.00014542512,0.0001699351,0.00014769037,0.00048362196,0.00047561625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032959264,0.00014738264,0.00029522937,0.000113273985,0.000015447578,0.000041513857,0.000008118262,0.0002365446,0.9821577,0.00030963504,0.00036389008,0.015981615],"study_design_scores_gemma":[0.00020133636,0.0033381996,0.0034607083,0.000017053391,0.000059585564,0.00029457762,0.000022769067,0.0016998883,0.9726007,0.00029863245,0.017995948,0.000010618239],"about_ca_topic_score_codex":0.00036678498,"about_ca_topic_score_gemma":0.00063213776,"teacher_disagreement_score":0.0039304383,"about_ca_system_score_codex":0.0002231843,"about_ca_system_score_gemma":0.00021243782,"threshold_uncertainty_score":0.013148665},"labels":[],"label_agreement":null},{"id":"W4414465167","doi":"10.1158/2326-6074.cimm25-b022","title":"Abstract B022: Investigating Biased GPCRs Activation by Nutraceutical Caffeine and Nicotine in Transactivating Glycosylated Receptors to Induce EMT in Cancer Metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"G protein-coupled receptor; Receptor; Cancer cell; Signal transduction; Inflammation; Caffeine; Cell signaling","score_opus":0.09163168663077802,"score_gpt":0.4273441446349585,"score_spread":0.3357124580041805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465167","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900013,0.0034337721,0.002703961,0.00024604576,0.000100729696,0.00015432402,0.0009737805,0.000054390246,0.002331585],"genre_scores_gemma":[0.9862175,0.0025435293,0.0034110188,0.00021857121,0.000032846754,0.00021324815,0.001093806,0.000029860144,0.006239759],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998578,0.000024958255,0.000011044255,0.000028911825,0.00004042861,0.000036811725],"domain_scores_gemma":[0.9999442,0.000008416812,0.000011603774,0.000005900353,0.000014488887,0.000015376108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020237126,0.0002726985,0.00034290567,0.00017501012,0.00019187134,0.00022546557,0.00019451021,0.00037424418,0.0024683538],"category_scores_gemma":[0.00010581714,0.000110422756,0.00054934726,0.0001707731,0.00013135593,0.00021138614,0.0001484848,0.0005141091,0.00062182883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034734266,0.00011484607,0.00017986677,0.000104835446,0.0000098465325,0.000035120298,0.000011608781,0.000048721544,0.9976889,0.00007307577,0.0000909302,0.0012950087],"study_design_scores_gemma":[0.000054139426,0.0022316112,0.006336815,0.000015387002,0.000059700593,0.00012497831,0.000051388422,0.0010142855,0.98581,0.000056578607,0.004234878,0.000010128663],"about_ca_topic_score_codex":0.0011599163,"about_ca_topic_score_gemma":0.0017319287,"teacher_disagreement_score":0.0024683538,"about_ca_system_score_codex":0.00025955736,"about_ca_system_score_gemma":0.00024893187,"threshold_uncertainty_score":0.008257449},"labels":[],"label_agreement":null},{"id":"W4414465170","doi":"10.1158/2326-6074.cimm25-pr-04","title":"Abstract PR-04: Targeting PRMT5 to modulate endogenous retroviruses expression in melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Protein arginine methyltransferase 5; Melanoma; Histone; Immune checkpoint; Epigenetics; Blockade; Endogeny; Immune system","score_opus":0.04452812077411537,"score_gpt":0.3593245265273861,"score_spread":0.3147964057532707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465170","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964685,0.0019388468,0.004943043,0.00015379136,0.000073848896,0.000088950925,0.000493709,0.00019521012,0.002465631],"genre_scores_gemma":[0.99381316,0.00043586278,0.0024305861,0.00006198492,0.000008358657,0.000036939826,0.00035826294,0.00001725536,0.0028375688],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998975,0.000013733053,0.00000825433,0.000025411748,0.00002950216,0.000025567031],"domain_scores_gemma":[0.9999647,0.0000043528908,0.000009777729,0.0000049109553,0.000004590366,0.00001154455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012224766,0.00028032454,0.00018705115,0.00015998118,0.000109970904,0.00023518785,0.00020316915,0.00027576613,0.0015485407],"category_scores_gemma":[0.000058364632,0.00007832174,0.00022502786,0.000115342686,0.00016444382,0.0001577353,0.00012516744,0.00067802536,0.0003368531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016657481,0.00005692036,0.000077705256,0.000030744824,0.0000042053152,0.00001653795,0.000007201473,0.00011623641,0.99737394,0.00012497789,0.0000734773,0.0019515593],"study_design_scores_gemma":[0.000029704903,0.0007039762,0.000671545,0.0000032297778,0.000010295732,0.00008547121,0.0000072760986,0.0012376318,0.9952769,0.00003069189,0.001941299,0.000001981397],"about_ca_topic_score_codex":0.00047999586,"about_ca_topic_score_gemma":0.00047904966,"teacher_disagreement_score":0.0015485407,"about_ca_system_score_codex":0.00031732538,"about_ca_system_score_gemma":0.00015953423,"threshold_uncertainty_score":0.005180359},"labels":[],"label_agreement":null},{"id":"W4414465177","doi":"10.1158/2326-6074.cimm25-b008","title":"Abstract B008: Unraveling the sexually dimorphic immune microenvironment in gastric cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Immune system; CD8; Cytotoxic T cell; Antigen; Sexual dimorphism; Immunotherapy; Tumor microenvironment; CDH1","score_opus":0.05364733650164636,"score_gpt":0.3832631809748934,"score_spread":0.32961584447324704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465177","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96566963,0.02147508,0.0053531374,0.0024490375,0.00016125318,0.00003800068,0.0009539445,0.000116599556,0.0037831452],"genre_scores_gemma":[0.9820588,0.008194529,0.004835038,0.0005580744,0.00016906747,0.000041178595,0.0006038946,0.000031494026,0.0035079352],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993813,0.000014404922,0.0000028666998,0.000010847068,0.000018174394,0.000015680793],"domain_scores_gemma":[0.9999256,0.000011354993,0.00001981304,0.000004814256,0.000011131928,0.000027291506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021182455,0.00021613586,0.00018951311,0.0003381507,0.000098475335,0.00031355754,0.00018733244,0.0002835212,0.0025461076],"category_scores_gemma":[0.00010393357,0.00010591193,0.00014184824,0.00015059167,0.00022521504,0.00027830998,0.0002471259,0.0006427838,0.00043401917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004464401,0.00006185997,0.0070148,0.00021282496,0.000011799801,0.00023561664,0.00005233272,0.00008193794,0.9601808,0.00050882465,0.00087974855,0.03031304],"study_design_scores_gemma":[0.0001814469,0.003098509,0.47297928,0.0002960307,0.0001258686,0.0044135493,0.0010235606,0.004110749,0.4582683,0.002370947,0.053079225,0.000052467032],"about_ca_topic_score_codex":0.00029208374,"about_ca_topic_score_gemma":0.0004266038,"teacher_disagreement_score":0.0025461076,"about_ca_system_score_codex":0.00017303259,"about_ca_system_score_gemma":0.00016476054,"threshold_uncertainty_score":0.008517563},"labels":[],"label_agreement":null},{"id":"W4414465186","doi":"10.1158/2326-6074.cimm25-a009","title":"Abstract A009: Novel roles of the nuclear autoantigen LEDGF/p75 in modulating prostate cancer related inflammatory pathways and cancer patient response to immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Downregulation and upregulation; Prostate cancer; Cancer; Gene silencing; Gene knockdown; Immunotherapy; Transcription factor; Autoantibody","score_opus":0.029976874850282574,"score_gpt":0.34496921669977226,"score_spread":0.3149923418494897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465186","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777705,0.014072267,0.0028137304,0.00050576957,0.00017725541,0.000074832606,0.0017577003,0.00015011456,0.002677755],"genre_scores_gemma":[0.99050844,0.0030924939,0.0022873734,0.00024801667,0.00009604401,0.00003424359,0.0014204447,0.000014273081,0.002298735],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992573,0.000007538924,0.000003862083,0.000016660071,0.000026923259,0.000019305478],"domain_scores_gemma":[0.99994874,0.0000064620267,0.000013826973,0.0000024419953,0.000012315757,0.000016231936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007939935,0.00030237436,0.00022178657,0.00048698272,0.00023446712,0.0004339617,0.000120858516,0.00017890203,0.0017053401],"category_scores_gemma":[0.00011405886,0.000056467932,0.0002921244,0.00052526355,0.00013396169,0.00013362359,0.00013937574,0.00030723005,0.00026756115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010742048,0.00013477975,0.01816968,0.00036610878,0.00010196729,0.001116712,0.000070390284,0.00033685923,0.93664664,0.00022247485,0.0012763751,0.04048381],"study_design_scores_gemma":[0.00015318725,0.0015903886,0.48745233,0.00012630076,0.0006667987,0.005905591,0.00063668925,0.006509639,0.46587962,0.0012538148,0.029756822,0.000068948335],"about_ca_topic_score_codex":0.0016046361,"about_ca_topic_score_gemma":0.0017881945,"teacher_disagreement_score":0.0017053401,"about_ca_system_score_codex":0.0003321011,"about_ca_system_score_gemma":0.0003191978,"threshold_uncertainty_score":0.0057049394},"labels":[],"label_agreement":null},{"id":"W4414465197","doi":"10.1158/2326-6074.cimm25-a018","title":"Abstract A018: Targeting PTPN1/PTPN2 with KQ-791 enhances NK cell cytotoxicity during tumor rechallenge","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cytotoxic T cell; Cytotoxicity; Lymphokine-activated killer cell; Cytolysis; NK-92; Immune system; Cancer immunotherapy; Immunotherapy; Interleukin 12","score_opus":0.032745077183752684,"score_gpt":0.33717363056702915,"score_spread":0.30442855338327646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465197","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375266,0.0015841752,0.0024304462,0.000082908795,0.000073202915,0.000055395114,0.0005001118,0.00008686182,0.0014342641],"genre_scores_gemma":[0.9950846,0.00047629836,0.0015202462,0.00003171721,0.000011809545,0.00006323549,0.00061598216,0.000013560877,0.0021824401],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997962,0.000022136694,0.000022960989,0.000052256153,0.00005681767,0.000049508883],"domain_scores_gemma":[0.9999343,0.000013646736,0.000017087405,0.000007862578,0.000009861262,0.000017238031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012995323,0.00029451287,0.0003708878,0.00009767395,0.00011067859,0.00020378125,0.0002579132,0.00028079477,0.0021659548],"category_scores_gemma":[0.00010145941,0.000081058104,0.00021343367,0.00013197653,0.00017890152,0.00020921457,0.00014645963,0.0005987909,0.00052128587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026963706,0.000060055645,0.00008391131,0.00004528593,0.0000044903845,0.000028899143,0.0000072373437,0.00010393987,0.99836844,0.000032017004,0.00006583436,0.0009301366],"study_design_scores_gemma":[0.000032763837,0.0004613604,0.001138581,0.0000024777512,0.000008678912,0.00009234915,0.000008763631,0.0007864106,0.99667645,0.0000094141515,0.0007802653,0.00000245986],"about_ca_topic_score_codex":0.0005433992,"about_ca_topic_score_gemma":0.0005329382,"teacher_disagreement_score":0.0021659548,"about_ca_system_score_codex":0.00026515976,"about_ca_system_score_gemma":0.0002228717,"threshold_uncertainty_score":0.007245779},"labels":[],"label_agreement":null},{"id":"W4414465199","doi":"10.1158/2326-6074.cimm25-a017","title":"Abstract A017: Neutrophil extracellular traps reprogram macrophages to an immunosuppressive phenotype in non-small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Immune system; Tumor microenvironment; Innate immune system; Macrophage; Neutrophil extracellular traps; Extracellular matrix; Lung cancer; Phenotype; Immunotherapy; Monocyte","score_opus":0.033842212402346486,"score_gpt":0.3616354447072392,"score_spread":0.3277932323048927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465199","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839415,0.006382836,0.0033065875,0.00061853294,0.00033620268,0.00012812224,0.001179085,0.00020188472,0.0039052356],"genre_scores_gemma":[0.9849745,0.002181223,0.0021477132,0.00020119266,0.000087030676,0.00009714874,0.0009826826,0.000021104372,0.009307482],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990463,0.000014267367,0.000010436019,0.000017607432,0.000029537561,0.000023466358],"domain_scores_gemma":[0.9999484,0.0000074807745,0.0000113759115,0.0000035444646,0.000013543051,0.000015718713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015272289,0.00030855183,0.00020068933,0.00015817734,0.00012796487,0.00028929047,0.00014469479,0.0002973455,0.0038612098],"category_scores_gemma":[0.00007130544,0.00006014955,0.0002291658,0.00010976661,0.00013731745,0.00015589582,0.0001384801,0.00039777922,0.00081029156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003158574,0.00006800502,0.00038472872,0.00015624583,0.000006256733,0.00007757202,0.000010057215,0.00003778024,0.9948797,0.0000988921,0.0003238236,0.003641057],"study_design_scores_gemma":[0.00006746967,0.0010706779,0.0070436955,0.000014654274,0.000022816828,0.0004544985,0.00003309334,0.0006091208,0.9859913,0.00006080606,0.0046269605,0.000004959891],"about_ca_topic_score_codex":0.00020088269,"about_ca_topic_score_gemma":0.00029209795,"teacher_disagreement_score":0.0038612098,"about_ca_system_score_codex":0.00018380384,"about_ca_system_score_gemma":0.00019892596,"threshold_uncertainty_score":0.012917042},"labels":[],"label_agreement":null},{"id":"W4414465201","doi":"10.1158/2326-6074.cimm25-a008","title":"Abstract A008: Relationship between CD4+ T cells and cancer stem cells in squamous cancers of the oro-esophageal tract","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"Cancer stem cell; CDKN2A; Tumor microenvironment; Stem cell; Flow cytometry; Cancer; Context (archaeology); Carcinogenesis; Immunotherapy","score_opus":0.07941855897713583,"score_gpt":0.3902459849650642,"score_spread":0.31082742598792834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465201","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917908,0.005044266,0.0009028311,0.00017195409,0.00006519916,0.00003216113,0.00030442912,0.000039469967,0.0016489308],"genre_scores_gemma":[0.9947621,0.0011748002,0.00073791336,0.00010141757,0.00006781902,0.00003756153,0.0003007845,0.000005750603,0.0028118847],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998858,0.000021229673,0.000009076403,0.000025950065,0.00002144398,0.000036451776],"domain_scores_gemma":[0.9998996,0.000011834007,0.000026889582,0.0000044021763,0.000022006685,0.0000351808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015235475,0.0002640341,0.00023555341,0.00064441084,0.0001453971,0.0002973109,0.00016735312,0.00033504688,0.00310198],"category_scores_gemma":[0.000100596044,0.00011048436,0.00023618962,0.00030654776,0.00021854482,0.00030517924,0.00016526105,0.00046523858,0.00039899757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025016156,0.00038401643,0.04762062,0.00052225374,0.00009853031,0.0007319565,0.00011895638,0.00029247825,0.9260783,0.0003365762,0.0008263571,0.020488294],"study_design_scores_gemma":[0.00040781082,0.0065309405,0.55912656,0.00017441527,0.00048875593,0.0035383084,0.0019030052,0.005746488,0.40312654,0.0017822172,0.017130539,0.000044508713],"about_ca_topic_score_codex":0.00030426442,"about_ca_topic_score_gemma":0.00026897527,"teacher_disagreement_score":0.00310198,"about_ca_system_score_codex":0.00020109159,"about_ca_system_score_gemma":0.00015363387,"threshold_uncertainty_score":0.010377169},"labels":[],"label_agreement":null},{"id":"W4414465206","doi":"10.1158/2326-6074.cimm25-b007","title":"Abstract B007: Tissue-Specific B Cell Differentiation Limits Anti-Tumor Efficacy of Radiation and Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Myeloid; Tumor microenvironment; Immune system; B cell; T cell; Context (archaeology); CD40; Blockade","score_opus":0.04515627670786234,"score_gpt":0.37673717325141115,"score_spread":0.33158089654354883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465206","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97921455,0.008706373,0.0042899046,0.0003363003,0.00009547719,0.00009264598,0.0006535568,0.00028280218,0.0063283667],"genre_scores_gemma":[0.9904046,0.0016484339,0.0030278554,0.00020846992,0.000050241153,0.000072257826,0.0006179146,0.00006238002,0.00390785],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996884,0.00004939734,0.00001956362,0.00006416004,0.0000978994,0.00008067721],"domain_scores_gemma":[0.99977714,0.000058197744,0.000052708863,0.00002105133,0.000024256402,0.00006666762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034589085,0.0004075403,0.00054823176,0.00038538792,0.00016002358,0.0005045985,0.00034034238,0.0006493265,0.006011192],"category_scores_gemma":[0.00019166437,0.00017093714,0.00021430521,0.0001511954,0.00032837383,0.0003313377,0.00025354695,0.0011927902,0.0019152965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028968704,0.00012714161,0.00021770301,0.00008986024,0.000007769242,0.000021774049,0.000009483383,0.000089965535,0.9937332,0.00018864719,0.00017238701,0.0050523086],"study_design_scores_gemma":[0.000065420885,0.003030818,0.0038885497,0.000027795153,0.000035789275,0.00036043688,0.000024297062,0.0010816752,0.9861535,0.00019023562,0.005136823,0.000004829023],"about_ca_topic_score_codex":0.0003680361,"about_ca_topic_score_gemma":0.00030008404,"teacher_disagreement_score":0.006011192,"about_ca_system_score_codex":0.00029730948,"about_ca_system_score_gemma":0.00029302482,"threshold_uncertainty_score":0.020109415},"labels":[],"label_agreement":null},{"id":"W4414465210","doi":"10.1158/2326-6074.cimm25-a007","title":"Abstract A007: Radiomics of anaplastic Wilms tumors: Unraveling oncogenic immune dynamics","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiomics; Immune system; Wilms' tumor; Immunotherapy; Chromothripsis; Tumor microenvironment; Myeloid","score_opus":0.018075518893864925,"score_gpt":0.33855697529164996,"score_spread":0.320481456397785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465210","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516087,0.014559832,0.020146884,0.002081049,0.0003985515,0.000071808645,0.0060284515,0.00041565028,0.004689197],"genre_scores_gemma":[0.98207366,0.0035822056,0.006310345,0.0004967292,0.00035163836,0.00005783518,0.004758425,0.00008564539,0.002283545],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976736,0.000039248946,0.00002444993,0.00008031661,0.000059190308,0.000029430797],"domain_scores_gemma":[0.9993611,0.00019868107,0.00021239396,0.000053810698,0.00010145672,0.00007248967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059113506,0.00033546382,0.00035008747,0.0012973686,0.00030923833,0.0008398003,0.00025138204,0.00047598948,0.00443177],"category_scores_gemma":[0.001581753,0.00016245533,0.00037435602,0.0012014043,0.00046976414,0.0005430293,0.00057139545,0.0004985207,0.0006601391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001315882,0.000089739966,0.47820947,0.0019642413,0.00046769978,0.006033367,0.00088010496,0.0030559578,0.2245282,0.0047675543,0.017465794,0.26122195],"study_design_scores_gemma":[0.000057523295,0.0002973236,0.8503154,0.00031601827,0.00044281318,0.01624926,0.0008481504,0.007597408,0.046190914,0.010510607,0.06707436,0.00010024475],"about_ca_topic_score_codex":0.0005085255,"about_ca_topic_score_gemma":0.0006615348,"teacher_disagreement_score":0.00443177,"about_ca_system_score_codex":0.00027005837,"about_ca_system_score_gemma":0.0003655299,"threshold_uncertainty_score":0.014825821},"labels":[],"label_agreement":null},{"id":"W4414465211","doi":"10.1158/2326-6074.cimm25-a022","title":"Abstract A022: Therapeutic inhibition of TREX1 elicits type I interferon–mediated antitumor immunity with minimal autoimmune toxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Knockout mouse; Immunotherapy; Cancer immunotherapy; Immunity; Downregulation and upregulation; Inflammation; Cancer; Interferon; Cytotoxic T cell","score_opus":0.04960441073779465,"score_gpt":0.3623942273463089,"score_spread":0.31278981660851424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465211","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799789,0.0027244915,0.005501738,0.00025980908,0.00013034664,0.00019155604,0.0026064506,0.0003779299,0.008228708],"genre_scores_gemma":[0.9848595,0.0011374619,0.0028377923,0.00014170117,0.000023087407,0.00012301399,0.0023415273,0.00003492573,0.008500862],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999018,0.000013022302,0.000008108078,0.000022152508,0.000031310938,0.00002358041],"domain_scores_gemma":[0.9999492,0.0000056541453,0.000011538967,0.000006516452,0.000009162366,0.000017839682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012659404,0.00052340265,0.00032473973,0.00019226893,0.000119506,0.00027472823,0.00028663728,0.00038265507,0.0036979725],"category_scores_gemma":[0.00006868548,0.00010313693,0.00026342712,0.0001545248,0.00012939348,0.00018677098,0.000108700006,0.0009450867,0.0008047616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056804833,0.0002173648,0.00006994098,0.000081858925,0.000011422973,0.00004803998,0.000007542237,0.00026123805,0.9953425,0.00011294711,0.0003423704,0.0029368943],"study_design_scores_gemma":[0.00017990363,0.0038155054,0.0009807032,0.00000974374,0.000023820392,0.00026709563,0.000011427287,0.0010734,0.9896679,0.000048347494,0.0039153937,0.000006822542],"about_ca_topic_score_codex":0.00025547488,"about_ca_topic_score_gemma":0.00041320364,"teacher_disagreement_score":0.0036979725,"about_ca_system_score_codex":0.0001668345,"about_ca_system_score_gemma":0.00022525327,"threshold_uncertainty_score":0.012370884},"labels":[],"label_agreement":null},{"id":"W4414465220","doi":"10.1158/2326-6074.cimm25-a001","title":"Abstract A001: nELISA high-throughput protein profiling applied to the RADIOHEAD cohort: insights from the largest plasma proteomics study of patients receiving checkpoint inhibitor therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Proteomics; Pembrolizumab; Biomarker discovery; Immunotherapy; Antibody; Antibody microarray; Biomarker; Limiting; Chemokine","score_opus":0.030574614917593085,"score_gpt":0.35456210833617924,"score_spread":0.3239874934185861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870907,0.00036071267,0.0019471529,0.0004163542,0.000029354622,0.00007374573,0.008401302,0.00011701405,0.0015637154],"genre_scores_gemma":[0.9854434,0.00016932398,0.0029250463,0.00048055415,0.00008145292,0.00010890981,0.0095071355,0.00006529228,0.0012189395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995073,0.00011825929,0.000032222062,0.00019956913,0.00010276181,0.00003994303],"domain_scores_gemma":[0.99863964,0.00036585383,0.000366848,0.00025533736,0.00019213294,0.00018011716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014831497,0.00032642085,0.0003485732,0.0005975329,0.0003499949,0.0010104361,0.0004387738,0.00032242667,0.0025607466],"category_scores_gemma":[0.0024058244,0.00013024874,0.00044407588,0.0005116852,0.0002635055,0.0003388324,0.0006880777,0.00057809555,0.000609736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049972804,0.00030617454,0.896715,0.00016613211,0.00081337773,0.0005457899,0.00030140602,0.0006879519,0.04398001,0.00029708922,0.013062138,0.038127568],"study_design_scores_gemma":[0.00020698262,0.00094975077,0.9816203,0.000022827346,0.00034075291,0.0008606315,0.00018554051,0.0019124397,0.006603299,0.00020188518,0.0070670657,0.000028524877],"about_ca_topic_score_codex":0.0018128933,"about_ca_topic_score_gemma":0.0029563268,"teacher_disagreement_score":0.0025607466,"about_ca_system_score_codex":0.00037297086,"about_ca_system_score_gemma":0.00040103655,"threshold_uncertainty_score":0.008566499},"labels":[],"label_agreement":null},{"id":"W4414465312","doi":"10.1158/2326-6074.cimm25-b026","title":"Abstract B026: Targeting the ApoE-LDLR pathway disrupts MDSC-mediated systemic immunosuppression and enhances the efficacy of NK cell immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunosuppression; Immunotherapy; Cancer immunotherapy; Tumor microenvironment; T cell; Immune tolerance; Ex vivo; Myeloid-derived Suppressor Cell","score_opus":0.02173951862785936,"score_gpt":0.326722989498132,"score_spread":0.30498347087027267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465312","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938485,0.0006671278,0.0031195572,0.0001441497,0.00005103272,0.00005284549,0.0006497751,0.00018561636,0.0012814662],"genre_scores_gemma":[0.9928544,0.00038207203,0.0019629945,0.000064902124,0.000013651232,0.00007559499,0.00059638923,0.000037908052,0.004012198],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998648,0.00002099437,0.000015547015,0.000030004578,0.000031960546,0.00003667644],"domain_scores_gemma":[0.9999163,0.0000063120747,0.00002688016,0.00000931784,0.000008773457,0.00003231238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014891471,0.0004182748,0.00031906,0.00021040245,0.000120549244,0.0002887259,0.00021373892,0.0002760013,0.0018642135],"category_scores_gemma":[0.00006277272,0.0001019976,0.00019213533,0.00011080817,0.00025221918,0.00013424824,0.00013338542,0.00066399435,0.00057792704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004968485,0.00010959799,0.00009690667,0.00003128169,0.0000049164196,0.00002916681,0.000006726187,0.000060345938,0.9979165,0.00006842937,0.000069913374,0.0011092708],"study_design_scores_gemma":[0.00008874862,0.0010356279,0.0013052981,0.0000068024997,0.000015987409,0.00014248348,0.000018109058,0.0007404755,0.9948555,0.00004094037,0.0017468482,0.000003249619],"about_ca_topic_score_codex":0.00041644307,"about_ca_topic_score_gemma":0.00046384108,"teacher_disagreement_score":0.0018642135,"about_ca_system_score_codex":0.00021577922,"about_ca_system_score_gemma":0.00031015658,"threshold_uncertainty_score":0.006236434},"labels":[],"label_agreement":null},{"id":"W4414465317","doi":"10.1158/2326-6074.cimm25-pr-13","title":"Abstract PR-13: Myeloid checkpoint blockade potentiates radiotherapy by modulating dendritic cells and reducing Treg-driven immunosuppression","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; Immunotherapy; Blockade; Tumor microenvironment; Immune checkpoint; Immune system; Immunogenic cell death; Myeloid; Radiation therapy; Dendritic cell","score_opus":0.021755572307615836,"score_gpt":0.33174573685429964,"score_spread":0.3099901645466838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465317","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950324,0.0014422133,0.0014453271,0.0001205301,0.00007850167,0.00008681458,0.00040932308,0.00015351892,0.0012312849],"genre_scores_gemma":[0.9947395,0.00086560217,0.0017032417,0.00006290415,0.000040387593,0.000079825484,0.0004949744,0.000023749346,0.0019898252],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998349,0.000027939153,0.000019027808,0.000029555085,0.000033223558,0.00005527776],"domain_scores_gemma":[0.9999112,0.00001005566,0.000024489482,0.000011499814,0.000008273516,0.000034632274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019894606,0.0005377662,0.0005708949,0.00023819171,0.0001086771,0.0002477232,0.0003094536,0.00031864503,0.0017285766],"category_scores_gemma":[0.000081422295,0.00011758639,0.00032205464,0.00016389124,0.0002707813,0.00017656793,0.00016322531,0.0011677424,0.0005123724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014531082,0.00045000706,0.00012946206,0.00011144958,0.000017092458,0.000044832548,0.000013268626,0.00025601877,0.99176204,0.00008980181,0.00014956959,0.005523272],"study_design_scores_gemma":[0.00027921007,0.0069827423,0.0015795769,0.000010095355,0.000049694583,0.00018998627,0.000014308082,0.0008101587,0.98797464,0.000036919704,0.002067629,0.0000050244203],"about_ca_topic_score_codex":0.000338845,"about_ca_topic_score_gemma":0.0005057867,"teacher_disagreement_score":0.0017285766,"about_ca_system_score_codex":0.00017005893,"about_ca_system_score_gemma":0.00026415396,"threshold_uncertainty_score":0.005782604},"labels":[],"label_agreement":null},{"id":"W4414465321","doi":"10.1158/2326-6074.cimm25-ia06","title":"Abstract IA06: Lifestyle induced susceptibility of immune related adverse events","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Immune system; Cancer; Microbiome; Immunotherapy; Immunity; Downregulation and upregulation; Immune Dysfunction","score_opus":0.03058466263710136,"score_gpt":0.37330585407823286,"score_spread":0.3427211914411315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465321","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450379,0.0042193825,0.010153124,0.0020186363,0.0018998435,0.00063363265,0.020412447,0.0013955854,0.014229434],"genre_scores_gemma":[0.95655656,0.0022771086,0.005923035,0.0010257533,0.00023278072,0.0007778069,0.008908292,0.00016094428,0.024137748],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996859,0.000063764855,0.0000336495,0.00007295646,0.000085027714,0.00005880291],"domain_scores_gemma":[0.99938595,0.000066477005,0.00020873392,0.00006614329,0.00009905574,0.00017364923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043520055,0.0003817822,0.00048628062,0.00060146546,0.00028601463,0.00060312013,0.00032264992,0.0005365504,0.015633754],"category_scores_gemma":[0.00053976744,0.000114451504,0.0008216618,0.00046067816,0.0002310057,0.00028872755,0.00042586308,0.0010751218,0.0021881745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011856778,0.0028152715,0.0641497,0.0024385485,0.0005630111,0.0017100795,0.00026961244,0.00119094,0.75513154,0.0021397695,0.03098013,0.12675464],"study_design_scores_gemma":[0.0014517469,0.026838584,0.5676818,0.00063255074,0.0013330537,0.006658115,0.0008562787,0.005098896,0.2776029,0.0035281386,0.10805844,0.00025945427],"about_ca_topic_score_codex":0.00047413784,"about_ca_topic_score_gemma":0.0005473898,"teacher_disagreement_score":0.015633754,"about_ca_system_score_codex":0.00032660077,"about_ca_system_score_gemma":0.0004128101,"threshold_uncertainty_score":0.052300155},"labels":[],"label_agreement":null},{"id":"W4414465336","doi":"10.1158/2326-6074.cimm25-ia05","title":"Abstract IA05: Endocrine organs in the crosshairs of the immune system","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Endocrine system; Immune system; Cancer; Adverse effect; Immunity; Immunotherapy","score_opus":0.016546669077372872,"score_gpt":0.34049742273075134,"score_spread":0.32395075365337844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465336","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14954838,0.5347642,0.008738267,0.053363387,0.027513819,0.0002434425,0.0026206076,0.00081456173,0.22239344],"genre_scores_gemma":[0.70194966,0.11309632,0.00514036,0.01313732,0.012453506,0.000073770716,0.0021728084,0.000085150496,0.15189108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996251,0.00009947377,0.0000328091,0.000060672886,0.00009382871,0.000088197405],"domain_scores_gemma":[0.99964,0.000056069897,0.00008170899,0.000022620477,0.00007741232,0.0001221411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073176937,0.00058808667,0.00045936301,0.001183795,0.00071113714,0.0026289206,0.00050399255,0.0012100628,0.02197906],"category_scores_gemma":[0.00053602137,0.00020447823,0.0004687814,0.00070408586,0.000630142,0.00093317375,0.0011419007,0.0016977029,0.0030602685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025745435,0.00045010782,0.060059637,0.0023097235,0.00026244868,0.020310087,0.0005512549,0.00074854674,0.04005734,0.04769655,0.34939125,0.4755885],"study_design_scores_gemma":[0.00019236738,0.0009473478,0.12518565,0.0014617083,0.0002574121,0.034656413,0.00074805634,0.00078247517,0.01206014,0.00921437,0.8144316,0.00006248334],"about_ca_topic_score_codex":0.0030258636,"about_ca_topic_score_gemma":0.0031045617,"teacher_disagreement_score":0.02197906,"about_ca_system_score_codex":0.001287441,"about_ca_system_score_gemma":0.00092977774,"threshold_uncertainty_score":0.07352728},"labels":[],"label_agreement":null},{"id":"W4414465438","doi":"10.1158/2326-6074.cimm25-b001","title":"Abstract B001: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blockade; Cytotoxic T cell; Immune checkpoint; T cell; CD8; Immune system; Cancer immunotherapy; Immunotherapy; Effector","score_opus":0.08841217000830207,"score_gpt":0.40870611114633854,"score_spread":0.32029394113803644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465438","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93879926,0.015762484,0.023894113,0.0019340198,0.0008777227,0.00066327193,0.0009996186,0.0017543265,0.01531516],"genre_scores_gemma":[0.9798645,0.003497279,0.0059629967,0.00062408077,0.00013585892,0.00025653074,0.0005826134,0.000114962466,0.008961247],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991524,0.000013067538,0.0000050972544,0.000014139783,0.000024656294,0.000027726259],"domain_scores_gemma":[0.99991894,0.000010863454,0.000018416233,0.0000060599077,0.000011133999,0.000034732795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019700892,0.000362137,0.00032627926,0.00024107922,0.00010376284,0.00043728956,0.00027934328,0.00028592846,0.005231789],"category_scores_gemma":[0.00022558469,0.00008296396,0.00017117219,0.00014415426,0.00011451701,0.00027500812,0.00026279473,0.0011571082,0.0014656928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00450364,0.0024697324,0.0009652928,0.00058844703,0.00006847494,0.0001284062,0.000039869454,0.0019600848,0.74131775,0.001126915,0.009782911,0.23704846],"study_design_scores_gemma":[0.0027599025,0.041972708,0.009946605,0.00022605291,0.00024330006,0.0012454866,0.00006361823,0.017481012,0.866526,0.0014397543,0.058044538,0.00005103817],"about_ca_topic_score_codex":0.00027203685,"about_ca_topic_score_gemma":0.00040057654,"teacher_disagreement_score":0.005231789,"about_ca_system_score_codex":0.00019811542,"about_ca_system_score_gemma":0.00034699216,"threshold_uncertainty_score":0.01750213},"labels":[],"label_agreement":null},{"id":"W4414465448","doi":"10.1158/2326-6074.cimm25-b020","title":"Abstract B020: NETosis-specific clipped histone H3 is a novel biomarker of response to neoadjuvant chemo-immunotherapy in resectable lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Nivolumab; Biomarker; Lung cancer; Immunotherapy; Chemotherapy; Pathological; Neoadjuvant therapy; Cancer","score_opus":0.0484603173720193,"score_gpt":0.4168798171258093,"score_spread":0.36841949975379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465448","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630165,0.0013335362,0.0005046649,0.00009610246,0.000019520508,0.000031110172,0.0007926964,0.000024835641,0.0008959802],"genre_scores_gemma":[0.99809533,0.00012378,0.00036425667,0.000056607743,0.00001456041,0.00001982468,0.0008632577,0.0000041788185,0.0004582596],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986756,0.000030103314,0.000015916294,0.000035593646,0.000032862314,0.000017860559],"domain_scores_gemma":[0.99966824,0.000057607103,0.00014264083,0.000015134543,0.000048124686,0.000068190166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035823046,0.00020835777,0.00025266447,0.00034243072,0.00014859358,0.00043475875,0.00017113073,0.00029343774,0.0022415293],"category_scores_gemma":[0.00048343852,0.00008534048,0.00015959144,0.0002696205,0.00019675831,0.00015674753,0.00017752596,0.0003372869,0.000412335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075080255,0.00023645528,0.83145916,0.00020840536,0.00021533914,0.00029210138,0.000072692725,0.0003625606,0.13897076,0.000054653043,0.0010031406,0.019616766],"study_design_scores_gemma":[0.00008467665,0.0015187007,0.9693471,0.000017485048,0.000098348486,0.0013570001,0.00009326511,0.0014910497,0.02486689,0.0000915868,0.0010242969,0.000009595839],"about_ca_topic_score_codex":0.00068881613,"about_ca_topic_score_gemma":0.000815671,"teacher_disagreement_score":0.0022415293,"about_ca_system_score_codex":0.00023991938,"about_ca_system_score_gemma":0.00017383348,"threshold_uncertainty_score":0.007498622},"labels":[],"label_agreement":null},{"id":"W4414465449","doi":"10.1158/2326-6074.cimm25-b013","title":"Abstract B013: Evaluating Chi3L1 as a potential target for immunotherapy in chordoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chordoma; Immunotherapy; Immune system; Peripheral blood mononuclear cell; Monoclonal antibody; Mesenchymal stem cell; Cancer immunotherapy; Progenitor cell","score_opus":0.08709911150087546,"score_gpt":0.499722002632255,"score_spread":0.41262289113137957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465449","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795472,0.01030282,0.003633142,0.00050247327,0.00017999006,0.00027543906,0.0018090091,0.0001882899,0.003561787],"genre_scores_gemma":[0.9869767,0.0026614156,0.003917163,0.00032681786,0.00006430824,0.00019480118,0.0024131478,0.000030423595,0.0034151652],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998584,0.000019599165,0.0000106240595,0.000025792067,0.000053315747,0.00003238019],"domain_scores_gemma":[0.9998282,0.0000354841,0.00002705377,0.000010586056,0.000049248538,0.000049388276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003678998,0.00034438257,0.00027161234,0.00027428594,0.00017969923,0.0004250045,0.00019655713,0.00047519954,0.0033804337],"category_scores_gemma":[0.00019853693,0.00007224469,0.00029439945,0.00022654817,0.00021057927,0.00021744987,0.00016349262,0.0006606977,0.00082486717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006167659,0.00010356305,0.0011314958,0.00026389997,0.000013988961,0.00006817165,0.000017926533,0.000127865,0.990729,0.000031290412,0.00030404463,0.0065920968],"study_design_scores_gemma":[0.00011664773,0.0033579266,0.013500265,0.000040443298,0.0000883309,0.0006952251,0.000097066375,0.0010912118,0.9736604,0.00008153115,0.0072605787,0.000010438027],"about_ca_topic_score_codex":0.0006075103,"about_ca_topic_score_gemma":0.000464712,"teacher_disagreement_score":0.0033804337,"about_ca_system_score_codex":0.00044467425,"about_ca_system_score_gemma":0.00037571177,"threshold_uncertainty_score":0.01130873},"labels":[],"label_agreement":null},{"id":"W4414465452","doi":"10.1158/2326-6074.cimm25-b012","title":"Abstract B012: Bromodomain and extra-terminal domain (BET) as a therapeutic target in a mouse model of secondary hemophagocytic lymphohistiocytosis (HLH)","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bromodomain; Spleen; Cytotoxic T cell; BET inhibitor; Perforin; Adoptive cell transfer; Anemia; Lymphocyte; Peripheral blood mononuclear cell","score_opus":0.04491956817156655,"score_gpt":0.37390060098249267,"score_spread":0.3289810328109261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465452","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108815,0.0018796677,0.00215947,0.00037019845,0.00023647021,0.0001977004,0.0014675554,0.00024006904,0.0023607714],"genre_scores_gemma":[0.985308,0.0015984379,0.003468884,0.00021644021,0.00006022664,0.00043864016,0.0018688649,0.000039963714,0.007000458],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972767,0.000040598792,0.000022044947,0.00005214236,0.00006713926,0.0000903954],"domain_scores_gemma":[0.99987245,0.000010949108,0.000029525063,0.000010974596,0.000008904619,0.00006714477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030956487,0.0007294036,0.0007585233,0.0006876388,0.00023899176,0.00038760857,0.000411056,0.00080697285,0.0023539448],"category_scores_gemma":[0.000088602435,0.00022104535,0.00041629406,0.00032223182,0.0004615007,0.00036898145,0.00016903045,0.0019321726,0.0006655891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034342643,0.001480739,0.00017958324,0.00012752539,0.000019306888,0.00010600374,0.000025036179,0.00018780556,0.9907132,0.00023396843,0.00036746528,0.0031251458],"study_design_scores_gemma":[0.0013118472,0.019354103,0.0034297265,0.00003723902,0.00010265827,0.00051304186,0.000089174304,0.0017115335,0.96777225,0.00014344543,0.0055168997,0.000018083232],"about_ca_topic_score_codex":0.00046311162,"about_ca_topic_score_gemma":0.00061592844,"teacher_disagreement_score":0.0023539448,"about_ca_system_score_codex":0.00029864442,"about_ca_system_score_gemma":0.00030419626,"threshold_uncertainty_score":0.007874727},"labels":[],"label_agreement":null},{"id":"W4414465467","doi":"10.1158/2326-6074.cimm25-b011","title":"Abstract B011: Mast cells mediate tumor-suppressive effects in head and neck cancer through immune-microenvironmental regulation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Downregulation and upregulation; Tumor microenvironment; Cytokine; Mast cell; Chemokine; Immune system; Interleukin 33; Immunotherapy; Cell cycle","score_opus":0.0179766665746558,"score_gpt":0.3154393146258206,"score_spread":0.2974626480511648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465467","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566849,0.020990122,0.003194454,0.0011268213,0.00045061478,0.00021932798,0.005913021,0.00034262516,0.011078228],"genre_scores_gemma":[0.974664,0.005379618,0.001515141,0.00040510614,0.00022261923,0.00011844944,0.004041944,0.000031174175,0.013621952],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999918,0.000009255867,0.000006034136,0.00001604114,0.000027244669,0.000023324457],"domain_scores_gemma":[0.99995136,0.000005566519,0.000010525536,0.0000030107688,0.000013777228,0.000015751308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001175948,0.00050054217,0.00024279053,0.00020803697,0.00019726665,0.00036434564,0.00016766424,0.00028349765,0.0066136573],"category_scores_gemma":[0.000079598816,0.000083382816,0.00024515903,0.00019044329,0.0001671243,0.0001665743,0.00015973287,0.0004741295,0.0014463753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074741594,0.00007451029,0.00074822106,0.0002830427,0.000010331228,0.00019383979,0.000013196462,0.000043170283,0.9918013,0.000093860035,0.00077448523,0.0052165305],"study_design_scores_gemma":[0.00038532607,0.0024100468,0.10078129,0.00008295652,0.00012710887,0.0015984776,0.00016068832,0.0013975069,0.8679124,0.0002950112,0.024832767,0.000016348758],"about_ca_topic_score_codex":0.00083069346,"about_ca_topic_score_gemma":0.00068902655,"teacher_disagreement_score":0.0066136573,"about_ca_system_score_codex":0.00031185464,"about_ca_system_score_gemma":0.0002590767,"threshold_uncertainty_score":0.022124946},"labels":[],"label_agreement":null},{"id":"W4414465471","doi":"10.1158/2326-6074.cimm25-a013","title":"Abstract A013: Fibroblast activation protein (FAP) enhances adoptive NK cell therapy in solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Extracellular matrix; Fibroblast activation protein, alpha; Stromal cell; Immunotherapy; Cell therapy; Tumor microenvironment; Fibroblast; Lymphokine-activated killer cell; Adoptive cell transfer","score_opus":0.0491018179758357,"score_gpt":0.4026614558409911,"score_spread":0.35355963786515543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465471","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881762,0.0030709754,0.0038876382,0.0002576854,0.00011077267,0.00008715683,0.00039537274,0.00013604588,0.0038782028],"genre_scores_gemma":[0.99231577,0.00091101736,0.0029872404,0.000054617634,0.0000230297,0.00004524982,0.00034762916,0.00001225647,0.003303096],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999285,0.00001202665,0.000005375707,0.000013991692,0.00002309902,0.000016977529],"domain_scores_gemma":[0.99995697,0.000007442846,0.00000877199,0.000003481804,0.0000059905524,0.000017286065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009027161,0.00033123724,0.00019379547,0.00021753322,0.000107396976,0.00019869072,0.00010658385,0.0002269373,0.003257993],"category_scores_gemma":[0.000061120896,0.000046262325,0.00017532648,0.00015872474,0.00015046133,0.0001548481,0.00013078826,0.00041021532,0.0007020151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003094705,0.0001330158,0.0002054131,0.000075814336,0.0000073659467,0.00008111142,0.000009517972,0.000111095855,0.9916094,0.000094272786,0.00024477748,0.007118795],"study_design_scores_gemma":[0.00007951364,0.001705375,0.0028673955,0.000008696026,0.000029227953,0.00055312965,0.000022368788,0.0010764305,0.98842686,0.00005617311,0.005170236,0.0000044964054],"about_ca_topic_score_codex":0.0004246803,"about_ca_topic_score_gemma":0.00039022387,"teacher_disagreement_score":0.003257993,"about_ca_system_score_codex":0.00013007101,"about_ca_system_score_gemma":0.00015506028,"threshold_uncertainty_score":0.010899067},"labels":[],"label_agreement":null},{"id":"W4414465472","doi":"10.1158/2326-6074.cimm25-a006","title":"Abstract A006: Assessment of EBV DNA methylation to guide antiviral use in EBV-associated lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA methylation; Lytic cycle; Methylation; CpG site; Biomarker; Lymphoma; Epstein–Barr virus","score_opus":0.0634626538248882,"score_gpt":0.4454780904948172,"score_spread":0.382015436669929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465472","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834029,0.002837535,0.0060055815,0.0001848338,0.00004402153,0.00016653811,0.0030962531,0.00023107485,0.00403118],"genre_scores_gemma":[0.9881847,0.00053759234,0.0069225235,0.00012842553,0.000021633507,0.000093111434,0.0014094472,0.000020849826,0.0026817052],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997526,0.00006428213,0.000027671562,0.000051991865,0.00008415933,0.000019339283],"domain_scores_gemma":[0.9996991,0.000070393835,0.00007465182,0.000018017701,0.000104773644,0.000033100714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058781327,0.00026487297,0.00022684256,0.00073596055,0.00021133032,0.00038753156,0.00027680796,0.00042565953,0.003306116],"category_scores_gemma":[0.001037565,0.00013814826,0.00015256148,0.00045492803,0.00013040632,0.00017812602,0.00019279635,0.0003166696,0.0010119269],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020815055,0.00023956277,0.6861783,0.00027892162,0.00012413002,0.00029187795,0.00021904283,0.0006225034,0.23426834,0.0001305507,0.0017744612,0.073790796],"study_design_scores_gemma":[0.00008413943,0.0021763863,0.8070141,0.00007689873,0.00017278422,0.0022823785,0.0003201959,0.005459767,0.17308526,0.00032029563,0.00897959,0.000028240485],"about_ca_topic_score_codex":0.0010311198,"about_ca_topic_score_gemma":0.0015498992,"teacher_disagreement_score":0.003306116,"about_ca_system_score_codex":0.00026462862,"about_ca_system_score_gemma":0.00016179183,"threshold_uncertainty_score":0.011060059},"labels":[],"label_agreement":null},{"id":"W4414465958","doi":"10.1158/2326-6074.cimm25-pr-12","title":"Abstract PR-12: Single-cell profiling of tumor-infiltrating B cells reveals autoantibody repertoires and potential cross-talk with T cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antigen; Antibody; Immunogenicity; Somatic cell; Autoantibody; Monoclonal antibody; Antibody Repertoire; Somatic hypermutation; B cell","score_opus":0.04045549451952006,"score_gpt":0.3715541339117001,"score_spread":0.33109863939218004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465958","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737611,0.001126791,0.018666577,0.000094437586,0.000025129913,0.000036572284,0.004449631,0.0003886148,0.0014512406],"genre_scores_gemma":[0.9752289,0.00048853434,0.015060803,0.00022168992,0.00002120746,0.000086482905,0.006387331,0.00013327356,0.0023718385],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997998,0.000022137303,0.0000095253945,0.00008285626,0.000049262686,0.00003645455],"domain_scores_gemma":[0.9998349,0.00003776935,0.000028017466,0.000025842994,0.000040795272,0.000032743494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000268172,0.00022970505,0.00031217712,0.000357204,0.00017501847,0.0005108173,0.0001690351,0.00029988095,0.0013763844],"category_scores_gemma":[0.00022190205,0.00014964721,0.00028149356,0.00033819507,0.000131832,0.0001832285,0.00026911483,0.00048653732,0.0007269027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106994616,0.000013458215,0.0055113994,0.00005273573,0.000017123106,0.000035966077,0.000029242248,0.00020973037,0.9896745,0.000033915745,0.00017845782,0.004136422],"study_design_scores_gemma":[0.000025561138,0.00048897055,0.21686597,0.000030704654,0.0000994567,0.0010384185,0.0003207423,0.017168926,0.7545624,0.00039766086,0.008974632,0.000026544925],"about_ca_topic_score_codex":0.0003195038,"about_ca_topic_score_gemma":0.0005121478,"teacher_disagreement_score":0.0013763844,"about_ca_system_score_codex":0.00012302262,"about_ca_system_score_gemma":0.00010107189,"threshold_uncertainty_score":0.004604459},"labels":[],"label_agreement":null},{"id":"W4414465964","doi":"10.1158/2326-6074.cimm25-ia03","title":"Abstract IA03: Therapeutic modulation of nucleic acids-induced immune activation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Innate immune system; Nucleic acid; Crosstalk; Epigenetics; Immunotherapy; DNA damage; Interferon; Immunity","score_opus":0.05852038867188895,"score_gpt":0.38309083767506785,"score_spread":0.3245704490031789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465964","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9219305,0.027966745,0.012194738,0.001384378,0.0018567775,0.0006674586,0.0022810402,0.001586228,0.030132052],"genre_scores_gemma":[0.9737167,0.006682409,0.0046803895,0.0006937782,0.00021444749,0.00037243872,0.00198652,0.0000903454,0.011562988],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998628,0.00003217173,0.000009524187,0.000020053398,0.000023966877,0.000051500087],"domain_scores_gemma":[0.9999006,0.000011681276,0.000020185613,0.00001599717,0.000014274317,0.00003729726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021737276,0.00047274018,0.00044317605,0.00047609705,0.00017387442,0.00058909116,0.00044575156,0.0005018282,0.005597896],"category_scores_gemma":[0.00018346887,0.000103628074,0.00048750013,0.00039878578,0.0002495659,0.0001732971,0.0002232984,0.0015832591,0.0015981185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006655365,0.0029657814,0.0005457677,0.00089298584,0.0001354283,0.0003507375,0.000072400966,0.001221018,0.86661726,0.0022402653,0.006253443,0.11204954],"study_design_scores_gemma":[0.0026415056,0.035413872,0.007793824,0.00027442936,0.00035652352,0.0018509387,0.00013944616,0.005951209,0.8566568,0.001141162,0.087726384,0.00005393568],"about_ca_topic_score_codex":0.00059183326,"about_ca_topic_score_gemma":0.0005596362,"teacher_disagreement_score":0.005597896,"about_ca_system_score_codex":0.00034899497,"about_ca_system_score_gemma":0.00067353324,"threshold_uncertainty_score":0.018726826},"labels":[],"label_agreement":null},{"id":"W4414465967","doi":"10.1158/2326-6074.cimm25-pr-03","title":"Abstract PR-03: Tumor-derived Complement Factor B drives tumor growth and anti-PD-1 resistance in <i>STK11</i>-mutant lung adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Complement system; Immunotherapy; Immune system; CD8; Downregulation and upregulation; Alternative complement pathway; Adenocarcinoma; Transfection; CD59","score_opus":0.025398230157341276,"score_gpt":0.34162553743679414,"score_spread":0.31622730727945286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971571,0.00018137052,0.0005577587,0.00010072614,0.0000147464925,0.000030155945,0.00062943384,0.00007475051,0.0012539802],"genre_scores_gemma":[0.9954064,0.00008299942,0.0006583344,0.000048944865,0.0000042668144,0.000035748024,0.00062328903,0.000024433197,0.0031155418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998373,0.000019483321,0.000017938524,0.00003822734,0.00004225542,0.000044703327],"domain_scores_gemma":[0.9998356,0.000022966296,0.000038500762,0.000018489345,0.000011850799,0.000072626935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001059869,0.00025848998,0.0001848295,0.00023901206,0.00017699457,0.0003432717,0.0002078387,0.0003526105,0.0023819073],"category_scores_gemma":[0.000089219924,0.0001420464,0.00023500269,0.00014623761,0.00029728623,0.00015979775,0.00015863017,0.0012608501,0.00072612107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023234988,0.00012657547,0.00046692046,0.000018983867,0.0000033830183,0.00007390365,0.000013461063,0.000054924985,0.99797124,0.00012130727,0.00010554939,0.00081142166],"study_design_scores_gemma":[0.00008524195,0.0017653533,0.015220343,0.000009129652,0.000017637401,0.0013187864,0.000082617116,0.0021937462,0.976594,0.00007718872,0.0026288514,0.000007291265],"about_ca_topic_score_codex":0.0011192049,"about_ca_topic_score_gemma":0.0014213901,"teacher_disagreement_score":0.0023819073,"about_ca_system_score_codex":0.00050323794,"about_ca_system_score_gemma":0.0003161869,"threshold_uncertainty_score":0.007968307},"labels":[],"label_agreement":null},{"id":"W4414465977","doi":"10.1158/2326-6074.cimm25-pr-02","title":"Abstract PR-02: Loss of tumor-intrinsic type I IFN facilitates and predicts bone-metastatic progression in advanced prostate cancer and drives radiotherapeutic resistance","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Bone metastasis; Metastasis; Immunotherapy; Tumor microenvironment; Lymph node; Cancer","score_opus":0.03552965024291679,"score_gpt":0.40923102450864074,"score_spread":0.373701374265724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762315,0.00035375013,0.0005826644,0.000046410503,0.0000044495077,0.0000091517295,0.00096195895,0.000018296907,0.00040014362],"genre_scores_gemma":[0.9986816,0.000058035537,0.00028010504,0.000025127172,0.0000032585285,0.000007331494,0.00068080064,0.000004288863,0.0002594783],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988353,0.000017343977,0.0000061468486,0.00004337167,0.000026437732,0.00002302815],"domain_scores_gemma":[0.9998056,0.000027911678,0.00007684615,0.000021069643,0.000027814795,0.000040731957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018297658,0.00015244602,0.0002205357,0.000243196,0.00014660535,0.0004442679,0.00016491632,0.00020322282,0.0020521306],"category_scores_gemma":[0.00032070314,0.000102015016,0.00017848851,0.0003698746,0.00021598279,0.00012053912,0.00021699523,0.00044816837,0.00035141414],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014729523,0.00009735415,0.69360113,0.00010616342,0.00011811992,0.00025598257,0.000114305316,0.0009491773,0.28741115,0.000113995164,0.00067313877,0.015086518],"study_design_scores_gemma":[0.000021263164,0.00033176376,0.9782503,0.0000074884924,0.000052286105,0.0013383852,0.00018689658,0.0016675314,0.017068617,0.00011545251,0.0009534457,0.0000064484757],"about_ca_topic_score_codex":0.0010284265,"about_ca_topic_score_gemma":0.0012030533,"teacher_disagreement_score":0.0020521306,"about_ca_system_score_codex":0.0001922979,"about_ca_system_score_gemma":0.00017216823,"threshold_uncertainty_score":0.0068650246},"labels":[],"label_agreement":null},{"id":"W4414465979","doi":"10.1158/2326-6074.cimm25-ia04","title":"Abstract IA04: Reprogramming the tumor–immune microenvironment: From stromal circuits to engineered microbial immunotherapies","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reprogramming; Immunotherapy; Stromal cell; Cancer immunotherapy; Tumor microenvironment; Immune system; Immune checkpoint; Chemokine","score_opus":0.022969191705989617,"score_gpt":0.28945892621860436,"score_spread":0.26648973451261476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305499,0.004903494,0.053988907,0.0004205142,0.00022671232,0.00009980562,0.0008473293,0.0008690183,0.008094297],"genre_scores_gemma":[0.9700549,0.0019198771,0.021298781,0.00016836259,0.000034915374,0.00007875952,0.0006258406,0.00009359643,0.005724961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999897,0.000015507461,0.000006437077,0.00002451341,0.000031105727,0.00002543865],"domain_scores_gemma":[0.9999387,0.0000075955572,0.000018418319,0.0000080237005,0.000011855547,0.000015420153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000135174,0.00033801858,0.0001653326,0.00026162947,0.0000913681,0.00050415716,0.00019888859,0.00026711024,0.0012317015],"category_scores_gemma":[0.00008969944,0.000092556955,0.00018457572,0.00018227064,0.00018935867,0.00016940947,0.00022044635,0.0004997491,0.00041588393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035888625,0.000021076317,0.00010346905,0.000028733222,0.000002801909,0.000024338104,0.000007018979,0.0002171583,0.99502486,0.00028005842,0.00009991458,0.0041545685],"study_design_scores_gemma":[0.00001030179,0.00022472496,0.00075075246,0.000007363411,0.0000118160515,0.00013587519,0.000017184253,0.0025811684,0.98895556,0.00016121428,0.0071387314,0.00000532641],"about_ca_topic_score_codex":0.0002691533,"about_ca_topic_score_gemma":0.00027627667,"teacher_disagreement_score":0.0012317015,"about_ca_system_score_codex":0.00026262688,"about_ca_system_score_gemma":0.00021862527,"threshold_uncertainty_score":0.004120469},"labels":[],"label_agreement":null},{"id":"W4414465995","doi":"10.1158/2326-6074.cimm25-b003","title":"Abstract B003: Oncolytic VSVd51-LIGHT and folfirinox chemotherapy increases anti-tumor immune response in pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Oncolytic virus; Immune system; Pancreatic cancer; Immunotherapy; Tumor microenvironment; FOLFIRINOX; Cytokine; Cancer; Oncolytic adenovirus","score_opus":0.021452818381954876,"score_gpt":0.3614463486068182,"score_spread":0.3399935302248633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967319,0.001107741,0.00049541646,0.0000688026,0.000040605963,0.000024446048,0.00022528693,0.000063629144,0.0012421396],"genre_scores_gemma":[0.9963297,0.00037207291,0.0007753641,0.000040013754,0.000013604819,0.000027686392,0.0004969341,0.000007577735,0.0019370532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999161,0.000012582325,0.000006611508,0.000018173127,0.000020720288,0.000025894951],"domain_scores_gemma":[0.9999583,0.000009171087,0.000008426238,0.000005456933,0.000004251972,0.000014304032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008471938,0.00025711968,0.00026392992,0.00017822048,0.00009679662,0.00023858332,0.0001132645,0.0003160775,0.0018960898],"category_scores_gemma":[0.000071530725,0.00008334418,0.00020047226,0.00013839825,0.00014600325,0.00014656692,0.000112455426,0.0005466447,0.0003405243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011075757,0.0002370068,0.000323969,0.000047536574,0.000009106564,0.000029652232,0.000011741916,0.0001036994,0.99354446,0.00004379045,0.0001466927,0.004394868],"study_design_scores_gemma":[0.00021096894,0.005618276,0.0087956935,0.000010057118,0.00003753316,0.00025860095,0.000036569,0.0011112941,0.9807976,0.000028441696,0.0030901714,0.0000048383326],"about_ca_topic_score_codex":0.00055827235,"about_ca_topic_score_gemma":0.00053937576,"teacher_disagreement_score":0.0018960898,"about_ca_system_score_codex":0.00022945399,"about_ca_system_score_gemma":0.0001876061,"threshold_uncertainty_score":0.006343007},"labels":[],"label_agreement":null},{"id":"W4414465996","doi":"10.1158/2326-6074.cimm25-pr-14","title":"Abstract PR-14: Unraveling the sexually dimorphic immune microenvironment in gastric cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Immune system; CD8; Cytotoxic T cell; Antigen; Sexual dimorphism; Immunotherapy; Tumor microenvironment; CDH1","score_opus":0.05215571832167075,"score_gpt":0.38088370511138075,"score_spread":0.32872798678971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526,0.024156706,0.0127854785,0.00337276,0.00034667226,0.000090296366,0.0012392618,0.00026766918,0.005141153],"genre_scores_gemma":[0.9725289,0.008993383,0.00863536,0.0007347563,0.00021594607,0.00007196688,0.0009933254,0.00008718439,0.0077392],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998647,0.000029339191,0.000008156808,0.000032420874,0.00003613714,0.00002932481],"domain_scores_gemma":[0.9998714,0.000012292873,0.00003781463,0.000012361517,0.000020315552,0.000045913803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003783902,0.0002656666,0.00026156462,0.000332826,0.00011382742,0.00041091556,0.00037412555,0.00032485154,0.0023361626],"category_scores_gemma":[0.00015032884,0.00016206296,0.00022300858,0.00018325227,0.00032571054,0.00045644992,0.0003827988,0.00087523874,0.00058418594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005597781,0.000081875754,0.0061680824,0.00028510508,0.000020637055,0.00034436316,0.000051942443,0.0002218265,0.95549184,0.0009334916,0.0011692775,0.03467185],"study_design_scores_gemma":[0.00024579657,0.0035851481,0.23393525,0.000244958,0.00016703528,0.0068548014,0.0008770693,0.007886213,0.66637385,0.00209793,0.077677295,0.00005463175],"about_ca_topic_score_codex":0.00022572002,"about_ca_topic_score_gemma":0.00041882144,"teacher_disagreement_score":0.0023361626,"about_ca_system_score_codex":0.00025256668,"about_ca_system_score_gemma":0.00026353664,"threshold_uncertainty_score":0.007815301},"labels":[],"label_agreement":null},{"id":"W4414466001","doi":"10.1158/2326-6074.cimm25-pr-05","title":"Abstract PR-05: Sumoylation blockade exposes the dark epigenome to drive ZBP1 viral mimicry for cancer immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Necroptosis; Innate immune system; Cancer immunotherapy; Epigenome; Effector; Cancer cell; SUMO protein; Chromatin","score_opus":0.03855332204006988,"score_gpt":0.35829045335405285,"score_spread":0.31973713131398296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97696054,0.0015846725,0.011555062,0.0005611482,0.00020749403,0.00017400611,0.0019769303,0.0006951624,0.006284859],"genre_scores_gemma":[0.98754126,0.00055192935,0.004001747,0.00009249703,0.000012970321,0.000093480856,0.0009059028,0.00006898706,0.00673119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998074,0.000018824343,0.00001728981,0.000053221847,0.000051037307,0.000052301264],"domain_scores_gemma":[0.99989283,0.00000985994,0.000029055498,0.000017483839,0.000009401488,0.000041270203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016919088,0.00043800427,0.00036692346,0.00022414928,0.00019088341,0.00042210735,0.00039826013,0.00047592958,0.0035151662],"category_scores_gemma":[0.00007879632,0.00016242047,0.00032878105,0.00020686482,0.0003282186,0.00032688424,0.00023628917,0.0014793961,0.00094748184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023079099,0.0000765766,0.000061546285,0.000032122545,0.000007655291,0.000026911335,0.000009062361,0.00015348167,0.9973387,0.0003273604,0.0001661184,0.0015697604],"study_design_scores_gemma":[0.000023345012,0.00028693816,0.0003496208,0.0000024200044,0.000008424328,0.000059830632,0.000008339828,0.0008557153,0.99573344,0.000046124398,0.0026231084,0.0000026845441],"about_ca_topic_score_codex":0.00070184626,"about_ca_topic_score_gemma":0.0006550389,"teacher_disagreement_score":0.0035151662,"about_ca_system_score_codex":0.00045692292,"about_ca_system_score_gemma":0.00031153965,"threshold_uncertainty_score":0.011759341},"labels":[],"label_agreement":null},{"id":"W4414466003","doi":"10.1158/2326-6074.cimm25-b004","title":"Abstract B004: Route dependent T-cell activation by mRNA cluster therapies","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peripheral blood mononuclear cell; Immunogenicity; Flow cytometry; Messenger RNA; Cell; T cell; Immunotherapy; CD8; Cancer vaccine","score_opus":0.053018574797816256,"score_gpt":0.40494907590402934,"score_spread":0.3519305011062131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95722985,0.00763617,0.017604798,0.00072365097,0.00038797318,0.00057524943,0.0010421637,0.0008621626,0.013938021],"genre_scores_gemma":[0.970689,0.002492284,0.008854686,0.00027020983,0.00011267416,0.00030783744,0.0012438564,0.00011392147,0.015915446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998549,0.00002580925,0.000007475903,0.00003050836,0.00004664866,0.000034582208],"domain_scores_gemma":[0.9999467,0.000011183901,0.000015233722,0.0000055746746,0.0000103946995,0.000010864335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016874299,0.0005128488,0.00028282922,0.00022917609,0.00010464742,0.00039828845,0.00027400916,0.00048570387,0.0066734846],"category_scores_gemma":[0.00014054644,0.00010791941,0.00025668417,0.000120778444,0.0001759894,0.00023569404,0.00020378456,0.0007854627,0.0024726996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047590793,0.00018190836,0.000087831846,0.00011336472,0.0000067499864,0.000033791028,0.000010220762,0.00022200859,0.98727536,0.00014383906,0.0005043489,0.010944766],"study_design_scores_gemma":[0.00033241673,0.0063738334,0.002054144,0.00003234187,0.0000641144,0.00038921722,0.00002369506,0.0027765601,0.97112983,0.00018936272,0.016623072,0.0000114802115],"about_ca_topic_score_codex":0.0003230057,"about_ca_topic_score_gemma":0.00033175017,"teacher_disagreement_score":0.0066734846,"about_ca_system_score_codex":0.00029701486,"about_ca_system_score_gemma":0.0003339734,"threshold_uncertainty_score":0.022325039},"labels":[],"label_agreement":null},{"id":"W4414466009","doi":"10.1158/2326-6074.cimm25-a019","title":"Abstract A019: Timed intracranial therapy with NK cells and NK cell-derived extracellular vesicles following temozolomide exhibits curative potential in mesenchymal glioblastoma model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Temozolomide; Glioma; Mesenchymal stem cell; Immunotherapy; NKG2D; In vivo; Immune system; Chemotherapy; CD8; Tumor microenvironment","score_opus":0.01584222301064171,"score_gpt":0.3088102247314494,"score_spread":0.2929680017208077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944989,0.0011457804,0.0017467292,0.00009648062,0.0000875978,0.000048253536,0.0009946614,0.00014532934,0.001236307],"genre_scores_gemma":[0.99505925,0.00047923235,0.0010104085,0.000042896045,0.000010250612,0.000071431896,0.0010299459,0.00001558966,0.0022810563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993837,0.000004578668,0.0000049770124,0.000017122824,0.000014335854,0.000020648453],"domain_scores_gemma":[0.9999689,0.0000024519954,0.000007094069,0.0000035056153,0.0000034777238,0.000014591275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060110386,0.00023401933,0.00028892636,0.00014774066,0.0000862449,0.00019919928,0.000157557,0.00019927963,0.001434818],"category_scores_gemma":[0.000047467736,0.00005325425,0.00018294832,0.00009774885,0.00016748258,0.00015676636,0.00012478835,0.00061996834,0.00027292845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096620026,0.00024208095,0.00026989807,0.000078066354,0.000012834079,0.0000643359,0.000024110164,0.00020137832,0.9932881,0.00021078563,0.00038933192,0.00425294],"study_design_scores_gemma":[0.00007754562,0.0025510157,0.0027585544,0.00000710184,0.000028952454,0.00017637212,0.000033879238,0.0015210013,0.9898885,0.00007281,0.002877656,0.0000067277356],"about_ca_topic_score_codex":0.00084033347,"about_ca_topic_score_gemma":0.000869237,"teacher_disagreement_score":0.001434818,"about_ca_system_score_codex":0.00015841672,"about_ca_system_score_gemma":0.00017878812,"threshold_uncertainty_score":0.0048000216},"labels":[],"label_agreement":null},{"id":"W4414466019","doi":"10.1158/2326-6074.cimm25-ia07","title":"Abstract IA07: Tumor editing suppresses innate and adaptive anti-tumor immunity and is reversed by inhibiting DNA methylation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA methylation; Carcinogenesis; Immune system; Innate immune system; Acquired immune system; Gene; Mammary tumor; Tumor microenvironment; Cancer","score_opus":0.034316785893821714,"score_gpt":0.3543683575743931,"score_spread":0.3200515716805714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915814,0.0006072413,0.0038602971,0.00015356606,0.00005585123,0.000031937692,0.00059298484,0.00043084525,0.0026860246],"genre_scores_gemma":[0.9925108,0.00024054828,0.0023587057,0.00008670497,0.000013176364,0.000048212536,0.0008310792,0.00009269515,0.0038180144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997651,0.000042924294,0.000020890264,0.00006170443,0.00004778086,0.000061677194],"domain_scores_gemma":[0.99977106,0.000037388363,0.00006278647,0.000039753348,0.000015606418,0.00007336766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001844976,0.00033875622,0.00032165725,0.00032758992,0.00013895429,0.00034246073,0.00038895538,0.00040690284,0.002361309],"category_scores_gemma":[0.00015011097,0.00014750545,0.0002964564,0.00016427989,0.00034956954,0.00014086724,0.00018388728,0.0009417667,0.0005913416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012562625,0.000046833098,0.00010502794,0.000013799495,0.0000054047177,0.000014397936,0.0000052521386,0.00006554235,0.9983462,0.000110748326,0.0000892852,0.0010719089],"study_design_scores_gemma":[0.000018740628,0.00043471347,0.0011261998,0.0000031914485,0.000011702056,0.000092721224,0.00001184865,0.0012365325,0.99547786,0.000039784547,0.0015437364,0.0000029366226],"about_ca_topic_score_codex":0.0004593232,"about_ca_topic_score_gemma":0.00051173323,"teacher_disagreement_score":0.002361309,"about_ca_system_score_codex":0.00030184005,"about_ca_system_score_gemma":0.00025013072,"threshold_uncertainty_score":0.007899344},"labels":[],"label_agreement":null},{"id":"W4414466025","doi":"10.1158/2326-6074.cimm25-pr-09","title":"Abstract PR-09: Meta-Analysis of Neoantigens: Insights from the Cancer Epitope Database and Analysis Resource (CEDAR)","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epitope; Human leukocyte antigen; Cancer; Gene; Colorectal cancer; Mutation; MHC class I; Major histocompatibility complex","score_opus":0.175173290439086,"score_gpt":0.45151718684010383,"score_spread":0.27634389640101786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466025","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32060748,0.28497133,0.047773525,0.003517304,0.00042601654,0.00092247495,0.33538583,0.0033083258,0.003087689],"genre_scores_gemma":[0.8429149,0.013257995,0.029340558,0.0010611293,0.00021961571,0.00083390006,0.11127229,0.0006312736,0.000468279],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98276776,0.009282481,0.0018975245,0.0039290073,0.0017312982,0.0003918363],"domain_scores_gemma":[0.95301116,0.037575904,0.0036720182,0.0038111245,0.0011624708,0.0007673965],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020389335,0.0016380551,0.0065739867,0.01238018,0.0005118508,0.0032311126,0.002971626,0.0014415008,0.0035250445],"category_scores_gemma":[0.034704175,0.0008363688,0.015064093,0.009207156,0.00037495556,0.0011209175,0.0024648001,0.0013374035,0.0005519073],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004982389,0.00017860478,0.32081193,0.035970364,0.5425168,0.0010675109,0.00019563365,0.022275785,0.005652769,0.0014886792,0.017253177,0.04760632],"study_design_scores_gemma":[0.001985683,0.002207713,0.32251853,0.005011765,0.5424952,0.0038798505,0.00046473698,0.051949106,0.0054253777,0.007179727,0.056540802,0.00034146203],"about_ca_topic_score_codex":0.004033516,"about_ca_topic_score_gemma":0.0049723773,"teacher_disagreement_score":0.9796107,"about_ca_system_score_codex":0.00097005314,"about_ca_system_score_gemma":0.0015076768,"threshold_uncertainty_score":0.107830405},"labels":[],"label_agreement":null},{"id":"W4414466036","doi":"10.1158/2326-6074.cimm25-pr-07","title":"Abstract PR-07: Immunosuppressive γδ T cells limit anti-tumor immunity in ICI-resistant tumors from autoimmune-prone mice","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Immune system; Immunotherapy; Immunity; T cell; Nod; Tumor microenvironment; Genetic predisposition; Phenotype","score_opus":0.042586539552492586,"score_gpt":0.36277736093828655,"score_spread":0.32019082138579397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853249,0.001375596,0.0043986235,0.00037085594,0.00013308068,0.00017473487,0.0024614884,0.00044168075,0.0053190948],"genre_scores_gemma":[0.98516995,0.00064178096,0.00362797,0.00041591746,0.000064559244,0.00019816567,0.0018731814,0.00017620377,0.007832187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996008,0.000044810975,0.000045309927,0.000107751715,0.00008700622,0.00011439948],"domain_scores_gemma":[0.99948907,0.00004883427,0.0001321214,0.00008073878,0.000043851553,0.00020539595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026419855,0.00060977205,0.00038518867,0.0007124589,0.00023171028,0.00050113775,0.00046569866,0.00067152735,0.0027505558],"category_scores_gemma":[0.00022257843,0.00027958385,0.00049634126,0.00022623777,0.00038367874,0.0004228173,0.0002431837,0.0029398703,0.0011890698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042371228,0.00027876464,0.00032946456,0.000057544163,0.0000112531725,0.000078196645,0.00003647784,0.00014172606,0.99608034,0.00020165325,0.00022506645,0.0021358966],"study_design_scores_gemma":[0.00032132928,0.0040483796,0.0080803055,0.000058583126,0.00006603798,0.0009493853,0.00015358716,0.002509557,0.9762725,0.00020837394,0.00731129,0.000020705611],"about_ca_topic_score_codex":0.0005063506,"about_ca_topic_score_gemma":0.0006750951,"teacher_disagreement_score":0.0027505558,"about_ca_system_score_codex":0.00032862782,"about_ca_system_score_gemma":0.00031663518,"threshold_uncertainty_score":0.009201467},"labels":[],"label_agreement":null},{"id":"W4414466039","doi":"10.1158/2326-6074.cimm25-a015","title":"Abstract A015: The emerging role of basophils in non-muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immune system; Bladder cancer; Granzyme B; Tumor microenvironment; Immunotherapy; Flow cytometry; Basophil; Granzyme; FOXP3","score_opus":0.033875515773117454,"score_gpt":0.39130752771747984,"score_spread":0.35743201194436236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96270066,0.02938019,0.0029326594,0.0011693137,0.00030618958,0.000058776903,0.0006033093,0.000064160995,0.002784775],"genre_scores_gemma":[0.99364674,0.0036156368,0.00093582756,0.00021980563,0.00037575976,0.000032854347,0.00032387726,0.000008178281,0.00084134965],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983776,0.000057896963,0.000015784826,0.000031029165,0.00003130532,0.000026228065],"domain_scores_gemma":[0.9996872,0.00008900341,0.000060209975,0.000021568057,0.00007806544,0.00006400425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056057615,0.00031423598,0.0002566712,0.00061321293,0.00021378968,0.0008200583,0.00023943995,0.00040732318,0.0034504987],"category_scores_gemma":[0.0004555178,0.0001057062,0.00021926867,0.0003769328,0.00031040682,0.00046281907,0.00039544847,0.0006382941,0.00057620957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004811132,0.00046113672,0.2671609,0.0016891143,0.00020920858,0.0038956774,0.00055167865,0.0002687957,0.5257656,0.0011593093,0.0042274734,0.18979996],"study_design_scores_gemma":[0.00019294227,0.0030563122,0.8815239,0.00041227252,0.00043627038,0.01323368,0.0013840905,0.0026185215,0.07125414,0.0029184318,0.022915691,0.000053817854],"about_ca_topic_score_codex":0.00022161576,"about_ca_topic_score_gemma":0.00012850827,"teacher_disagreement_score":0.0034504987,"about_ca_system_score_codex":0.00011008097,"about_ca_system_score_gemma":0.0001326968,"threshold_uncertainty_score":0.011543095},"labels":[],"label_agreement":null},{"id":"W4414466041","doi":"10.1158/2326-6074.cimm25-a020","title":"Abstract A020: TLR10 as a key innate immune effector regulating metabolic and redox homeostasis in head and neck squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Innate immune system; Head and neck squamous-cell carcinoma; Immune system; Cancer; Effector; Context (archaeology); Cancer cell","score_opus":0.01828997316745211,"score_gpt":0.3262717455150127,"score_spread":0.3079817723475606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346228,0.022330798,0.008880109,0.0042877053,0.0018478846,0.0002201263,0.005318945,0.0006499339,0.021841696],"genre_scores_gemma":[0.9517315,0.007649473,0.003570998,0.0008582815,0.00020314466,0.00011453465,0.003509208,0.00005036255,0.03231247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999884,0.000015217739,0.000012741979,0.000028168854,0.000033737215,0.00002616305],"domain_scores_gemma":[0.99991405,0.000006759767,0.000018572853,0.0000044081758,0.000029148006,0.000026930698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020644059,0.0003063742,0.0002782821,0.00034715264,0.0002420987,0.00047597362,0.0003414952,0.00050780544,0.008559912],"category_scores_gemma":[0.000104188985,0.00012303317,0.0003961563,0.0002211942,0.00023567764,0.00032399507,0.00034399782,0.00050725613,0.001874579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010317697,0.00010001651,0.0049950443,0.0004149968,0.000023396602,0.0005193217,0.000044509386,0.0001651781,0.9717723,0.0003396385,0.0037219892,0.016871762],"study_design_scores_gemma":[0.00016949704,0.001358349,0.10026627,0.00015996731,0.00017307448,0.004173693,0.00058529153,0.0027391857,0.84519845,0.0005431188,0.04458904,0.000044071003],"about_ca_topic_score_codex":0.0017611511,"about_ca_topic_score_gemma":0.0018656213,"teacher_disagreement_score":0.008559912,"about_ca_system_score_codex":0.000650588,"about_ca_system_score_gemma":0.00056497805,"threshold_uncertainty_score":0.02863574},"labels":[],"label_agreement":null},{"id":"W4414466042","doi":"10.1158/2326-6074.cimm25-a023","title":"Abstract A023: Myeloid checkpoint blockade potentiates radiotherapy by modulating dendritic cells and reducing Treg-driven immunosuppression","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; Immunotherapy; Blockade; Tumor microenvironment; Immune checkpoint; Immune system; Immunogenic cell death; Myeloid; Radiation therapy; Dendritic cell","score_opus":0.02251415690197339,"score_gpt":0.33439144070793575,"score_spread":0.31187728380596236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957087,0.0012127893,0.00096682913,0.00011296421,0.00007690659,0.00007559723,0.00047130074,0.00011994146,0.001254827],"genre_scores_gemma":[0.9952962,0.0007735975,0.001326907,0.00006896831,0.00005664723,0.00008830322,0.00051161036,0.000020862437,0.0018571254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998605,0.000025337196,0.00001544831,0.000022631424,0.0000283977,0.000047671583],"domain_scores_gemma":[0.99991715,0.000009845081,0.000023531731,0.000009550792,0.000007707237,0.000032245916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018312178,0.00052512414,0.00050766993,0.00025148704,0.0001143735,0.00026454337,0.00030523163,0.0003305543,0.0021477889],"category_scores_gemma":[0.00007875005,0.000109611814,0.00032491778,0.00017598369,0.00022908825,0.00015658351,0.00013902904,0.00097380765,0.00056761806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001578452,0.00045494325,0.00010877397,0.00009988251,0.000017565832,0.000039080733,0.000011896432,0.00017199886,0.9927967,0.00010062059,0.00015232588,0.004467819],"study_design_scores_gemma":[0.00048021966,0.011478419,0.0021205903,0.000012622359,0.0000632989,0.00023961677,0.000017155688,0.00090116146,0.9817531,0.000053808704,0.002873688,0.0000063566977],"about_ca_topic_score_codex":0.0003518939,"about_ca_topic_score_gemma":0.0004973962,"teacher_disagreement_score":0.0021477889,"about_ca_system_score_codex":0.0001553216,"about_ca_system_score_gemma":0.00025466576,"threshold_uncertainty_score":0.0071851015},"labels":[],"label_agreement":null},{"id":"W4414490560","doi":"10.1158/2326-6074.cimm25-b018","title":"Abstract B018: Gut microbiome influences the antitumor response to BCG immunotherapy in bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Microbiome; Gut flora; ELISPOT; Immunotherapy; Feces; Bladder cancer; Colorectal cancer; Gut microbiome","score_opus":0.058597466461270495,"score_gpt":0.4462746043513444,"score_spread":0.3876771378900739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635553,0.0017544277,0.00041192758,0.00021413139,0.000024564486,0.000013778903,0.00083358516,0.000020806574,0.0003713025],"genre_scores_gemma":[0.9972989,0.0006319267,0.00061598734,0.0001237669,0.00001932408,0.00002073017,0.00069274526,0.000011417669,0.0005851639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998715,0.000035616846,0.000009367672,0.000034108827,0.000022472092,0.000026850312],"domain_scores_gemma":[0.9997634,0.000035446217,0.00009887396,0.000010321707,0.000029559766,0.00006229186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023364033,0.00023948583,0.00040329716,0.0002998724,0.00026284583,0.00050976494,0.00010148708,0.00031235514,0.0028950914],"category_scores_gemma":[0.00042049985,0.00012231249,0.00035502244,0.00033538722,0.00016654095,0.00019496086,0.00038614418,0.00043006116,0.00036947653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007470934,0.0003549116,0.48156694,0.0006388409,0.00033299645,0.00033302634,0.000271299,0.0005429373,0.46170235,0.00013131832,0.001555213,0.045099206],"study_design_scores_gemma":[0.00005046713,0.0017694836,0.9725088,0.00010195691,0.00023807122,0.0007583789,0.00032968828,0.0014877508,0.020188423,0.0001785123,0.002370073,0.000018381468],"about_ca_topic_score_codex":0.001005186,"about_ca_topic_score_gemma":0.0008064612,"teacher_disagreement_score":0.0028950914,"about_ca_system_score_codex":0.00025556135,"about_ca_system_score_gemma":0.0003405152,"threshold_uncertainty_score":0.0096850395},"labels":[],"label_agreement":null},{"id":"W4414490756","doi":"10.1158/2326-6074.cimm25-b016","title":"Abstract B016: Evaluation of the anti-breast cancer activity of isolates and semi-synthesized compounds from <i>Alstonia scholaris</i> leaves and <i>Psorospermum guineense</i> twigs","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phytochemical; Apocynaceae; Cancer; Cytotoxicity; Lung cancer; Terpene; Cancer cell","score_opus":0.044747573438255264,"score_gpt":0.3833544308863079,"score_spread":0.33860685744805263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588747,0.006596466,0.0013120128,0.0001337699,0.000047768415,0.000118115946,0.0010759283,0.00004947604,0.004779082],"genre_scores_gemma":[0.9900596,0.0028060605,0.0020731746,0.00011307092,0.000015334375,0.000037752343,0.0012114295,0.000011199231,0.0036722708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999565,0.000007985475,0.0000039540023,0.000008887957,0.000015392952,0.0000073694996],"domain_scores_gemma":[0.999954,0.00000757919,0.000010777606,0.0000037264244,0.000013872944,0.000010126865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007010262,0.0003998608,0.00022740626,0.00041040266,0.00015701573,0.00014200997,0.0001871655,0.00021494881,0.0017969649],"category_scores_gemma":[0.000073313124,0.00008102456,0.00037414374,0.00032450206,0.00010115974,0.00016926236,0.00012896309,0.00030548955,0.00029736987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029135586,0.00015557825,0.0003532359,0.0003569695,0.000026605743,0.00015706486,0.00002703029,0.00019920767,0.99154294,0.00005533016,0.0000944868,0.0067402953],"study_design_scores_gemma":[0.000121353194,0.004913387,0.013869363,0.00007144097,0.00016917214,0.0006558277,0.00012605157,0.0007312806,0.9700483,0.00008193887,0.00919174,0.000020143607],"about_ca_topic_score_codex":0.00090736686,"about_ca_topic_score_gemma":0.0015242978,"teacher_disagreement_score":0.0017969649,"about_ca_system_score_codex":0.00009294541,"about_ca_system_score_gemma":0.00014944017,"threshold_uncertainty_score":0.0060114264},"labels":[],"label_agreement":null},{"id":"W4414490802","doi":"10.1158/2326-6074.cimm25-a014","title":"Abstract A014: Chronic stress impairs anti-tumor immunity in ovarian cancer via MDSCs and notch pathway activation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Myeloid-derived Suppressor Cell; Immunosuppression; Chronic stress; Ovarian cancer; Infiltration (HVAC); Bone marrow; Cancer","score_opus":0.03504871739862629,"score_gpt":0.37237237456404965,"score_spread":0.33732365716542334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829085,0.003615298,0.0014551071,0.0005414369,0.00019597066,0.000078040845,0.003220412,0.00010437275,0.0024984733],"genre_scores_gemma":[0.99024206,0.0017559774,0.000991432,0.00039265802,0.000054925993,0.00017067634,0.0016872999,0.00001721117,0.004687791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998504,0.000015668189,0.000017691476,0.000030060595,0.000033259643,0.000053008946],"domain_scores_gemma":[0.9999101,0.000006768255,0.000022926668,0.000009172762,0.000011930894,0.000039174218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012423839,0.00028619572,0.00034248782,0.00032553234,0.0001984003,0.00028624566,0.00017828932,0.0004027796,0.005213954],"category_scores_gemma":[0.00009065886,0.00014080734,0.00044856226,0.00023930735,0.00030347006,0.00026760192,0.00026328576,0.0011788495,0.00050312286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031626178,0.00039077742,0.0038662697,0.00045710392,0.000046208716,0.00017702262,0.00010487364,0.0001495249,0.9811257,0.00030233475,0.0010753407,0.00914234],"study_design_scores_gemma":[0.00075061957,0.008977646,0.11111926,0.0001663189,0.00025129435,0.0011140399,0.0009615969,0.002612127,0.8494238,0.0010827509,0.023497393,0.000043068132],"about_ca_topic_score_codex":0.0007295968,"about_ca_topic_score_gemma":0.0009915148,"teacher_disagreement_score":0.005213954,"about_ca_system_score_codex":0.0002417315,"about_ca_system_score_gemma":0.0003468458,"threshold_uncertainty_score":0.017442405},"labels":[],"label_agreement":null},{"id":"W4414490996","doi":"10.1158/2326-6074.cimm25-ia02","title":"Abstract IA02: Mechanisms of TCF1 regulation of stem-like T cells in cancer and autoimmunity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Cancer immunotherapy; Priming (agriculture); Immunotherapy; T cell; Tumor microenvironment; Cytotoxic T cell; Cancer; Peripheral tolerance","score_opus":0.06277460242488528,"score_gpt":0.39214207110304544,"score_spread":0.32936746867816014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89161706,0.057272706,0.01675239,0.0027215544,0.0006596814,0.00014079774,0.0010284835,0.000513014,0.029294271],"genre_scores_gemma":[0.9841781,0.004143872,0.0015793575,0.00033202354,0.00014034488,0.00005882604,0.00057622674,0.000029605046,0.008961556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983275,0.000019916675,0.00000847685,0.00003671243,0.00003633517,0.00006571892],"domain_scores_gemma":[0.99984205,0.000015471378,0.000035451107,0.0000150126025,0.00003740478,0.00005464889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002990496,0.00038932113,0.00022935489,0.00054870226,0.00035088556,0.00065783825,0.00049052783,0.00061572326,0.003484391],"category_scores_gemma":[0.00018879314,0.000118528864,0.0003061511,0.00023005396,0.0004230941,0.00039212438,0.00030928903,0.0007288355,0.0010773132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046454777,0.00010721661,0.0020701843,0.00028994126,0.000019933921,0.0003807924,0.00007583759,0.00048427188,0.9668911,0.005325595,0.0015188679,0.022371694],"study_design_scores_gemma":[0.00013530685,0.0012239196,0.04601598,0.00016242165,0.00007511823,0.0021919147,0.00031559478,0.0073753367,0.8844098,0.0056773806,0.05237883,0.000038520215],"about_ca_topic_score_codex":0.0008138403,"about_ca_topic_score_gemma":0.00054185925,"teacher_disagreement_score":0.003484391,"about_ca_system_score_codex":0.00076743495,"about_ca_system_score_gemma":0.0002762743,"threshold_uncertainty_score":0.011656463},"labels":[],"label_agreement":null},{"id":"W4414491666","doi":"10.1158/2326-6074.cimm25-a021","title":"Abstract A021: Sumoylation blockade exposes the dark epigenome to drive ZBP1 viral mimicry for cancer immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Necroptosis; Innate immune system; Cancer immunotherapy; Epigenome; Effector; Cancer cell; SUMO protein; Chromatin","score_opus":0.039047621450065524,"score_gpt":0.3601640786472587,"score_spread":0.3211164571971932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98058116,0.0014608237,0.01023948,0.0004901701,0.0001825336,0.00012696172,0.001645577,0.00050169055,0.0047716745],"genre_scores_gemma":[0.98835236,0.0006192525,0.00350654,0.000080855185,0.000013223752,0.000086767126,0.0007816578,0.00005738168,0.0065019676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998659,0.000013742523,0.000012240292,0.000034031953,0.000039046787,0.000034964152],"domain_scores_gemma":[0.99991715,0.000007812811,0.000024230112,0.000011951681,0.0000086007185,0.000030333485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015202549,0.00041252808,0.00034073877,0.00022528399,0.00019566165,0.0004003469,0.00033745897,0.00043551618,0.0032053294],"category_scores_gemma":[0.0000713557,0.00014837201,0.0002983385,0.00019625056,0.00027474004,0.0002832691,0.00020922055,0.0011340448,0.0008412596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020382574,0.00005718192,0.00005953628,0.000026452795,0.0000064276064,0.0000213736,0.000007170185,0.00014121922,0.99761117,0.0003142991,0.0001397839,0.0014116578],"study_design_scores_gemma":[0.000023543374,0.0002715125,0.00039493124,0.000002619468,0.0000084676085,0.00005781033,0.000007786739,0.0009777475,0.9955029,0.000057492878,0.0026922673,0.0000029781447],"about_ca_topic_score_codex":0.0006908953,"about_ca_topic_score_gemma":0.00064350833,"teacher_disagreement_score":0.0032053294,"about_ca_system_score_codex":0.00041167557,"about_ca_system_score_gemma":0.00026745631,"threshold_uncertainty_score":0.010722876},"labels":[],"label_agreement":null},{"id":"W4414491675","doi":"10.1158/2326-6074.cimm25-b009","title":"Abstract B009: Targeting PAR-2 improves tumor antigen presentation and primes the immune system for anti-PD-1 immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Espace pour la vie","funders":"","keywords":"Immunotherapy; Immune system; Tumor microenvironment; Flow cytometry; Cancer; Myeloid; Cancer immunotherapy; Cytokine; Downregulation and upregulation","score_opus":0.03480508903454207,"score_gpt":0.38543541415212335,"score_spread":0.3506303251175813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977861,0.0032815516,0.007831299,0.00085506967,0.0002832536,0.0001470092,0.001766843,0.00045269693,0.0075212233],"genre_scores_gemma":[0.98201054,0.0011343997,0.004602447,0.00032029639,0.00010254094,0.000082100596,0.0013422183,0.00006767595,0.010337756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987316,0.000019543759,0.00000850715,0.00002783841,0.000036523412,0.000034535577],"domain_scores_gemma":[0.99996257,0.000004046404,0.000010907208,0.0000033053136,0.0000041093963,0.000015185994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012203823,0.0004116634,0.0003421052,0.00014565479,0.000096927775,0.00034969006,0.00021292776,0.00033172994,0.0065574865],"category_scores_gemma":[0.0000742585,0.00010674588,0.00018755154,0.00009885807,0.00016573445,0.00023049835,0.00016663338,0.0009662165,0.0013908658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050332415,0.00008467972,0.000046631558,0.000042918382,0.0000050726107,0.000018096913,0.0000033229323,0.00006203016,0.9966366,0.0001041059,0.0002754611,0.002217696],"study_design_scores_gemma":[0.00018287486,0.0017566915,0.0020078307,0.000008132979,0.000021061589,0.00023067712,0.0000136146045,0.0013605746,0.9886515,0.00007553285,0.0056864885,0.000004922918],"about_ca_topic_score_codex":0.00019961793,"about_ca_topic_score_gemma":0.00020910108,"teacher_disagreement_score":0.0065574865,"about_ca_system_score_codex":0.00020721067,"about_ca_system_score_gemma":0.00019006904,"threshold_uncertainty_score":0.021937013},"labels":[],"label_agreement":null},{"id":"W4414491700","doi":"10.1158/2326-6074.cimm25-b024","title":"Abstract B024: Tumor Resection Status Modulates Cardiometabolic Response to Imatinib in GIST","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Imatinib; GiST; Stromal tumor; Body mass index; Imatinib mesylate; Cholesterol; Cancer; Hemoglobin","score_opus":0.05933869661216293,"score_gpt":0.4414475311599105,"score_spread":0.3821088345477476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989876,0.00013236642,0.0000450163,0.000038183633,0.0000051434426,0.000003744458,0.0005436308,0.0000018933347,0.00024244636],"genre_scores_gemma":[0.99913603,0.000036853027,0.000056682224,0.000022866641,0.000007593348,0.000008366866,0.00052116555,0.000001244333,0.00020910444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998542,0.00005347364,0.000016495807,0.000036403446,0.000017133534,0.00002233292],"domain_scores_gemma":[0.99949586,0.00010077932,0.00023187965,0.00003377381,0.000042598444,0.00009508592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003327273,0.00017951685,0.00017138595,0.00018653765,0.00016615551,0.0004300509,0.00014428793,0.00021048692,0.0028356963],"category_scores_gemma":[0.00096435274,0.00009554411,0.00030031786,0.00032603953,0.00013048791,0.00018388906,0.0002596794,0.00032141083,0.00032564375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013353706,0.000053653854,0.99496126,0.000018997189,0.0000968808,0.000056276287,0.000031288197,0.0000627808,0.0012887492,0.000013978357,0.0001974991,0.0018832973],"study_design_scores_gemma":[0.000017747167,0.00018573304,0.9991523,0.0000040536456,0.000032302505,0.00009357689,0.000039728217,0.00017770345,0.00014933992,0.0000141115015,0.00013169051,0.0000015932956],"about_ca_topic_score_codex":0.001154429,"about_ca_topic_score_gemma":0.0009770846,"teacher_disagreement_score":0.0028356963,"about_ca_system_score_codex":0.00018326241,"about_ca_system_score_gemma":0.00019170548,"threshold_uncertainty_score":0.009486318},"labels":[],"label_agreement":null},{"id":"W4414491793","doi":"10.1158/2326-6074.cimm25-ia08","title":"Abstract IA08: Development and use of Engineered Regulatory T cells to treat Autoimmune Diseases","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Peripheral tolerance; Immune tolerance; Effector; T cell; Population; Immunotherapy; Antigen; Regulatory T cell","score_opus":0.06425826163130895,"score_gpt":0.3799349477968155,"score_spread":0.3156766861655066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8746755,0.044390693,0.05289419,0.0011673153,0.0010113184,0.00057468645,0.0012551601,0.0011992656,0.022831907],"genre_scores_gemma":[0.93473005,0.013166678,0.0355259,0.0005516445,0.00018223011,0.00042656861,0.0014703717,0.00010827452,0.013838305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998944,0.000018571089,0.000007776612,0.000021016405,0.00003651033,0.000021743672],"domain_scores_gemma":[0.9999522,0.000005223852,0.000012730579,0.000004462457,0.000010453948,0.000014887614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022621425,0.00038874388,0.00017772632,0.0003012501,0.00007826343,0.00032700953,0.0003374519,0.0003704318,0.000927294],"category_scores_gemma":[0.00010598396,0.00007591743,0.00020629635,0.00013102156,0.00017944924,0.00013811138,0.00016026881,0.0007117015,0.0006408008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026703725,0.00019096328,0.00026331376,0.00017023252,0.000015910684,0.00016189464,0.000024670226,0.0006215642,0.9432477,0.0007748047,0.0010891249,0.05317288],"study_design_scores_gemma":[0.00031622787,0.0050305277,0.0016320848,0.00007216227,0.000081249906,0.0013880893,0.000018220459,0.0025931785,0.9243668,0.0002607645,0.06422252,0.00001822402],"about_ca_topic_score_codex":0.00027964197,"about_ca_topic_score_gemma":0.00022210399,"teacher_disagreement_score":0.000927294,"about_ca_system_score_codex":0.00019992977,"about_ca_system_score_gemma":0.0002835374,"threshold_uncertainty_score":0.0031021237},"labels":[],"label_agreement":null},{"id":"W4414491827","doi":"10.1158/2326-6074.cimm25-pr-15","title":"Abstract PR-15: Neuroimmune dysregulation in ovarian cancer: the role of chronic stress on microglial activation and systemic inflammation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroinflammation; Inflammation; Microglia; Systemic inflammation; Immune system; Downregulation and upregulation; Ovarian cancer; Hormone; Chronic stress","score_opus":0.02160939953698773,"score_gpt":0.33929256730202645,"score_spread":0.31768316776503874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880568,0.008126056,0.00076345855,0.00048518105,0.00012655529,0.00006527616,0.0008711178,0.00004203163,0.0014636214],"genre_scores_gemma":[0.9936274,0.0030126849,0.0004514571,0.00019523919,0.000051644853,0.000068815454,0.0006356003,0.0000074938243,0.0019496744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989974,0.000011649138,0.000010786872,0.00002382242,0.00001767515,0.00003638209],"domain_scores_gemma":[0.9999049,0.0000046153045,0.000033828965,0.000006380556,0.000013494272,0.00003683611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013615274,0.00031708862,0.0003278208,0.00021645386,0.00028118485,0.00036456887,0.00015437073,0.00031355934,0.001975208],"category_scores_gemma":[0.00010950837,0.000107400345,0.000377243,0.00026243666,0.0002517776,0.00018970674,0.00032463574,0.00064144086,0.00025071687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057698824,0.00055303593,0.039467923,0.001237706,0.00019530777,0.0016072744,0.00021943677,0.0002867544,0.91738975,0.00039083522,0.0021370028,0.030745104],"study_design_scores_gemma":[0.0005900694,0.007373687,0.6837328,0.00027455325,0.0004619535,0.0075610057,0.0011713675,0.0018092665,0.27354676,0.0009777527,0.022449411,0.000051430576],"about_ca_topic_score_codex":0.0008203701,"about_ca_topic_score_gemma":0.00096430175,"teacher_disagreement_score":0.001975208,"about_ca_system_score_codex":0.00033264802,"about_ca_system_score_gemma":0.00036342462,"threshold_uncertainty_score":0.0066077113},"labels":[],"label_agreement":null},{"id":"W4414491842","doi":"10.1158/2326-6074.cimm25-b005","title":"Abstract B005: Tumor-derived extracellular vesicles induce intrinsic apoptosis of activated T cells by early transcriptional activation of cellular stress response genes","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jurkat cells; Downregulation and upregulation; MAPK/ERK pathway; Cytotoxic T cell; ZAP70; Signal transduction; Transcriptome; Effector; p38 mitogen-activated protein kinases; T cell","score_opus":0.0251646552919913,"score_gpt":0.31365918411537197,"score_spread":0.28849452882338067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846257,0.003310148,0.004417444,0.00017797241,0.00015496775,0.000052007686,0.003938831,0.00016604223,0.0031569104],"genre_scores_gemma":[0.9781251,0.001224692,0.002234898,0.00011822248,0.0000335353,0.000062508836,0.008080937,0.000055631084,0.010064497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989486,0.000010296547,0.000007848154,0.000021890972,0.000029802115,0.000035257886],"domain_scores_gemma":[0.99994755,0.0000047419735,0.00001620006,0.000003598844,0.0000063522793,0.00002156522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008113814,0.00042632574,0.0002262203,0.00016458359,0.00015920417,0.00033170337,0.00008457296,0.00026249723,0.0045462046],"category_scores_gemma":[0.00006165678,0.00010889941,0.0002894662,0.00019072695,0.00010097768,0.00015414935,0.00020320172,0.000480868,0.0014758229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001714492,0.000011568202,0.000098609096,0.00003418757,0.000003685201,0.000022145161,0.000003917757,0.00001723317,0.99885166,0.000036448193,0.00008695419,0.00066216],"study_design_scores_gemma":[0.000033439304,0.00036839338,0.012978631,0.000013111852,0.000023870682,0.0003041324,0.00003697975,0.00059898675,0.97822875,0.00006723728,0.0073411586,0.0000053443473],"about_ca_topic_score_codex":0.00020760302,"about_ca_topic_score_gemma":0.00016886998,"teacher_disagreement_score":0.0045462046,"about_ca_system_score_codex":0.00021585471,"about_ca_system_score_gemma":0.00013745815,"threshold_uncertainty_score":0.015208542},"labels":[],"label_agreement":null},{"id":"W4414491856","doi":"10.1158/2326-6074.cimm25-pr-08","title":"Abstract PR-08: Impact of gut microbiota on response to Bacillus Calmette-Guérin immunotherapy in bladder cancer: Towards a predictive molecular model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Gut flora; Bladder cancer; Antibiotics; Bacteria; Probiotic; Cancer","score_opus":0.049512098751903516,"score_gpt":0.4361155299961281,"score_spread":0.3866034312442246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797183,0.0029073388,0.011929208,0.00075964036,0.000073636875,0.00008639709,0.0030342005,0.00019250542,0.0012987131],"genre_scores_gemma":[0.99357057,0.00057695893,0.0034754765,0.00012559727,0.000026693197,0.000044044788,0.001741129,0.000026178328,0.00041343787],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99958295,0.00015741128,0.000022253544,0.00012241631,0.0000592623,0.00005569228],"domain_scores_gemma":[0.9991602,0.00024304388,0.00030617972,0.00007144325,0.00011527316,0.00010388015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010811161,0.0007109407,0.0006013133,0.00060405757,0.00021984498,0.0012044699,0.00039809616,0.0005030843,0.0018151669],"category_scores_gemma":[0.0017729012,0.00021215442,0.0010946478,0.0005405544,0.00030713898,0.00049940316,0.0008384558,0.0010137062,0.00047935615],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024833125,0.0004783917,0.8792911,0.00051892345,0.0010549846,0.0001951263,0.00014244058,0.0122657865,0.050045885,0.00074228714,0.0016141741,0.05116743],"study_design_scores_gemma":[0.0000618787,0.0020794065,0.8359855,0.00014524013,0.0007324856,0.0004800218,0.00034752028,0.1442042,0.011067247,0.0022176022,0.0026343681,0.000044508477],"about_ca_topic_score_codex":0.0026587585,"about_ca_topic_score_gemma":0.0014388895,"teacher_disagreement_score":0.0026587585,"about_ca_system_score_codex":0.00052064675,"about_ca_system_score_gemma":0.00068898743,"threshold_uncertainty_score":0.0060723424},"labels":[],"label_agreement":null},{"id":"W4414491882","doi":"10.1158/2326-6074.cimm25-b019","title":"Abstract B019: CCR5 inhibition with leronlimab is associated with enhanced PD-L1 expression, ICI response, and long-term survival in metastatic TNBC.","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Attodyne (Canada)","funders":"","keywords":"Immunotherapy; Metastatic breast cancer; Clinical trial; Metastasis; Breast cancer; Adverse effect; Cancer; Antibody; Breast cancer metastasis","score_opus":0.05078881003570925,"score_gpt":0.3867239364335297,"score_spread":0.33593512639782047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963806,0.0012033724,0.0002909545,0.00008985774,0.00002275036,0.000059769398,0.00050276174,0.000037797206,0.0014121043],"genre_scores_gemma":[0.9968278,0.0001854452,0.0002659774,0.00008145162,0.000015539994,0.000042922522,0.0013200224,0.000007252382,0.001253608],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998965,0.000023599387,0.0000075000376,0.000022787288,0.000021633887,0.000027970336],"domain_scores_gemma":[0.99986446,0.000025897394,0.000031063097,0.000009823657,0.000013587219,0.000055064298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029209795,0.00021183043,0.00038013706,0.00012869172,0.00013413295,0.0003289331,0.00014965291,0.00021087742,0.0037352322],"category_scores_gemma":[0.0002560267,0.00007796183,0.00018820846,0.00012185464,0.00016266675,0.00014416745,0.00010126803,0.00055844453,0.00056057266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034694284,0.0028996188,0.02509605,0.00044070103,0.00019316806,0.00052397867,0.00010233388,0.0006790728,0.8668664,0.00014649959,0.0041560424,0.06420191],"study_design_scores_gemma":[0.005499347,0.081152,0.40168902,0.00006662618,0.00046283472,0.0047141677,0.0001906526,0.004893577,0.48776013,0.0001671088,0.013361289,0.00004324934],"about_ca_topic_score_codex":0.0005751169,"about_ca_topic_score_gemma":0.00074689934,"teacher_disagreement_score":0.0037352322,"about_ca_system_score_codex":0.00037263113,"about_ca_system_score_gemma":0.0003713401,"threshold_uncertainty_score":0.012495637},"labels":[],"label_agreement":null},{"id":"W4414491888","doi":"10.1158/2326-6074.cimm25-b015","title":"Abstract B015: 3D Organoid-Based Therapeutics with Translational Potential in Cancer Immunity and Autoimmune Risk Prediction","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cancer immunotherapy; Organoid; Immunotherapy; Immune checkpoint; Immune system; Immunity; Precision medicine; Ipilimumab","score_opus":0.026583111330941735,"score_gpt":0.31514172776611266,"score_spread":0.28855861643517094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69507265,0.030211361,0.2355202,0.0031921465,0.0016592942,0.0004034166,0.0030875104,0.0020021591,0.028851267],"genre_scores_gemma":[0.903417,0.005589383,0.07481704,0.0007177142,0.00008642837,0.0001731434,0.0010461998,0.00010800395,0.014045015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999887,0.000030401556,0.000006931157,0.000021867847,0.00003855418,0.000015260643],"domain_scores_gemma":[0.9998934,0.000033423403,0.000024911109,0.00001046628,0.00001650092,0.000021350703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002586194,0.00034632147,0.00034149113,0.00032435884,0.0001500543,0.0005275518,0.00024294917,0.00046938844,0.0041024163],"category_scores_gemma":[0.00020985489,0.0001502665,0.0003363193,0.00015889737,0.00031448863,0.0003147583,0.00036068683,0.0005569211,0.00086558214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033331136,0.00007001313,0.00032312362,0.00015211909,0.000016130163,0.00012173137,0.00003717458,0.0016071951,0.96827155,0.0011281769,0.0022423856,0.025697036],"study_design_scores_gemma":[0.00009853691,0.0010895944,0.003416957,0.0000447768,0.000060242284,0.0008091975,0.000045585934,0.017900134,0.93558764,0.0010864576,0.03981607,0.000044902135],"about_ca_topic_score_codex":0.0008297149,"about_ca_topic_score_gemma":0.0010192678,"teacher_disagreement_score":0.0041024163,"about_ca_system_score_codex":0.00049901084,"about_ca_system_score_gemma":0.00035878792,"threshold_uncertainty_score":0.01372391},"labels":[],"label_agreement":null},{"id":"W4414491893","doi":"10.1158/2326-6074.cimm25-pr-06","title":"Abstract PR-06: Disrupting TACI signaling to restore immune balance: harnessing translational opportunities at the intersection of cancer and autoimmunity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Immune system; Chronic lymphocytic leukemia; Autoantibody; Bruton's tyrosine kinase; Systemic lupus erythematosus; Cancer; Immune dysregulation; Gene knockdown","score_opus":0.13757882584727818,"score_gpt":0.44775759904405665,"score_spread":0.31017877319677845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688408,0.0055698855,0.013514804,0.0008301879,0.00017940467,0.000112698086,0.0015210942,0.0010502058,0.0083809635],"genre_scores_gemma":[0.98111814,0.0022280747,0.0070577026,0.0003087559,0.000035928464,0.000078606965,0.0011369478,0.00006641539,0.007969437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998319,0.000016573113,0.000013028125,0.000038740724,0.000052610107,0.000047238344],"domain_scores_gemma":[0.9998467,0.000012405227,0.00004588794,0.000017579734,0.000018215784,0.00005919365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020270034,0.00039993055,0.00028531736,0.00024739015,0.00015223018,0.0005598427,0.00031985276,0.0003052651,0.0024097129],"category_scores_gemma":[0.00009345502,0.000117784344,0.00026176422,0.00018237304,0.0002930617,0.00024114677,0.00024264822,0.0012843381,0.00063094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018143922,0.00005290853,0.00015519111,0.000066850575,0.000007218189,0.000032644344,0.000009187306,0.00009940417,0.9955362,0.0001613309,0.00021250316,0.0034850335],"study_design_scores_gemma":[0.000051563424,0.0011531851,0.0019445064,0.00001557148,0.000036696965,0.0003012397,0.000029953075,0.0009027634,0.9878463,0.000100827245,0.0076102167,0.0000072123876],"about_ca_topic_score_codex":0.00032757118,"about_ca_topic_score_gemma":0.0005712789,"teacher_disagreement_score":0.0024097129,"about_ca_system_score_codex":0.00033685484,"about_ca_system_score_gemma":0.0003563012,"threshold_uncertainty_score":0.008061349},"labels":[],"label_agreement":null},{"id":"W4414491894","doi":"10.1158/2326-6074.cimm25-b002","title":"Abstract B002: Meta-Analysis of Neoantigens: Insights from the Cancer Epitope Database and Analysis Resource (CEDAR)","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epitope; Human leukocyte antigen; Cancer; Gene; Colorectal cancer; Mutation; MHC class I; Major histocompatibility complex","score_opus":0.17940600139161,"score_gpt":0.45245536011773907,"score_spread":0.27304935872612907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491894","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2634369,0.28077704,0.040725403,0.0035214233,0.00043547386,0.001051168,0.40351093,0.0032026912,0.003338998],"genre_scores_gemma":[0.79476666,0.01622387,0.036642484,0.0012148707,0.00026687956,0.0012571478,0.14824635,0.0006840559,0.0006976056],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98443675,0.008704976,0.0015763652,0.003124554,0.0017735412,0.00038375513],"domain_scores_gemma":[0.94952136,0.04148697,0.003724296,0.0031579945,0.001263902,0.0008454616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019624462,0.0016700394,0.0063592186,0.014602449,0.00057620683,0.0033451621,0.0028264257,0.0013532836,0.0044165957],"category_scores_gemma":[0.034439918,0.0007724981,0.013902967,0.009807756,0.00035109266,0.0010368016,0.0022161345,0.0012378821,0.0006287268],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006528083,0.00023636801,0.28569975,0.04628444,0.54297966,0.0010244823,0.00022981655,0.021862334,0.0068284883,0.0016730012,0.025469046,0.061184656],"study_design_scores_gemma":[0.0025477675,0.002152675,0.32725984,0.006147555,0.52420634,0.0032924246,0.00047523156,0.051781975,0.0054737646,0.0074747414,0.06881893,0.0003687578],"about_ca_topic_score_codex":0.005137407,"about_ca_topic_score_gemma":0.0062240637,"teacher_disagreement_score":0.019624462,"about_ca_system_score_codex":0.0010629578,"about_ca_system_score_gemma":0.0015481866,"threshold_uncertainty_score":0.10378528},"labels":[],"label_agreement":null},{"id":"W4414491903","doi":"10.1158/2326-6074.cimm25-ia01","title":"Abstract IA01: B cell checkpoints as regulators of tumor immunity and self-tolerance","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; TIGIT; Cancer immunotherapy; Immunity; Melanoma; B cell; Cancer; Immune checkpoint; Immunotherapy","score_opus":0.029520254604255947,"score_gpt":0.36995281460628293,"score_spread":0.340432560002027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491903","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22276318,0.4370394,0.013835026,0.030268213,0.023547182,0.0005934143,0.004140904,0.0019203586,0.26589224],"genre_scores_gemma":[0.42032495,0.098411165,0.0035989068,0.0036549906,0.0063827015,0.00016666269,0.0035316779,0.00017518866,0.46375382],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999151,0.000012777067,0.0000067717756,0.000016450229,0.000025761106,0.00002311361],"domain_scores_gemma":[0.9999,0.000011901533,0.000013178145,0.0000052274563,0.00003254792,0.000037085487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034110574,0.00046080045,0.00036975738,0.0010602766,0.00038470354,0.0013167446,0.0006537052,0.0008742256,0.018734487],"category_scores_gemma":[0.00018097476,0.00016784036,0.00016825522,0.0004929272,0.00036969112,0.0005693063,0.00032329158,0.0009385532,0.005235277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032680149,0.0003857015,0.0024375683,0.0024126081,0.00005018213,0.0009882551,0.00018083537,0.0010433674,0.37327462,0.015956555,0.24354278,0.3564595],"study_design_scores_gemma":[0.00031773237,0.0012887185,0.028647874,0.0007029974,0.00010535848,0.001198779,0.00027064735,0.0025501715,0.199575,0.0059257676,0.75936544,0.000051520034],"about_ca_topic_score_codex":0.0022993071,"about_ca_topic_score_gemma":0.0022239487,"teacher_disagreement_score":0.018734487,"about_ca_system_score_codex":0.0013536059,"about_ca_system_score_gemma":0.00051613525,"threshold_uncertainty_score":0.06267309},"labels":[],"label_agreement":null},{"id":"W4414491946","doi":"10.1158/2326-6074.cimm25-b027","title":"Abstract B027: iSIGN panel identifies germ cell tumors via whole-proteome phage immunoprecipitation sequencing","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Seminoma; Autoantibody; Antibody; Phage display; Antigen; Differential diagnosis; Cancer; Immunoprecipitation","score_opus":0.04663039989724286,"score_gpt":0.34755375773832153,"score_spread":0.30092335784107865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814259,0.0005533083,0.009597168,0.00013659547,0.000034673438,0.000094721014,0.006052735,0.0005052845,0.0015998333],"genre_scores_gemma":[0.97299284,0.0002046214,0.0131525565,0.00024461618,0.000029769386,0.00009645649,0.0120347,0.000056307876,0.0011880475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995055,0.00006631937,0.0000310883,0.00018021026,0.00017019322,0.000046726025],"domain_scores_gemma":[0.99953926,0.00008183839,0.000087761604,0.000043671957,0.00016869868,0.00007875675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007723803,0.0005419979,0.00044250398,0.00092247274,0.0002974181,0.00068803603,0.0002749122,0.00036196754,0.0015131753],"category_scores_gemma":[0.00080868363,0.00017794948,0.00039257866,0.0004932525,0.00022181554,0.00013385403,0.00039347296,0.00046167162,0.0006536327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012453785,0.0002072035,0.25833768,0.00021534458,0.00031521943,0.00026148377,0.0001193602,0.0018576668,0.70658594,0.0001514078,0.003164805,0.027538566],"study_design_scores_gemma":[0.00012103723,0.0012258528,0.61351275,0.000051403404,0.00040808212,0.0025613408,0.00012987331,0.030265236,0.34308076,0.00035262297,0.008231387,0.00005969135],"about_ca_topic_score_codex":0.0015772727,"about_ca_topic_score_gemma":0.0022972068,"teacher_disagreement_score":0.0015772727,"about_ca_system_score_codex":0.00038230376,"about_ca_system_score_gemma":0.00033955224,"threshold_uncertainty_score":0.0050621033},"labels":[],"label_agreement":null},{"id":"W4414492330","doi":"10.1158/2326-6074.cimm25-a011","title":"Abstract A011: Tumor-derived Complement Factor B drives tumor growth and anti-PD-1 resistance in <i>STK11</i>-mutant lung adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Complement system; Immunotherapy; Immune system; CD8; Downregulation and upregulation; Alternative complement pathway; Adenocarcinoma; Transfection; CD59","score_opus":0.02575699047768508,"score_gpt":0.341683828428069,"score_spread":0.3159268379503839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969406,0.00019673794,0.000612845,0.00010451015,0.000017616387,0.000027333288,0.000722576,0.00007692335,0.0013008321],"genre_scores_gemma":[0.99485993,0.00009265192,0.0007245528,0.00004963615,0.0000050018843,0.000035242647,0.0006900244,0.000024104624,0.003518918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998627,0.000015284653,0.000015707641,0.00003259513,0.000037958824,0.000035751767],"domain_scores_gemma":[0.9998542,0.000020927959,0.000033414664,0.000014517458,0.000010888181,0.00006613613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097304975,0.00026554352,0.00017147373,0.00025787632,0.00017928284,0.00033613577,0.00018913871,0.00035539138,0.0027289884],"category_scores_gemma":[0.00008688057,0.00013945298,0.0002224626,0.00015036768,0.0002706915,0.00016467244,0.0001549534,0.0011470508,0.0007405998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026697767,0.00010556338,0.00060706295,0.00002191825,0.0000035781375,0.00007215532,0.000012754308,0.000051378734,0.9977818,0.0001243148,0.00011826168,0.00083420984],"study_design_scores_gemma":[0.000072111216,0.0014649025,0.015433109,0.000009497005,0.000017489785,0.0012386295,0.000072718605,0.0018804681,0.97717345,0.000076145305,0.002554493,0.000007047271],"about_ca_topic_score_codex":0.0010900497,"about_ca_topic_score_gemma":0.001281236,"teacher_disagreement_score":0.0027289884,"about_ca_system_score_codex":0.0004949055,"about_ca_system_score_gemma":0.00029054063,"threshold_uncertainty_score":0.009129405},"labels":[],"label_agreement":null},{"id":"W4414492800","doi":"10.1158/2326-6074.cimm25-b025","title":"Abstract B025: An agentic platform for designing cancer immunotherapies: From automated variant interpretation to in silico therapeutic validation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In silico; CRISPR; Workflow; Precision medicine; Adept; Bottleneck; Mechanism (biology); Cancer","score_opus":0.11748728624943236,"score_gpt":0.4718240936813109,"score_spread":0.35433680743187856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492800","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019765526,0.00022914186,0.9559538,0.0004943068,0.00013657016,0.0002027256,0.0005047377,0.013282351,0.009431001],"genre_scores_gemma":[0.3880387,0.00047066854,0.59936583,0.0004801055,0.000050245497,0.00035780953,0.0016803817,0.0017584673,0.0077978135],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990885,0.0002545164,0.000041198757,0.00016183556,0.00039373685,0.000060140643],"domain_scores_gemma":[0.99909675,0.00035744492,0.00010530144,0.00019828689,0.0001658885,0.00007634681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020342565,0.0010790501,0.00061332196,0.0005229498,0.0004299872,0.0018071893,0.0014399126,0.0012133925,0.006081498],"category_scores_gemma":[0.0024923093,0.00050500553,0.0008036523,0.00017912171,0.0008785655,0.00080233935,0.001529315,0.0015943972,0.0021729346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007357684,0.00036338036,0.0031454745,0.0004820359,0.00022431057,0.0005340515,0.00022754697,0.5945434,0.1772506,0.06904214,0.015779154,0.13767228],"study_design_scores_gemma":[0.000052603427,0.00014555678,0.00022196073,0.000029161625,0.000026446223,0.000076892444,0.000014830178,0.9295163,0.03879465,0.014849165,0.016236316,0.00003611242],"about_ca_topic_score_codex":0.0021590549,"about_ca_topic_score_gemma":0.0013283031,"teacher_disagreement_score":0.006081498,"about_ca_system_score_codex":0.0007903471,"about_ca_system_score_gemma":0.0011664358,"threshold_uncertainty_score":0.020344615},"labels":[],"label_agreement":null},{"id":"W4414492857","doi":"10.1158/2326-6074.cimm25-a003","title":"Abstract A003: Identification of immunomodulatory compounds by high-throughput proteomics: Insights from quantification of 1000 proteins in a 20,000 sample screen","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Immune system; Proteomics; Identification (biology); Drug discovery; Immunotherapy; Quantitative proteomics; Label-free quantification; Leverage (statistics); In vitro","score_opus":0.0721455010753637,"score_gpt":0.41212643617966,"score_spread":0.3399809351042963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86917835,0.004648132,0.05739824,0.0010295311,0.0002562929,0.000737189,0.054482125,0.005376138,0.0068939794],"genre_scores_gemma":[0.7266004,0.004577965,0.17075367,0.0011663428,0.00014787487,0.0011993771,0.086924516,0.0011002326,0.007529635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993088,0.00006742227,0.0000583436,0.0001390725,0.00036911006,0.000057202094],"domain_scores_gemma":[0.99951994,0.00014728618,0.00006210463,0.000051732794,0.00015852533,0.000060551014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009740318,0.0010849129,0.0009348517,0.0015821069,0.000636512,0.0012323268,0.00041117435,0.0009086057,0.003282334],"category_scores_gemma":[0.001096974,0.00034529832,0.0009873775,0.0015084062,0.00035918836,0.0005656244,0.00043679052,0.0008018616,0.0014702603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005914225,0.0002686909,0.004975655,0.00043886976,0.00016017986,0.00017855946,0.000040657585,0.0009126621,0.97225845,0.00020789333,0.0033163333,0.016650582],"study_design_scores_gemma":[0.00010959935,0.0011136327,0.05106997,0.000051806135,0.00023118606,0.0009122012,0.00009565217,0.018606927,0.9061575,0.0005924693,0.02098506,0.00007404542],"about_ca_topic_score_codex":0.00091111887,"about_ca_topic_score_gemma":0.0017834108,"teacher_disagreement_score":0.003282334,"about_ca_system_score_codex":0.00038208824,"about_ca_system_score_gemma":0.00048741038,"threshold_uncertainty_score":0.010980487},"labels":[],"label_agreement":null},{"id":"W4414492865","doi":"10.1158/2326-6074.cimm25-b006","title":"Abstract B006: Immunosuppressive γδ T cells limit anti-tumor immunity in ICI-resistant tumors from autoimmune-prone mice","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Immune system; Immunotherapy; Immunity; T cell; Nod; Tumor microenvironment; Genetic predisposition; Phenotype","score_opus":0.04207406639913272,"score_gpt":0.3629962655184762,"score_spread":0.3209221991193435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98448896,0.0016478722,0.00467257,0.000393732,0.00014833445,0.0001376338,0.0027362863,0.0004144228,0.0053602303],"genre_scores_gemma":[0.9864499,0.000730931,0.0032838003,0.00036134452,0.0000655506,0.0001496524,0.0017311468,0.0001412559,0.007086623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970907,0.000028879283,0.00003207706,0.00007111186,0.000075949756,0.000082918785],"domain_scores_gemma":[0.99965537,0.000032865868,0.00009083312,0.000046597826,0.000033262546,0.0001411241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020572887,0.0005874041,0.00031614953,0.0007017322,0.00021155833,0.00043514313,0.00035847662,0.0006217625,0.0029357446],"category_scores_gemma":[0.00016867285,0.00023790097,0.0004048653,0.00021103855,0.0002851265,0.0003182285,0.00021199894,0.0022755382,0.0012139336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033999587,0.00016559572,0.00024142356,0.00004470455,0.000007715466,0.000045262368,0.000023928553,0.00009739976,0.99706703,0.00014130879,0.00017806688,0.0016475666],"study_design_scores_gemma":[0.00024829796,0.0026568018,0.0074882815,0.000050984156,0.000046697696,0.00064702204,0.000104716506,0.0019643535,0.9799753,0.0001738082,0.0066266335,0.000017236493],"about_ca_topic_score_codex":0.0005615649,"about_ca_topic_score_gemma":0.00065077405,"teacher_disagreement_score":0.0029357446,"about_ca_system_score_codex":0.00027277158,"about_ca_system_score_gemma":0.00025672946,"threshold_uncertainty_score":0.009820998},"labels":[],"label_agreement":null},{"id":"W4414492908","doi":"10.1158/2326-6074.cimm25-b021","title":"Abstract B021: Multi-functional telodendrimer nanodrug: Nanocarrier for ovarian cancer treatment and immunomodulator to control inflammation and sensitize the tumor","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Dendrimers and Hyperbranched Polymers","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proinflammatory cytokine; Inflammation; TLR2; Ovarian cancer; Immune system; Autocrine signalling; Nanocarriers; TLR4; Ovarian tumor","score_opus":0.04545716927208186,"score_gpt":0.35485480440199646,"score_spread":0.3093976351299146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95208657,0.010545563,0.025793267,0.00054958917,0.0002322564,0.00020956901,0.0008702608,0.0005899083,0.009123082],"genre_scores_gemma":[0.97120595,0.0022212663,0.015652128,0.00027941438,0.000029912888,0.00011526833,0.0006748142,0.000054653097,0.009766608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994445,0.0000056752956,0.0000044377057,0.000015032738,0.000018074224,0.000012345631],"domain_scores_gemma":[0.9999715,0.0000030192025,0.000008577816,0.0000021722458,0.00000623332,0.000008463881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007162779,0.00028593064,0.00016602232,0.00021565887,0.000112385,0.00020455896,0.0001788877,0.00034067495,0.0016348299],"category_scores_gemma":[0.000059147653,0.00007649611,0.00022882172,0.00015732613,0.00010076356,0.0001731922,0.00014485505,0.00029975234,0.00056834565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011388237,0.000049392893,0.000101806414,0.00008365092,0.00000750082,0.00004273971,0.0000067163082,0.00017345425,0.99305177,0.00015698405,0.00028985384,0.005922339],"study_design_scores_gemma":[0.000031328884,0.00033903768,0.00061219296,0.0000050011276,0.000018961307,0.0002107686,0.0000059092235,0.0014400941,0.9910885,0.00002853828,0.0062122806,0.000007344882],"about_ca_topic_score_codex":0.00043066914,"about_ca_topic_score_gemma":0.00047576497,"teacher_disagreement_score":0.0016348299,"about_ca_system_score_codex":0.00031537734,"about_ca_system_score_gemma":0.00018760002,"threshold_uncertainty_score":0.005469084},"labels":[],"label_agreement":null},{"id":"W4414493011","doi":"10.1158/2326-6074.cimm25-a016","title":"Abstract A016: KRASG12D inhibition enhances tumor cell sensitivity to natural killer cell-mediated cytotoxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immunotherapy; Immune system; Natural killer cell; Cancer immunotherapy; Lymphokine-activated killer cell; Cancer; Immunosuppression; Flow cytometry; Cytotoxicity","score_opus":0.01809014768180236,"score_gpt":0.34952513686847375,"score_spread":0.3314349891866714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414493011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959241,0.00063309487,0.0009949285,0.00007362289,0.00003205989,0.000033689597,0.0007642673,0.00012295227,0.0014212705],"genre_scores_gemma":[0.99642205,0.00023804326,0.00068866956,0.0000266464,0.000004840172,0.00003005287,0.00059318874,0.0000115727635,0.0019848114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990034,0.000011219039,0.000014909419,0.00002166589,0.000030204981,0.00002172869],"domain_scores_gemma":[0.9999484,0.000009732087,0.00001341648,0.0000073462206,0.0000063672414,0.000014744004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007237523,0.0002808518,0.00025533704,0.00015141339,0.0000783272,0.0002202352,0.00013842927,0.00019222511,0.002964032],"category_scores_gemma":[0.0000635657,0.00006320544,0.00016171996,0.00014894639,0.00014794254,0.000072377225,0.00010986054,0.0005331394,0.0006707665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006009024,0.00010628186,0.00026442317,0.000054351996,0.0000067025726,0.00003244104,0.000008442276,0.00014991962,0.9956494,0.000055536428,0.00012745748,0.0029441933],"study_design_scores_gemma":[0.000046354042,0.0011902535,0.0024343077,0.000003907743,0.00000994,0.00016493694,0.000015457397,0.00087039836,0.9936614,0.000022349244,0.0015774991,0.0000031674308],"about_ca_topic_score_codex":0.00046817877,"about_ca_topic_score_gemma":0.00048064394,"teacher_disagreement_score":0.002964032,"about_ca_system_score_codex":0.00016851145,"about_ca_system_score_gemma":0.00019526522,"threshold_uncertainty_score":0.00991565},"labels":[],"label_agreement":null},{"id":"W4414493055","doi":"10.1158/2326-6074.cimm25-a012","title":"Abstract A012: Cancer acquires therapy resistance by converting immune infiltration to exclusion through NK cell-macrophage interactions","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunotherapy; Tumor microenvironment; Melanoma; Innate immune system; Crosstalk; Immunoediting; Cancer; Cancer immunotherapy","score_opus":0.04525560702644258,"score_gpt":0.39722058720615167,"score_spread":0.35196498017970906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414493055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94810164,0.005921361,0.018916324,0.0027342064,0.0009493541,0.00016402078,0.0031747976,0.0019274327,0.01811089],"genre_scores_gemma":[0.9608201,0.0017512855,0.0045909267,0.0007088233,0.00010549564,0.00011210455,0.0016588501,0.00016302532,0.03008939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972695,0.000023008673,0.000018539491,0.00008341765,0.00009974136,0.000048296162],"domain_scores_gemma":[0.9998573,0.000016697979,0.000029715688,0.000018396773,0.000029961633,0.000047972066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019610222,0.0002531163,0.00040124514,0.00036216358,0.0003510793,0.0009287746,0.00028966498,0.0005258998,0.009377208],"category_scores_gemma":[0.00021704077,0.00017521484,0.0003454068,0.00028371264,0.00039647144,0.000377623,0.00042934908,0.0009926897,0.0017604446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024235788,0.00004440284,0.0014264275,0.00010509595,0.000014694527,0.00023222242,0.000046871337,0.0001568391,0.98644674,0.0009007062,0.0019332669,0.008450337],"study_design_scores_gemma":[0.00009073027,0.0006331557,0.03510082,0.000057817982,0.00007615122,0.0024194727,0.00028735906,0.0048937607,0.9049049,0.0013934971,0.050106004,0.000036388712],"about_ca_topic_score_codex":0.0005579351,"about_ca_topic_score_gemma":0.00076111907,"teacher_disagreement_score":0.009377208,"about_ca_system_score_codex":0.0005031353,"about_ca_system_score_gemma":0.00038656298,"threshold_uncertainty_score":0.031369925},"labels":[],"label_agreement":null},{"id":"W4416548268","doi":"10.1158/2326-6066.cir-25-0445","title":"Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"BC Cancer Foundation; Canada Research Chairs; Canadian Cancer Society; Michael Smith Health Research BC; Terry Fox Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Flow cytometry; Lymph node; Phenotype; Lymphoma; Cytotoxic T cell; Population; Immunophenotyping; Diffuse large B-cell lymphoma; T cell; Transcriptome","score_opus":0.02971413439104169,"score_gpt":0.38436654717757895,"score_spread":0.35465241278653725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416548268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774617,0.0007338862,0.00044385495,0.000023311537,0.0000036544614,0.000010810075,0.0006305224,0.000027515052,0.00038022717],"genre_scores_gemma":[0.9978727,0.00018484778,0.00035499997,0.00004079851,0.0000075923795,0.000017076552,0.0013017385,0.000010319926,0.0002099005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998332,0.000024764553,0.00001658455,0.000055417066,0.000028653236,0.000041438743],"domain_scores_gemma":[0.9998342,0.000028744622,0.000041163108,0.000020969053,0.000029896806,0.000045026823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023210738,0.00014585603,0.00024785503,0.0005581548,0.00017822439,0.000666513,0.00012978469,0.00023131761,0.00086898473],"category_scores_gemma":[0.0003867659,0.00009669514,0.000118700555,0.00043225515,0.00012797756,0.00015483628,0.00019615983,0.0003225567,0.0003486144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017490473,0.000120519224,0.5814035,0.00019284243,0.000101593396,0.00061786774,0.00043209465,0.00073023804,0.36551696,0.00014481945,0.0010479268,0.04794262],"study_design_scores_gemma":[0.000074267635,0.00052779616,0.9499086,0.000048478927,0.00014014778,0.0035825162,0.00082517276,0.003828301,0.035018243,0.0003199017,0.0057043172,0.000022195312],"about_ca_topic_score_codex":0.000696934,"about_ca_topic_score_gemma":0.0010954646,"teacher_disagreement_score":0.00086898473,"about_ca_system_score_codex":0.00019412707,"about_ca_system_score_gemma":0.000087322864,"threshold_uncertainty_score":0.0029070377},"labels":[],"label_agreement":null},{"id":"W4417129324","doi":"10.1158/2326-6066.cir-25-0070","title":"A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; McMaster University Medical Centre","funders":"Institute of Cancer Research; Terry Fox Foundation; Canada Research Chairs","keywords":"Boosting (machine learning); Antigen; Chimeric antigen receptor; Adoptive cell transfer; Cytotoxic T cell; Epitope; Immunotherapy; Cancer immunotherapy","score_opus":0.1669757946377332,"score_gpt":0.44288927577131776,"score_spread":0.27591348113358455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417129324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8438651,0.0047636237,0.147759,0.00017306185,0.00014383622,0.00043814158,0.00012559409,0.00051699055,0.0022146297],"genre_scores_gemma":[0.9544177,0.0010605514,0.04306252,0.00011774429,0.000028890356,0.00011156888,0.00009183464,0.000029233664,0.0010799579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996215,0.00006469039,0.00002614471,0.0001120623,0.00006840268,0.00010726775],"domain_scores_gemma":[0.99988997,0.000012644535,0.000032879285,0.00002851526,0.000010890347,0.000025085197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038621307,0.00077832065,0.00057572155,0.0002984796,0.00013591899,0.00041693263,0.00042337392,0.0004930842,0.0008389018],"category_scores_gemma":[0.00016896486,0.00027744047,0.00044971093,0.0001941602,0.00039432576,0.0004574646,0.0005520073,0.0010830691,0.0003084195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016453955,0.00019484365,0.00036597997,0.000116718424,0.00002591086,0.000101130805,0.000028277016,0.0012055561,0.98125136,0.00077611476,0.00011206998,0.01565733],"study_design_scores_gemma":[0.000059804333,0.0024283563,0.00080188696,0.000012550454,0.00010542535,0.00087105413,0.000018070361,0.0071360967,0.9828928,0.00022462639,0.005434834,0.000014471503],"about_ca_topic_score_codex":0.00020792452,"about_ca_topic_score_gemma":0.0003066252,"teacher_disagreement_score":0.0008389018,"about_ca_system_score_codex":0.00027069304,"about_ca_system_score_gemma":0.00039401534,"threshold_uncertainty_score":0.002806425},"labels":[],"label_agreement":null},{"id":"W7083170942","doi":"10.1158/2326-6074.cimm25-a010","title":"Abstract A010: B cell infiltration and clonal expansion in tertiary lymphoid structures: Insights from intravital microscopy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Agriculture, Water, and Health","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"High endothelial venules; Immune system; Lymph; Lymphatic system; B cell; Intravital microscopy; Infiltration (HVAC); Tumor microenvironment; Lymphocyte","score_opus":0.014596035716897493,"score_gpt":0.32404795399174047,"score_spread":0.309451918274843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7083170942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426848,0.005255294,0.04020706,0.0004539627,0.000051946616,0.00007818276,0.0012984079,0.0006485384,0.009321918],"genre_scores_gemma":[0.9647129,0.0015819945,0.02534808,0.00014575524,0.000025516212,0.000074303265,0.0007328331,0.00008749547,0.0072911405],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990225,0.000015255666,0.00000497401,0.000027451952,0.000021029182,0.0000290856],"domain_scores_gemma":[0.9998907,0.000025242112,0.000028539413,0.000009999261,0.000022497052,0.000023097025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020874293,0.00019042222,0.00010616685,0.00063010113,0.00026289295,0.0003458666,0.00021610576,0.00042664201,0.0027138419],"category_scores_gemma":[0.000084948646,0.00016149221,0.00014421434,0.00021722438,0.00020397683,0.00028748432,0.00023709732,0.00066178606,0.00071125507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042017302,0.00002256122,0.00060275156,0.000033077467,0.000003201009,0.00005848593,0.000029070388,0.00007441997,0.99610317,0.0003284456,0.00013407905,0.0025686563],"study_design_scores_gemma":[0.000021272333,0.00021037592,0.027257662,0.000030645515,0.00001933806,0.0011272075,0.00018539054,0.009579556,0.9506355,0.0006585942,0.010260299,0.000014137722],"about_ca_topic_score_codex":0.0016014704,"about_ca_topic_score_gemma":0.0011628197,"teacher_disagreement_score":0.0027138419,"about_ca_system_score_codex":0.00037237012,"about_ca_system_score_gemma":0.00013579839,"threshold_uncertainty_score":0.0090786815},"labels":[],"label_agreement":null},{"id":"W7083171088","doi":"10.1158/2326-6074.cimm25-a005","title":"Abstract A005: TAZ-TEAD signaling alters the immune microenvironment of cutaneous melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Melanoma; Immune checkpoint; Immune system; Tumor microenvironment; Downregulation and upregulation; Immunotherapy; Galectin-1; Galectin; Transcription factor","score_opus":0.0263870912666626,"score_gpt":0.32734256560252073,"score_spread":0.3009554743358581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7083171088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131364,0.0017362663,0.0017086815,0.0004131369,0.00011299927,0.000023828783,0.0015880358,0.00013625348,0.0029672405],"genre_scores_gemma":[0.9925688,0.00045729795,0.0005121601,0.00014068309,0.000012012765,0.000024736833,0.0009819358,0.000014174652,0.005288139],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994457,0.000006257441,0.00000291126,0.000015635973,0.000012697962,0.000017943066],"domain_scores_gemma":[0.99996674,0.0000044595313,0.000008093725,0.000002966433,0.0000041896296,0.0000135464015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047790993,0.0001472928,0.00011482766,0.0001446676,0.00014668689,0.00022717957,0.00011408441,0.0002865851,0.007791205],"category_scores_gemma":[0.000051925417,0.00006682719,0.0002645378,0.00013180738,0.00011311545,0.00015513628,0.00012117008,0.0005478246,0.00085409614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028718074,0.00004790022,0.00047516738,0.000047866746,0.000005713995,0.00006906432,0.000010395985,0.000039407583,0.9966313,0.00008424873,0.0002196323,0.0020820512],"study_design_scores_gemma":[0.000080907696,0.0010440631,0.05291961,0.000015958662,0.00003803534,0.00063932524,0.00019672264,0.0014188866,0.9346702,0.00020343781,0.008765766,0.0000071916984],"about_ca_topic_score_codex":0.00043672614,"about_ca_topic_score_gemma":0.00032905984,"teacher_disagreement_score":0.007791205,"about_ca_system_score_codex":0.00022069324,"about_ca_system_score_gemma":0.00011435027,"threshold_uncertainty_score":0.026064157},"labels":[],"label_agreement":null},{"id":"W7117449343","doi":"10.1158/2326-6066.cir-25-0583","title":"The CCL17–CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"Cole Foundation; Canadian Cancer Society; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Lymphoma; Infiltration (HVAC); Chemokine; STAT protein; Ex vivo; In vivo; Chemokine receptor; Mutant; Doxorubicin; STAT3","score_opus":0.033104659551749814,"score_gpt":0.3643765976180743,"score_spread":0.3312719380663245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117449343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976265,0.00058065023,0.0007288234,0.000103310114,0.000015013459,0.000015675754,0.00024069002,0.00004936282,0.0006400332],"genre_scores_gemma":[0.9982327,0.00023414045,0.0004351215,0.000033527347,0.0000053689355,0.000015859689,0.00023187611,0.000008885659,0.0008025619],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979335,0.000041091338,0.000018557881,0.000029087316,0.0000581355,0.000059755628],"domain_scores_gemma":[0.9998888,0.000008618587,0.000037408634,0.000010962693,0.0000063045795,0.000047886042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012748573,0.00029972976,0.00019351038,0.0003359956,0.0001550236,0.00036178538,0.00018111373,0.0002934993,0.0014109187],"category_scores_gemma":[0.00007102868,0.0001860538,0.00029544684,0.00013476358,0.0003558933,0.00018145062,0.0001444844,0.00076816813,0.0003392897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026058126,0.00006793903,0.0006889877,0.000019848201,0.0000043297728,0.00009379155,0.000011728277,0.00016083552,0.9973592,0.00013463672,0.000052139123,0.0011459335],"study_design_scores_gemma":[0.00019304293,0.0017471513,0.026809117,0.000015420277,0.000048218135,0.0020848766,0.0001274253,0.0051274584,0.95946926,0.00023402032,0.004128239,0.000015785914],"about_ca_topic_score_codex":0.0005287192,"about_ca_topic_score_gemma":0.0008543766,"teacher_disagreement_score":0.0014109187,"about_ca_system_score_codex":0.00044128025,"about_ca_system_score_gemma":0.00026024572,"threshold_uncertainty_score":0.004720032},"labels":[],"label_agreement":null}]}